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I am among those who think that science has great beauty. A scientist in his laboratory is 
not only a technician: he is also a child placed before natural phenomena which impress him like 
a fairy tale. 
– Maria Skłodowska-Curie (1867 –  1934)
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Summary 
Biotechnology is an increasingly relevant field, at a time when most industries strive for 
the development of greener processes by reducing and/or eliminating the environmental impact 
of industrial processes, often by limiting the use of certain compounds (e.g. harsh solvents, 
metal-based catalysts), but also by reducing the number of reaction steps and the quantity of 
generated waste. The use of biological systems, such as biocatalysts and cells, enables operation 
at milder conditions, creating new synthetic routes, improving regio- and stereoselectivity, and 
avoiding (de)protection steps requiring harsh solvents or compounds, among other advantages. 
However, due to the complexity of biological systems, the development of fermentation or 
biocatalyst based processes is not straightforward. Similar enzymes may act on similar 
substrates but operate at different temperatures. Combinations of enzymes in cascade systems 
may require the spatial separation of the involved enzymes due to incompatible side-products 
or inhibitions from the reaction components. Certain cells present a faster growth rate at high 
densities, or different production titres depending on the formation of aggregates or cell 
adherence. The broad range of biological molecules and cells available for bioprocesses thus 
require the optimization of specific substrates or operation conditions, which as illustrated, can 
vary widely between them. Furthermore, the discovery and tailoring of new biocatalysts or cells 
involves environmental sampling and the generation of new variants, resulting in thousands of 
biological systems whose industrial or clinical potential needs to be evaluated, often in a 
relatively short timeframe. 
High-throughput analytical systems are the main tool applied to biocatalyst screening. 
They enable the parallel operation of different reactions and/or fermentations at different 
conditions (e.g. substrate concentrations, different substrates, enzymes, medium, oxygen 
availability, etc.). Thus, high-throughput systems allow to cover the possible variations and 
narrow the feasible operation conditions, substrates and biocatalysts or cells for application at 
industrial scale. The need for fast and comprehensive characterization of biocatalysts has also 
pushed the development of new screening platforms, based on microfluidics. Microfluidic 
systems involve the manipulation of small sample volumes (µL to nL) in miniaturized vessels 
and structures. Through miniaturization, mass and heat transfer becomes significantly faster, 
but surface and mass transfer limitations due to diffusion are also increased. Furthermore, 
microfluidics allows the use of different strategies for each of the unit operations involved in 
such optimization and screening studies, as well as new sensing and monitoring approaches.  
Within microfluidics there are several approaches regarding the integration of the 
required unit operations, ranging from integration on a single chip to a fully modular approach, 
where the different units correspond to a single chip but are interconnected through fluidic 
devices. The latter approach offers more flexibility at a lower cost in terms of the achievable 
studies with the same unit operations, since these can be placed in a different order depending 
on the purpose or sample being characterized. 
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The main goal of this dissertation was to develop a biocatalyst screening platform based 
on modular microfluidics. With this purpose in mind, three microfluidic modules are presented 
that can be integrated and used in such modular platform: a microreactor module with 
integrated oxygen sensors, a microfluidic dilution and quantification module compatible with 
electrochemical sensors and a module for continuous thermal inactivation of enzymes. The last 
two modules were developed specifically for applications in online screening. The focus during 
development was on achieving user-friendly and simple to use platforms that were furthermore 
easy to connect with other existing platforms and compatible with a wide range of biocatalytic 
reactions. 
The microreactor module enables the continuous monitoring of oxygen levels and was 
characterized with a biocatalytic oxidation reaction in order to highlight the operational 
limitations of the system in terms of oxygen depletion at certain enzyme and substrate 
concentrations. Strategies for in situ oxygen generation involving addition of catalase and 
hydrogen peroxide were applied as solutions to overcoming the identified oxygen depletion 
limitations. Furthermore, the reactions carried out in the microfluidic system were modelled 
using computational fluid dynamics, with a good fit between the experimental and simulated 
data, and the results provided extra insight into the reaction dynamics. The same microreactor 
was applied to the screening of whole cell variants of a dioxygenase capable of converting alkene 
substrates. It was used as a complement to the screening of genetically modified biocatalysts 
using end-point product quantification. The oxygen consumption rate of each variant in the 
presence of a standard substrate was used as the screening parameter to select the variant with 
the faster oxidation reaction rate as the best variant for a possible industrial application.  
The second module was developed for integration of different types of sensors to achieve 
online quantification. The module presents a standardized fitting enabling the connection to 
either other microfluidic platforms or laboratory scale equipment. Screen-printed 
electrochemical sensors were integrated through pockets that allowed their easy replacement 
and thus the re-use of the microfluidics’ platform. Also, the developed platform included a 
mixing/dilution channel enclosed by a two-sensor system, which allowed expanding the sensors’ 
detection range by controlling the sample dilution at which the measurements were performed. 
The dilution unit was optimized with computational fluid dynamic methods that enabled testing 
several geometries before fabrication, thus accelerating the platform development. 
The third microfluidic module was developed to allow unspecific inactivation of 
biocatalysts (especially enzymes), and thus precisely control the reaction (residence) time at the 
point of product quantification in the second module. Such control is important when different 
modules – reactors and/ or sensing units – are used and frequently changed. It can furthermore 
help to regulate the state of the biocatalyst, since it is depending on the temperature and 
exposure time. In this way, reversible or irreversible denaturation of the enzymes can be 
achieved.  
The different modules presented in the dissertation are useful additions to a modular 
microfluidic toolbox for biocatalyst screening. They provide online monitoring of biocatalytic 
reactions or biotransformations, quantification of reaction products and controlled reaction end-
points due to the potential to achieve precise temperature control. Furthermore, the developed 
computational fluid dynamic models allow for a better understanding of the reaction performed 
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in the microsystem. The model can be further improved to achieve online data acquisition of 
reaction kinetics by coupling with a mechanistic model. In the case of the developed 
mixing/dilution channel, the developed model enabled a fast optimization of the unit operation, 
thereby decreasing the cost and time spent on such endeavour.  
The potential of modular microsystems in biotechnological applications was the main 
driver for the work performed and presented in this dissertation. The objective of this 
dissertation was to provide, beside three interesting microfluidic systems, a better 
understanding of the potential that microfluidics, especially in a modular approach and tightly 
connected to mathematical modelling, can offer to biotechnology and society. 
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Resumé 
Interessen for bioteknologi har vokset støt, i en tid hvor de fleste industrier i stigende grad 
fokuserer på grøn omstilling og udvikling. Der er generelt stor fokus på at reducere og/eller 
eliminere mange af de miljøbelastende effekter fra industrielle processer. Dette afspejles i 
industrielle processers udviklingen, som går i retning mod at finde alternativer til anvendelsen 
barske opløsningsmidler og metalbaserede katalysatorer, samt at reducere antallet af 
reaktionstrin og mængden af genereret affald.  
Dette har betydet store fremskridt i udviklingen og anvendelsen af biologiske systemer, 
såsom biokatalysatorer og celler. Sådanne biologiske systemer giver mange procesmæssige 
fordele, såsom; 1) muligheden om at køre kemiske reaktioner ved mildere reaktionsforhold; 2) 
nye syntese reaktioner; 3) forbedret regio- og stereoselektivitet.; 4) overflødiggørelse af kemiske 
beskyttelses og af-beskyttelses reaktioner der er afhængige af brug af barske 
opløsningsmidler/kemikalier.  
Det er dog ret krævende at udvikle biologiske systemer til industrielle processer, idet 
udviklingen af fermenteringsprocesser og/eller biokatalysatorbaserede processer er komplekst. 
F.eks. ensartede enzymer kan håndtere ensartede substrater, men have meget stor variation i 
performance ved forskellige temperaturer. Derudover kan kombinationen af flere enzymer i 
kaskade reaktionssystemer kræve en fysisk adskillelse af enzymerne i processen, grundet 
påvirkningen af biprodukter og/eller inhibering fra forskellige reaktionskomponenter. 
Yderligere kan det tilføjes at visse celler har en hurtigere væksthastighed ved høje tætheder 
eller forskellige produkt koncentrationer afhængig af dannelsen af aggregater eller 
sammenhængende celler. Den brede vifte af biologiske molekyler og celler, der kan fremstilles 
vha bioprocesser, kræver således optimering af specifikke substrater eller driftsbetingelser der, 
som ovenfor illustreret, kan variere meget mellem dem. Dertil skal tilføjes at opdagelsen og 
tilpasningen af nye biokatalysatorer og/eller celler kræver omfattende udtagelse af miljøprøver 
og dannelsen af nye varianter, hvilket nemt kan resultere i tusindvis af biologiske systemer, 
der potentielt kan være af stor industriel og/eller klinisk interesse, som skal analyseres og 
evalueres på relativt kort tid. 
Analysesystemer der er i stand til at screene disse mange varianter af biokatalysatorer er 
derfor et meget vigtigt værktøj. Sådanne analysesystemer gør det muligt at analysere 
forskellige reaktioner og/eller fermenteringer i parallel ved forskellige reaktionsbetingelser. 
F.eks. varierende substratkoncentrationer, sammensætning af medier, etc. Dette gør det muligt 
at identificere mulige variationer, procesbetingelser, substrater og biokatalysatorer eller celler 
der har potentiale til industrielle applikationer.  
Dette behov for hurtig og omfattende karakterisering af biokatalysatorer har skubbet 
udviklingen af nye screeningsplatforme baseret på mikrofluidsystemer. Mikrofluidsystemer 
indebærer manipulation af små væskevolumener (μL til nL) i miniaturiserede beholder, kanaler 
og/eller strukturer. Fordelen ved miniaturisering er at masse og varmeoverførsel bliver 
markant hurtigere. Dog bliver overflade- og masseoverførselsbegrænsninger på grund af 
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diffusion også øget. Mikrofluidsystemer gør det muligt at bruge forskellige strategier for 
forskellige enhedsoperationer, der er involveret i sådanne optimerings- og 
screeningsundersøgelser, samt nye målings- og monitoreringsmetoder. 
Der er flere tilgange til at kombinere og/eller integrere enhedsoperationer i 
mikrofluidsystemer. Disse tilgange strækker sig fra integration på en enkelt chip til fuldt ud 
modulære elementer der er linket sammen med rør og slanger. Sidstnævnte mulighed giver stor 
fleksibilitet idet det er muligt at kombinere modulerne i den rækkefølge der er krævet, afhængig 
af hvad der ønskes testet. 
 
Hovedformålet med denne afhandling var at udvikle en screeningsplatform baseret på 
modulære mikrofluidsystemer, til at ”screene” biokatalysatorer. I denne afhandling 
præsenteres tre mikrofluidmoduler, der kan integreres og anvendes som en modulær 
undersøgelseplatform. Det ene modul er et mikroreaktormodul med integrerede oxygen-
sensorer, samt et fortyndings og kvantificeringsmodul. Dette modul er kompatibelt med 
elektrokemiske sensorer og kontinuerlig termisk inaktivering af enzymer. De to sidste moduler 
blev udviklet specielt til applikationer i online screening. Fokus under udviklingen af disse 
moduler var på at opnå simpel og brugervenlig betjening af platformene, samt at de var nemme 
at forbinde med andre eksisterende platforme og kompatible med en lang række biokatalytiske 
reaktioner. 
 
Mikroreaktormodulet gjorde kontinuerlig monitorering af iltniveauer mulig og blev 
karakteriseret med en biokatalytisk oxideringsreaktion. Formålet med karakteriseringen var 
at identificere operationelle begrænsninger af systemet i form af iltudtømning ved visse enzym- 
og substratkoncentrationer. I samme system blev strategier for in-situ oxygen regenerering også 
testet, ved tilsætning af katalase og hydrogenperoxid, for at overvinde de operationelle 
iltbegrænsninger i systemet. Derudover blev reaktionerne i mikroreaktormodulet modelleret 
ved hjælp af strømnings beregninger, hvor der blev vist en god sammenhæng mellem modellen 
og de eksperimentelle data. Detter resulterede i ekstra indsigt i reaktionsdynamikken. Den 
samme mikroreaktor blev brugt til at screene variationer af en dioxygenase enzym i hele celler 
for deres potentiale til at omdanne alkensubstrater. Dette supplerede til screeningen af genetisk 
modificerede biokatalysatorer ved anvendelse af produktkvantificering ved reaktionens 
slutpunkt. Oxygenomdannelsesraten blev bestemt for hver variant, hvor et standard substrat 
blev brugt som screeningsparameter, for at bestemme varianten med hurtigst oxygen 
omdannelse som den bedste kandidat til fremtidig industribrug. 
 
Det andet modul blev udviklet for at kunne integrere forskellige typer af sensorer til at 
sikre online kvantificering. Modulet har en standardiseret samlingsopkobling, hvilket gør det 
muligt at forbinde andre mikrofluidmoduler eller standard laboratorie udstyr. Trykte 
elektrokemiske sensorer blev integreret gennem åbninger i modulet, der tillod nem udskiftning 
og dermed genbrug af modulet. Det udviklede modul omfattede også en blandings- / 
fortyndingskanal, der var vedlagt et to-sensorsystem, hvilket tillod at udvide sensorernes 
detekteringsområde ved at kontrollere fortyndingsfaktoren som målingen blev foretaget ved. 
Fortyndingsenheden blev optimeret vha fluid dynamiske beregningsmetoder, der gjorde det 
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muligt at teste flere geometrier inden fremstillingen og derved bidrog til at accelerere modul 
udviklingen. 
 
Det tredje mikrofluidmodul blev udviklet for at sikre uspecifik inaktivering af 
biokatalysatorer (især enzymer) og derved sikre præcis kontrol af reaktiontidspunktet 
(opholdstiden) ved produktkvantificering i det samme modul. Denne kontrol er vigtig når 
forskellige reaktormoduler og/eller sensorer anvendes og ofte udskiftes. Det kan endvidere 
bidrage til at regulere biokatalysatorens tilstand, da det afhænger af temperatur og 
eksponeringstid. Dermed kan reversibel eller irreversibel denaturering af enzymerne opnås. 
 
De forskellige præsenterede moduler er nyttige tilføjelser til etableringen af en modulær 
mikrofluid værktøjskasse til biokatalysator screening. Modulerne tillader online overvågning af 
biokatalytiske reaktioner eller biotransformationer, kvantificering af reaktionsprodukter og 
kontrollerede reaktionsendepunkter på grund af præcis temperaturkontrol. Desuden giver de 
udviklede fluid dynamiske modeller mulighed for en bedre forståelse af den reaktion, der 
udføres i mikrosystemet. Modellen kan forbedres yderligere for at opnå online dataindsamling 
af reaktionskinetik ved kobling med en mekanistisk model. I tilfælde af den udviklede 
blandings- / fortyndingskanal muliggjorde den udviklede model en hurtig optimering af 
enhedsoperationen, hvilket reducerede omkostningerne og den tid, der blev brugt til en sådan 
indsats. 
Demonstration af potentialet for modulære mikrosystemer i bioteknologiske anvendelser 
var hovedformålet med det udførte arbejde præsenteret i denne afhandling. Formålet med 
denne afhandling var at, udover etablering ad de tre mikrofluidsystemer, give en bedre 
forståelse for potentialet i brugen af mikrofluidsystemer til procesudvikling i bioteknologi, hvor 
specielt den modulære tilgang i kombination med fluiddynamisk modellering byder på 
spændende muligheder til fremtidig procesudvikling. 
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Chapter 1 
Introduction 
Microfluidics was defined by Whitesides in 2006 as the science and technology involving 
the study, manipulation and control of small volumes of fluids and particles in channels with 
dimensions of tens to hundreds of micrometers [1].  
From its birth, microfluidics has been referenced as the “promised land” of technology. 
Microfluidics has for example been envisioned as: (1) capable of miniaturizing industrial plants, 
thereby increasing their automation and operational safety at low cost; (2) being able to identify 
rare diseases by running bioanalytics directly on the patient’s skin; (3) allowing health 
diagnostics in point-of-care sites through cheap lab-on-a-chip devices. However, the current 
state of microfluidics, although technologically advanced, has failed to reach the originally 
promised widespread use.  
In this chapter, some of the key aspects that have prevented microfluidics from reaching 
its full potential are identified and discussed, addressing mainly the specialization on a single 
target of most microfluidic devices. The alternate, multi-use, “plug and play” approach is offered 
as a possible solution. An overview of the current possibilities for modular unit operations for 
use in such approach is presented, as well as a brief review of the main materials and fabrication 
strategies applied in microfluidics. Furthermore, a step-wise guide towards the development of 
microfluidic platforms is introduced with special focus on the integration of sensors in 
microfluidics. Finally, the potential of microfluidics in biotechnology is described as the 
motivation for the work presented in this dissertation. A thesis outline stating the main goals 
of the presented work, and a brief description of the thesis’s different chapters, concludes this 
introductory chapter. 
1.1 Introduction 
Nowadays, the use of micro- or nanofluidics is moderately wide-spread across several 
academic fields, from proteomics and drug discovery to waste management and point-of-care 
(POC) diagnostics [2],[3]. Since the first proof-of-concept [4], the rapidly increasing interest on 
the micro- or nanofluidics technology can be associated with its advantages, such as the low 
manufacturing costs, reduced usage of reagents and the possibility for parallelization and 
automation [5]. These characteristics along with a highly automated control of the fluidic flow, 
an easy tuning of temperature and concentration diffusion gradients, as well as the available 
semiconductor technology, have pushed the interest towards miniaturization of unit operations, 
together with the development of suitable analytical devices and techniques. This subsequently 
led to an effort towards the integration of these miniaturized units in a single device.  
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1.1.1 Physics in microfluidics 
The main advantages associated with microfluidics are related with the decreased scale of 
the vessels, such as a lower reagent consumption, smaller sample volumes and faster heat and 
mass transfer rates. Furthermore, at microscale, certain boundary effects (e.g. surface tension) 
and physical phenomena that increase inversely with scale (e.g. pressure drop), become more 
relevant. To fully understand the impact and potential of the strategies employed in 
microfluidics, it is therefore important to know not only the more relevant phenomena occurring 
at microscale, but also the mathematical description behind them. This mathematical 
description is used both in the design of new microfluidic platforms and in the fluidic and 
mathematical models developed for studying and predicting reactions and molecular 
interactions in microstructures. 
 
Most microfluidic systems currently used are pressure-driven [6]. In this case, the flow 
(velocity) of fluids that can be considered as incompressible and uniform-viscous Newtonian (e.g. 
aqueous solutions) can be described using the Navier-Stokes equation (Equation 1), where ?⃗?  is 
the velocity field, dependent on spatial position and time (m s-1), 𝜌  is the fluid density (kg m-3), 
𝜂 is the viscosity (Pa s) and 𝑝 is the pressure (Pa) [6].  
Equation 1 
 
The velocity field of fully developed laminar flow in steady-state is unidirectional and can 
in turn be described by Equation 2, where the frictional forces the liquid is subjected to at the 
channel walls due to its viscosity are considered. In the case of circular channels of radius R 
(m), this is termed Poiseuille flow (Equation 3) and results in a parabolic velocity profile (velocity 
at the center is higher than close to the walls, as observed in Figure 1) [6]. This assumes a no-
slip boundary condition for the velocity field at the interface between liquid flow and the channel 
walls. The no-slip assumption at a solid-liquid interface results from the assumption of complete 
momentum relaxation of the molecules at the interface in a length scale in the order of the 
molecular mean free path in the fluid [7]. This assumption may not always be valid in 
microchannels, especially in the case of non-wetted hydrophobic surfaces [8]. 
Equation 2 
 
Equation 3 
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Figure 1 – Schematic representation of parabolic velocity profile in circular channels. 
 
From the Poiseuille flow, assuming a straight and infinitely long channel, Hagen-
Poiseuille’s law (Equation 4) can be obtained for a straight channel of length L (m) with a 
uniform pressure gradient and L/R>>1 and L/R>>Re (fully developed flow). The Hagen-
Poiseuille law is applied to most pressure-driven microfluidic channels, as a simple 
(approximate) way of calculating the pressure drop between the inlet and the outlet [6]. 
Equation 4 
 
From the previous equation, it is possible to define the hydraulic resistance (RH) 
(Pa s3 m-1) for circular channels (Equation 5), where rH (m) is the hydraulic radius (a geometric 
constant defined as twice the cross-sectional area over the wetted perimeter). This equation can 
also be applied to rectangular channels with a low aspect ratio, however with around 20% of 
error in the obtained value. Other expressions have been derived for rectangular channels that 
result in a lower error [7]. For H(height)/W(width)<<1 aspect ratio channels, Equation 6 can be 
used [6]. 
Equation 5 
 
Equation 6 
 
The type of flow (laminar, transient or turbulent) can be characterized through the 
Reynolds (Re) number (Equation 7), which is defined as the ratio between inertial and viscous 
forces. In Equation 7, V (m s-1) is the characteristic velocity, U (m s-1) is the area-averaged 
velocity, D (m) is the characteristic length and DH (m) is the hydraulic diameter. Surface 
roughness in microchannels can significantly affect flow behaviour, surface functionalization 
and molecular adsorption dynamics, however at the Re numbers found in microchannels, the 
friction factor follows the Hagen-Poiseuille theory, being equal to 64/Re [9].  
Equation 7 
 
In microfluidic channels flow is laminar (Re<2100) and usually in the Stokes regime 
(Re<1), and so inertial effects are usually negligible [6]. However, for flows with 1<Re<100, 
inertial forces become relevant and can be used to achieve facilitated separation, focusing and 
concentration of cells and particles with inertial microfluidics [10]. In the inertial microfluidics 
regime two phenomena occur: inertial migration and secondary flow. Inertial migration involves 
the migration of particles randomly dispersed in the fluid to equilibrium positions next to the 
Micro scale reactor system development with integrated advanced sensor technology  
4 
 
channel walls, after a certain distance from the inlet. This occurs due to two counteracting 
effects resulting from the interaction of the fluid either with the particles (the shear gradient 
lift force, directing particles towards the channel walls) or the channel walls (the wall lift force, 
directing particles away from the channel walls) [10]. Secondary flow usually occurs in curved 
channels or straight channels with obstacles. In curved channels it results from a pressure 
gradient in the radial direction due to higher momentum of the fluid in the centerline relative 
to the walls, which leads it to flow outwards, pushing the stagnant flow inwards and creating 
counter-rotating streams (Dean vortices), illustrated in Figure 2 [10]. 
 
 
Figure 2 – Schematics of Dean flow effects in a curved circular microchannel, where the arrows indicate the counter-
rotating streams. 
 
An extremely relevant phenomenon at microscale is diffusion. Diffusion is the permeation 
of molecules or particles in a fluid across an interface due to the random Brownian motion 
resulting from the frequent collisions with atoms or molecules in the liquid or gas [11]. The 
diffusion coefficient increases with the temperature and depends on the material diffusing and 
the fluid where diffusion is occurring [11]. The minimum length LD (m) required for the complete 
diffusion of a certain molecule or compound in a channel can be calculated by Equation 8, 
knowing U (m s-1) the area-averaged velocity, DD (m2 s-1) the diffusion coefficient of the molecules 
or compounds diffusing, d (m) the distance it travels in a time t (s) (Equation 9) and the 
approximate diffusion time, tD it takes to cross the width of the channel (Equation 10) [6]. 
However, due to the parabolic velocity profile, since the fluid near the walls moves slower than 
in the centerline, the growth of the interdiffusion zone varies from l1/3 near the top and bottom 
walls to l1/2 in the center of the channel, where l (m) is the distance traveled along the channel 
[8]. 
Equation 8 
 
Equation 9 
 
Equation 10 
 
A measure of whether mixing between two fluids occurs through diffusion or convection is 
given by the Péclet (Pe) number ( 
Equation 11), where V (m s-1) is the characteristic velocity transverse to the diffusion, U 
(m s-1) is the area-averaged velocity, D (m) is the characteristic length, DH (m) is the hydraulic 
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diameter and DD (m2 s-1) is the diffusion coefficient [6]. Pe gives an idea of the number of channel 
widths required for complete diffusional mixing to occur [8]. The larger Pe, the more relevant 
convection is in the transport of particles or fluid mixing [11]. 
 
Equation 11 
 
Another relevant effect in microchannels is the effect that the channel walls surface has 
on the flow, such as adhesion (in the case of cells and biomolecules), adsorption and shear stress. 
At microscale, these effects are not negligible. Adhesion and adsorption may be tailored by 
changing the material forming the channel or by surface functionalization. Surface 
functionalization (e.g. with hydrophobic stripes created through selectively coating portions of 
the channel bottom wall) can even be used to achieve wall-less channels [8]. However, shear 
stress is mainly dependent on the geometry and type of flow. Shear stress is the ratio between 
a force applied on the fluid in motion, which has the opposite direction of the velocity applied, 
and the area of the surface of the wall in contact with the fluid in motion. When motion begins, 
it starts from a position away from the wall, being then transmitted linearly, at steady state, to 
the other “layers” of liquid until the layer next to the wall. This transmission of motion depends 
on the liquid properties, namely the liquid viscosity. The shear stress at the wall can thus be 
described by Newton’s law of viscosity (Equation 12), where 𝜏𝑊 (Pa) is the shear stress at the 
wall, η (Pa s) is the viscocity, u (m s-1) is the flow velocity and h (m) is the position along the 
height of the channel [6]. For aspect ratio (H/W<<1) channels with parabolic flow, the expression 
for shear stress can be approximated by Equation 13 [6].   
Equation 12 
 
Equation 13 
 
Another interesting phenomenon at microscale involves the competition between surface 
tension to reduce the interfacial area of an immiscible fluid and the viscous stresses, which 
extend the interface in the direction of flow. This can be described by the Capillary number (Ca) 
(Equation 14), where 𝛾 (N m-1) is the surface tension [8]. The manipulation of surface tension at 
microscale gave rise to droplet microfluidics  [12], a growing area in microfluidics with wide 
applicability [13]. Capillary forces have also been used to drive and manipulate flow in 
microfluidics, using thermal, electric or wettability gradients for example, as an alternative to 
external pumping devices [8]. 
Equation 14 
 
The presented physical description of flow in microchannels is a summary of the main 
phenomena involved in flow at the microscale and a simplification of the principal equations 
describing these phenomena. Other important phenomena, used in more specific applications, 
that were not mentioned involve polymer deformability and elastic behavior (used in rheology 
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and the study of polymers), properties of buoyancy-driven flows (influence of gravity on solution 
density gradients that are described by the Rayleigh and Grashof numbers and are highly 
relevant for protein crystallization in microfluidics), effects of charge accumulation on the 
surface and formation of the Debye layer (frequently applied in electrokinetics to drive flow [14] 
and separate molecules) [8]. 
The particularity of the phenomena presented, and the possibilities they offer in terms of 
device geometry, flow and material manipulation, and types of study, are one of the main 
characteristics driving the interest and investment in microfluidic-based devices. Microfluidics 
is thus a powerful tool to perform both fundamental studies in diverse areas of physics, 
chemistry and biology [15], as well as a powerful technology to improve industrial processes, 
clinical diagnostics and applied research. 
1.1.2 Microfluidics and the technological market 
Initially, microfluidics’ research and development activities focused on areas where the 
highest potential for short-term commercial success was expected [5]. For example, 
pharmaceutical companies started performing initial screening tests in lab-on-a-chip devices 
since these presented less false positives and thus higher quality results [16]. Despite the 
obvious potential, microfluidics has still a very small impact in the technological/analytical 
market today [2],[3]. Current fields of application of microfluidics are confined to in vitro 
diagnostics (e.g. DNA/RNA hybridization and PCR) [17], [18], [19] pharmaceutical applications 
(such as drug discovery and screening, as well as drug delivery) [20], [21], biotechnology (e.g. on 
and in-line process monitoring of fermentations and biocatalytic reactions at small scale) [22], 
[23], and ecology (e.g. water quality assessment and biological threat detection) [24], [25]. Even 
though a few microfluidic-based technologies or solutions that include microfluidic parts are 
available in the market [26], they are mainly used in research laboratories [3]. It is therefore 
important to reflect on the reason for this relatively low impact, which stands in sharp contrast 
with the original sky-high ambitions for this field. A more thorough analysis reveals a relatively 
low impact of microfluidics due to the systems complexity, frequently observed repeatability 
issues of the existing platforms and the low application flexibility of the majority of the 
developed microfluidic systems. The difference in physical phenomena occurring at microscale 
relative to larger scale (e.g. laboratory and large scale fermenters), can lead to the selection of 
sub-optimal parameters, resulting in process failures, and consequently in a lower trust on data 
obtained with these platforms. Also, the manufacturing costs and the required initial 
investment, which translate into high costs of the final devices, lead to a specific and closed 
company-customer based business model, instead of a general model relying on publicly 
available and well described systems that can be combined in order to address a wide range of 
specific customer needs [2]. In this respect, the solution to the low market spread might be found 
in the development of simpler devices which are easier to (inter)connect, whether in ”plug and 
play” approaches or to already existing external analytical equipment. Changing the focus from 
finding the “killer application” [27], [28], to designing and manufacturing  generic platforms, 
more flexible in terms of connectivity and application [16], [2], [29], which are capable of 
facilitating the integration of multiple unit operations and their associated fluid handling, 
would undoubtedly boost the microfluidic field’s influence in the global market [2], [30]. Multi-
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purpose devices, especially reusable ones, enable to: (i) lower the cost of the method(s) used; 
(ii) increase the diversity of tests that can be performed, as well as the diversity of samples that 
can be handled; and, (iii) probably allow for a higher degree of comparison between samples, 
since the same devices can be used even if assembled differently. It is important to note here 
that the wide-spread application of microfluidics is bound by the costs of the final device, the 
complexity of operation and the dependency on external equipment [31].  
Some companies, focused on the development of microfluidic systems have already shifted 
towards more flexible chips. Nanogen’s (Nanogen, Inc., San Diego, US) electronic addressing 
technology (NanoChip® Electronic Microarray) allows capturing DNA probes in specific 
locations towards detection of single-base-pair differences, in a “blank slate” platform where the 
users can define their own assay [32]. This system however, as other similar devices, requires a 
bulky benchtop workstation for microfluidic device operation, such as the use of robotic liquid 
handling instruments for liquid handling automation in microfluidic systems [16]. Epigem 
(Redcar, United Kingdom) designs and fabricates devices for specific applications, while also 
providing their own strategy for fluidic connection and gaskets for reversible encapsulation, as 
well as embedded circuit layers. However, there is no standardization, since the systems are 
either application or client specific. Other commercial producers, such as Micronit 
Microtechnologies (Enschede, the Netherlands), Microfluidic ChipShop (Jena, Germany) and 
ThinXXS Microtechnology (Zweibrücken, Germany) also strive towards multiple application 
systems by having developed standard chips for certain unit operations (capillary 
electrophoresis, reactors, mixers, etc.) [27]. They also manufacture chips with standardized 
sizes (for instance microscopy slides and microtiter plates) and microfluidic connections, 
providing even stages for easy fluidic connection. Connectivity between their own chips is 
facilitated, while the connectivity with chips from other manufacturers or developed in house 
by the end user is not easily achieved. Some academic groups have also tackled this issue with 
interesting approaches based on the LEGO® (Billund, Denmark) “plug and play” concept [33], 
[34], [35], [36], [37], or even using LEGO® components [30], [38], [39]. There exists also a 
commercial prototyping system called The LabMatrixTM that provides a set of standard modular 
chips for molecular studies that can be assembled on a microfluidic breadboard. The set includes 
microvalves, syringe pumps, a stereomicroscope, UV detection and NanoFlow flow cells [40]. 
 
An extremely relevant market for modular microfluidics has been synthetic chemistry and 
the production of valuable chemicals [41], such as positron emission tomography (PET) tracers, 
active pharmaceutical ingredients (API) [3], natural products [42], fine and bulk chemicals, 
particle synthesis, pigments [43], among others. Microfluidics provides valuable advantages in 
chemistry such as improved selectivity and process safety, smaller footprint, acceleration of 
mass-transfer limited reactions, faster kinetic information, increase in production rates through 
a scale-out approach and the intrinsic continuous, rather than batch, production [3]. Hartman 
et al. (2011) provided a good analysis of flow chemistry vs. batch reactors [44], illustrating the 
advantageous vessel dimensions and mixing properties of microfluidics for flash-chemistry and 
fast and/or exothermic reactions. Microfluidics, especially based on droplet generation, is 
enabling the production of new microparticles and nanomaterials [3], but there are already 
examples of modular-based flow chemistry being applied to industrial or industrial sized 
production [43]. For example, Adamo et al. (2016) presented a module-based continuous 
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manufacturing platform capable of combining both synthesis and formulation of several 
pharmaceutical compounds. As proof-of-principle, they produced four different compounds in a 
gram-per-hour scale. The use of such flexible, reliable and compact manufacturing platforms 
could simplify formulation of compounds with short shelf-life as well as lower the price of 
pharmaceuticals for small patient populations [45]. 
Another relevant example of the potential of modular platforms is biotechnology, by taking 
advantage of novel approaches to synthesis developed in flow chemistry [46], [47] . 
1.1.3 Microfluidics and Biotechnology 
Enzyme and strain screening, as well as optimization of bioprocess operation conditions 
are key steps in the development of a biotechnological process (Figure 3). They involve a reliable 
and scalable study of all process parameters, along with mapping their influence and 
interactions for each of the potential biocatalysts/strains [48]. The final process target 
determines the different requirements and conditions which are in focus during design 
development, thus further increasing the number of variables to consider during optimization, 
as well as the variability of the process development as a whole. The high number and variety 
of enzyme/strain candidates [49] and corresponding optimal conditions, thus result in an 
expensive and time-consuming development process. Often it is not possible to test all the 
desired options. Therefore, dependent on the application, high throughput methods [50],[51], 
mainly performed on microtiter plates and shake flasks are the preferred experimental test 
platforms. These allow a high throughput due to the use of easily programmed and flexible 
automatic fluid handling systems [2]. Despite the level of obtained parallelization, these 
systems offer a reduced amount of available analytics, as well as low process controllability, 
which results in low quality of information retrieved. Thus the knowledge gained about the 
process and enzyme/strains is strongly limited [52]. Additionally, the differences in scale 
between the vessels used for optimization and for the final bioprocess, can lead to the selection 
of a set of parameters or conditions during the process screening stage which are sub-optimal 
for the larger scale. This will often result in a less effective industrial process that requires 
further optimization at the final stage, or even lead to scale-up failure with large economic 
impact [53]. An increase of monitoring and control of reaction parameters in the screening stage 
potentially contributes to improve the scale-up of bioprocesses. When developing or choosing a 
high throughput platform (HTP), it is very important to consider the maximum variation 
between reactors in the platform (in terms of reproducibility of reaction kinetics, product 
formation, cell growth, metabolic activities and productivity), which should be less than the 
detectable level of change in the parameters under investigation. Also, the type of reaction, 
biocatalyst or cell, the fermentation and minimum culture/reaction volume, as well as, the 
sampling volume for process characterization (including product titre and quality analysis), the 
sampling frequency and the required oxygen transfer rate should be taken into account. The 
capability for online monitoring towards high information on process conditions plus actuation 
on these conditions for a more tightly controlled process is highly desirable [54], [55], [51]. 
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Figure 3 - Schematics of scale-up in bioprocesses and possible role of microfluidics. 
Microfluidics and miniaturized analytics can greatly contribute to accelerate the first 
stage of process development, where the optimization of process parameters is primarily 
achieved [56]. They can also decrease the error obtained during the first stage of process 
development by providing platforms capable of parallelization in high numbers and with a 
variety of integrated sensors, providing both reliable data and substantial process control. The 
application of microfluidics to biocatalysis, for example, has been considered a key step towards 
greener processes and process development, by enabling safer handling and point-of-use 
generation of hazardous compounds [57], as well as production of a lower amount of waste [47]. 
Microreactors can also increase the process window of a given bioprocess by allowing the 
performance at wider ranges of temperature, pressure, reaction rate and compound 
concentrations [47], [57]. Furthermore, due to the different phenomena occurring at small scale 
(higher influence of surface tension, diffusion control of mass and heat transfer, capillary forces) 
they can more easily mimic and study the influence of phenomena such as adsorption of 
biomolecules, cell-cell interaction, formation of biofilms, substrate depletion or excess, etc. These 
characteristics also allow the use of microdevices for process intensification, especially for 
multiphase processes [46]. Since a lower consumption of sample and reagents is used, and 
smaller laboratory space is required, even for the parallelized platforms, a reduction in cost of 
this development stage is also generally achieved. Microsystems can also contribute to quality-
by-design (QbD) by enabling continuous production in the same microreactors used for reaction 
screening and optimization, through a scale-out approach [46], [47]. The miniaturized platforms 
and corresponding scale-up strategies towards an industrial process will however vary from 
field to field. Therefore, the development of single-unit microfluidic platforms, with the above-
mentioned characteristics, which can also be easily inter-combined according to the needs of 
each process, would greatly decrease the equipment cost of this developmental stage. 
Microfluidics has been applied to cell cultures and fermentations in the form of 
microbioreactors, with interesting results and challenges, as can be observed in the reviews 
written by Schäpper et al. in 2009 [52] and Lattermann and Büchs in 2015 [58], but also to 
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biocatalysis enabling improving yield and/or biocatalyst activity and stability, as presented in 
Asanomi et al. (2011) [59], Wohlgemuth et al. (2015) [47] and Gruber et al. (2017) [60]. 
Microfluidic systems can accelerate first stage parameter optimization besides biocatalyst/ 
cell strain characterization and screening. It is however important to take into consideration 
that there are still differences in phenomena which must be considered when scaling up the 
optimized parameters. Furthermore, current microfluidic devices, except droplet microfluidic 
systems [61], still cannot rival with the screening capacity of most microtiter plate systems, 
especially when supported with robotic fluid handling equipment [46]. Also, due to the decreased 
dimensions, the available liquid volume for sampling is limited and thus the integration of 
sensors previously validated using standard analytical equipment is of upmost importance in 
these systems. Mathematical and fluid dynamic simulation tools could ease the scaling-up from 
microfluidic systems, by providing a good understanding of the phenomena occurring at both 
scales and allowing a faster testing and validation of the key operating parameters to consider 
when scaling. 
On the other hand, the small sampling volume required for the integrated sensors can also 
be used for on-line sensing of processes in larger vessels [62], [63], [64], [65]. However, the type 
of sample that needs to be handled might require pre-processing due to the presence of 
contaminants or particles that lead to channel clogging. When pre-treatment is not possible, 
both the integrated sensor and microchannel need to be resistant to biofouling. Biofouling can 
be decreased by varying the surface charge or by covering the channel surface with excess of a 
molecule that does not participate in the process (e.g. proteins like Bovine serum albumin 
(BSA)). Another issue with detection systems that require biomolecules or dry reagents to 
achieve target detection is shelf-life of the molecules and reagents in immobilized form before 
denaturation or degradation occurs, which will, in turn, limit the life-time of the final device. 
The use of materials with low vapour transition rates for dry reagents, and the encapsulation 
of the biomolecules within biocompatible polymers can increase these platforms shelf life. A 
review by Gernaey et al. (2012) [56] offers further points to consider as well as improvements to 
introduce into microfluidic platforms towards a better fit in the biotechnological field (especially 
fermentation and cell culture). Some of the key points involve: (i) standardization of world-to-
chip and chip-to-chip connections, (ii) improved connectivity to benchtop analytics, as well as 
(iii) the need for improved integrated online sensors and process control software, which is 
tested and validated in the target industrial environment, and (iv) devices capable of coping 
with rapidly changing environments in order to better mimic processes at larger scales [56]. 
1.1.4 Past ideas and current state of microfluidics 
Most of the major developments in the microfluidics field foreseen in 2004 by Erickson and 
Li [5], such as decreased dependence on external equipment towards higher portability, and an 
increased use of simulation and modelling for device design optimization in the initial stages of 
device development, still remain to be achieved. Even though a decreased reliance on external 
equipment was obtained for some applications, most systems still rely on external pumps, 
potentiostats, manual/automatic external sample pre-treatment, microscopes, power sources, 
etc. A higher number of fabricated microfluidic devices are currently being studied by means of 
mathematical and numerical tools, such as Matlab® and computational fluid dynamics (CFD) 
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[66], with the aim of reducing development time. CFD allows the visualization of spatial 
distribution of flow velocity, the generation of substrate gradients, as well as the simulation of 
dynamic flow [6]. These software tools have contributed to a considerable progress in recent 
years in accommodating the challenges faced when modelling at this scale. However, the lack 
of standard analytical tools at microscale often hampers the experimental validation of the 
numerically predicted phenomena. Thus, without proper experimental validation, it is often 
difficult to convince the user of microfluidic devices of the legitimacy of simulation results.  
1.2 The challenge of integration 
The integration of several unit operations at microscale was initiated together with the 
microfluidic fabrication field at the end of the 1980’s (e.g. fluid displacement [67], sensing and 
separation [68], [69], [2]). The semiconductor industry investigated the development of 
monolithic miniaturized components called micro-electro-mechanical systems (MEMS), such as 
sensors, valves, separators and mixers, due to the discovery of a suitable material, silicon [70]. 
The development of MEMS systems was further enabled by the outsourcing of the 
semiconductor production to the upcoming Asian countries, which allowed to free the existing 
semiconductor production capacities for research purposes [71]. Miniaturized components based 
on polymeric materials were also developed, with the appearance of soft-lithography methods 
[72], [73]. The coupling of several of these components proved however to be technically 
complicated. The main reason behind this was the choice in fabrication technologies of the 
individual components, which were usually incompatible [2], as well as the design of both the 
channels with different dimensions (leading for example to disparate required flow rates for 
different components) and connections between platforms (mostly un-standardized). Therefore, 
simpler approaches, applying bench scale equipment (external pumps, microscopes, etc.) were 
pursued to facilitate the development of individual unit operations [74]. Consequently, in order 
to reduce the dependency on external devices, the effort towards the development of stand-alone 
microfabricated devices has recently increased.  
 
A microfluidic platform consists of a set of microfluidic elements, each previously and 
individually validated, capable of performing a given fluid handling or sample 
treatment/measuring step (unit operation). Ideally, these unit operations should be capable of 
being combined and assembled differently depending on the final application [2]. The 
integration of various unit operations on a single chip requires a holistic understanding of the 
characteristics of the substrate materials, the available or possible fabrication technologies, the 
characteristics of the target sample, the chip’s final application and the environment in which 
it will be applied.  
The material(s) composition of a microfluidic system is chosen according to the platform’s 
required function, degree of integration and application [75]. Characteristics such as air 
permeability, biocompatibility, nonspecific adsorption, surface functionalization, optical 
transparency, flexibility, solvent compatibility, electrical compatibility, and opportunity for 
sterilization are considered when choosing a material for a specific application. Material 
properties also influence the fabrication process and the minimum attainable feature dimension 
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[76]. The robust and leakage free integration of different materials in the same platform is a 
further challenge [77]. The most frequently used materials can be divided in three categories: 
inorganic, polymeric, and paper, and a summary of their characteristics is presented in Table 
1. 
The selection of the fabrication technique is dependent on the choice of materials, the final 
application of the device, how robust it needs to be and whether or not reusability is required. 
The choice is also dependent on the type of end user (experienced or not), location of use (point-
of-care vs. research laboratory, for example), and the time between fabrication and use (is 
storage required?). These characteristics will guide the choice of the fabrication methods, from 
a wide variety available for the production of microfluidic devices. These include prototyping 
techniques (such as hot embossing, injection molding and soft lithography) and direct 
fabrication techniques (such as thin film deposition, laser photoablation, 
photolithography/optical lithography and etching). Furthermore, the choice of a fabrication 
method takes into account the desired minimum feature dimensions, surface roughness and 
aspect ratio of the channels, as well as the tolerances and reproducibility of the method, the 
selected chip material and the final application. For more complex applications, compatibility 
between different fabrication methods should also be considered during the selection. Heckele 
et al (2003) [78], Ziaie et al (2004) [79], Becker and Gärtner (2008) [80], Wu and Gu (2011) [29], 
Iliescu et al (2012) [81], Cheng et al (2012) [82], Li et al. (2012) [83], Ho et al (2015) [84] and 
Au et al (2016) [28] present a good overview of past and current fabrication techniques, and also 
discuss the main considerations related to the selection of the different methods. A summary of 
fabrication techniques applied to polymeric substrates is presented in Table 2. 
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Table 1 –Materials used for microfluidic platforms and their main characteristics [2],[29],[75],[81],[83],[85],[86],[87],[88],[89],[90]. 
Material 
Inorganic Polymer Paper 
e.g. Silicon, glass, low-temperature co-fired ceramics 
(LTCC) 
e.g. Polydimethylsiloxane (PDMS), Polyfluoropolyethers, 
Poly(methyl methacrylate) (PMMA), Polystyrene (PS), 
Cyclic-olefin copolymer (COC), SU-8 
e.g. Whatman no. 1 
Fabrication 
strategies 
Batch Batch or continuous Batch 
Fabrication 
techniques 
Semiconductor industry techniques (etching, 
lithography, bonding, powder blasting and chemical or 
physical vapor deposition) 
Hot embossing, injection molding, soft lithography, 
thermoforming, laser ablation, micromachining and 
photolithography 
Inkjet and solid wax printing obtaining 
hydrophilic channels bound by hydrophobic 
barriers and either sealed with thin polymer 
sheets or left open 
Smallest dimension < 100 nm < 1 µm ~200 µm 
Material cost High Low Low 
Fabrication cost 
High (during development) 
Low (during mass production) 
Low (except for prototyping in the case of injection 
molding and thermoforming) 
Low 
Channel 
characteristics 
Hydrophilic, charge stable, defined walls, limited 3D 
capability 
Generally hydrophobic, channel definition dependent on 
polymer and fabrication strategy, moderate to high 3D 
capability 
Amphiphilic, not very defined channels, moderate 
3D capability 
Surface 
functionalization 
Yes Yes Yes 
Integration 
With electronic systems (e.g. for data acquisition) or 
electrodes (for detection) 
With electrodes (by deposition onto polymer) 
With electronic and magnetic systems, and 
electrodes (by containing electrical conducting 
inks) 
Combination with 
other materials 
Glass and polymers (transparent materials) Glass, silicon, other polymers 
Electrical conducting inks, carbon or metals 
(silver, gold, etc.) 
Functional 
elements (e.g. 
valves and pumps) 
Yes (complex fabrication) 
Yes (simple to complex fabrication depending on 
technique) 
Yes 
Advantages 
High chemical stability, known surface and insulating 
properties, high thermoconductivity, high aspect ratio 
channels 
More resistant to mechanical shock, high to low oxygen 
permeability, easy bonding strategies, less stringent 
cleaning techniques, disposability, biocompatibility, 
transparency to most wavelengths 
Highly porous matrix, fluid flow through wicking, 
low cost, easy reagent storage on channel (by 
dried spots), easy assembly of multiple operation 
units (e.g. sample metering, filtering and 
separation), disposability, visual readout 
Limitations 
High cost of development and fabrication, fragile, low 
oxygen permeability, requires annealing at high 
temperatures 
Low to high resistance to organic solvents, water 
evaporation 
Challenging precise liquid handling, sample 
retention during transport, relatively high limit of 
detection (LOD), limited detection techniques 
Commercial 
availability 
Yes 
Yes (genetic and molecular biology analysis, protein 
crystallization, immunoassays) 
Yes (mostly qualitative output) 
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Table 2 - Summary table of the characteristics of the main fabrication strategies used for polymeric microfluidic devices [78], [79], [80], [84], [91], [92], [93], [94]. 
Fabrication 
process 
Description Throughput 
Surface 
roughness 
Material 
choice 
Cost Replication Characteristics 
Photolithography 
Exposition of a polymeric 
surface using a laser or UV light 
limited 
Low High 
Low to 
high 
Medium to 
high 
- 
Stereolithography 
Exposition and polymerization 
of a liquid resin, forming 3D 
structures 
High Limited 
Medium to 
high 
Medium to 
high 
3D fabrication with no additional mechanical 
process steps 
Laser ablation 
Removal of a defined amount of 
material (depending on material 
type, laser wavelength and 
intensity/ tool size and velocity 
Good (fast 
techniques) 
Medium to 
High 
High 
Low to 
medium 
High 
Surface chemistry and charge are changed in the 
process 
Micromachining High 
Low to 
medium 
High - 
Hot embossing 
Application of a pattern (via a 
stamp) onto a polymer heated 
just above its glass transition 
temperature 
Good (fast 
techniques) 
Low 
High Low High Low stress replication of nanometer structures 
Injection molding 
Injection of a heated polymer in 
a mould with the desired 
microfluidic structure 
High Low High 
3D objects fabrication with no additional 
mechanical process steps 
Casting 
Pouring of a heated polymer into 
a mould with the desired 
microfluidic structure 
Limited Low High Low Medium 
Allows manufacturing highly complex structures 
(e.g. pumps and valves), using thermoset resins 
containing metal powder is possible to fabricate 
embedded electronic components by casting 
3D printing 
In situ polymerization by layer-
by-layer focusing if a laser on a 
photopolymeric liquid or powder 
resin or bonding of multiple 
polymer, metal or ceramic laser 
cutted layers 
Limited 
Medium to 
high 
High 
Low to 
High 
Low to High 
Requires expensive equipment; thickness of each 
layer during fabrication depends on resolution of 
the stage; allows re-use of left-over polymer 
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Along with the choice of the material and the fabrication technique, the type of microfluidic 
platform needs to be considered in advance, such as: (i) single or multiple unit operations on the 
same chip; (ii) single platform or part of a platform; (iii) integrated quantification and fluidic 
handling or connection with external equipment; and, (iv) how to perform data and signal 
acquisition and treatment.  
When considering connectivity of the microfluidic chip, several other aspects should also 
be taken into account: (i) disposability of the device; (ii) to which devices it will connect; (iii) 
inlets positioned in-plane or perpendicular to the chip; (iv) should it be application-specific; (v) 
area occupied by connections; (vi) fabrication process; (vii) pressure and temperature tolerance; 
(viii) compatibility between materials used (e.g. solvents as target detection solutions); (ix) dead 
volume generated in the connections; (x) sterility; (xi) permeability; (xii) type of sample; and,  
(xiii) price [81]. Microfluidic interconnections need to provide a low pressure drop and dead 
volume and hermetic seal, coupled with a reliable performance under multiple uses [95]. 
Manually fabricated connections may not be built reproducibly, and are thus adding variability 
to the flow or the operation of the system. The adoption of a standard size inlet diameter, that 
allows the use of finger tight fittings and standard tubing, facilitates interconnection with other 
platforms using the same type of connectors, as well as connectivity to most external equipment 
(HPLC devices and mass spectrometers [96] or Raman spectrophotometers [97] as well as 
syringe pumps).  
1.2.1 Available unit operations in microfluidic chips 
To guarantee a wide applicability of modular microfluidic platforms it is essential that the 
relevant unit operations to most applications are available, and exist or can rapidly be made in 
such a format. In general, a “plug-and-play” system should contain the following elements: 
• Fluid handling unit: Such a unit could function as a pump, allowing appropriate flow of 
the sample in the system, with good control of flowrate and type of flow, ideally allowing 
a range of possible flow velocities. Another important fluid handling function is a valve 
system, especially a multi-port valve that enables the control of fluid introduction and 
followed path inside the system. Sabourin et al (2013) [30] developed a very interesting 
system where liquid handling is automatically achieved with miniaturized and integrated 
pumps. Other groups decided on a simpler approach such as a magnetically actuated 
stirrer-based micropump [98], valves actuated by tightening a screw [99], using a Braille 
display [100], or even capillary forces [101]. Oh et al. (2012) presented an interesting guide 
on design of microfluidic networks to ease fluid handling [6]. Electroosmotic flow (EOF) 
offers an interesting alternative to pressure driven flow, where the flow front has a flat 
profile, being capable of generating high flowrates without moving parts [102], [14]. It has 
been widely applied in bioassays, drug delivery, fuel cells, sludge treatment and 
microelectronic chip cooling [14], [103]. 
• Mixing/dilution unit: Mixing is an extremely important function when performing 
reactions or studying the influence of certain compounds, since it needs to occur faster 
than the reaction effect being studied in order not to influence the outcome [104]. At 
microscale, mixing occurs mainly through diffusion, but certain strategies can be adopted 
to improve mixing efficiency. Significant mixing strategies involve passive approaches 
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which are based on the generation of chaotic mixing with channel bends or topology in the 
channel [104], or in increasing the contact area between samples via lamination or 
intersecting channels [105]. Diverse active mixing strategies, such as acoustically-induced 
microstreams, dielectrophoretic micromixers, electrokinetic actuation [14], velocity 
pulsing and magneto-hydrodynamic flow have also been thoroughly developed and applied 
[105]. 
Mixing can also be performed in order to achieve gradients of certain components through 
dilution. Niu et al. (2011) developed a droplet-based platform capable of performing 
dilutions within a range of four orders of magnitude by splitting and (re)merging droplets 
to create reagent gradients [106]. Rho et al.  (2016) used peristaltic mixing in controlled 
volume microreactors to generate stepwise concentration gradients of two reagents [107]. 
• Sample concentration unit: This is especially critical for applications that involve 
extremely diluted samples [77], from water quality testing to detection of cancer cells or 
viruses in blood. Also, in the human body the physiological concentration of considerable 
compounds is in the order of nM or lower, thus requiring pre-concentration units for 
detection. Several strategies involve adhesion of the molecules or cells to the channel 
walls, which can be functionalized [108] or not [109], using chaotic flow induction to 
increase enrichment performance. Recently, Pereiro et al. (2017) developed a fluidized bed 
microreactor capable of capturing bacteria from liquid raw samples (e.g. milk) using 
functionalized magnetic beads [110].  
• Filtration/ purification unit: Units capable of removing contaminants, or separating 
cell debris or types of cells from the sample are highly valuable as sample treatment units. 
Strategies applied to sample filtration/ purification use differences in (i) size (e.g. using 
capillary forces in a microchannel integrated micropillars (MIMPs) chip to separate 
plasma from blood [101] or simultaneous isolation of multiple antibodies from serum and 
multiple cell types from blood using microbeads [111]), (ii) functionalization of channel 
surface (e.g. with avidin and treated with antibodies conjugated with biotinylated 
photocleavable crosslinkers with a specific 19-mer DNA sequence to capture cancer 
biomarkers directly from whole blood [112]), (iii) immunomagnetic separation (e.g. 
immunomagnetic beads and a micro-aperture chip to separate circulating tumour cells 
(CTC) from whole blood samples [113]), (iv) adhesion to silica (e.g. extraction of RNA from 
prepared rat tissue samples using a porous silica monolith column [114]), and (v) solid-
phase extraction (e.g. using cation exchange resins [115]). 
 
Concentration and filtration/purification units often function as the same unit, since by 
isolating or separating a target cell/particle/molecule, its concentration from the initial sample 
is achieved. 
 
• Sorting unit: Besides the ability to isolate a target molecule or cell from a complex 
sample, it might also be required to differentiate among the purified molecules or cells for 
a certain characteristic, for which sorters can be used. This is especially relevant when 
establishing protein or genetic libraries or developing mutants. Sorting of molecules, cells, 
particles or droplets can be performed using electrostatic actuation (such as, 
dielectrophoresis [116], [117], [118] or electrostatic charging [119]), optical approaches 
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(such as optical tweezers or traps [120] or fluorescent activated cell sorting (FACS)), 
mechanical approaches (e.g. with membrane valves [121]), acoustic approaches (e.g. 
surface acoustic waves [122]), magnetic approaches (e.g. magnetophoresis or magnetic 
activated cell sorting (MACS)), channel topography [123],  inertial or hydrodynamic 
focusing or affinity approaches [124]. 
• Sample amplification: Such a unit may enable working around the issue of highly 
diluted samples, allowing to replicate the target molecules (e.g. DNA or mRNA) [77]. 
However, the issue of retaining or capturing such molecules remains. Most amplification 
units perform polymerase chain reaction (PCR) either in chambers (e.g. reverse 
transcription PCR (RT-PCR) using a thermoelectric Peltier element for temperature 
control during amplification [114]) or continuously in channels (e.g. real-time PCR of 
single-DNA per droplet in a circular channel design with zones at different temperatures 
[125]). Other amplification techniques such as multiple annealing and looping-based 
amplification cycles (MALBAC) [126]  and nucleic acid sequence-based amplification 
(NASBA) [127] have also been miniaturized in microfluidic devices. 
• Incubation unit: Such a unit can either work as a reactor, allowing a certain reaction to 
occur for a defined residence time, a labelling unit, or even as an incubation chamber, 
allowing growth of organisms. This type of unit requires an excellent control of volume 
and residence time, and has been extensively used together with droplet microfluidics or 
single-cell platforms. Several droplet microfluidic platforms present incubation units, 
which are chambers where the cells or droplets are stored [128], [129] or long channels 
that allow for a tight control of incubation (residence) time [117]. 
 
Strategies for other sample pre-treatment units are presented by de Mello and Beard 
(2003) [130], Chen and Cui (2009) [131] and Huang et al. (2002) [132]. 
 
• Detection unit: Quantitation of target compounds is one of the major functions and 
advantages of microfluidics, due to the variety of available sensors, which offer a 
possibility for real-time and continuous monitoring and proximity to the samples. An 
overview of the different types of available sensors for microfluidic applications is 
presented later in the text, but the variety of available sensors ranges from dielectric (e.g. 
determination of size, shape and composition of droplets at high speed [116]) to optical 
(e.g. recent application of stroboscopic epifluorescence imaging to hundreds of droplets 
simultaneously [133] or surface-enhanced Raman scattering (SERS) detection of 
hazardous materials [134]) and even nano-wires (e.g. nanoribbons capable of performing 
the detection of multiple biomarkers simultaneously [112]). 
 
The presented list of existing microfluidic chips capable of performing the most relevant 
and essential unit operations in any screening, optimization or development study is not 
exhaustive. There is a multitude of approaches for solving pre-treatment and sample 
concentration issues for example, that with little or no modification could be coupled and/or 
integrated in a modular platform. By combining the different presented microfluidic systems, 
most processes in the biotechnological and health fields could be studied on-chip in a flexible 
“plug-and-play” approach. 
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A wide application of microfluidics can be achieved if not only modularization, but also 
standardization of connectors is achieved. Connectivity between the above units could be 
attained with some of the connectors and interconnectivity ports presented in Pepper et al. 
(2007) [33], where “click on” connectors to standard tubing sizes were developed, and Sabourin 
et al. (2013), which developed multi-connector ports. Connectivity to electrical interfaces could 
be carried out as presented in Yuen et al.  (2008) [34], who based their design of fluidic and 
electrical connections on an electrical breadboard. Adaptation of the above units to the building 
block concept introduced by Rhee and Burns (2008) [35], Langelier et al.  (2011) [38] and 
Vittayarukskul and Lee (2017) [39] would further increase the flexibility and potential of the 
modules as part of a multi-use “plug-and-play” platform. A set of building blocks that can be 
arranged in a multitude of different channels and even 3D shapes could be acquired by every 
research institute, company or diagnostics center, for easy assembly towards their target 
research. The building blocks could be available together with a simple set of miniaturized 
electronic components (e.g. pump, charge-coupled device (CCD) imaging technology, 
potentiostat) that function both as part of the fluidic and detection units, but also as user-
friendly validation units for the assembly. For applications that require a higher degree of 
validation, such as biomedical applications, more complete individual unit blocks could be used.  
A concern in the use of a modular approach is the accumulation of fluidic resistance with 
each module, which can affect flow (and thus downstream) performance and lead to the loss of 
reagents or involved particles/cells [3]. However, there are several strategies available to reduce 
pressure drop (e.g. division of flow in different channels) and fluidic resistance (e.g. surface 
modification towards high hydrophilicity). Furthermore, diverse flow generating strategies (e.g. 
electroosmotic or capillary flow) could be applied in combination with pressure-driven flow. Also, 
modules to control backpressure in the pumps, or facilitating pressure equalization along the 
module assembly, can be integrated.  
 
It is also relevant to highlight the importance of applying mathematical modeling and 
fluid dynamic simulation to the first stage of development of individual fluidic parts [74]. Such 
tools can help boost the development progress of microfluidic platforms [135], by aiding in 
geometry optimization, evaluation of transport phenomena, determination and prediction of 
reaction (kinetic) parameters and mechanisms and in analyzing experimental data [135]. 
Modelling provides a more targeted and therefore often more efficient strategy of device 
development and sensor design, which can result in faster, less wasteful, and more economical 
device development processes [66]. It also provides information for evaluation and choice of 
materials (either by modeling interaction between materials, absorption of molecules on the 
surface or elucidating the influence of properties such as, for example, thermal coefficients). The 
development of numerical simulation tools with a simple user interface might also contribute to 
spreading the use of microfluidics to other fields (e.g. environmental sampling, resource 
recovery, structural analysis of soils or buildings, etc.), including transferring their use to non-
microfabrication specialists [74]. As suggested by Chiu et al. (2017), the assembly of the building 
blocks of a modular microfluidic system could be guided by software, taking into consideration 
both the requirements of the specific application along with the characteristics of the available 
building blocks [3].  
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Most modelling approaches applied to microfluidics assume a discretization of the 
continuum approximation of Navier-Stokes equations to describe flow and phenomena at the 
microscale through finite difference/volume/element or boundary element methods [47]. 
Computational fluid dynamic software such as COMSOL Multiphysics® (Burlington, MA, 
USA), or ANSYS CFX (Canonsburg, Pennsylvania, USA) are used for description of fluid flow 
in micrometer channels [136]. This, however, cannot appropriately describe phenomena 
occurring at the molecular scale (such as, for example, chemical bond interactions). As the 
dimensions of the channels decrease from micrometer to nanometer size, the continuum model 
no longer holds [136]. The use of hierarchical multi-scale modelling might improve modelling of 
the involved phenomena (mainly, molecular interactions and biochemical processes) in the 
reactions/processes performed in microfluidic systems [136], [137], [47]. Hierarchical multi-scale 
modelling involves the association of the mentioned macroscale methods with atom-based 
models (within which atoms and molecules are interacting points whose position and velocity is 
described by a vector, such as in the Molecular dynamics simulation model [136]) and particle-
based models (that assume clusters of interconnected particles to simulate molecules or fluid 
according to a distribution function governed in time by discrete Boltzmann equations, such as 
in the lattice Boltzmann method) [136], [137], [47].  
1.2.2 Other considerations 
One of the attractive features of polymeric materials for diagnostic platforms used in 
biomedical and clinical applications is their disposability due to their low fabrication cost [74]. 
These attributes decrease the risk of user contamination when handling potentially dangerous 
samples or of substances being analysed erroneously due to sample carry-over. However, for 
most applications in other fields, where contamination issues can be easily solved or are less 
critical, the use of disposable devices will lead to the generation of unnecessary and possibly 
difficult to handle waste (most materials used in microfluidic platforms and microsensors are 
not biodegradable [138]). Furthermore, most microfluidic platforms consist of a variety of 
materials (including e.g. heavy metals and other compounds potentially toxic to the 
environment) assembled in an irreversible way or that is difficult to separate, thus increasing 
the difficulty in disposing of such devices in an environmentally sustainable way. The academic 
and industrial community should seek to develop multiple use platforms in such situations, as 
well as invest in biodegradable or transformable/reusable materials, especially when many 
microfluidic platforms may be used (e.g. screening of enzymes or process parameters). Zein (a 
prolamin protein from corn), poly (lactic acid) (PLA) [139], silk fibroin and gelatin are examples 
of biodegradable materials that can be used to fabricate microfluidic devices [138]. Zein has 
great potential as a plastic substitute [138], [140], [141], [142] since it is biodegradable and can 
be produced from the excess in the corn industry, adding value to a traditional bioethanol 
production process and also reducing waste in industry [143]. PMMA is another promising 
material to obtain “green microchips” since it can be reused after decomposition to methyl 
methacrylate (MMA) at high temperatures [144]. 
To conclude, besides the effort to use alternative, more environmentally friendly and/or 
reusable materials, the microfluidic community should strive to build easily disassembled 
devices. This would facilitate the reuse or disposal of the different parts of microdevices towards 
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decreasing the possible environmental impact that an intense use of this technology might 
bring. 
1.3 A guide to the development of stand-alone platforms 
In order to develop a stand-alone multi-unit operations microfluidic platform, compatible 
with a wide range of applications, several considerations should be made. To illustrate the 
complexity of such endeavor, a guide for the development of a single unit operation microfluidic 
system is presented here.  
In this work, the chosen unit operation is sensing, focusing on biomolecules and/or 
biological components, due to its relevance and variety of detection techniques. If microfluidic 
platforms are to be used widely, the integration of sensors and their validation as quantitative 
detection systems is of major importance. There are three main detection methods used in 
microfluidics: optical methods, electrochemical methods and mass spectrometry methods, of 
which optical and electrochemical methods are the most applied due to their selectivity and 
sensitivity. Other methods involve techniques such as nuclear magnetic resonance (NMR) 
spectroscopy and mechanical detection (e.g. quartz crystal microbalance (QCM) sensors or 
microcantilevers) [74]. Within each detection method there are several techniques, whose 
usefulness or applicability is highly dependent on the desired function of the device and where 
it will be integrated. Table 3 presents a summary of the main characteristics to consider when 
selecting a detection method for integration in a microfluidic platform. 
Recently, even though new sensing technologies are discovered every year, there has been 
a shift in sensing research towards more efficient and hybrid integration of the sensing 
approaches by further developing already existing and validated sensors [145]. The combination 
of different sensing technologies on the same device can widen its application, by increasing the 
number of targets it is able to monitor and/or quantify simultaneously. 
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Table 3 – Summary of the leading detection systems available for microfluidic applications. 
Integration capability is here assumed as the ease of miniaturization of the sensing system itself in order 
to be integrated inside any or most microfluidic structures. Portability relates to the miniaturization of 
required auxiliary equipment to perform the measurement (e.g. potentiometer, microscope, etc.). 
Detection 
method 
Advantages Challenges 
Integration 
capability 
Portability 
Optical 
Fast response; High sensitivity; 
Compact; Usually contactless; can 
allow for real-time monitoring and 
spatially resolved imaging; 
Usually dependent on microscopy 
equipment; May require labelling; 
High 
Usually low, but can be 
high if CCD cameras or 
mobile phones are used 
Electrochemical 
Can allow for real-time monitoring; 
can be applied to most biological 
and chemical samples; potentially 
low costs in terms of fabrication; 
Requires the presence or 
generation of an electroactive 
species; difficult miniaturization of 
measurement equipment; short 
shelf life of most biosensors; 
requires control of ionic 
concentrations pre-experiment; 
High 
Medium, if 
measurement systems 
are miniaturized 
Mass 
Spectrometry 
High sensitivity and selectivity; 
very low detection limits; can be 
label-free; requires low electrical 
operation power; 
Long analysis time; bulky 
detection equipment; extensive 
sample preparation; 
Low Very low 
Magnetic 
Highly specific (reduced sources of 
magnetic behaviour in nature, for 
magneto-resistive sensors); allows 
for studying behaviour of atoms and 
molecules (in the case of NMR); No 
need for optical accessibility (in the 
case of NMR);  
Requires labelling of the target 
samples and/or very strong 
magnets; requires expensive 
fabrication methods; limited 
reaction time scale (for NMR); 
High 
High, if measurement 
systems are 
miniaturized [146] 
Mechanical 
Usually label-free detection; sensor 
integration performed during 
fabrication (monolithic); 
Sensitive to damping effects in the 
presence of liquid; long detection 
times; Complex fabrication 
High 
Medium to high, if 
measurement systems 
are miniaturized 
 
The scheme in Figure 4 illustrates the major steps to be considered during the 
development of a new system for sensor integration. This scheme is divided in 3 steps:  
• Step I - development of the system’s concept: It is addressing a current need (of a potential 
client, a clinically relevant analytical device or a research project) and involves the 
preliminary design, literature research for current technology, and preliminary concept 
tests in the laboratory. The concept of the device should be concurrent with existing 
regulations in the field of application, especially when food or health related applications 
are planned (e.g. highly regulated by the Food and Drug Administration [FDA] and 
European Medicines Agency [EMA]). Further regulatory issues will not be considered here 
due to the complexity and variety of the subject. It should also take into consideration the 
end-users and their requirements for the device [147], [148]. The more general the “need” 
identified, the more challenging the design of the system, but a wider use microfluidic chip 
might be achieved. In Figure 4 we use two specific hypothetical examples (monitoring of 
blood glucose levels in real-time and inline monitoring of glucose concentration in a 
reactor), but a more generic need could be the development of a system that is adaptable 
for the online monitoring of several components;  
• Step II – Sensor choice and fabrication: It includes an iterative choice and test of the sensor 
approach (and design) that is best matching the need defined in Step I, as well as the 
selection of chip material and fabrication method. These choices are often limited by the 
available technology and materials, as well as their cost of operation and use. 
• Step III – Sensor integration: It involves the assembly of the final system for integration 
of the chosen sensors, based on the desired final application and type of device operation. 
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The type of integration strategy should be defined from the concept step (step I), since it 
can limit the used materials or fabrication methods. At this point, further improvement 
or alterations of the components (developed during step II) of the prototype might be 
required. Since the final goal is the commercialization or wide use of the device, scaling of 
fabrication towards mass production should also be considered during development of the 
prototype. 
 
  
Figure 4 – Decision analysis cycle scheme for developing microfluidic systems for sensor integration, and its 
application to two hypothetical case studies: (i) a hypothetical portable glucose electrochemical sensing device and 
(ii) a hypothetical inline glucose monitoring device.  
It is important to highlight the need to take a holistic approach to device design, as well 
as the relevance of thinking about connectivity to other systems during the design phase. When 
developing a multi-unit operation platform or a system compatible with other multi-unit 
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operation platforms, these steps should be followed first for each unit operation, and then for 
their consecutive integration with each other, until the whole-platform integration is achieved. 
All the time, one should keep all the considerations presented in Figure 4 (e.g. final user, type 
of sample, location, etc.) in mind. 
1.3.1 Guide application to several case-studies: 
To illustrate the developed guide, the different steps described in Figure 4 were applied in 
two hypothetical case studies: (i) a portable glucose electrochemical sensing device; and, (ii) an 
inline glucose monitoring device. The case studies were included for bringing further 
clarification of the considerations and decisions involved during the development process of a 
microfluidic device, and that the decision analysis cycle scheme in Figure 4 intends to facilitate. 
For each case study, the conclusion of the considerations presented at each step is shown in the 
figure. 
For case study (i), in Step I, the key concept to address is the need for monitoring glucose 
in blood. This is achieved by defining a device capable of performing measurements in real-time 
that should be portable and able to draw samples subcutaneously. This concept is achieved by 
considering the patient as the end user, the importance of constant monitoring of glucose levels 
in diabetic patients, and therewith of portability, and the best sample format as the blood. In 
Step II, the development of such a device begins by choosing the best sensing approach, and the 
appropriate materials and fabrication methods. In the chosen example, an electrochemical 
sensor is selected due to its ease of miniaturization and the extensive available knowledge on 
applications of electrochemical sensors for glucose monitoring. Then, considering that the device 
will be in close and continuous contact with the patient’s skin, a biocompatible material was 
chosen (PDMS). Furthermore, when using some biomolecules, such as the enzyme glucose 
oxidase, if certain mediators are used, oxygen is required for the reaction and can also be used 
as a target analyte. Therefore, the use of PDMS is further highlighted due to its permeability 
to oxygen. The choice of material and the dimensions of the device (also defined in Step I) would 
then limit the choice of fabrication methods, together with the available methods for the device 
developer. Finally, in Step III, the combination of the different already described parts (through 
the use of a casing for easier re-use or substitution of sensors or channels) and the test of the 
prototype occur.  
For case study (ii), the key notion guiding the concept development is the continuous 
monitoring of glucose in an outlet stream of a lab scale fermenter. Thus, in Step I, the device 
needs to be robust, withstand relatively high pressures/flowrates, and be easily used by an 
operator. Furthermore, since the samples contain a complex matrix (media) with organisms, the 
system needs to be able to withstand sterilization and be connected to a sample pre-treatment 
device, where biomass is removed to minimize fouling of the sensors. In Step II, an 
electrochemical sensor is selected due to its price (in case substitution is required due to fouling) 
and straightforward connectivity and monitoring with electrical interfaces. Then, due to the 
required robustness of the device and compatibility with cleaning-in-place procedures, stainless 
steel is chosen as the platform’s material. This limits the available fabrication techniques, of 
which milling offers a relatively lower cost and device completion time. In Step III, the 
combination of the different components is achieved, with the test on the device’s robustness, 
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the influence of biofouling on sensor performance, as well as the capability of sample pre-
treatment to reduce this effect. 
1.3.2 Further deliberations 
The discussed case studies allow for a clear presentation of the suggested guidelines. 
However, they are a simplification of real applications of the described devices.  
In reality, the extremely strict regulations involving health applications would further 
limit the types of structures, materials and fabrication methods in the case of case-study (i). A 
close collaboration between microfluidic developers, physicians and health regulation agencies 
could be established (such as ISO 13485:2016 for Medical Devices) in order to satisfy demands 
related to both health safety and patients’ quality of life. Regarding case-study (ii), the 
integration of such a device might be easy to implement into a laboratory scale reactor, as 
presented, but the final goal would always be its use in pilot or industrial scale reactors. For 
such larger scale reactors, once again, tighter regulations exist, mainly related with the existing 
inlets for the reactors and the costs associated with the potentially necessary modifications. 
These more rigid regulations would very likely add additional iteration steps in the development 
of the platforms. 
Furthermore, simply fabricating more easily connected devices might not be enough to 
increase their use in the market. As previously mentioned, their validation with currently used 
analytical methods, which can vary greatly across fields, is of upmost importance to gain trust 
from the stakeholders (the final customers and/or investors). A wide or multi-use device would 
have to be validated by all analytical methods commonly used in each specific field, which due 
to its characteristics, namely dimensions, might be challenging to achieve, and should therefore 
also be considered as a main objective from Step I. Once validated, such device could in turn 
become a reference analytical tool of the field, with a simpler application and a lower price. 
Microfluidics can become an interesting analytical tool, more accessible to the general public, 
both in terms of cost, portability, and footprint, but also in terms of simplicity of use. 
Additionally, it is relevant to highlight that the end-user plays an important role in the 
development of microfluidic platforms. When the final user of the platform is a patient or 
someone with little to no-training in the technology or field in question, the device needs to be 
not only easy to assemble, but “fail-proof”. This means it should have a robust operation in order 
to withstand possible operation errors, such as wrong types of samples, labels or reagent 
concentrations, and present higher number of redundancies and security protocols, being at a 
high level of developmental maturity. Such a device should provide limited options in terms of 
operation and minimize required external input (so to minimize errors from the operator), and 
provide sufficient and detailed protocols and operation guides. Moreover, if samples from the 
patient are needed (e.g. in the case of diagnostic devices), the sampling procedure should 
preferably be non-invasive or at least reduce invasive sample as much as possible, and avoid 
sample cross-contamination (if measurements of multiple samples are required for monitoring 
of a disease status for example). Such a platform should also provide already treated data, and 
if possible guidelines of steps to proceed or suggestions of what the data might signify [149]. On 
the other hand, if the end-user belongs to a research or medical laboratory, or an industry 
environment, although the same requirements in terms of validation and safety are expected, 
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the flexibility in terms of operation modes and assembly structures is higher. Also, additional 
analytical components and a lower or no data processing effort are expected. 
1.4 Motivation and project goals 
Synthetic chemistry has had a big impact from microfluidics, in particular modular 
microfluidics, both at laboratorial and industrial scale. Biotechnology, especially biocatalysis, 
uses similar approaches to synthetic chemistry in reaction and process development, and can 
thus have a lot to gain from the adoption of modular microfluidic technology as a standard tool. 
As mentioned earlier, there is a great need in bioprocess development for high-throughput, low 
cost and automated screening platforms. Microfluidic systems, with their smaller dimensions, 
high fluidic and mass/heat transfer control, small footprint and high variety of sensor 
approaches can offer a solution to this need. Furthermore, the presented concept of modular 
microfluidics can provide an increased flexibility and applicability to the screening microfluidic 
systems. A microfluidic system that is compatible with different substrates, reactions and 
operation conditions, as well as capable of association with other microfluidic systems, can 
greatly extend its usefulness and field of application. The different existing microfluidic unit 
operations suitable for a “plug-and-play” platform that were reviewed, along with the presented 
strategies for their integration and novel connectivity approaches illustrate the potential of 
modular microfluidics as screening platforms, capable of integrating all the required unit 
operations (e.g. sample treatment, concentration, detection, purification, etc.). 
1.4.1 Project goals 
The main goal of this project was thus to develop a microfluidic modular platform for 
enzyme screening with online reaction monitoring and quantification. The platform was 
designed considering some of the issues identified in microfluidics, such as the lack of reusability 
of the materials composing most developed microfluidic platforms, and the difficulty in 
integration between different developed microfluidic systems due to lack of standardization of 
channel dimensions and connections. 
Following the presented step-wise guide (Figure 4) for the development of stand-alone 
microfluidic platforms, the modular platform was envisioned for application in an intermediary 
state of screening, when reaction parameters and kinetic mechanisms of a promising biocatalyst 
are characterized and/or optimized. This platform is intended for laboratory use by non-
microfluidic experts, so each of its modules was designed or chosen to allow easy connection to 
each other or to benchtop laboratory equipment, and be simple to use. Furthermore, each 
module enables flexible application, meaning it is compatible with different types of reaction 
and biocatalyst. The developed modules were also, within available material and fabrication 
technology limitations, designed to allow easy disassembly of the different components, both to 
facilitate cleaning and substitution of parts, but also recycling or re-use of the different 
materials and components. The selected materials were additionally both biocompatible and 
suitable for most functionalization approaches, to increase compatibility with a wide variety of 
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biocatalysts. The fabrication methods used were limited to the equipment available in the 
laboratory (laser ablation and micromilling).  
The basic modules identified as useful for such a platform are presented in Figure 5. 
 
Figure 5 – Schematics of modular platform for enzyme screening. 
The final goal was to achieve online monitoring coupled with data analysis for fast 
comparison between variants or screened reactions, based on data gathered both in the reactor 
and in the quantification module. Considering the identified basic modules, in such a modular 
platform, the reactor module should provide insight on the reaction behavior at different 
residence times (spatial points) in the reactor, while the quantification module was intended for 
quantification of the target compound and for providing insight on conversion yield and 
productivity.  
A commercial microfluidic system with integrated oxygen sensors was chosen as the 
reactor module, while the quantification module was developed in-house to allow integration of 
different types of sensors and sensor geometries and thus be applicable to a wide range of 
reactions. Between these two modules, a platform for continuous enzyme inactivation, based on 
temperature, was also developed. This module was designed to guarantee an appropriate 
quantification and good control of the reaction residence time in between modules, by employing 
a non-specific method to stop biocatalytic reactions. Additionally, a commercial microfluidic 
valve was used as a module to enable dynamic measurements or introduction of controlled 
volumes of compounds. Standardized connectors (HPLC-type connectors and tubing) were used 
as world-to-chip and chip-to-chip connectivity, hence widening the applicability of the developed 
modules and the assembled platform. The envisioned platform with the different described 
modules is shown in Figure 6. Finally, as a step towards online data analysis, all the developed 
microfluidic platforms and the reactor module were characterized using computational fluid 
dynamics.   
 
 
Figure 6 – Schematics of the different microfluidic modules developed for the enzyme screening platform. 
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1.4.2 Thesis outline 
The thesis consists of six chapters, where Chapter 1 includes an overview of microfluidics 
and the main motivations for the work and Chapter 6 brings the main conclusions of the work 
achieved and future perspectives for the developed microfluidic modules. Each of the 
microfluidic modules have a corresponding chapter, each with an introduction more focused on 
its specific application and state-of-the-art. In each chapter, a materials section is included, and 
the main obtained results and challenges observed with each module are specified and the main 
conclusions drawn. 
 
The thesis is thus structured as follows: 
 
• Chapter 1: Introduction to microfluidics, with a particular focus on modular microfluidics. 
A brief review on physics at microscale, and the main materials and fabrication methods 
used. A step-wise guide to develop stand-alone microfluidic platforms, which highlights 
the main considerations to take into account when conceptualizing such a platform, as 
well as the precautions to take during fabrication.  
• Chapter 2: Characterization of the microfluidic reactor module with integrated oxygen 
sensors using an oxidation reaction with enzymes in solution. The reaction inside the 
microchannel was also simulated using CFD, which presented a reasonable match with 
the experimental data.  
• Chapter 3: Application of the microfluidic reaction module with integrated oxygen sensors 
to the screening of dioxygenase variants in whole cell catalysts, as a novel screening tool 
for an oxidation reaction in whole cell biocatalysts.  
• Chapter 4: Development of a microfluidic platform for sensor integration and application 
with electrochemical sensors to the in-flow quantification and dilution of glucose samples. 
The dilution channel was optimized based on CFD modelling of different mixing 
geometries. 
• Chapter 5: Development of a microfluidic platform for continuous enzyme thermal 
inactivation and application to the inactivation of glucose oxidase and catalase solutions. 
The microfluidic platform’s thermal characteristics were simulated using CFD. 
• Chapter 6: Summary of the main results obtained from the development and/or 
characterization of the different microfluidic modules presented. Future perspectives for 
the further development and potential applications of the developed modules as a 
screening platform. 
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Chapter 2 
System for monitoring biocatalytic reactions 
Biocatalysis is a highly relevant field in biotechnology, with an annual revenue that is 
expected to reach 400 billion USD by the end of 2017 [49]. Within this field, the enzyme market 
has grown exponentially from the 1960s and has revolutionized a significant number of products 
and processes, such as detergents, drug discovery, bioanalytics, organic synthesis and biofuels 
[150], [22]. To keep up with current market demands new enzymes with higher stability, higher 
solvent resistance, suitable activity and substrate specificity, and the ability to act on new 
substrates with high turnover rates are required. Discovery and tailoring of such enzymes 
involves environmental sampling and generation of variants [49] that results in thousands of 
enzymes whose industrial or clinical relevance needs to be evaluated. High-throughput 
techniques are thus highly demanded both for the initial screening of (engineered) variants, as 
well as for the reaction and process characterization of the most promising biocatalysts. 
Microfluidics, due to its dimensions and available unit operations, is an increasingly used and 
valuable screening tool that allows high-throughput and fast screening of the small volume of 
each generated variant. However, considering the current state of sensor integration and 
automation in microfluidic-based systems, they are mostly considered for an intermediate stage 
of biocatalyst screening, when the characterization of more specific parameters is required [46]. 
In this chapter, a microfluidic system capable, of continuously monitoring oxygen levels, 
is evaluated as a potential microreactor for application in screening activity and studying 
reaction kinetics of biocatalysts in solution. Oxidation of glucose by glucose oxidase was 
performed and allowed to highlight the operational limitations of the system in terms of oxygen 
depletion at certain enzyme and substrate concentrations. Strategies for in situ oxygen 
generation involving addition of catalase and hydrogen peroxide were likewise applied. 
Additionally, a calibration curve relating measured oxygen with product concentration at the 
outlet of the microchannel was performed. The reactions carried out in the microfluidic system 
were also modelled using computational fluid dynamics, with a good fit between the 
experimental and simulated data, and the results provided extra insight into the reaction 
dynamics and limitations.  
2.1 Introduction 
Enzymes are ubiquitous in daily life, from the use in the food (e.g. as food additives) and 
textile industry (e.g. for bleaching), to the production of bulk chemicals and application in 
clinical assays [22]. They enable greener and safer production processes (operation at mild 
conditions of pressure and temperature and with low energy demands), simpler reaction 
pathways for certain compounds and even production of new molecules, with high turnover 
rates and substrate selectivity [22]. There is, therefore, a great demand towards finding new 
biocatalysts. Biocatalysts (and new compounds) can be discovered for instance by terrestrial and 
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marine microbial sampling, requiring extra steps of isolation, optimization of growth conditions 
in the laboratory, metagenomics (searching for homology with known enzymes) and activity 
tests [49], to name a few strategies. New biocatalysts can also be attained through genetic 
manipulation, constructing functional metagenomic libraries or performing directed evolution, 
thus generating recombinant biocatalysts that need also to be selected in terms of activity and 
selectivity towards a target process and/or product [49]. To achieve this, thousands of enzymes 
and/or cells (in the case of whole cell biocatalysis) need to be screened and new, automated and 
faster screening procedures are in demand.  
2.1.1 Miniaturized systems for biocatalysis and enzyme screening 
A strategy to improve the screening efficiency involves miniaturization of the involved 
technology [22]. Miniaturization has been achieved mainly through two strategies: multi-well 
plates and microfluidic systems. 
2.1.1.1 Multi-well plates 
Multi-well plates are polymeric (polypropylene or polystyrene) plates containing usually 6 
to 1536 wells with 16 mL down to 10 µL volume, respectively, which are arranged in a 8 cm by 
12 cm matrix. They enable screening of up to 106 variants on liquid or solid (e.g. agar) media by 
detection of a chromo- or fluorogenic compound that is produced or consumed in the presence of 
the target enzyme [22]. 
 It has also been applied to determine kinetic parameters, where substrate concentration, 
type of substrate, amount of enzyme, etc., can be varied between wells within the same assay 
[151], [152], [153]. Association with robotic equipment facilitates accurate definition of the 
concentration range or other varied parameters in each assay [154], [155]. Some adapted trays 
have been developed that enable single well temperature control and inline monitoring of some 
parameters through sensor integration in the wells. Individual temperature control, however, 
is cost-intensive so integrated incubation chambers are usually preferred [58]. The sensors (pH, 
dissolved oxygen and carbon dioxide concentration [58]) are usually sensor spots based on 
fluorescent or luminescent detection which are embedded at the bottom of each well [22]. The 
sensors are evaluated in a matrix by a probe (e.g. optical fiber), and so time-related data 
obtained depends on the number of samples (wells) being measured and the speed of the 
scanning probe [156]. Individual well sensor addressing has also been achieved, requiring 
however more complicated setups [157]. Furthermore, modified microtiter plates, that 
incorporate a microfluidic network have been developed that enable controlled addition of liquid 
solutions (e.g. for pH control) through a pneumatic microvalve [157]. 
In microwell plates, oxygenation and mixing are promoted mostly through shaking, which 
can lead to mass transfer limitations of oxygen to the reaction taking place. Performed studies 
have shown that the amplitude and intensity of shaking, the surface (in contact with air) vs. 
volume ratio and the wells’ shape influence the oxygen transfer [22]. Different aeration 
strategies, such as sparging with air, using square or flower-shaped wells or magnetic micro-
stir bars have thus been used [158], [22]. Evaporation is usually minimized in these systems by 
covering the wells and/or flushing the microwell plate environment with humidified air [159], 
[157]. 
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Despite the possibility for automation with robotic handling and the variety of strategies 
employed in microwell plates for improving monitoring and parameter control, the number of 
parameters that can be monitored continuously is still limited to pH, oxygen, carbon dioxide 
and optical density. This can limit the scalability of the obtained data due to the lack of proper 
process overview. The application of mechanistic models can help increasing the level of 
confidence and applicability of the gathered data [151]. Furthermore, the limitations regarding 
oxygen mass transfer and evaporation, despite being mitigated with the strategies developed, 
can limit the application of these systems to certain processes (e.g. using solvents with high 
evaporation rate, or fast oxidation reactions). 
2.1.1.2 Microfluidic systems 
Microfluidic systems present a set of characteristics that makes them valuable for high-
throughput applications, such as screening of biocatalysts. The reduced dimensions decrease 
the amount of required reagents and samples, but also increase the surface to volume ratio 
[160]. This results in increased surface interactions, which are required in many assays (e.g. 
immunoassays, enzyme immobilization), but also increases contact area between the different 
solutions, which is highly relevant for example in liquid-liquid extraction and mixing. It also 
opens the possibility to new assay or reaction geometries and catalyst or reactants positioning 
inside the channels. Moreover, the small dimensions increase portability of these systems, as 
well as the ability for parallel operation with a small footprint. Microfluidic systems enable a 
higher degree of integration (of different components and unit operations on the same chip or of 
different chips together), which facilitates the development of automated processes [22], [10]. 
As discussed already in Chapter 1, depending on the material and fabrication method, they can 
enable a significant cost reduction of the unit operations and the screening platform. 
Furthermore, the types of available sensors, their integration within the microfluidic system 
and the type of interactions occurring at this scale can result in a significantly increased 
sensitivity and a limit of detection hard to rival in macro-devices and microwell plates. 
Microfluidics also enables studying reactions and/or physical phenomena otherwise impossible, 
either by allowing a higher control of the environmental conditions (fast mass and heat 
transport) or by allowing a better control on the phenomena occurring or even eliminating 
certain effects (e.g. inertial effects) [8]. Another advantage of microfluidics is the freedom and 
variety of geometries available, which enables taking advantage of the phenomena more 
relevant at this scale. The main advantages of microfluidics relative to microwell plates are 
however the possibility for continuous operation [22] and the availability of incorporating a 
wider range of biosensors. 
Microfluidic systems have mostly been applied to enzymes or cell lysates [22]. The simplest 
approach involves two-inlet microchannels where aqueous solutions of the substrate(s) and 
enzyme(s) are introduced separately and the reaction occurs along the microchannel [22]. This 
allows a good control of the reaction residence time (through flowrate selection and length of the 
channel) and diffusion/mixing of the two solutions (by introducing bends or obstacles in the 
channel), which can easily be calculated from the equations presented in Chapter 1. In reactions 
where one of the components has a low solubility in water, two-liquid phase systems can be used 
by introducing an aqueous and an organic phase or ionic liquid through separate inlets. This 
approach has also been applied for the enzymatic resolution of chiral compounds [22], or as an 
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in situ product removal/substrate feeding approach [161]. It is important to consider in this 
approach how the solvent might affect enzyme activity and stability during operation [60]. 
Enzymes can also be immobilized (through covalent cross-linking [59], cross-linked enzyme 
aggregates, (non-)specific adsorption [162], polymer brushes [163]) in the microchannels either 
by binding to the walls or by immobilization on carriers (e.g. agarose or glass beads), membranes 
(e.g. nylon, poly(vinylidene)) [59] or monoliths (porous matrices of polymers or silica for 
example) inside the reactors [22], [150]. Enzyme immobilization improves in general the 
stability and durability of the biocatalyst [150], but may result in some cases in a loss of activity 
[60]. Micro-packed-bed reactors have also been developed where the enzymes are immobilized 
on microparticles and introduced inside a microchamber or a capillary tube, serving as packed-
bed reactors [22]. This approach may however lead to increase of backpressure, requiring higher 
pumping efficiencies.  
Multi-enzyme cascade reactions can also be achieved with microsystems by physically 
separating the reactions in reactors connected in series [60]. This allows a better control of the 
reaction, especially if the product acts as an inhibitor on the following reaction or promotes 
undesired side reactions [60]. This spatial separation of the reactions also permits their 
operation at the optimum conditions for each (temperature, pH, solvent, etc.), thus improving 
the reaction yield [60]. However, it may be difficult to match the enzyme reaction rates to each 
other, in order to operate the cascade reaction with the maximum productivity [150]. An enzyme 
can also be kept in a single reactor, thus avoiding possible side-reactions in the following reactor, 
either through one of the mentioned immobilization strategies, or by using in-line filtration 
steps coupled with re-circulation [60]. Enzyme immobilization or retention in a reactor module 
also facilitates downstream product purification steps, besides enabling a higher degree of 
control on the reaction space [150]. Furthermore, a simple reversible enzyme immobilization 
technique would also grant the re-use of the microfluidic reactor and its easy application in a 
new process [46]. Connection of the reactor modules with chiral columns, solvent extraction 
modules, filtration and separation systems, allows the exchange of solvents or buffers between 
reactor modules, as well as removing enzymes and/or products that might affect the next 
reaction in the sequence, and thus greatly improve the overall yield and productivity [59], [60]. 
The integration of sensors in microfluidic platforms would facilitate the monitoring and 
characterization of biocatalytic reactions as well as the optimization of the parameters that fit 
each and all of the reactions in a cascade system [46]. Of the wide variety of sensing strategies 
available for microfluidic devices (optical [164], [165], electrochemical [166], mass spectrometry 
[167], magnetic [168], Raman spectrometry [169], among others [74]), very few have been 
applied for monitoring and characterization of biocatalytic reactions due to the wide spectrum 
of generated substrate(s) and product(s) and the need to identify chiral compounds. 
Quantification is thus usually performed at- or offline with analytical equipment such as high-
performance chromatography (HPLC), gas chromatography (GC), mass spectrometry (MS), UV-
VIS spectrophotometry and nuclear magnetic resonance (NMR). Even though, miniaturization 
of some of these techniques (e.g. NMR [146], UV-VIS spectrometry [170], Absorption [171]) or 
improved world-to-chip connectivity to others (e.g. MS [167], Infrared and UV-VIS spectrometry 
[170]) have been developed, a simpler approach involves the production of a compound that can 
easily be detected with existing technology (e.g. optical detection of colorimetric or fluorescent 
compounds [170]). Another approach, is to monitor the reaction by the change of an operation 
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parameter which can be directly related to the reaction [46], such as temperature (e.g. 
exothermic reaction), pH [172], [173] or oxygen [174], [173]. 
2.1.2 Optical sensing 
As highlighted in Chapter 1, and mentioned in the previous section, there are several 
detection methods that can be applied in microfluidics. Optical detection is one of the most 
extensively used, especially towards biological applications. Optical-based sensors present 
several attractive characteristics, such as fast response, compactness, high sensitivity and the 
possibility of contactless measurement [74]. However, for more complex and dense matrices 
found in biotechnological or medical applications, and auto-fluorescent or light responsive 
materials, their application can become difficult or strictly limited. Optical methods can be 
separated into methods that comprise direct detection by monitoring the light properties, and 
the detection of modulation of such properties.  
Direct detection can be achieved through: 
• Fluorescence emission of fluorophores or fluorescent dyes that label the target analyte 
when excited by a given wavelength is a type of direct detection method. It is a highly 
sensitive and selective detection method that requires target sample labelling and is the 
most common method used for biological samples. Fluorescent detection is sensitive to 
interferences from the sample matrix, thus usually requiring sample pre-treatment [170]. 
It can also present sensitivity to certain materials (namely polymers) used in microfluidic 
systems, which present auto-fluorescence; 
• Absorbance measurements occur by monitoring the attenuation of a specific wavelength 
of incident light by absorption by certain functional groups when crossing the sample 
[170]. It is usually achieved through the use of optical fibers connected to a benchtop 
absorbance spectroscopic equipment and integrated microlens and slits to extend the 
optical path. The simplicity of absorbance measurement instrumentation overcomes its 
lower sensitivity relative to other optical methods (e.g. fluorescence) for application in 
point-of-care [175]; 
• Luminescence-based methods are characterized by the entrapment of a luminescent probe 
in a matrix. The analyte permeates through the matrix affecting the emission signal of 
the probe, which is monitored [176]. A more extensive description of luminescent detection 
is provided in section 2.1.2.1. 
Detection due to modulation of light properties includes: 
• Surface plasmon resonance (SPR) detection is based on resonant oscillations of conduction 
of metallic electrons (e.g. gold or silver) when coupled with photons from polarised light 
exposed at a particular angle or wavelength. This produces an evanescent wave effect on 
the metallic sensing surface.  Detection occurs through the difference of refractive index 
between the target sample bound on the surface of the sensor and the dielectric 
environment [177], [178], [179]; 
• Evanescent waves are based on a mono-mode optical waveguide, where the field of the 
guided light decays exponentially with the distance to the core region of the waveguide. 
When the analyte interacts specifically with the label immobilized on the waveguide, its 
guiding properties change, consequently changing the evanescent field. Evanescent-based 
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sensing requires a reduced or no sample pre-treatment since only surface phenomena are 
detected [180]. 
• Optical waveguides are based on the formation of a standing wave when an incident light 
beam fulfils the condition of total reflection. They allow the propagation of light over an 
increased region that presents a higher refractive index than the surrounding medium. 
The coupled light intensity used for quantification will vary with the thickness of the 
adsorbed biomolecules layer (the higher the thickness, the higher the amount of molecules 
adsorbed at the surface) [177], [181]. These sensors consist of dielectric metal oxides, 
which can be coated with an indium doped tin oxide (ITO) layer to integrate them with 
electrochemical sensors [182], [183]. 
• Interferometry is based on the interference that a light wave that passed through the 
sample has on another light wave that followed a reference path, considering that both 
have the same source. When the two light waves are recombined, they produce 
interference fringes that represent the phase difference between the two light waves. 
Analyte information is contained in the shifts of the phase and position of the interference 
fringes [184]. The reference path allows removing the effect of non-specific adsorption and 
temperature and intensity changes [175]. This type of sensors when combined with 
waveguides possess a high sensitivity and a broad dynamic range [180].  
• Raman spectrometry is based on the detection of Stokes and anti-Stokes shifts of non-zero 
polarizability molecules. It allows identification of materials through “fingerprinting” with 
a sub-micron spatial resolution in low concentration samples [185],[169]; 
• Optical microfibers are micro or nano waveguides with high-contrast index relative to the 
surrounding material, that enable optical detection with a very low percentage of energy 
loss of evanescent waves [186]; 
Optical methods can be coupled with each other to enhance detection or to stimulate a 
certain specific phenomenon, an example of which is the use of optical fibres and waveguides to 
increase sensitivity  [74]. Table 4 presents a summary of the main characteristics of some of the 
presented optical detection methods. 
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Table 4 - Main characteristics of optical detection methods to consider when choosing a sensing approach [74]. In this table disposability refers to the devices 
ability to be discarded as general waste (once decontaminated). 
Detection method 
Type of 
sample 
Analyte 
concentration 
Sample pre-
treatment 
Limit of 
detection 
(LOD) 
Compatible 
materials/ 
fabrication 
methods 
Reusability Cost Disposability Issues Examples 
O
p
ti
c
a
l 
Fluorescence 
Mainly 
liquid, but 
also solid; 
usually 
biological 
Low to high Yes, labelling  
Down to µM  
and single 
biomolecule  
[74] 
Optically clear 
materials 
Medium (risk of 
cross-contamination 
or traces of 
fluorophore) 
High 
High, but depends 
on toxicity of 
device material 
and fluorophores 
used 
Requires mathematical tools 
for signal corrections; 
Depends on available 
appropriate fluorophores 
[74]; Usually requires 
external readout systems 
(e.g. microscopes) 
Temperature and flow 
velocity 
determination; cell 
function monitoring; 
interaction of 
biomolecules and 
protein binding [187]; 
polymer dynamics [74] 
Absorbance Gas, liquid Low to high 
Little to none 
(except 
maybe 
dilution) 
Down to µM 
Optically clear 
materials, coupled 
with integrated 
mirrors and 
microlenses [175] 
High Medium High 
Requires mathematical tools 
for signal corrections 
specially for biological 
samples due to the presence 
of water; sensitivity 
decreases with decreasing 
path length due to reduced 
sample volume 
Quantitative 
immunoassays, 
quantification of 
biomarkers [188] 
Luminescence 
Mainly 
liquid and 
gas, 
especially 
small 
molecules, 
 
 
 
Low to high 
 
 
 
Little to none, 
but depends 
on probe 
sensitivity 
and matrix 
chosen 
Down to µM 
Optically clear 
materials; mild 
temperatures or 
sensor integration 
post chip 
fabrication 
High (risk of cross-
contamination or 
traces of 
fluorophore) 
Medium to 
low 
(depending 
on probe 
material 
and 
readout 
system 
used) 
Low, but depends 
on toxicity of 
device material 
and luminophores 
used? 
Requires mathematical tools 
for signal analysis; Care 
must be taken during 
fabrication in order not to 
affect probe; measurement 
may depend on matrix/probe 
homogeneity; photobleaching 
Determination of 
process parameters 
(oxygen and pH), 
measurement of small 
molecules (e.g. oxygen, 
glucose, ethanol) 
[176];  
SPR 
High 
molecular 
weight 
analytes (> 
100 Da) 
Low to high 
Little to none 
[180] 
Down to 
nanomolar 
(pM if gold 
nanoparticles 
are used 
[188]) and 
single 
biomolecule 
[74] 
Optically clear 
materials, coupled 
with nano 
structures 
Medium to low (due 
to surface 
functionalization) 
Medium to 
low 
Low, but depends 
on toxicity of 
device material 
Requires a large sensing 
area, having a low 
throughput and a small 
penetration depth; Hard to 
differentiate specific from 
non-specific interactions[74], 
highly dependent on 
temperature [175] 
Material’s refractive 
index, molecular and 
chemical reactions, 
binding of 
biomolecules, polymer 
dynamics[74], 
biomolecules and cells 
[175] detection 
Raman 
Spectrometry 
Liquid 
Very low (highly 
diluted samples) 
Yes, but 
label-free 
Down to sub-
picomolar and 
single 
molecule[74] 
Optically clear 
materials, coupled 
with nano 
structures 
Medium (risk of 
cross-contamination 
or traces of 
fluorophore) 
High High 
May have overlapping peaks; 
Has a small penetration 
depth; denaturation of 
biomolecules may occur due 
to laser used [74] 
Detection of single 
molecules, study of 
large biomolecules, 
analysis of chemical 
processes [74] 
Micro scale reactor system development with integrated advanced sensor technology  
36 
 
2.1.2.1 Luminescent sensors 
Luminescent-based sensing elements can be easily integrated by immobilization of the 
matrix used for entrapment. The selected matrix should allow diffusion of the target sample 
through so recognition occurs, but simultaneously prevent leaching of the entrapped sensing 
element [176]. Luminescent sensors are thus mostly used to monitor small molecules (such as 
ions and gases) and process parameters (such as temperature and pH) [173]. The choice of 
matrix, usually polymeric, depends on the sensing probe to be entrapped and target sample, but 
also on the immobilization surface and/or method.  The fabrication method also affects the 
sensor performance and sensitivity, especially for intensity-based detection approaches where 
uniformity and homogeneity of the sensing layer impacts accuracy and spatial resolution [176], 
[164].  
A highly relevant factor to consider when integrating this type of sensors is compatibility 
of the sensor material with the microfluidic chip fabrication steps, especially bonding, when it 
occurs at high pressure and/or temperature, and plasma treatments [164]. A sensor layer can 
be integrated in a microdevice through different methods. The most common are spin or blade 
(or knife) coating, that create films with thicknesses down to hundreds of nanometers, but 
require patterning after layer deposition with (wet) etching and photolithography techniques 
[176], [165]. Another commonly used technique is spray-coating, which allows homogenous 
sensor deposition on different types of surfaces, and where patterning depends on the use of 
stencils [165]. In situ polymerization, for example using sol-gel or photopolymerization of PEG 
acrylates [176], is also often used, especially for glass or quartz substrates. Photopolymerization 
results in sensors with highly accurate and small dimensions, through the use of photomasks 
or moulds [165]. Another approach, involves covalent binding of the probes to the surface 
(usually glass or modified glass) [189]. Some research groups have opted to use PDMS as the 
matrix material, thus allowing a simple and direct integration of the sensing probe in the 
microchannel (also of PDMS or glass) [165]. Another technique, that allows precise definition 
and positioning of the sensor spots, is inkjet printing [176], [165]. Other research groups have 
used less standard approaches such as magnetic trapping (embedding magnetic nanoparticles 
together with the luminescent dye [190]) and optical tweezers (achieving entrapment of 
functionalized luminescent particles along the channel [191]).  
In terms of measurement, sensing can be intensity-based, lifetime-based or based on 
ratiometric methods [176]. The intensity of the probe’s signal can be directly related to the 
analyte concentration, however it is affected by background fluorescence, inhomogeneities in 
the dye distribution, excitation intensity, ambient light and photobleaching (especially when 
long-term and constant excitation of the luminophores is performed) [176], [164]. Both lifetime 
and ratiometric detection methods are referenced, thus overcoming the influence of external 
factors in the measurement [164]. Luminescent lifetime methods can be performed based on the 
frequency-domain, where the excitation light is sinusoidally modulated, resulting in a signal 
with the same waveform,  where the delay (phase shift) of the emission wavelength relative to 
the excitation is related to the lifetime of the used fluorophore [176]. Lifetime determination in 
the time domain, on the other hand, can be performed either through single photon counting, 
where the time between excitation and photon detection is recorded in a decay curve and fitted 
by an exponential function, or by recording the emission phase in (usually two) time-gates whose 
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intensity ratio is used for quantification [165]. Fluorescent lifetime imaging microscopy (FLIM), 
used in cell applications, uses a modulated excitation source and detects the decay in intensity 
either in the time or frequency domain [192]. In the ratiometric measurements, two compounds 
(one analyte sensitive and the other a reference dye) which emit at distinct wavelengths are 
used. The ratio between the two emitted wavelengths is then used for analyte quantification 
[176], [164].  
Readout of luminescent-based systems can be performed with optical fibers, when sensor 
spots are integrated [174] or if single point measurements are required, resulting in a simple 
measurement setup. These sensors can also be integrated on the tips of optical fibers, allowing 
the reuse of the sensors and their application in more cell culturing or biocatalytic reaction 
formats and scales. However, if a sensing layer is immobilized over the entire surface of the 
device, spatial imaging of the target analyte can be achieved, enabling the imaging of gradients 
of the target compound [176]. Furthermore, if multiple fluorophores are immobilized, they can 
be measured simultaneously allowing measurement of the same analyte or measurement of 
different analytes in parallel channels [193], [194]. 
2.1.2.2 Chemical oxygen sensors 
Oxygen sensors are among the most well-developed and widely applied sensors, especially 
within biotechnological and cell applications [176], [164]. There are several types of sensors used 
for probing oxygen. 
The classical oxygen sensor is the Clark electrode, which is composed of a platinum working 
electrode and a silver chloride reference electrode with potassium chloride as the electrolyte, 
being all the components covered with a PTFE gas-permeable layer to protect the electrodes 
from fouling. At a potential of 0.8 V, oxygen is reduced at the working electrode, and an electrical 
current proportional to the amount of oxygen is produced. These sensors present several 
disadvantages, such as a low temporal and spatial resolution, the relative size (which 
complicates their integration in microfluidic systems) and the fact that oxygen consumption is 
required for its quantification, thus requiring stirring, while producing hydroxide ions which 
are potentially harmful to cells and biological samples. They are furthermore sensitive to 
temperature and unreliable for long-term measurements due to depletion of the electrolyte, 
adsorption of biomolecules to the PTFE layer (which loses permeability) and anode coating with 
AgCl [192]. 
On the other hand, optical (chemical) oxygen sensors are usually highly sensitive and fast, 
inexpensive to produce and easy to integrate in microdevices, even enabling non-invasive 
monitoring [164]. Furthermore, they do not consume oxygen, thus enabling their application in 
static environments, and also do not suffer fouling thus being capable of being used for long-
term measurements. Optical oxygen sensors are often based on luminophores whose 
phosphorescent emission is quenched (by collisional quenching [164]) in the presence of oxygen. 
The decrease in intensity results from an energy transfer from the excited luminophore to the 
oxygen molecule, generating a singlet (state) oxygen [165]. Singlet oxygen has been observed to 
interfere with oxygen measurements in microchannels [190]. The quenching mechanism is 
usually reversible and the degree of quenching depends on the oxygen partial pressure in 
solution. 
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The relationship between intensity measured and oxygen partial pressure is described by 
the Stern-Volmer equation (Equation 15), where 𝐼0  and 𝐼  correspond to the luminescent 
intensities without and with the quencher, 𝜏0 and 𝜏 are the corresponding lifetimes, 𝐾𝑆𝑉 is the 
Stern-Volmer quenching efficiency constant and 𝑝𝑂2 is the oxygen partial value [164], which is 
directly related to oxygen concentration by Henry’s Law [165]. According to Henry’s law, when 
a liquid and a gas mixture are at equilibrium, the concentrations of the gases in the liquid are 
proportional to their partial pressures/molar concentrations in the gas mixture. 
Equation 15 
 
Most dyes are either based on ruthenium or metalloporphyrins (e.g. Pt(II) or Pd(II) 
complexes), usually trapped in a polymeric layer for easier integration in microfluidic channels 
or other features [192]. Platinum(II) octaethylporphyrine ketone (PtOEPK), which has a high 
quantum yield, is one of the most used dyes as sensing element for oxygen studies in cellular 
applications due to its long lifetime, high photostability, and low photobleaching rate relative to 
other fluorescent dyes [195]. Furthermore, the excitation (570 nm) and emission (760 nm) 
wavelengths of this dye induce a large Stokes shift which allows reducing the signal-to-
background ratio [196], while reducing influence of background fluorescence or scattering from 
the polymeric material [164]. 
Oxygen sensors for microtechnological applications exist in a variety of formats. Soluble, 
usually water soluble, indicators (oxygen sensitive dyes) are free or entrapped in a polymer that 
can be mixed with the solution and introduced in the system (a microchannel, for example) [165]. 
However, they require a high luminophore concentration (turning them sensitive to 
interferences from the sample) and display a low sensitivity and selectivity, as well as an 
aggregation tendency, among other disadvantages [164]. An important issue to consider is the 
need to separate the indicator dye at the outlet, if further analysis are required [165]. The most 
common sensor format is the sensor layer, a mix of luminescent dye, polymeric matrix and 
additives dissolved in a solvent which can be deposited through one of the several methods 
explained in section 2.3.1. and then dried, polymerized or cured on a surface. This format allows 
for higher signal-to-noise ratios and decreasing signal interference by the sample, however they 
present longer response times (time for sample diffusion through the matrix) and are usually 
restricted to point measurement or 2D imaging [164]. Another sensor format are sensor 
particles, obtained either by adsorption of the sensitive dye to the surface of micro or 
nanoparticles, polymerization or precipitation of the sensor cocktail or by grinding the matrix 
with embedded dye.  This format is the most flexible in terms of integration and application 
since it can be used either as a dissolved indicator or as a layer. Due to their dimensions, they 
also present significantly faster response times, a higher dye loading, selectivity and sensitivity, 
while also featuring three-dimensional imaging [164]. Two- or three-dimensional oxygen 
imaging provides a better understanding on oxygen distribution and fluidic dynamics in the 
microfluidic system, as well as on the generation of gradients and other interactions involved in 
the studied biological systems [164]. 
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2.1.3 Model reaction/ Enzyme models used 
Most of the microfluidic platforms presented in this work were characterized with the 
same model reaction, the oxidation of glucose by glucose oxidase coupled with the decomposition 
of hydrogen peroxide by catalase, (Chapter 2 and Chapter 4), or using these two enzymes 
(Chapter 5). Thus, a brief description of these enzymes and their reaction kinetics is presented 
below. These enzymes were selected as models for the study of the presented platforms due to 
their commercial availability and extensive accessible literature. 
2.1.3.1 Glucose oxidase 
Glucose oxidase (GOx, β-D-Glucose, oxygen 1-oxidoreductase, EC 1.1.3.4) is an 8 nm 
globular flavo-containing glycoprotein, composed of two identical 80 kDa subunits, that contains 
two tightly (but not covalently) bound  molecules of flavin adenine dinucleotide (FAD), acting as 
redox carriers [197], [198]. It was first identified in 1928 by Muller in Aspergillus niger, but it 
has since been isolated from a variety of sources over the years (e.g. red algae, citrus fruits, 
bacteria) [197]. GOx has been widely applied in biosensors and the clinical analytical field for 
the selective quantification of glucose in biological samples (especially for glucose quantification 
in the blood of type I diabetes patients), but also in other areas such as food industry (e.g. as a 
preservative, to improve color and shelf-life of food) and biochemistry (e.g. as a label in 
immunoassays) [135], [197], [199]. GOx from Aspergillus niger is capable of oxidizing glucose, 
with a preference for β-glucose, to glucono-δ-lactone, using a variety of oxidizing substrates, 
such as oxygen, quinones, certain diamines, ferricyanide (widely used in glucose electrochemical 
sensors) and indophenols [197]. It has been observed that in the absence of an oxidizing 
substrate (e.g. in anoxic conditions), GOx can become fully reduced, which disturbs the reaction 
mechanism. In this form, the enzyme is in turn 100 times more sensitive (than the oxidized form 
of the enzyme) to one of the reaction products from oxidation with oxygen, hydrogen peroxide 
(at concentrations above 5 mM) [200]. However, the reduced form is also the more stable of the 
two states [197]. The initial product of glucose oxidation, glucono-δ-lactone is a mild competitive 
inhibitor of GOx. Glucono-δ-lactone however can hydrolyse spontaneously to gluconic acid, and 
the higher the pH the more the equilibrium tends to the gluconic acid side [197]. Inhibitors of 
GOx include micromolar amounts of heavy metals (e.g. mercury and silver), aldohexoses (act as 
competitors), halide ions at low pH and hydrazines [197]. 
In terms of reaction kinetics, GOx reacts according with the Ping Pong Bi Bi mechanism 
(Figure 7,Equation 16) [198]. When β-D-glucose and oxygen are the substrates, the reaction is 
nearly irreversible (𝑘2 ≈ 𝑘4 ≈ 𝑘6 ≈ 𝑘8 ≈ 0), and can be simplified to a two-substrate substituted-
enzyme Michaelis-Menten kinetics (Equation 17) [201], [202] with 𝐾𝑚 𝑜𝑥𝑦𝑔𝑒𝑛 0.25 mM [197] – 
0.82 mM [202] and 𝐾𝑚 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 around 33 mM [203] – 110 mM [202] for GOx from Aspergillus 
niger. In Equation 17, kcat is the catalytic constant or turnover number (number of molecules of 
substrate that one molecule of enzyme can convert into product(s) in one unit of time), [E0] is 
the total concentration of enzyme at the start of the experiment, and Km oxygen and Km glucose are 
the Michaelis constants (concentration at which the reaction rate is half of the limiting rate, 
where the enzyme is saturated by the substrate) of oxygen and glucose, respectively [204]. The 
reaction mechanism initiates with the rapid formation of an enzyme-substrate complex, 
followed by the reduction of FAD. After release of the formed product (glucono-δ-lactone), the 
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active reduced form of the enzyme (FADH2) is then oxidized by oxygen, generating hydrogen 
peroxide (and FAD) [197], [198]. 
 
Figure 7 – Scheme (according to the Cleland notation) of the Ping Pong Bi Bi mechanism for GOx, where E is the 
oxidized form of GOx, F is the reduced form of GOx, A is the β-D-glucose, P is the glucono-δ-lactone, B is the oxidizing 
substrate (e.g. oxygen) and Q is the reduced oxidizing substrate (e.g. hydrogen peroxide) (from [198]). 
 
Equation 16 
  
Equation 17 
  
The reaction of GOx using oxygen as the oxidizing agent generates hydrogen peroxide, 
which is harmful and toxic to most organisms, Thus, in nature, these enzymes are often coupled 
with peroxidases (enzymes capable of reducing hydrogen peroxide) [205], and especially, 
catalase. 
2.1.3.2 Catalase 
Catalase (EC 1.11.1.6), which was identified as a new enzyme and named by Loew in 1902 
[206], is mostly an intracellular enzyme found in cells (from plants and bacteria to mammals) 
that contain a cytochrome system. It is presumed to protect cells exposed to ionizing radiation 
by decomposing the hydrogen peroxide produced in the process, but other functions are also 
possible (e.g. oxygen regeneration for re-use by aerobic dehydrogenases) [207]. Catalase is 
currently used in different applications from assessing the state of wastewater, to fabrication of 
biofuel cells and cosmetic materials [208].  
Catalase is a peroxidase capable of decomposing hydrogen peroxide to oxygen and water, 
but also of oxidizing H-donors (e.g. ethanol, phenols) [209]. It has four subunits with a hematin 
(porphyrin heme) prosthetic group each, and an overall molecular weight of 150 kDa [207]. It 
presents a low stability at low enzyme concentrations, due to a mass action effect that leads to 
subunit dissociation [208], [210]. At very high concentrations, thermally induced denaturation 
and aggregation is promoted [208]. It is inhibited by anions such as, acetate, fluoride or cyanide, 
but also compounds like cyanogen bromide, cyanide, azide, hydroxylamine, mercaptoethanol 
and aminotriazole [207]. 
The reaction occurs by formation of an enzyme-H2O2 complex through the iron of the 
prosthetic group (oxidixing the heme to an oxylferryl species), followed by H2O2 decomposition 
where a second H2O2 molecule acts as H-donor (and regenerates the resting state of the enzyme) 
[211]. This reaction is favoured relative to using other H-donors when the substrate 
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concentration is above 0.1 mM [207]. The decomposition of H2O2 does not follow a Michaelis-
Menten kinetics, but for hydrogen peroxide concentrations below 200 mM, apparent Michaelis-
Menten values can be retrieved [211]. However, it is usually considered to follow a first order 
reaction (Equation 18), which is proportional to the concentration of H2O2 (at least up to 50 mM 
of hydrogen peroxide) [209]. Turnover numbers of 5.4x104 s-1 [211] to 3.5x106 s-1 [207] have been 
reported for catalase. 
Equation 18 
 
The reaction of catalase with hydrogen peroxide is exothermic, like the glucose oxidation 
reaction by GOx [197]. Hydrogen peroxide seems to have a significant harmful effect on catalase 
at concentrations above 100 mM [212]. However, addition of hydrogen peroxide and catalase 
solutions has been applied in bioreactors [213], [208] as an alternative to bubbling the 
fermentation broth with air. 
2.2 Goal 
In this chapter, it is intended to provide strategies for the application of a commercially 
available microfluidic system in the study of enzymatic reactions and biocatalyst screening. This 
involved the characterization of the system with a specific enzymatic cascade reaction, the 
oxidation of glucose with glucose oxidase coupled to the decomposition of hydrogen peroxide by 
catalase. The performed reaction was monitored using integrated luminescent oxygen sensors, 
coupled with analytical quantification of the main product (gluconic acid) at the outlet by high-
performance liquid chromatography (HPLC).  
Strategies for in situ oxygen generation and validation of the integrated oxygen sensors 
with external analytical measurements were developed and are also presented. Furthermore, a 
computational fluid dynamic model including the enzymatic reaction mechanism was developed 
to gain a more comprehensive understanding of both the chosen reaction and the performance 
of the used microfluidic system. The model was used to investigate underlying phenomena, such 
as oxygen limitation, reaction dynamics and the influence of chosen materials, to achieve a 
better understanding of the obtained experimental data. 
2.3 Materials & Methods 
2.3.1 Reagents and Materials 
Glucose oxidase (EC 1.1.3.4, type VII, from Aspergillus niger, ≥100,000 U/g solid), 
Catalase (EC 232-577-1, from bovine liver, lyophilized powder, 2000-5000 units/mg protein) and 
Horseradish peroxidase (EC 1.11.1.7, lyophilized, 150 U/mg) were obtained from Sigma (St. 
Louis, MO, USA). Gluzyme® Mono 10 000 BG (Glucose oxidase from Aspergillus niger (23%) 
with 10000 U/g, wheat solids (39%), Sodium Chloride 32%) and water (6%)) was acquired from 
Novozymes (Bagsvaerd, Denmark). D- Glucose (anhydrous) was provided by Fluka 
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(Loughborough, UK). Mono – and di-potassium hydrogen phosphate (anhydrous) were obtained 
from Merck (Darmstadt, Germany). Poly(ethylene glycol) (PEG) MW 6000 was acquired from 
Acrōs Organics (Geel, Belgium). Hydrogen peroxide (PerdrogenTM, 30% (w/w)), Sodium sulphite, 
Sodium hydroxide (reagent grade, 98%, pellets (anhydrous)), Phosphoric acid (85 wt. % in H2O, 
99.99% trace metals basis), Sodium 3,5-dichloro-2-hydroxy-benzenesulfonate (DCHBS) and 4 
Aminoantipyrine (4-AAP, reagent grade) were obtained from Sigma (St. Louis, MO, USA). All 
the solutions for sensor preparation were prepared with 50 mM phosphate buffer pH 7.5. All 
solutions were prepared in buffer. 
The two 10 mm acryl plates that form the custom-made holder were acquired from Rias 
A/S (Roskilde, Denmark). The holder was completed with one 5 mm thick SS304 stainless steel 
plate from Sanistål (Aalborg, Denmark), placed in-between the acryl plates for integration of 
the microfluidic chip. Flangeless polypropylene (PP) fingertight 1.5875 mm (ID) fittings (XP-
201) and flangeless ferrules (P200X) from Upchurch Scientific® (Washington, USA) were used 
to connect polytetrafluoroethylene (PTFE) 1.5875 mm (OD) x 1 mm (ID) tubing (S 1810-12) or 
1.5875 mm (OD) x 0.5 mm (ID) tubing (S 1810-08) from Bohlender (Grünsfeld, Germany). The 
extrusion poly (methyl methacrylate) (PMMA) sheet with thickness of 2 mm of the second 
meander channel was acquired from Nordisk Plast (Assentoft, Denmark). The PMMA plate was 
patterned using laser ablation with a CMA-4030 Laser Engraving machine from GD Han’s 
Yueming Laser Technology co., Ltd (Guangdong, China) and bonded to a 2-mm thick SS304 
stainless steel plate from Sanistål (Aalborg, Denmark) with a 142 µm thick double-sided 
adhesive tape mcs-foil 008 from microfluidic ChipShop (Jena, Germany) also defined with laser 
abrasion.  
2.3.2 Meander microfluidic channel 
The used microfluidic channel to perform the oxidation reactions presented in this chapter 
is a glass and silicon chip developed and batch-produced by iX-factory (now part of Micronit, 
Enschede, Netherlands) in Dortmund, Germany. The microchannel has two main inlets and one 
outlet, with 6 side inlets/outlets. It has a serpentine shape with 18.5 turns, 0.504 m length and 
a total volume of 10.08 µL, while the main inlet branched-channels have a volume of 0.44 µL. 
The 200 µm deep and 100 µm wide microchannel, as well as the seven chambers with the same 
geometry of the sensing areas (3.5 mm length and 1 mm width) were defined in a 675 µm silicon 
wafer by photolithography and deep reactive ion etch. The 1.5-mm inlets for fluidic access were 
fabricated on a glass wafer through powder blasting. The sensor layer was airbrush spray-dried 
onto the glass wafer to a thickness of ~2.2 µm using a silicon stencil and then cured for 24h at 
60 ⁰C. The glass and silicon wafers were irreversibly bonded using an anodic bonding process at 
180 ⁰C, 1000 V and 5 kN pressure for 4 h. After bonding, the wafers were diced into chips the 
size of microscopic slides (75.5 mm x 25.5 mm) [174]. The final meander microchannel with 
integrated oxygen sensors is presented in Figure 8. 
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Figure 8 – Schematics of the meander microfluidic channel with the main inlets and outlet emphasized. In orange, 
the five side inlets are highlighted, and in blue one of the seven oxygen sensors is indicated. 
2.3.2.1 Oxygen sensors 
The integrated oxygen sensors were developed and fabricated by the group of Ingo Klimant 
from the Working Group Sensor Materials of the Institute of Analytical Chemistry and Food 
Chemistry at the Technical University of Graz in Graz, Austria [174]. The sensors are based on 
the frequency-domain lifetime luminescence measurement of a luminescent platinum(II) meso-
tetra(4-fluorophenyl) tetrabenzoporphyrin (PtTPTBPF) sensor dye entrapped in a silicone 
rubber and polystyrene composite matrix [174]. The PtTPTBPF dye is excitable with red light 
(620 nm), and emits in the near-infrared (NIR) range (760 nm), which decreases background 
fluorescence or scattering due to the presence of biological matter. Moreover, the red light used 
for sensor excitation does not damage biological samples such as cells, enabling its use in a wide 
variety of biological applications [174]. The sinusoidally modulated red light excites the 
luminescent dye at a known frequency, which has a phase shift relative to the intensity 
modulated emitted luminescence [214]. Detection is performed by the measurement of the depth 
of modulation and phase angle shift of the emitted luminescence as a function of frequency in 
the presence of oxygen, which quenches the luminescence of the sensor’s dye [215]. The 
quenching behaviour is usually described by a modified Stern-Volmer equation, called the two-
site model, where it is considered that the dye can exist in two different environments that are 
quenchable, but at different rates (Equation 19) [216]. In the equation, 𝐼  and 𝐼0  are the 
luminescence intensity of the sensor in the presence and absence of the quencher (oxygen), 𝜏 
and 𝜏0 the corresponding luminescence lifetime, 𝑓 describes the distribution coefficient between 
the two media, 𝐾𝑆𝑉 is the quenching efficiency for the first environment, while 𝑚 is the factor 
defining the Stern–Volmer constant for the second environment [164], [189]. 
 
Equation 19 
 
These oxygen sensors are capable of measuring oxygen concentrations in solution and gas 
through the measurement of the decrease in luminescent intensity and lifetime as a function of 
the sensor’s oxygen tension [216]. The sensors can be calibrated through a two-point calibration 
using the two-site model to fit the calibration data and the constants from Table 5. These sensors 
have a resolution of 0.2-0.6 hPa (2.46x10-4 to 7.40x10-4 mM of oxygen) at oxygen concentrations 
below 50 hPa (0.06 mM of oxygen) and 1-2 hPa (0.001 – 0.002 mM of oxygen) at ambient air 
oxygen concentrations (8.6 mM of oxygen), with a limit of detection of 0.08 hPa (9.85x10-5 mM 
of oxygen) [174].  
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Table 5 - Constants of two-site model for the sensors used at 25 ⁰C. 
Fixed f  0.83858 
KSV 0.01923 
m 0.09793 
2.3.2.2 Polymeric valve chip 
The used valve microfluidic chip (product code: 19-1850-0155-03) was developed and 
manufactured by injection molding at Microfluidic ChipShop in Jena, Germany. The chip was 
made of polycarbonate and contains two different channels, one with 21 µL volume (and 6 
possible connections to channels) and another with 7 µL volume (and 4 possible connections to 
channels), each with their respective manually turned rotary valve. The microfluidic channels 
defined in the valve chip are 400 x 400 µm [217]. The chip is compatible with 1 mm inner 
diameter male mini Luer fluid connectors. In order to connect this chip to the meander 
microreactor, a strategy was devised involving small portions of PTFE tubing with a wider 
diameter that were used to connect the mini Luer connectors and the 1/16’’ outer diameter PTFE 
tubing compatible with the fingertight connectors used in the microreactor and the modular 
syringe pump system. 
 
 
Figure 9 – Schematics of the turning valve system from Microfluidic ChipShop. In orange, the valve corresponding 
to the 21 µL volume outlet channel and in green the valve corresponding to the 7 µL one. 
2.3.2.2 Permeable meander reactor 
The used PMMA microchannel was also a meandering microchannel with approximately 
100 µm width x 400 µm height and 44 µL volume. The microreactor was defined with one inlet 
and one outlet, that had the same dimensions as the tube used, i.e. 1.6 mm outer diameter. The 
channel was fabricated using laser abrasion and bonded to a stainless steel plate with a 142 µm 
thick double-sided adhesive tape. Plastic o-rings and a small PMMA plate with a hole with 1.6 
mm diameter were used as a simple connector to join the outlet of the silicon and glass 
microreactor to the PMMA microchannel. The o-rings and PMMA plate were kept in place with 
small office binder clips that provided sufficient pressure to avoid leakage in the inlet during 
flow conditions. 
 
 
Figure 10 – Photograph of PMMA meander channel. 
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2.3.3 Enzyme activity measurements 
Activity measurements of Glucose oxidase (GOx) and Catalase (Cat) were performed in a 
UV-1800 UV-Vis spectrophotometer with a CPS 240A cell positioner from Shimadzu (Kyoto, 
Japan). GOx activity was measured using a protocol adapted from Heuts et al. (2007) [218], 
where the hydrogen peroxide formed in the presence of glucose, is used by horseradish 
peroxidase (HRP,  4 U/mL) to oxidize 4-AAP (0.1 mM) and DCHBS (1 mM), forming a 
colorimetric (pink) compound. The formation of this compound can be followed at 515 nm (ε515= 
26 mM-1 cm -1) and its absorbance can be directly related to the amount of glucose consumed. To 
measure GOx activity 10 µL of 1:30 diluted GOx solution (~30 U/mL) were added to 990 µL of 
the reaction mixture. The activity of Cat (~400 U/mL, 0.00241 mM) was measured based on the 
protocols by Beers and Sizer (1952) [219] and Lück (1965) [220], by following the decrease of 
hydrogen peroxide concentration at 240 nm (ε240= 43.6 M-1 cm -1). To measure Cat activity 30 µL 
of 1:10 diluted catalase solution was added to 2970 µL of 10 mM hydrogen peroxide. Each 
spectrophotometric measurement was performed in triplicate for 2 min. 
The average kinetic parameters obtained for the two enzymes from the UV 
spectrophotometer-based assays are presented in Table 6. Table 7 presents the average activity 
of the GOx solutions used during this work and the corresponding nomenclature used 
throughout the text. 
 
Table 6 – Kinetic parameters obtained for GOx and catalase from the UV-based activity assays. 
Kinetic parameters Value 
KM, Glucose 26 - 33 mM 
Vmax 1 - 2x10-4 mM s-1 
kcat, Glucose 300 -500 s-1 
kcatalase 1.1– 2.6 x10-3 s-1 
 
Table 7 – Summary of glucose oxidase enzyme solutions and the corresponding nomenclature used here. 
Name Activity range (U mL-1) Concentration (mol m-3) 
10xGOx 110 – 170 0.006406 
5xGOx 55 – 85 (1:1 dilution of 10xGOx) 0.003023 
1xGOx 15 – 30 0.0006406 
0.5xGOx 7.5 – 15 (1:1 dilution of GOx) 0.0003023 
2.3.4 High-Performance Liquid Chromatography (HPLC) method  
All the reaction samples were analysed in an HPLC for quantification of consumed glucose 
and produced gluconic acid. The measurement was performed with a reversed-phase 
chromatography on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA) equipped with a 
Phenomenex column with 5-µm sized amine particles (Luna 5µm NH2 100Å), operated at 40 ⁰C 
and 140 bar. The mobile phase consisted of a 20 mM phosphoric acid (H3PO4) solution, flowing 
at 1 mL/min. The eluted gluconic acid was quantified in the ultraviolet (UV) multiple 
wavelength detector at 205 nm, while the glucose concentration was determined in the Refract 
Max 520 refractive index (RI) detector. The amount of each component was obtained by 
integration of the areas under the corresponding peaks using the HPLC commercial analytical 
software (Chromeleon 6.8), based on a calibration curve performed for each component. Samples 
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were measured mixed with 0.5 M sodium hydroxide (NaOH) solution in a proportion 1:2 of 
solution relative to the sample. 
2.3.5 Oxygen concentration measurements 
 The oxygen measurements inside the silicon meander microchannel were performed using 
four optical fibres ((Plastic fibre cable, simplex fibre 1 mm, PE-jacket 2.2 mm from Ratioplast-
Optoelectronics GmbH, Lübbecke, Germany) connected to a four-channel optical oxygen meter 
(FireStingO2 from PyroScience, Aachen, Germany). The lifetime luminescent measurement was 
performed through Pyro Oxygen Logger software provided by PyroScience with the parameters 
presented in Table 8. 
 
Table 8 – Parameters used for oxygen measurement in the microreactor with FireStingO2 and Pyro Oxygen Logger. 
LED intensity 30% 
Amplification of signal 400x 
Modulation frequency 4000 Hz 
Temperature 25 ⁰C 
Sample rate  1 sample per second 
 
Before each set of experiments, the sensors of the microfluidic chip being used were 
calibrated. Calibration was performed by measuring the dphi values (phase shift of luminescent 
emission relative to modulated excitation light) for 0 % and 100 % oxygen conditions. In this 
case, 100 % oxygen condition corresponded to an oxygen saturated buffer solution, which was 
achieved by shaking the flask containing the solution for several minutes before introducing the 
solution inside the channel. The 0 % oxygen condition was achieved either by adding an excess 
of Gluzyme to a glucose solution or using a solution with a sufficient amount of sodium sulphite. 
In the initial microchannel characterization experiments, this calibration was performed once 
per day, before initiating the experiments. For most of the data presented in this chapter, 
however, a simplified calibration was applied. The 2-point calibration was performed before the 
start of each set of experiments or when some deviation in sensor signal was observed, but not 
every day. Instead, the same dphi values recorded in the calibration were used and a manual 
background calibration (to adjust for the light conditions) was performed daily before initiating 
the experiments. 
Monitoring of oxygen during the experiments was performed by measuring partial 
pressure of oxygen inside the channel with the Pyro Oxygen Logger software. Afterwards, the 
data was extracted in an Excel file and converted to oxygen concentration using the Henry’s law 
(Equation 20), where 𝑝 is the partial pressure of the solute in the solution, 𝑐 is the concentration 
of the solute in the solution, and 𝑘𝐻 is the Henry constant.  
Equation 20 
 
For the calculations, a Henry constant of 811.899 L bar mol-1 was considered, which was 
obtained from an average of Henry constant values presented by Sander (1999) [221]. The 
oxygen concentration values presented in this work were calculated from an average of three 
intervals of oxygen partial pressure values measured during each experiment. Each interval 
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corresponded to the average sampling time at the outlet of one of the three samples measured 
in the HPLC per initial glucose concentration per experiment.  
2.3.6 Oxidation of glucose in the meander microfluidic channel 
The performance of the microfluidic channel in terms of quantification was evaluated 
through the use of an enzymatic cascade reaction, the oxidation of glucose with glucose oxidase 
coupled with the decomposition of hydrogen peroxide by catalase (Figure 11).  
 
Figure 11 – Glucose oxidation reaction with glucose oxidase (a) and hydrogen peroxide decomposition with catalase 
(b). 
Both enzymes were introduced through inlet 1 (the ratio between the enzymes varied 
between the different experiments) and the substrates (glucose and oxygen) were introduced 
through inlet 2, as shown in Figure 12. The glucose solution introduced was always shaken for 
several minutes before introduction inside the channel, so it would be oxygen saturated. It is 
thus assumed that the solution in inlet 2 is oxygen saturated, while the concentration of oxygen 
in the enzyme solution is unknown but lower than in inlet 2. To facilitate the retrieval of the 
samples a 5-cm long PTFE tube (with 0.5 mm inner diameter) was placed at the outlet. This 
corresponded to an added 9.82 µL of reaction volume relative to the volume of the meander 
microchannel. Sampling was performed by submerging the tip of the outlet tube in 100 µL of 
0.5 M NaOH solution, used to stop the reaction and move the product towards gluconic acid 
[222]. The outlet used in the experiments was not the outlet of the reactor due to a limitation of 
the casing built in-house, so the last side inlet was used as the outlet. The syringe pump system 
used to introduce the solutions inside the microreactor was a stepper motor-driven modular 
digital pump Cavro® XP 3000 with two glass syringes with a stroke volume of 250 µL and one 
glass syringe with 500 µL stroke volume from Cavro Scientific Instruments, Inc. (San Jose, 
California, USA). The flowrates were defined using LabViewTM 2010 (v10.0) from National 
Instruments (Austin, Texas, USA). The sensors were positioned in accordance with Figure 12 
to concede a good overview of the progression of the reaction inside the microreactor. 
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Figure 12 – Schematics of the experimental setup used for monitoring the glucose oxidation reaction coupled with 
hydrogen peroxide decomposition, calibration curve determination and increase of oxygen concentration inside the 
channel, with the sampling procedure represented and the position of the four sensors used for measurement 
highlighted. 
2.3.6.1 Characterization of the meander microfluidic channel 
The residence time until detection in the different sensors used for monitoring was 
obtained by introducing water in the channel at a known flowrate (1 µL s-1) and observing when 
a change in sensor signal was observed for the different sensors. The values used for the 
calculations, presented in Table 9, are average values of five experiments. Since the values were 
taken by observation of the raw data, one by one, with an approximate value for the start of 
flow, they have a wide margin of error associated with them, as can be observed in the table 
below. 
 
Table 9 – Average values of residence time obtained for the sensors used for reaction monitoring. 
Sensor position Residence time (s) 
1 3.55±1.4 
2 5.05±1.5 
4 7.55±1.6 
5 9.25±1.5 
 
For the determination of reaction volume, the whole channel was considered, including a 
portion between the fifth side inlet and the main outlet, actually not used. The reaction volume 
considered corresponded to the sum of the volume of the meander microchannel (10.08 µL) and 
the 5-cm tubing connected to the outlet, thus resulting in a total volume of 19.9 µL for the 0.5 
mm ID tubing.  
The microfluidic system was also evaluated in terms of enzyme adsorption by comparing 
a reaction performed with and without polyethylene glycol (PEG). PEG is a hydrophilic molecule 
that preferably adsorbs to the surface, passivating it and decreasing adsorption by the 
biomolecules [223]. A solution of Gluzyme (0.2 g L-1) and a solution of glucose (50 mM), both 
either with or without PEG 6000 (1% w/w) were introduced inside the channel at a flowrate of 
0.4 µL s-1 and monitored for 4 h. A decrease in oxygen partial pressure would indicate the 
occurrence of enzyme adsorption in the channel and thus adsorption and accumulation of GOx 
in the channel. Since no significant decrease of signal was observed during the experiment 
without PEG (Figure 13), enzyme adsorption was not considered to be a major issue in this 
system if proper cleaning procedures were implemented. However, the observed variability in 
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sensor performance between experiments at the same conditions (Figure 13) was thought to 
derive from inaccurate calibration. Thus, to improve sensor performance and decrease 
variability between experiments, the final calibration procedure described in section 2.5 was 
adopted. 
 
Figure 13 – Oxygen partial pressure measurement of experiments with solution with and without PEG 6000, 
performed at the same conditions. 
Characterization of the meander microfluidic channel was initially performed using 
Gluzyme®. However, since the amount and activity of catalase in this enzyme preparation is 
unknown [224], pure GOx and catalase (commercially available) were used for the 
quantification experiments. 
2.3.6.2 Oxygen quantification calibration curve 
In order to achieve a quantitative output of glucose and gluconic acid concentrations from 
the oxygen sensors, reactions with different residence times were executed. These experiments 
were performed at different flowrates and structured to be able to match the residence time in 
oxygen sensor 5, to the residence time at the outlet of the tube, as presented in Table 10. This 
was performed for only one sensor, since it would be extremely time-consuming to perform the 
necessary experiments to match the residence time of each sensor with an equivalent residence 
time at the outlet. Sensor 5 was chosen because it was the last of the monitored oxygen sensors, 
but not the last of the available oxygen sensors thus allowing a reference point before the 
reaction was thought to run to an end. This sensor also resulted in a closer match between the 
flowrate at the outlet and at the sensor between the selected consecutive flowrates. Two 
different concentrations of GOx were used (6.046x10-4 mol m-3 and 3.023x10-4 mol m-3) with a 
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high amount of catalase (830 U mL-1), to achieve a higher range of oxygen vs. glucose and 
gluconic acid concentrations. To achieve the residence times presented in Table 10, experiments 
were performed at 2, 1, 0.5 and 0.25 µL s-1. 
 
Table 10 – Flowrates and corresponding residence times at sensor 5 and outlet used to achieve the sensors calibration 
curve (indicated by the green arrows). 
 
2.3.6.3 Increase of oxygen availability in the meander microfluidic 
channel 
Two strategies were applied to increase oxygen availability inside the microfluidic 
channel: addition of catalase and addition of hydrogen peroxide. Both strategies used catalase’s 
ability to decompose hydrogen peroxide in oxygen and water as in Equation 19 (b). Solutions 
with different amounts of catalase (460 U mL-1, 830 U mL-1 and 2950 U mL-1) or various 
hydrogen peroxide concentrations (0.1 mM, 0.25 mM and 0.5 mM) were introduced at the same 
flowrate (0.34 µL s-1) through the third side inlet of the microchannel, as presented with a purple 
arrow in Figure 12. To account for oxygen present in the buffer, water was also introduced in 
the side inlet, as a third strategy to increase the oxygen concentration in the microchannel. Inlet 
solutions introduced in the main inlets, also at a flowrate of 0.34 µL s-1, contained 5xGOx with 
either 94 U mL-1 or 830 U mL-1 of catalase. The flowrate of 0.34 µL s-1 was chosen in order to 
achieve a total flowrate at the outlet close to 1 µL s-1 and allow a better comparison with the 
experiments performed with only two inlets, with a flowrate of 0.5 µL s-1 at each inlet. 
 
2.3.7 CFD simulations of the oxidation of glucose in the meander 
microfluidic channel 
The same glucose oxidase and catalase cascade reactions performed inside the 
microreactor were simulated using a computational fluid dynamic simulation software, ANSYS-
CFX Version 16.2 (Canonsburg, Pennsylvania, USA). The three-dimensional designs of the 
microchannel and tube geometries were designed using a meshing software, ANSYS ICEM 
CFD® 16.0 (Canonsburg, Pennsylvania, USA), and discretization of the geometry into smaller 
elements (where the equations for momentum, energy and mass balance are solved by ANSYS-
CFX software) was performed (Figure 14). The microchannel geometry contained 478744 
elements (61264 elements/ µL). The geometry of the tube used was divided in the fluid region 
and in the tube region, both defined with o-grids so as to allow a structured circular mesh. The 
0.5 mm ID tubing geometry with both the fluid and tube region has 386561 elements (3852 
elements/ µL). All designs were simulated with a structured hexahedron mesh.  
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Figure 14 – 3D designs of the silicon and glass meander microchannel (a) and 0.5 mm ID tubing and fluid regions 
integrated (b) obtained using the meshing software, ANSYS ICEM CFD® 16.0.  
The simulations were performed with the same flowrates and substrate concentrations as 
used in the corresponding experiments, considering laminar flow (as described in Chapter 1) 
and fluid velocity as the input parameter at the inlets. The outlet was defined as an opening. 
More details regarding the boundary conditions defined in the simulations can be found in 
Appendix III. The velocities used in the simulations and corresponding Reynolds numbers are 
presented in Table 11.  
 
Table 11 – Flowrates used in the experiments and the simulations with the corresponding velocities and Reynolds 
numbers. 
Flowrate 
(µL s-1) 
Velocitychannel 
(m s-1) 
Rechannel 
Velocitytube 
(m s-1) 
Retube 0.5 mm 
2 0.05 7.45 0.01 1.49 
1 0.025 3.72 0.005 0.74 
0.5 0.0125 1.86 0.0025 0.37 
0.25 0.0625 0.93 0.00127 0.19 
 
Oxygen concentration was assumed to be at saturation values (0.258 mM is the solubility 
of oxygen in water at room temperature [225]) in the inlet where glucose was introduced, but at 
a lower concentration (0.19 mM) in the other(s). The lower value of oxygen was chosen by testing 
values between 0.15 mM and 0.2 mM of oxygen for one of the simulations. The kinetic 
parameters were based on the ones obtained in the activity measurements (Table 12), but the 
catalase reaction rate and the kcat of GOx were altered in order to match the experimental values 
of oxygen concentration measured by sensor 5 (reference sensor for the calibration curve).  
 
Table 12 – Kinetic parameters used in the CFD simulation of the enzymatic cascade reaction. 
Kinetic parameters Value 
KM, Glucose 33 mM 
KM, Oxygen 0.3 mM 
kcat, Glucose 250 - 1200 s-1 
kcatalase 2.586 x10-3 – 25.86s-1 
 
The enzymatic cascade reaction was simulated considering the substituted-enzyme 
mechanism of the Michaelis-Menten equation (Equation 17) [201], while hydrogen peroxide 
decomposition was assumed to be a first order-reaction (Equation 21) [209] for the experimental 
conditions tested. The rate constant for catalase was obtained spectrophotometrically for a 
different catalase concentration, so the ratio between the catalase concentration used in the 
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experiment and the one used to obtain 𝒌𝒄𝒂𝒕𝒂𝒍𝒂𝒔𝒆 was added to the rate expression. The turnover 
number (𝒌𝒄𝒂𝒕) was chosen instead of Vmax so that the amount of GOx added in each experiment 
(and which was changed between experiments) could be taken into account in the model.  
 
Equation 21 
 
In the simulation, it was further assumed that the amount of oxygen obtained from the 
reaction should be -𝑣𝑀𝑀 + 0.5 𝑣𝑐𝑎𝑡𝑎𝑙𝑎𝑠𝑒 , according to the reaction stoichiometry (Figure 11), 
meaning that the amount of oxygen corresponds to the amount consumed by GOx (equal to the 
amount of glucose consumed and the hydrogen peroxide and gluconic acid produced) plus the 
amount produced by catalase (which is half of the amount of hydrogen peroxide consumed). 
 
A diffusivity of 4.95x10-11 m2s-1 was assumed for the enzymes [197], 6.7x10-10 m2 s-1 was 
assumed for glucose and gluconic acid, and a value of 2.1x10-9 m2 s-1 assumed for oxygen and 
hydrogen peroxide [226], [227]. The compound concentrations obtained at the outlet of the 
microreactor simulation were used as inputs for the corresponding simulation in the tube. The 
tube material was set to polystyrene with diffusivity for oxygen (the only compound diffusing 
through the tube material towards the fluid) of 2.8x10-7 cm2 s-1 (2.8x10-11 m2 s-1, considered the 
theoretical value) [228]. This value is close to one hundred times slower than oxygen diffusivity 
in water. PTFE oxygen diffusivity values of 2.8x10-6 cm2 s-1 (10 times slower than in water) and 
2.8x10-5 cm2 s-1 (the same order of magnitude as oxygen diffusivity in water) were also considered 
in the simulations. Concentration of oxygen on the outside of the tube was assumed to be the 
atmospheric oxygen concentration, 8.6 mM at 25 ⁰C, calculated from the ideal gas law and 
assuming a molar fraction of oxygen of 0.21. Further simulations were performed, where oxygen 
at the interface between the tube and the fluid was fixed at 0.258 mM (oxygen solubility in 
water), meaning the tube is completely permeable to oxygen. Inside the tube, the same 
diffusivities and kinetic parameters used in the microreactor simulation were also used for the 
fluid simulation. All the materials were simulated considering the materials’ properties 
provided by ANSYS-CFX, and the liquid was defined as water. 
2.3.7.1 CFD simulation strategy 
The objective of the CFD model was to achieve an accurate description of the enzymatic 
reaction performed in the meander microreactor. To assess the similarity of the simulations to 
the executed experiments, two parameters were used for comparison: oxygen concentration in 
sensor 5 (for evaluation of the simulations performed in the microreactor geometry) and 
measured gluconic acid concentration at the outlet (evaluation of meander and tube simulations 
by comparison with the HPLC measurements).  
In order to mimic the enzymatic reaction in the silicon meander channel, different 
parameters defined as input in the simulation (kinetic parameters and inlet oxygen 
concentration) were evaluated. For this purpose, one experiment (5xGOx + 94 U/mL catalase at 
1 µL s-1) was chosen as the reference for model parameter optimization, since it was the 
reference to assess the effect of added catalase and hydrogen peroxide in the increase of oxygen 
availability experiment. For the reference simulation, at the experimentally used enzyme and 
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substrate amounts, the concentration of oxygen in inlet 2 and GOx turnover number (𝑘𝑐𝑎𝑡) were 
varied between 0.15 and 0.20 mM and between 50 s-1 and 4000 s-1, respectively. The different 
values were simulated only for the meander channel geometry, until an oxygen concentration 
in sensor 5 was reached that matched the value obtained experimentally was reached.  
Then, the oxygen concentration in inlet 2 (0.19 mM) and turnover number (300 s-1) that 
resulted in the best match with the experimental data were used to simulate all the performed 
experiments in the meander channel geometry. In addition to the mentioned input parameters, 
each simulation was defined with the enzyme, glucose and hydrogen peroxide concentrations, 
as well as the flow velocities used experimentally. In the cases where the oxygen concentration 
in sensor 5 did not match the experimental values, new values for the kinetic parameters were 
used. The kinetic parameters (GOx turnover number and catalase reaction rate) were varied 
within the range presented in Table 12. In the experiments with added hydrogen peroxide and 
catalase, since catalase should have a prominent role, the reaction rate for catalase (kcatalase) was 
varied between 0.002586 s-1 and 25.86 s-1. In the experiments for the different residence times, 
since GOx should have the highest influence, the turnover number was again varied, between 
300 s-1 and 1200 s-1. Unexpectedly, for some simulations corresponding to experiments 
performed at similar conditions, different kinetic parameters resulted in the best fit of oxygen 
values at sensor 5, indicating possible variations in the experimental conditions that were not 
previously observed. However, in order to allow the comparison of the different simulations, the 
simulations within a given set of experiments (e.g. calibration curve or amount of GOx) were 
simulated using the same kinetic parameters, as can be seen in Table 13. The selected 
parameters corresponded to the values that resulted in the best match with oxygen sensor 
values for the majority of the simulations within a set of experiments.  
The values obtained from the simulations in the meander geometry were afterwards used 
as inputs in the corresponding simulations in the tube geometry. The same set of parameters 
was used, and the concentration values of glucose, oxygen, gluconic acid and hydrogen peroxide 
at the outlet of the meander, were used as inlet concentrations of these compounds in the tube 
simulations. The effect of oxygen diffusivity in the PTFE outlet tube, as well as catalase’s 
reaction rate in the final gluconic acid production was also assessed in the tube geometry 
simulations. The value of the catalase reaction rate was varied between 0.002586 and 25.86 s-1 
only in the tube, to see whether catalase kinetics could change with increased concentration of 
hydrogen peroxide (in a case were no extra hydrogen peroxide was added). Also, the 
concentration of oxygen at the interface between the tube and the fluid was either fixed at 0.258 
mM (maximum concentration of soluble oxygen) or varied between 2.8x10-7 and 2.8x10-5 cm2 s-
1, to check how much the amount of oxygen diffusing through the tube can affect the final 
product concentration obtained.  
Table 13 presents a summary of the simulation parameters varied in each simulation, as 
well as the final value used to obtain the data presented in this chapter.  The simulations were 
performed at different glucose concentrations since not all experiments were performed at the 
full glucose concentration range (5 to 200 mM). Thus, the simulations corresponding to sets of 
experiments where lower glucose concentrations were used in some of the experiments, were 
performed at a lower glucose concentration, as for the experiment set “Amount of GOx” and 
“Calibration curve”.
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Table 13 – Summary of the simulations performed and corresponding varied and selected parameters. 
Simulation name 
Experiment 
set 
[Glucose] 
(mM) 
kcat (s-1) 
used 
kcat (s-1) 
range 
kcatalase (s-1) 
used 
kcatalase (s-1) 
range 
Oxygen 
diffusivity in the 
tube (cm2 s-1) 
used 
Oxygen 
diffusivity in the 
tube (cm2 s-1) 
range 
10xGOx 
Amount of GOx 
5 300 250-1000 - - 2.8x10-6 - 
5xGOx 5 300 250-1000 - - 2.8x10-6 - 
1xGOx 5 300 250-1000 - - 2.8x10-6 - 
5xGOx+94 U/mL 
In
cr
e
a
se
 o
f 
o
x
y
g
e
n
 
a
v
a
il
a
b
il
it
y
 
50 300 50-4000 2.586x10-3 - 2.8x10-6 - 
5xGOx+830 U/mL 50 300 - 2.586x10-3 - 2.8x10-6 - 
5xGOx+94 U/mL+0.25 mM H2O2 50 300 - 2.586 
2.586x10-3-
25.86 
2.8x10-6 
- 
5xGOx+830 U/mL+0.25 mM H2O2 50 300 - 2.586 
2.586x10-3-
25.86 
2.8x10-6 
- 
5xGOx+94 U/mL+830 U/mL 50 300 - 0.2586 
2.586x10-3-
25.86 
2.8x10-6 
- 
5xGOx+830 U/mL+830 U/mL 50 300 - 0.2586 
2.586x10-3-
25.86 
2.8x10-6 
- 
5xGOx+94 U/mL+H2O 50 300 - 2.586x10-3 - 2.8x10-6 - 
5xGOx+830 U/mL+H2O 50 300 - 2.586x10-3 - 2.8x10-6 - 
1xGOx+830 U/mL 
C
a
li
b
ra
ti
o
n
 c
u
rv
e
/ 
R
e
si
d
e
n
ce
 t
im
e
 
50 1000 800-1000 2.586x10-3 - 2.8x10-6 - 
0.5xGOx+830 U/mL 50 1000 800-1200 2.586x10-3 - 2.8x10-6 - 
1xGOx+830U/mL (4.625 s) 10 1000 800-1000 2.586x10-3 - 2.8x10-6 2.8x10-6-0.258 mM 
1xGOx+830U/mL (9.25 s) 10 1000 800-1000 2.586x10-3 
2.586x10-3-
25.86 (in the 
tube) 
2.8x10-6  
(but 2.8x10-7 in the 
different kcatalase in 
the tube 
simulations) 
- 
1xGOx+830U/mL (18.5 s) 
10 1000 800-1000 2.586x10-3 - 2.8x10-6 - 
200 1000 800-3000 2.586x10-3 - 2.8x10-6 - 
1xGOx+830U/mL (37 s) 10 1000 800-1000 2.586x10-3 - 2.8x10-6 2.8x10-6-0.258 mM 
0.5xGOx+830U/mL (4.625 s) 10 1000 800-1200 2.586x10-3 - 2.8x10-6 2.8x10-6-0.258 mM 
0.5xGOx+830U/mL (9.25 s) 10 1000 800-1200 2.586x10-3 - 2.8x10-6 - 
0.5xGOx+830U/mL (18.5 s) 
10 1000 800-1200 2.586x10-3 - 2.8x10-6 - 
200 1000 800-3000 2.586x10-3 - 2.8x10-6 - 
0.5xGOx+830U/mL (37 s) 10 1000 800-1200 2.586x10-3 - 2.8x10-6 2.8x10-6-0.258 mM 
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2.4 Results and Discussion  
In this chapter, an enzymatic cascade reaction was used to test the applicability of a 
commercially available meander microchannel with integrated oxygen sensors to the study of 
enzymatic reactions. The goal was to obtain quantitative data on the reaction progress, as well 
as to assess the limitations of the channel regarding its intended application. The silicon 
meander microchannel was thus tested using commercially available purified enzymes, to allow 
a good degree of control on the proportion of enzymes used in the experiments. This information 
was then applied, together with the kinetic parameters obtained from the activity 
measurements performed, as input in the built CFD simulation.  
 
The CFD simulations were executed as a complement of the experimental work, in order 
to aid in the analysis of the obtained data and provide a higher degree of understanding of the 
reaction occurring inside the microfluidic channel. This was deemed necessary due to the low 
concentrations of product measured (<1 mM) and significant degree of variability of the data 
measured in the HPLC (an average of ±0.35 mM for glucose measurements and ±0.04 mM for 
gluconic acid measurements). This variability can be caused by the manual sampling method, 
where the depth of the tubing in the sodium hydroxide (NaOH) solution and the time at which 
the sampling vial is removed from the outlet may add to the observed variability despite the 
care taken to avoid its influence on the data measured. Another concern that led to the 
development of the CFD model was the difference in the mass balance of the HPLC measured 
samples. An average difference of 1.2 mM±1.6 mM was obtained between the glucose and 
gluconic acid samples, which is higher than the amount of gluconic acid produced. At first, such 
difference was thought to occur due to glucose or gluconic acid decomposition in the presence of 
sodium hydroxide. Both the concentration and amount of added solution to the reaction samples 
was decreased, and despite some decrease in mass balance difference, the difference was 
maintained to a large extent. Therefore, part of the observed mass balance difference probably 
corresponds to the amount of hydrogen peroxide produced that is not converted to oxygen by 
catalase, and which was not quantified in the experiments. 
2.4.1 Experimental results 
A well-studied reaction (oxidation of glucose by glucose oxidase (GOx)), resulting in a 1:1 
stoichiometric consumption of oxygen and formation of product, was chosen to achieve a 
quantitative understanding of an enzymatic reaction based on the integrated oxygen sensors.  
Knowing the amount of oxygen present, the amount of oxygen consumed would correspond to 
the amount of product (gluconic acid) formed. The position of the oxygen sensors along the 
channel can further enable the knowledge of the concentration of product at different residence 
times, corresponding to the sensor positions, thus providing additional information on the 
reaction. However, in a closed system such as the silicon and glass channel, the amount of 
oxygen available is limited by the amount of oxygen provided, which is the oxygen solubility. 
Hence, at certain glucose concentrations and GOx amounts, oxygen limitation may be reached.  
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2.4.1.1 Range of enzyme concentration 
Figure 15 presents HPLC results of the amount of gluconic acid measured at the outlet for 
different initial glucose concentrations and GOx activities. If the outlet tube was impermeable 
to oxygen, the maximum gluconic concentration obtainable would be limited to the oxygen 
amount inside the channel, the oxygen solubility (0.258 mM). Since for most of the experiments 
performed the value obtained was above 0.258 mM, it implies that the PTFE tube used at the 
outlet is permeable to oxygen and therefore the diffused oxygen was involved in the reaction as 
well. 
As can be observed, a higher concentration of product is obtained with the increase of 
enzyme activity. However, for the highest activity used (150 U/mL), a very low concentration 
was measured and results for only two glucose concentrations were possible to obtain. The 
amount of gluconic acid produced was very similar to the values measured for the lowest GOx 
activity tested. This could indicate that a very low activity of GOx had actually been used in the 
experiments. However, in Figure 16 the oxygen measurements for the different GOx activities 
are shown, and it can be observed that the profile for the highest and lowest GOx activity 
measurements are quite distinct. At the highest GOx activity, oxygen was consumed very fast 
inside the channel (Figure 16), since for the first sensor a very small concentration of oxygen 
was obtained for the lowest glucose concentration. Oxygen limitation was thus probably reached 
in the first portion of the channel and as a consequence the reaction was unable to proceed. As 
the value obtained at the outlet was close to the amount of oxygen present inside the channel 
(0.258 mM), it suggests that the reaction was also not performed in the outlet tube when oxygen 
was again available, indicating a possible enzyme inactivation.  
For the remaining tested GOx amounts a higher concentration of gluconic acid was 
measured with increasing GOx activity.  
 
Figure 15 - HPLC measurements at the outlet of the tube for the experiments performed with different amounts of 
GOx without the presence of catalase. 
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Figure 16 – Oxygen concentration, calculated from oxygen partial pressure values, at the four oxygen sensors for 
the experiments performed with different amounts of GOx without the presence of catalase. 
2.4.1.2 Oxygen sensor calibration curve 
Characterization of a new enzyme or comparison of different enzymes, involves the 
measurement of product formation and/or substrate consumption, so kinetic parameters, 
substrate specificity, reaction time, etc. can be ascertained. To perform enzyme studies with 
unknown enzymes in the presented meander channel, a correlation between the oxygen values 
measured in the sensors and the product concentration measured in the HPLC at a given 
residence time is necessary. Thus, a calibration curve was established where a reference sensor 
was chosen and its oxygen concentration matched to a gluconic acid concentration measured at 
the outlet at an equivalent residence time, as presented in Table 10.  
To achieve the calibration curve, experiments were performed at four residence times and 
two enzyme concentrations for six glucose inlet concentrations (Figure 17). The enzyme amounts 
were selected based on the previous range of enzyme concentration experiments (section 
2.4.1.1). The amount of enzyme that allowed performing experiments at longer residence times 
without achieving oxygen limitation (1xGOx) was chosen. Experiments with half that amount 
(0.5xGOx) were also performed in order to have a higher number of experimental points.  
As expected, an increase in gluconic acid concentration was obtained with increasing 
residence time (except for 79.6s, 1xGOx, 10 mM), and at a higher enzyme concentration. It is 
also possible to observe a product concentration plateau for the higher glucose concentrations 
used (50 mM, 100 mM and 200 mM), especially with the increase in residence time. Considering 
a Michaelis-Menten kinetics, these concentrations could correspond to the substrate saturation 
of the reaction, meaning that the maximum reaction rate (Vmax) had been reached. Hence, in 
this case, with the increase of residence time, a constant increase of product concentration would 
be expected. However, as can be observed below, gluconic acid concentration at the longest 
residence time (79.6 s) is the same (for 1xGOx) or only slightly higher (for 0.5xGOx) than the 
product concentration at half that residence time (39.48 s). This again points towards the 
occurrence of oxygen limitation in the meander channel under the reaction conditions in the 
meandering channel. 
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Figure 17 – Gluconic acid concentration for the GOx and catalase reaction performed at different residence times. 
The data of the reaction performed at different residence times was used to obtain a 
calibration curve for oxygen sensor 5, by plotting the gluconic acid values measured in the outlet 
of the tube against the oxygen concentration values measured at the sensor (Figure 18), as 
presented in Table 10. The calibration curves for the two tested GOx amounts present similar 
slopes (1.5 – 1.9 mM of gluconic acid produced per mM of oxygen available). This is in agreement 
with the assumed enzymatic cascade reaction stoichiometry, since if all the hydrogen peroxide 
is converted to oxygen, then for each 1 mole of consumed oxygen, half of the produced hydrogen 
peroxide can be reconverted to oxygen, and 1.5 mM of gluconic acid is produced. However, the 
previous presented data indicates the occurrence of oxygen limitation, which means that no 
significant conversion of hydrogen peroxide to oxygen occurs. Thus, the obtained slope should 
be smaller (between 1 and 1.5 mMproduct mMoxygen-1). The correlation factor of the obtained slopes 
was improved when data acquired for the higher glucose concentrations (under oxygen 
limitation) was disregarded. Simultaneously, the slope of the calibration curves increased to 
values above the ones expected from the reaction stoichiometry.  
The trends obtained for the calibration curves in Figure 18 can thus be an artifact with no 
real biological meaning, resulting from the high variability of the experimental data and the 
low oxygen concentration at the reference sensor. 
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Figure 18 – Calibration curves obtained from experimental data considering experiments up to 25 mM initial glucose 
concentration (a) or all experiments (b). 
2.4.1.3 Increase of oxygen availability inside the channel 
As observed in the previous section, oxygen limitation may be easily achieved in this 
microfluidic system, which can be an issue when performing enzyme screening and reaction 
characterization. Hence, as a possible solution, different strategies capable of increasing the 
oxygen concentration inside the system were tested. These strategies involved the introduction 
of a solution through one of the side inlets (between sensors 2 and 4) available in the silicon 
meander channel. This side inlet was selected due to its position close to the middle of the 
microreactor, where a significant decrease of oxygen concentration was expected to occur, and 
between two of the monitoring points thus allowing a good evaluation of the success of the 
different applied strategies.  
The strategies tested were: 
• Increase amount of provided catalase; 
• Introduction of oxygen saturated water (through the side inlet); 
• Introduction of extra solution of catalase (in different amounts through the side inlet); 
• Introduction of hydrogen peroxide (at different concentrations through the side inlet). 
 
Figure 19 presents the summary of the experimental data. As can be observed, a small 
increase of product concentration was obtained when catalase was added relative to the 
situation where only GOx is present, but addition of water or extra catalase solutions did not 
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yield a significant increase of the gluconic acid concentration. If the amount of hydrogen 
peroxide produced is very small, then addition of increasing amounts of catalase would yield no 
effect. However, hydrogen peroxide production should be close to the amount of produced 
gluconic acid, according to the reaction stoichiometry and so sufficient to generate at least 0.10 
mM of oxygen. Another explanation is that since the amount of gluconic acid present is 
approximately the same for the experiments with extra catalase, the catalase reaction rate 
should be similar between the different experiments, thus resulting in a similar oxygen 
production from the hydrogen peroxide formed. 
The addition of hydrogen peroxide, on the contrary, resulted in an up to 3-fold increase of 
the amount of gluconic acid produced. Product concentration increased both with concentration 
of hydrogen peroxide and amount of catalase present. During the experiments with the highest 
concentration of hydrogen peroxide (0.5 mM), and the highest amount of catalase (830 U/mL), 
production of oxygen bubbles in the outlet tube was observed, meaning oxygen was being 
produced in a concentration above the water saturation level (0.258 mM). Since oxygen bubbles 
can get trapped in the sensors’ chambers, this was considered to be the maximum dose of 
hydrogen peroxide and catalase that could be added in this system for the GOx concentration 
used. Also, since hydrogen peroxide can lead to enzyme inactivation, higher concentrations or 
at higher residence times were not considered.  
 
Figure 19 – HPLC measurements at the outlet of the tube for the experiments performed towards increasing oxygen 
availability in the silicon meander channel. 
Even though the oxygen concentration inside the channel can be increased with the 
presented strategies, when using the silicon meander channel for studying an unknown reaction 
or cascade reaction, these strategies may not be applicable. There are, however, other strategies 
for in situ oxygen generation, mostly applied in cell culture applications. These strategies can 
involve: 
• a constant flow of air or oxygen gas in the channels or in parallel chambers, which 
requires the use of bulky pressurized gas cylinders and complex fluidic connections 
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[229]. This strategy would not be compatible with the presented system, since 
addition of a flow of oxygen would perturb the oxygen measurements; 
• Spatially confined chemical reactions capable of creating (or scavenging) oxygen, 
such as pyrogallol and sodium hydroxide for scavenging and hydrogen peroxide 
and sodium hypochlorite for generation. The reactions occur in channels parallel 
to the cell culture one, taking advantage of the high permeability to oxygen of 
PDMS. Furthermore, by controlling both reaction rates, different oxygen gradients 
can be created inside the cell culture chambers [229]. This strategy would also not 
be compatible with the presented system, since integration of membranes or 
permeable parallel channels would require a considerable change in design; 
• Titanium/ Platinum microelectrodes positioned in channels below the culture 
chamber, where the amount of oxygen generated is directly proportional to the 
amount of current running between the anode and the cathode. A special care must 
be taken in order to quantify and control the amount of reactive oxygen species 
generated during water electrolysis, which are damaging for biological samples 
[230]. These electrodes could be integrated in the channel in a similar approach as 
the oxygen sensors, requiring a membrane to avoid formation of bubbles inside the 
channel; 
• Photocatalytic cells, that mimic a part of the photosynthesis (Photo System II) to 
generate oxygen from water, are based on the indirect interaction of ultraviolet 
UV light with a semiconducting titanium dioxide (TiO2) thin film [231], [232], 
[233]. TiO2, however, is also used for disinfection of water due to its anti-microbial 
properties when illuminated and so its application to most cell-based biocatalytic 
applications can only occur if there is no direct contact between the thin film and 
the cells, and no accumulation of reactive oxygen and peroxide species [234]. This 
strategy would also require a change in channel design since silicon is not 
transparent to UV light and illumination should not be through the top of the 
channel since UV affects biological materials. 
 
Furthermore, by adding catalase and/or hydrogen peroxide, the values measured by the 
integrated oxygen sensor cannot be directly used. A well-characterized model of the reaction 
could be used instead to predict product formation and oxygen levels. 
This platform is thus more suitable for studying enzymes with a low activity or highly 
diluted samples. However, by greatly decreasing the amount of enzyme used, the concentration 
of product at the outlet would also be greatly reduced which could lead to issues in the validation 
of the oxygen measurements. The same issue could be met if a slower reaction would be studied. 
The balance between enzyme amount, reaction kinetics, residence time, substrate concentration 
and product concentration are part of the development and optimization of an enzymatic-based 
system, and the integration of oxygen sensors can facilitate a fast optimization of such 
parameters by allowing an overview of the (oxidation) reaction proceeding inside the reactor. 
Moreover, it can allow a fast observation of the effects of other substrates or compounds that 
can be introduced through one of the 6 side-inlets available. 
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2.4.2 Simulation data 
During the experimental work, as mentioned in the previous section, unexpected 
phenomena were observed. A very small product concentration was obtained for the highest 
GOx activity tested. Furthermore, even though the obtained calibration curve presented a slope 
concurring with the expected cascade reaction stoichiometry, the indication of oxygen limitation 
in the channel renders it questionable. Finally, when testing different strategies to increase 
oxygen concentration inside the channel, no significant variation in product at the outlet was 
observed with the increase of the amount of catalase. 
To achieve a better understanding of the observed phenomena and attain a better 
characterization of the microfluidic system, a computational fluid dynamic model, including the 
enzymatic cascade reaction, was developed, as explained in section 2.3.7. In the simulation, the 
experimental conditions and spectrophotometrically measured kinetic parameters were used as 
initial inputs. By comparing the simulations with the experimental data, an optimization of the 
input parameters, especially enzyme reaction rate and oxygen diffusivity in the tube, was 
performed. The final obtained input parameters provide an extra insight into the reaction 
occurring inside the meander microchannel, as well as a model that more accurately describes 
it. 
2.4.2.1 Mixing and diffusion effects in the CFD simulation 
To provide confidence in the developed CFD model, the physical characterization of flow 
in the microchannel was performed. Hence, some physical phenomena, known to occur in 
microchannels were evaluated for the developed CFD simulation.  
One such phenomena is the “butterfly effect”, whereby the components on the top and 
bottom of the channels have a longer diffusion length (and thus residence time) than in the 
middle, resulting in a “butterfly” image in the cross section. This effect results from the non-
uniform velocity profile in low Reynolds number systems under pressure-driven flows, which 
generates a difference in residence time of the components in different positions in the channel 
and consequently a wider diffusion region near the top and bottom of the channel [235]. Such 
effect was also observed in the simulations and can be observed in Figure 20.  
 
Figure 20 –Cross-section of the simulated silicon meander channel at 1µL s-1 1xGOx+830 U mL-1 at 10 mM, 
highlighting the “butterfly effect”. 
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Lateral diffusion of the different components and corresponding diffusion coefficients used 
in the CFD simulation were calculated, based on Fick’s law as presented in Nock et al. (2010) 
[227] (Equation 22), where D is the diffusion coefficient, x is the diffusion length perpendicular 
to the flow direction and t is the residence time in the channel. 
Equation 22 
 
As can be observed in Table 14, the diffused distance in a direction perpendicular to the 
flow by the substances is higher than the width of the channel (> 200 µm) for the diffusion 
constants considered in the simulation, and so complete diffusion of substrates and products is 
obtained at both channel locations considered in this work (sensor 5 and tube outlet). However, 
for the enzymes, these only diffuse between 30 and 125 µm (see Figure 21 for residence time in 
sensor 5 of 9.25 s corresponding to a diffusion distance of 43 µm). Access of the enzymes to the 
substrates is then only partial and may result in significant gradient generation across the 
channel cross-section.  
 
Table 14 – Lateral diffusion of the different components achieved at the position of the reference sensor and the 
outlet according with Fick’s law [227]. 
Components D (m2 s-1) tsensor 5 (s) xsensor 5 (m) toutlet (s) xoutlet (m) 
Oxygen and 
hydrogen peroxide 
2.1x10-9 
4.625 1.97x10-4 9.95 2.89x10-4 
9.25 2.78x10-4 19.9 4.10x10-4 
18.50 3.94x10-4 39.8 5.78x10-4 
37.00 5.57x10-4 79.6 8.18x10-4 
Glucose and gluconic 
acid 
6.7x10-10 
4.625 1.11x10-4 9.95 1.63x10-4 
9.25 1.57x10-4 19.9 2.31x10-4 
18.50 2.23x10-4 39.8 3.27x10-4 
37.00 3.15x10-4 79.6 4.62x10-4 
  4.625 3.03x10-5 9.95 4.44x10-5 
Enzymes 4.95x10-11 [197] 9.25 4.28x10-5 19.9 6.28x10-5 
  18.50 6.05x10-5 39.8 8.88x10-5 
  37.00 8.56x10-5 79.6 1.26x10-4 
 
 
Figure 21 – Simulated 1xGOx diffusion at 1 µL s-1 along the channel considering D=4.95x10-11 m2 s-1. 
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Simulations were also performed considering the enzyme diffusion as being the same as 
for the substrates (6.7x10-10 m2 s-1), meaning one order of magnitude faster than the theoretical 
value. Different experiments and corresponding simulations, at different conditions (e.g. 
presence or absence of catalase, different residence times, introduction of solutions through a 
side inlet) are presented in Figure 22. All were simulated considering the two diffusion values, 
and results are presented side by side (in blue) and compared with the corresponding 
experimental value (in red).  
The use of diffusion values with one order of magnitude difference resulted in a small 
variation in the oxygen concentration in the sensors, as well as in the concentration of gluconic 
acid at the outlet at the same kcat (250 s-1). The biggest difference between the compared 
simulations was observed for 0.5xGOx+830U/mL (9.25 s), which is highlighted in the figure 
below. However, as can be observed in the data presented in Appendix I, the observed 
differences at the different considered diffusion coefficients, were significant enough to consider 
a different optimal kcat for some of the simulations (300 s-1 instead of 250 s-1), while for others a 
kcat of 1000 s-1 was still the value selected. All the values for both simulations are presented in 
Appendix I.  
The small influence of the diffusion coefficient in the data output can be explained if we 
consider that when the enzymes diffuse completely across the channel width, a dilution of the 
enzyme occurs. In this case, half the enzyme amount has access to the entire substrate 
concentration (also half from the inlet concentration). On the other hand, when the enzymes do 
not diffuse completely across the channel width, the enzymes have access to half of the 
substrate. However, their faster consumption in half the channel may further promote the 
substrate diffusion to the portion of the channel containing the enzymes. The resulting 
substrate consumption and product formation are similar, even though a slightly different 
reaction rate was obtained for some of the experiments, and thus a similar overall effect is 
observed. 
Micro scale reactor system development with integrated advanced sensor technology  
65 
 
 
Figure 22 – Influence of the value of diffusivity chosen for the enzymes on the outcome of some of the simulations 
performed. 
Another common effect in microchannels is the development of a parabolic profile (already 
discussed in Chapter 1). This occurs due to a slower velocity of the flow next to the channel 
walls, causing an acceleration in the middle of the channel, as can be observed in Figure 23 (a). 
In Figure 23 (b) it is also possible to observe the effect of the bends of the meander channel and 
their contribution to mixing. The bends induce a centrifugal force on the fluid, causing an 
acceleration towards the outside of the channel, exemplified by the deviation from the center of 
the interface between the two fluids. This rotation is responsible for the asymmetry observed in 
the “butterfly effect”.  
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Figure 23 – Axial cross-sections of the simulated silicon meander channel at 1µL s-1 1xGOx+830 U mL-1 at 10 mM, 
highlighting the parabolic profile with velocity vectors (a) and the influence of the channel bends in diffusional mixing 
(b). 
Even though a parabolic profile is observed, no diffusion in the axial direction seems to 
occur. This is further confirmed, in accordance with the definition presented in Song et al. (2012) 
[235], by the calculation of the Péclet number, Pe (Equation 11), for the different velocities used. 
Axial diffusion can be neglected for Pe larger than 
1
𝑙
=
1
𝐿
𝑊
=
1
𝐿𝑒𝑛𝑔𝑡ℎ
𝑊𝑖𝑑𝑡ℎ
= 1.98𝑥10−4. Pe was calculated 
considering the oxygen diffusivity (2.1x10-9 m2 s-1). 
 
Table 15 – Péclet number values for the different velocities used in the silicon meander channel. 
Velocitychannel 
(m s-1) 
Pe 
0.05 2381 
0.025 1190 
0.0125 595 
0.00625 298 
 
According to Figure 24, especially for glucose, is possible to observe that from the fourth 
sensor spot onward, a relatively homogenous and well-mixed solution is observed. In terms of 
the oxygen concentration, and thus of how representative the oxygen measurements obtained 
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from the integrated sensor spots are, the figure shows a good homogeneity in all the sensor spots 
except for the first one (sensor 1). The performed measurements at the sensor counted as 
reference (sensor 5) can thus be considered as representative of the solution at the corresponding 
residence time.  
 
Figure 24 – Oxygen (top) and glucose (bottom) concentrations along the simulated silicon meander channel at 1µL 
s-1 1xGOx+830 U mL-1 at 10 mM. 
2.4.2.2 Range of enzyme concentration 
Simulations mimicking the reaction with only GOx (section 2.4.1.1) inside the silicon 
meander channel plus outlet tube system were performed with 𝑘𝑐𝑎𝑡 of 300 s-1, 800 s-1 and 1000 
s-1 (a range which includes the values measured spectrophotometrically (300 to 500 s-1) and is 
lower than the value found in literature, 1440 s-1 [236], [202]) (Figure 25). Similar values of 
product concentration (Figure 25 (b)) were obtained except for the 150 U/mL experiment, where 
a much higher concentration of gluconic acid was obtained in the simulation. This clearly 
indicates the occurrence of an issue in the corresponding experiment (e.g. different enzyme 
concentration, lower initial oxygen concentration, enzyme inhibition due to low oxygen 
concentration), while highlighting the usefulness of a reaction model, such as the one presented. 
Parameters such as enzyme concentration and  𝑘𝑐𝑎𝑡 or oxygen concentration could easily be 
varied in the model in order to explain which issue occurred experimentally. This was, however, 
not performed due to time constraints, since the parameters are changed manually in the model.  
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From Figure 25 (b), it is possible to assume that 300 s-1 is the turnover number associated 
with the glucose oxidase used in the experiments, which is similar to the values obtained 
experimentally (300 to 500 s-1). This value resulted in the smallest deviation from the 
experimental product at the outlet. However, if only the oxygen sensor data was available, 
another turnover number, 800 s-1, would be the selected value, which highlights the need of a 
comprehensive data set when validating such models. 
 
Figure 25 - Comparison between the CFD simulations and experiments performed with different amounts of GOx 
and 5 mM initial glucose concentration for (a) the oxygen measured in sensor 5 and (b) gluconic acid measured at the 
outlet of the tube. 
2.4.2.3 Oxygen sensor calibration curve 
Simulations were also performed for the different residence times and enzyme 
concentrations at 10 mM inlet glucose concentration (Figure 26). For this set of simulations, a 
higher kcat of 1000 s-1 allowed to better match the measured oxygen values at sensor 5. This 
value is close to 4-fold the one used in the previous simulations (300 s-1), which indicates that 
the GOx activity measured experimentally was not correct for this enzyme solutions, thus 
resulting in a change in the kinetic parameters that best fit the model. This is again a good 
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example of how models such as the one presented in this work can aid and complement 
laboratory work. 
As expected, from the experimental data presented in section 2.4.1.2 in Figure 17, an 
increase in gluconic acid concentration is obtained with increasing residence time, and a higher 
concentration is obtained for the higher enzyme concentration. However, in the simulations a 
much higher concentration of gluconic acid was obtained for 79.6 s residence time. This can 
indicate that either the experimental residence time was lower than the one considered in the 
simulation (and thus the considered flow velocity was higher), or that there is some factor 
limiting the enzyme performance. A relevant factor could be the concentration of hydrogen 
peroxide present, whose concentration (and hence inactivating effect) would increase with the 
residence time. In the presented simulations, inactivation of the enzymes due to the presence of 
hydrogen peroxide was not considered, since this was not initially assumed to influence the 
performed reactions for most of the experimental conditions tested. 
 
Figure 26 - Comparison between the CFD simulations and experiments performed for different residence times and 
amount of GOx with 830 U/mL catalase present at 10 mM initial glucose concentration for (a) the oxygen 
concentration measured in sensor 5; and, (b) the gluconic acid concentration measured at the outlet of the tube. 
Simulations were also performed at a higher glucose concentration (200 mM) for 
0.5xGOx+830 U/mL Cat and 1xGOx+830 U/mL Cat for the residence time at the outlet of 39.48 
s. As can be observed in Figure 27, the simulations were capable of predicting values of the 
obtained gluconic acid concentration that were similar to the ones achieved experimentally, 
indicating that the observed stabilization of product concentration is most likely due to the 
enzymatic system at the conditions in the tube. It is relevant to highlight that the 
experimentally observed gluconic acid, glucose and oxygen concentrations result from a 
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combination of the flow conditions applied, the channel geometry, the rate of the enzymatic 
reactions and the diffusion characteristics of the different components involved. In order to fully 
understand the influence of each of these parameters on the reaction dynamics, models that 
account for the influence of flow, geometry and diffusion on reaction dynamics, such as the one 
presented in this chapter, are required. 
From what can be observed in Figure 27, hydrogen peroxide does not seem to yield an 
inactivation effect in the performed experiments, which is expected since according to the 
simulations, concentrations of up to 1 mM (lower than the inactivating concentration) were 
obtained. The divergence between the simulation and the experimental data for the 79.6 s 
residence time is thus most likely due to oxygen limitation conditions, since experiments at 
glucose concentrations higher than 10 Mm could not be performed due to very fast oxygen 
consumption inside the channel. The model was however not capable of capturing this 
phenomenon, and hence further optimization of the kinetic parameters used or oxygen 
diffusivity is required.  
 
Figure 27 – Comparison between the CFD simulations and experiments performed for different glucose 
concentration and amount of GOx at 0.5 µL s-1 for the gluconic acid measured at the outlet of the tube. 
2.4.2.4 Increase of oxygen availability inside the channel 
To avoid reaching oxygen limitation inside the channel, a known amount of catalase was 
added to the GOx reaction. Catalase is capable of decomposing hydrogen peroxide (a side-
product of glucose oxidation) to oxygen and water, in a 1:2 stoichiometry of oxygen to hydrogen 
peroxide. So, for every 0.1 mM of hydrogen peroxide consumed, 0.05 mM of oxygen are expected 
to be produced, assuming that a sufficient amount of catalase is present, in order to maintain a 
minimum oxygen concentration inside the channel and a good control on the amount of oxygen 
provided [210].  
Figure 28 presents a comparison between experimental and simulation data for the 
addition of 830 U/mL of catalase to different concentrations of GOx. It is possible to observe in 
Figure 28 (b), that approximately the same amount of product was obtained for 5xGOx and 
1xGOx, while a concentration above half of 1xGOx was obtained for 0.5xGOx in the experimental 
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data. This again indicates that oxygen limitation was reached inside the channel for the highest 
concentration of GOx, which would explain a similar product concentration as for 1xGOx. On 
the other hand, a very small increase in gluconic acid with increase of GOx concentration was 
obtained for the simulation data, indicating that the influence of GOx concentration on the 
reaction, at the concentrations used is highly dependent on the amount of oxygen available in 
the reactor. Once more, it is possible to observe that the differences between experimental and 
simulated data observed in terms of oxygen values do not always translate into similar 
differences in the gluconic acid values. 
 
Figure 28 - Comparison between the CFD simulations and experiments performed with different amounts of GOx 
at the same catalase concentration and 50 mM initial glucose concentration for (a) the oxygen measured in sensor 5 
and (b) gluconic acid measured at the outlet of the tube. 
The tested strategies to increase oxygen concentration inside the channel (addition of 
water, extra catalase and extra hydrogen peroxide solutions through a side inlet presented in 
section 2.4.1.3, Figure 19) were also simulated. Simulations were performed for two catalase 
amounts at the inlet, and 1 type of side solution (water, catalase 830 U/mL and 0.25 mM). The 
corresponding simulated experiments (Figure 29) showed a similar trend as observed 
experimentally. Added water did not yield an increase in product concentration, but addition of 
extra catalase resulted in a small increase in gluconic acid concentration. In this set of 
simulations, both the extra catalase and extra hydrogen peroxide simulations were performed 
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with an increased kcatalase of 0.2586 s-1 and 2.586 s-1, respectively, compared with 2.586x10-3 s-1 
used for the other simulations. By altering the catalase reaction rate in order to match the 
measured oxygen values, the amount of obtained gluconic acid was slightly increased. Addition 
of hydrogen peroxide resulted in the highest increase, but still smaller (less than 2-fold) than 
the one observed experimentally. Since the difference in oxygen concentration at sensor 5 
(Figure 29 (a)) between experimental and simulated points is small, the difference in product 
concentrations at the outlet (Figure 29 (b)) can be due to a difference in oxygen availability in 
the outlet tube portion, relative to the one of the experiments. However, as the values are 
significantly lower than the experimental ones for the hydrogen peroxide simulation, the 
assumed kcatalase value is probably lower than the real one when hydrogen peroxide is present. 
In Appendix I, Table 2 it is possible to observe that even at the highest tested kcatalase (25.86 s-1), 
the experimental values were not achieved and the oxygen values presented a higher difference 
than with 0.2586 s-1. 
 
Figure 29 – Comparison between the CFD simulations and experiments performed towards increasing oxygen 
availability in the silicon meander channel, for (a) the oxygen measured in sensor 5 and (b) gluconic acid measured 
at the outlet of the tube at 50 mM initial glucose concentration. No experiment was performed corresponding to 
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5xGOx+830 U/mL Cat+830 U/mL. One of the simulations (5xGOx+830 U/mL Cat+830 U/mL Cat) does not have a 
corresponding experiment, because it was only deemed interesting to perform an experiment when performing the 
simulations. 
2.4.3 Observations from the CFD simulations 
Some parameters in the simulations were altered relative to the ones obtained through 
spectrophotometric activity measurements. The catalase reaction rate was one of such 
parameters. As can be seen in Figure 30 (a) it was necessary to significantly increase this 
parameter in order to more closely match the oxygen concentration values measured 
experimentally. This may indicate that the addition of hydrogen peroxide to the reaction, led to 
a change in the catalase reaction rate.  
On the other hand, the GOx kinetic parameters obtained from spectrophotometric 
measurements are apparent kinetic values for the reaction, since they were obtained for a single 
(and not well controlled) oxygen concentration. Furthermore, along with the catalase reaction 
rate, they were measured at different conditions (especially in terms of substrate availability) 
compared to the performed reactions, and thus introduce a deviation from the real case inside 
the microreactor, that the simulations allow to highlight.  
 
Figure 30 – Effect of the use of different rates of hydrogen peroxide decomposition in the CFD simulations and 
comparison with experimental data at 50 mM initial glucose concentration for (a) the oxygen concentration measured 
in sensor 5; and, (b) the gluconic acid concentration measured at the outlet of the tube. These simulations were 
performed considering diffusivity of oxygen in the tube as 2.8x10-6 cm2 s-1. 
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The amount of oxygen diffusing through the outlet tube to the enzymatic solution is also 
an important parameter to consider in the simulations. Thus, simulations were performed 
where either the oxygen concentration at the interface between the tube and the fluid was fixed 
at the maximum possible concentration of soluble oxygen (0.258 mM), or oxygen diffusivity was 
varied between 2.8x10-7 and 2.8x10-5 cm2 s-1. This variation in oxygen transferred through the 
tube was performed for two of the residence time experiments, 9.95 s and 79.6 s residence time 
at the outlet, respectively (Figure 31). When 0.258 mM was considered at the interface, a 
significant increase of gluconic acid concentration was obtained for the highest residence time 
(79.6 s). This increase was obtained even though at the fastest residence time the difference 
between simulated and experimental values is small. The value of gluconic acid concentration, 
however, was more than 2-fold the experimental one, indicating that the amount of oxygen being 
transferred is between the theoretical diffusivity value for PTFE and the maximum oxygen 
concentration (0.258 mM). However, also for the other values of diffusivity simulated (10-fold 
and 100-fold the theoretical value) the gluconic acid concentration at the outlet was higher than 
the experimental value for 79.6 s. When all the simulations were performed with both diffusivity 
values, the 10-fold diffusivity seemed to yield values closer to the experimental data and was 
thus chosen for data comparison in the previous graphs unless stated otherwise (check Appendix 
I). 
 
Figure 31 - Comparison between the CFD simulations and experiments performed at 10 mM initial glucose 
concentration but considering either oxygen diffusivity in the tube or a fixed concentration of oxygen at the interface 
between the tube and the fluid. 
Figure 32 shows the distribution of oxygen concentration inside the tube and inside the 
fluid for the longer residence time and smaller enzyme concentration. It is possible to observe 
that for the smaller oxygen diffusivity value (D theo in the figure corresponds to 2.8x10-7 cm2 s-
1) for the tube, no oxygen or a very low concentration seems to be transferred to the fluid (Figure 
32 (b)). On the other hand, when the oxygen concentration at the interface is fixed at the 
maximum oxygen solubility value, a three-fold increase in oxygen concentration is observed in 
the middle and outlet of the tube, thus explaining the considerably higher product concentration 
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values obtained for this simulation. On the contrary, for the shortest residence time and with a 
higher enzyme concentration, even though increasing the oxygen concentration at the interface 
increases the oxygen concentration in the bulk, the difference relative to the lowest diffusivity 
case is not as sharp, as observed in Figure 33. There is a higher oxygen availability at the inlet 
of the tube in this case, which in turn reduces the influence of oxygen diffusing from the tube. 
The oxygen concentration values obtained at the outlet and in the middle of the tube are very 
similar in this case.  
 
Figure 32 – Oxygen distribution in different regions of the tube and fluid for the longer residence time and 0.5xGOx, 
considering D=2.8x10-7 cm2 s-1 (a) and oxygen distribution in the fluid considering D=2.8x10-7 cm2 s-1 or oxygen 
concentration at the interface equal to 0.258 mM (b). 
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Figure 33 – Oxygen distribution in the fluid considering D=2.8x10-7 cm2 s-1 or oxygen concentration at the interface 
equal to 0.258 mM. 
Besides oxygen diffusivity, the influence of kcatalase for the reaction occurring only in the 
tube region was also tested. In this set of simulations, the possible influence of an increased 
concentration of hydrogen peroxide (relative to the reaction in the meander channel), which 
would result in a different reaction rate for catalase, was tested. Simulations of 1xGOx at 1 µL 
s-1 (19.9 s residence time at the outlet) were performed in the tube for kcatalase values between 
2.586x10-3 s-1 and 25.86 s-1 considering an oxygen diffusivity in the PTFE tube of 2.8x10-7 cm2 s-
1. The latter value of diffusivity was used, instead of 2.8x10-6 cm2 s-1 used in the other 
experiments, to discard the effect of increased oxygen diffusivity. As can be observed in Figure 
34, only kcatalase values above 2.586 s-1 seem to significantly affect the obtained gluconic acid 
concentration. However, even at the highest kcatalase value, the experimentally measured values 
were not achieved, and thus this should not be a significant factor in the reaction occurring in 
the tube.  
 
Figure 34 - Comparison between the CFD simulations and experiments performed at 10 mM initial glucose 
concentration and 1 GOx with 19.9 s residence time but considering different kcatalase values in the tube. 
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A well-characterized model of the reaction could be used to predict product formation and 
oxygen levels. However, as can be observed from the presented simulations, such model may be 
complicated and time-consuming to achieve, especially in terms of the selection of appropriate 
kinetic parameters. The different parameters tested in the simulations were manually changed 
and are thus most likely not realistic values. Coupling of the above CFD model with a 
mechanistic kinetic model, capable of performing parameter optimization, would yield a better 
fit to the data, while simultaneously providing more accurate kinetic parameters. The most 
relevant parameters requiring optimization in the developed model are GOx turnover number, 
catalase reaction rate, oxygen concentration at the inlets and oxygen diffusivity through the 
PTFE tube. Furthermore, even though several mechanistic models, already applied to the study 
of the coupled GOx and catalase reaction, are based on the two-substrate Michaelis-Menten 
kinetic mechanism [202], this is a simplification of the actual mechanism of the enzymatic 
cascade reaction, and may introduce a certain degree of error in the obtained simulation results. 
For example, one of the assumptions is that the amount of oxygen present is considerably higher 
than the concentration of GOx [202], which in the case presented is not always true. Thus, the 
connection to a mechanistic model, where different reaction mechanisms could be rapidly tested, 
would also greatly improve the applicability of this model to other enzymes and/or cascade 
reactions.  
Such a mechanistic model, validated with oxygen imaging experiments, and its usefulness 
has already been demonstrated by Ungerböck et al. (2013) for a similar microreactor and the 
glucose oxidation reaction with GOx [135]. They were capable of modeling the Ping Pong Bi-Bi 
reaction mechanism both for a batch and a microreactor, finding the reaction of the reduced 
form of the enzyme with oxygen as the rate limiting step. Furthermore, they observed that the 
Michaelis-Menten kinetics was able to appropriately describe the reaction in the microreactor. 
They also concluded that for most microfluidic systems, studies can be performed without 
considering diffusion through convection [135]. Tao et al. (2009) developed a mechanistic model 
for the coupled GOx and catalase reaction, which was also validated with experimental oxygen 
measurements with and without cell respiration [237]. They also assumed a Ping Pong Bi Bi 
type mechanism where all the reactions were irreversible for GOx and a first order reaction for 
catalase. However, they observed that at 25 ⁰C, the catalase reaction seemed to have a higher 
order (1.5) than the one assumed and observed at 37 ⁰C (1), apparently depending on 
temperature. They proposed another reaction mechanism for the catalase reaction that included 
the reverse of the first reaction (production of water after reaction with the first hydrogen 
peroxide molecule) [237]. 
 
The use of a mechanistic model coupled with CFD simulation of the reactor and connected 
online or offline with the oxygen sensors integrated in the silicon meander channel would 
significantly improve the amount of information collected from the silicon meander channel, 
since several kinetic mechanisms and parameter values could be compared with the data, both 
from the sensors and from the quantification of reaction components at the outlet. This would 
increase the characterization speed of the reaction and/or enzymes being tested, but also the 
quantification of reaction parameters that are usually difficult to measure experimentally (e.g. 
certain reaction rates, Km of the different substrates in a multi-substrate reaction). 
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2.4.4 Use in a modular platform 
Since the focus of this thesis is the development of a modular microfluidic platform for 
enzyme screening, the silicon meander channel was tested as part of a modular platform by 
connecting it to other simple microfluidic systems: a commercial polymeric valve chip and a 
PMMA meander channel fabricated in-house.  
2.4.4.2 Connection to a valve chip 
The silicon meander channel was connected to a valve microfluidc chip from Microfluidic 
ChipShop as explained in section 2.2.2.2 and the 21 µL volume outlet channel was used as 
presented in Figure 35. A solution of Gluzyme (0.2 g L-1) was continuously pumped through the 
silicon meander channel, while pulses of glucose at different concentrations were introduced 
using the valve system, and alternated with water. 
 
Figure 35 – Schematics of valve chip and silicon meander channel assembly. 
As can be observed in Figure 36, for the majority of the glucose concentrations tested a 
stable value for oxygen partial pressure was obtained when only Gluzyme was present. 
Introduction of glucose caused a rapid decrease in oxygen values, which tended to be faster the 
higher the glucose concentration. Also, a lower value of partial pressure was obtained for the 
slower flowrate used (0.4 µL s-1), since the residence time inside the reactor was increased. 
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Figure 36 – Variation of oxygen partial pressure in sensor 4 when pulses of glucose at different concentration are 
introduced in the silicon meander channel at two different flowrates. 
The two-chip assembly operated for a minimum of 60 minutes at a time without leakage, 
and a rapid effect of the introduced solution was observed with the integrated oxygen sensors. 
Before performing the experiment presented in Figure 36, a test with a food coloring dye (since 
the valve ship is transparent) was performed. This test intended to more precisely time how 
long after switching the valve position (for glucose introduction), it would take for the glucose 
pulse to reach the meander channel (time required to flow through the 21 µL outlet channel 
plus the outlet tube connecting to the silicon meander channel). This visual test, which main 
steps are presented in Appendix II, allowed a more detailed and accurate interpretation of the 
oxygen signal observed during the experiment with Gluzyme and glucose. 
2.4.4.3 Connection to a PMMA meander channel 
The silicon meander channel was also connected to an in-house developed PMMA meander 
channel, as presented in Figure 37. This meander channel was the first version of the thermal 
inactivation platform, whose final version will be discussed in Chapter 5. The enzymatic 
reaction performed in this reactor was used as reference to evaluate the efficiency of the applied 
enzyme inactivation strategy. Without the application of temperature, this channel allowed to 
greatly extend the reaction time to around 132 s (10.08 µL + 79.5 µL of connecting tube + 44 µL 
of PMMA channel), which resulted in a significantly larger concentration of gluconic acid 
(Figure 38). However, as observed before, a stabilization of product concentration occurred for 
the higher initial glucose concentrations. This is an indication that at these concentrations 
oxygen limitation was again achieved, and that the oxygen diffusing through the PMMA 
material can still not compensate the amount being consumed in the reaction. 
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Figure 37 – Schematics of assembly of the silicon meander channel with the PMMA meander channel. 
 
Figure 38 – Concentration of gluconic acid at the outlet of the silicon meander channel and at the outlet of the 
assembled silicon meander and PMMA meander channel, for the same enzyme concentrations. 
2.5 Conclusions 
In this chapter, a commercially available silicon and glass meander microchannel with 
integrated oxygen sensors was investigated as an online monitoring and reactor unit operation 
in a microfluidic modular platform for biocatalyst screening. The silicon meander channel was 
used to monitor the oxidation of glucose by glucose oxidase coupled to the decomposition of 
hydrogen peroxide by catalase. A CFD model of the enzymatic cascade reaction was also 
developed and its prediction compared with the experimental data.  
Oxygen availability was identified as a major issue in the system, since a rapid oxygen 
consumption occurred with increasing enzyme and substrate concentration, which was closely 
mimicked in the performed simulations. 
To increase the applicability of the meander channel, several strategies for increasing 
oxygen concentration inside the channel were tested. These involved either introduction of more 
oxygen, simply by introducing a fresh solution in the middle of the channel, or in situ oxygen 
generation by increasing the amount of catalase present and/or introducing hydrogen peroxide. 
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Hydrogen peroxide introduction allowed to significantly increase the amount of formed product 
at the outlet. However, in this case the obtained simulations under-estimated this value, which 
signifies the kinetic parameter used (kcatalase) was probably also below the real value. 
To validate the information provided by the oxygen sensors, a strategy was developed 
whereby the oxygen concentration in a reference sensor at a certain residence time was matched 
to the product concentration quantified in a standard analytical equipment (HPLC) for the same 
residence time. This strategy allowed a direct connection between the oxygen and product 
concentrations, if the reaction is not at oxygen limitation in the sensor used for reference. In the 
presented experiments, this was a significant issue, but calibration curves with similar slopes 
were obtained, which seems to indicate the feasibility of this strategy. Another approach, would 
be to integrate sensors for the quantification of the other compounds involved in the reaction 
(e.g. glucose sensors) in the same microfluidic platform or in a modular unit in sequence (see 
microfluidic module for sensor integration in Chapter 4). However, to achieve this the reaction 
would have to have stopped at the point of substrate(s)/product(s) quantification. A simple and 
unspecific way of attaining this is thermal inactivation, for which another microfluidic platform 
(presented in Chapter 5) was developed. An alternative to the developed thermal inactivation 
platform, could be in situ heating of the reaction mixture in the tube, immediately at the outlet 
of the silicon meander channel. This would have the added issues of isolating the silicon chip 
from the heat source, while complicating the heating setup required. Another alternative could 
be the introduction of an inactivating compound through one of the last side inlets or in a T-
junction place in the outlet tube. The sensors for quantification would, however, have to be 
immune to the chosen inactivating compound (e.g. sodium hydroxide). 
Several parameters in the CFD simulations were also varied for a single experiment to 
check its possible effect on the obtained simulation output. Even though kcatalase increase resulted 
in an increased gluconic acid concentration at the outlet, its effect is less significant than the 
amount of oxygen diffusing through the outlet PTFE tube, with which it was possible to match 
most of the experimental data. A difference of one order of magnitude was found for PTFE 
oxygen diffusivity relative to the value found in the literature.  
The accuracy of the developed model would be significantly increased if it was coupled 
with a mechanistic model. This would allow a more rapid optimization of the kinetic parameters, 
that could then be iteratively used in the fluidic model, until a close match to the experimental 
output would be obtained. A mechanistic model, developed for example in Matlab®, would also 
increase this fluidic model’s applicability, since different and more complex reaction 
mechanisms could be easily implemented and interfaced with the CFD model, widening its 
applicability to more reactions. 
The microfluidic meander channel was also successfully used as a modular unit with two 
other microfluidic systems, a commercially available polymeric valve and an in-house developed 
PMMA meander channel. The connection between the systems was performed through the use 
of either standardized connectors or in-house built connectors with standard sizes. The 
operation of the silicon meander channel with both these systems proves its compatibility with 
operation in a modular format, which together with the presented reaction characterization, 
makes it a highly useful tool in modular enzymatic screening platforms. 
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Chapter 3 
System for screening whole cell catalysts  
All the cell samples and the experiments presented in this chapter were produced in collaboration with 
Julia Halder and Prof. Bernhard Hauer during an external stay at the Biocatalysis Group, Institut für 
Technische Biochemie, Universität Stuttgart.  
Selective oxidative functionalization of molecules is a highly relevant and often 
demanding reaction in organic chemistry, requiring the use of complex group-protection 
schemes and toxic compounds. Certain enzymes, such as oxygenases, are capable of performing 
selective stereo- and regioselective introduction of oxygen molecules in organic compounds 
towards the biosynthesis of important precursors or chemicals in the pharmaceutical and 
chemical industries, and are also capable of bioremediation by degrading insecticides or 
polyaromatic compounds. Dioxygenases, in particular, are enzymes capable of converting a wide 
variety of interesting arene as well as alkene substrates, and a considerable effort has been put 
in their development towards enzymes with better activity and selectivity for certain 
compounds, This, however, greatly increases the need for screening strategies that allow the 
identification of the adequate properties for the target reaction and/or substrate.  
In this chapter, the meander microchannel with integrated oxygen sensors described in 
the previous chapter (Chapter 2), was applied to the screening of wild-type and variants of 
naphthalene dioxygenase (NDO) from Pseudomonas sp. NICB 9816-4. These variants were 
generated through site-directed mutagenesis to obtain enzymes capable of converting alkenes 
[238]. The oxygen sensors were used to measure the oxygen consumption rate of several variants 
during the conversion of styrene (substrate) to 1-Phenylethanediol (product). The oxygen 
consumption rate can be used to compare the different variants in terms of their ability to 
convert this substrate, and potentially in terms of substrate specificity and reaction rate. It was 
possible to distinguish endogenous respiration from oxygen consumed in the reaction for the E. 
coli cells tested. Furthermore, it was also possible to identify the higher activity and different 
reaction rate of two variants, relative to the wild-type NDO. The meander microchannel with 
integrated oxygen sensors can therefore be used as a simple and fast screening platform for 
selection of dioxygenase mutants. 
3.1 Introduction 
The use of biocatalysts has enabled the production of (new) compounds, with high stereo- 
and/or regioselectivity at milder conditions (lower temperatures, close to neutral pH and 
atmospheric pressure), in a simpler process (no need for protection of functional groups) and 
with less toxic substrates, than the equivalent (when existent) organic chemistry methods [239]. 
Furthermore, they usually present a several fold increase of reaction rate and may be capable 
of catalyzing the conversion of non-natural substrates. Also, biocatalysts: (i) require a lower 
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energy demand that lead to less waste of the catalyst (through recovery and/or immobilization); 
(ii) allow an increased product titer; and, (iii) demand the use of lower amounts of water [239]. 
They can, however, represent a significant fraction of the bioprocess operation cost, due to the 
cost of development, need of co-factors, loss of productivity (from loss of activity at the reaction 
conditions), or complex downstream processing emerging from a low enantioselectivity [240]. 
Nonetheless, by appropriate selection and/or tailoring of the biocatalyst to the desired reaction 
and/or process, this cost can be decreased and the process made lucrative [240]. In 2014, over 
500 industrial products were based on biocatalysis, 150 of which were in the chemical and/or 
pharmaceutical industry  [239].  
3.1.1 Whole cell biocatalysts 
Whole cell biocatalysis involves the use of a microbial cell (bacteria, fungi or yeast cell) 
inside which the conversion of (non-)native substrates into a target product occurs [241]. The 
enzymes involved in the reaction can be from the organism itself but in most cases they are from 
a heterologous source and are inserted in a microorganism (i.e. named genetically modified 
expression host); which is easier to grow, better characterized, considered safe and/or already 
used in industry (e.g. Escherichia coli, Pseudomonas sp., Pichia pastoris, Saccharomyces 
cerevisiae, Bacillus spp., Aspergillus spp., Trichoderma reesei) [239]. The use of whole cell 
biocatalysts has generally a lower cost than isolated or immobilized enzymes, since there is no 
need for enzyme purification, or addition of high amounts of co-factors, while simultaneously 
simplifying the downstream processing [242]. The use of whole cells can additionally increase 
the stability of the catalysts, by providing a protective casing from the reaction mixture [243]. 
The use of whole cells further allows a simpler application of enzymes which are membrane-
bound, part of a multiprotein complex or co-factor dependent. The encapsulation of an enzyme 
in a cell enables a faster reaction due to proximity of all the required components for the 
reaction, such as co-factors, co-substrates or metabolites, besides other enzymes involved in the 
bioconversion. Regarding co-factor (such as NAD(P)H)) regeneration, the use of whole cells 
grants the use of regeneration systems of the host organism or its integration into the host 
organism, hence enabling in situ co-factor regeneration without loss of the often expensive 
compound [240]. The co-factor is regenerated either by using a co-substrate or by enzyme-
coupled systems integrated in or part of the microbial host. The coupling of enzymes requires a 
proper balance between the reaction rates of the different enzymes involved and an efficient 
drive of the enzymatic route towards the target product. However, co-expression of multiple 
enzymes can lead to a high metabolic burden and to a lower catalytic performance. An 
alternative is the expression of each enzyme in a separate organism and combining the different 
organisms for the bioconversion [244]. Whole cell biocatalysts also shield the enzymes from the 
environment enabling reactions at harsher or non-natural conditions [244]. Examples of such 
non-natural conditions are: 
- Biphasic systems of water immiscible organic solvents; 
- Neat substrate systems (NSSs), where the substrates are usually used as solvents, 
allowing a monophasic system environment with minimum water addition and high-
substrate loads; 
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- Micro-aqueous solvent systems, where the advantages of NSSs are maintained but the 
substrates are diluted in another organic solvent; 
- Ionic liquids and deep eutectic solvents, which are less toxic and have a lower 
flammability and vapor pressure than organic solvents. 
The use of whole cell biocatalysts as resting cells, besides separating growth phase from 
catalysis, can moreover decrease the competition of cellular reactions like oxidative 
phosphorylation with co-factor regeneration. On the other hand, in resting cells, changes in gene 
regulation can result in protein or membrane instability or a decrease in intracellular enzyme 
levels, in turn leading to a lower biocatalytic activity [245].  
Whole cell biosystems may, furthermore, result in decreased reaction rate due to 
limitations in substrate mass transport through the cell wall, which can be improved by 
permeabilization of the wall with chemical (e.g. adding organic solvents, surfactants, chelating 
agents or altering the cell wall’s fatty acid content) or physical (e.g. temperature shock, 
electroporation) methods [246]. Other approaches involve the expression of membrane 
transporters, to increase influx of substrate to the cell, or the use of cell surface techniques to 
display the enzymes on the cell membrane, and even temperature-controlled pore-formation 
through the use of lytic phage proteins [244].  
Whole cell catalysts can also be immobilized during the bioconversion, however there are 
less immobilization strategies than for purified enzymes. Nevertheless, whole cell catalysts 
have been immobilized in lentil-like shaped porous polyvinyl alcohol (PVA) carriers from 
LentiKat’s (Prague, Czech Republic), storable for up to 15 months, in ion exchange resins by 
covering with silicon coating (allowing their application in NSSs), and in polyvinylidene 
difluoride membranes (with good recyclability in micro-aqueous conditions) in order to ease 
recovery, increase catalyst load and improve stability and recyclability of these catalysts [244]. 
In whole cell biotransformations the main parameters to be optimized for process 
implementation are the oxygen supply, substrate and product toxicity, product stability and co-
factor recycling [245]. All the above-mentioned parameters need to be fully characterized and 
optimized in order to achieve a cost-effective and productive bioprocess.  
Engineered enzymes in crude or semi purified form are currently considered more 
economically viable than whole cell biocatalysts. They present an increased tolerance to harsher 
conditions (organic solvents, lower or higher pH, high temperature, etc.), can perform the 
reaction at lower concentrations due to their higher activity and are easier to separate and 
remove from the reaction media due to immobilization strategies [247]. Nonetheless, around 
60% of the industrial biocatalysis is performed using whole cell catalysts [242]. 
3.1.1.1 E. coli as a recombinant whole cell catalyst 
E. coli was the first microorganism used as a recombinant host, and has since been used 
extensively. The preference for E. coli is related to its fast growth rates and ability to reach high 
cell densities (average doubling time is 40 minutes [248]) in simple and low cost media. Also, 
the ease in genome modification or integration of new DNA through plasmids, as well as the 
capability of accumulating heterologous proteins up to 50% of its dry cell weight are relevant 
factors for its wide use. However, it cannot be applied to the production of more complex proteins 
(e.g. human protein requiring post-translational modifications). It may also form inclusion 
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bodies where the target heterologous protein might be aggregated and inactive [239]. Recent 
research has shown that it is possible to retrieve some proteins by solubilizing the inclusion 
bodies [249], [250], but it is still preferable to avoid their formation during expression of the 
target protein.  
3.1.2 Dioxygenases 
Oxidative biocatalysts can solve some of the issues in conventional chemical oxidative 
reactions, such as lack of predictability of product structures and cost of oxidizing agents, when 
trying to obtain relevant hydroxy- and oxo- compounds for the pharmaceutical, agrochemical 
and food industries. Oxidative enzymes can also be used in other industries, namely for 
bioremediation, oxidizing insecticides, haloaromatics and polyaromatic hydrocarbons [251].  
Oxidases, peroxidases and oxygenases are oxidizing enzymes, which use oxygen as the 
electron acceptor during the reaction. While oxy- and peroxidases often result in reactive oxygen 
intermediates, which can react non-specifically, oxygenases are quite stereoselective [251]. 
Oxygenases can be involved either in the biodegradation/detoxification of carbon sources and 
toxic compounds, or in the biosynthesis of secondary metabolites (e.g. hormones) [252]. They are 
usually NAD(P)H dependent and can be further divided into monooxygenases and dioxygenases. 
Monooxygenases (e.g. cytochrome P450 BM-3) catalyze the introduction of one oxygen atom in 
the substrate using NAD(P)H as the reducing electron acceptor and are usually dependent on a 
metal, heme group of a flavin. Dioxygenases (e.g. catechol dioxygenase) are multimeric non-
heme iron proteins that can introduce stereo- and regioselectively two oxygen atoms from 
molecular oxygen in the substrate (e.g. aromatic compounds) [253]. A very important group of 
dioxygenases are the Rieske non-heme iron-sulfur oxygenases, which have a Rieske group [2Fe-
2S] coordinated to the protein by two cysteine and two histidine residues [254].  Rieske non-
heme iron-dependent oxygenases (ROs) are best known for the regio- and stereospecific cis-
hydroxylation of aromatic compounds to produce dihydrodiols, but are also involved in several 
catabolic and biosynthetic pathways [255]. These enzymes show a great potential for the 
asymmetric dihydroxylation of alkenes, allowing for a more environmental-friendly process. 
This reaction in organic synthesis (e.g. Sharpless dihydroxylation) uses toxic metallic 
compounds (e.g. osmium(VIII) oxide) and often leads to overoxidation and byproduct formation. 
Furthermore, ROs are capable of catalyzing various oxidation reactions (e.g. 
monohydroxylations, desaturations, oxidative cyclizations) in a variety of substrates, and the 
range of substrates can be increased by changes in the topology of the active site, as 
demonstrated by Gally et al. (2015) [256]. The first ROs identified, Naphthalene and Toluene 
dioxygenases, were discovered in the 1970s and are responsible for the degradation of aromatic 
compounds by Pseudomonas putida. ROs consist of a two- or three-component system that 
includes (i)  a reductase (an electron-transfer protein to obtain the reduction equivalents from 
NAD(P)H), (ii) a ferredoxin (the protein that shuttles the electrons to the active site (in the three 
component systems)), and (iii) an oxygenase (the enzyme that performs the conversion) [254]. 
Naphthalene dioxygenase (NDO), the most studied enzyme in this class, catalyzes the cis-1,2-
dihydroxylation of naphthalene using both oxygen atoms from molecular oxygen. The dioxygen 
reduction occurs by first transferring electrons from the co-substrate (NADH) to a Rieske [2Fe-
2S] cluster within the NDO via a flavin-dependent ferredoxin reductase and a separate 
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ferredoxin. The electrons are then donated to the non-heme iron center in the active site and 
used in the final reduction of dioxygen. A full account of possible catalytic mechanisms for NDO 
is presented in Barry and Challis (2013) [255], a good characterization of the three-component 
system can be found in Kauppi et al. (1998) [257], and the structural influence on enzyme 
substrate plasticity of ROs is presented in Ferraro et al. (2005) [254]. This enzyme has 
demonstrated a great degree of customization, allowing to widen the range of obtainable 
products beyond the ones of the wild-type NDO by site-directed mutagenesis [253].  
In terms of application to biotransformations at industrial scale, oxygenases present some 
limitations due to low stability and dependency on expensive co-factors, as well as the 
membrane-bound nature of some components of the enzyme system. These factors lead to the 
application of oxygenases in whole cell systems in order to stabilize the enzyme and achieve in 
situ co-factor regeneration using the metabolism of the host cells [251]. Furthermore, due to the 
poor water solubility of most oxygenase substrates and products, biotransformations are mostly 
performed in two-liquid phase systems. Additionally, oxygenases usually present relatively low 
turnover rates, which coupled with diffusion limitations in the cell membrane, require high 
expression levels of these enzymes to reach significant whole cell oxygenase activities. 
Uncoupling effects where reduction of molecular oxygen (and thus oxygen consumption) occurs 
without substrate oxidation, result in the production of hydrogen peroxide (two-electron 
reduction) or water (four-electron reduction). This effect can occur in the absence of substrate, 
when the substrate cannot be oxidized or in the presence of compounds that do not properly fit 
the active site. Uncoupling effects can in turn lead to an increase in oxygen demand, as well as 
the production of toxic hydrogen peroxide and a lowered specific activity in the final 
bioconversion [252]. Overoxidation of the substrate, beyond the desired product, can occur under 
non-physiological conditions or when the electron transfer components are fused to the 
oxygenase and may also be an issue with these enzymes [252]. In whole cell systems, the diols 
produced by dioxygenases are usually further metabolized and so blocked variants are 
developed for their production [251]. Moreover, insertion of the oxygenase and auxiliary proteins 
genes in the host’s chromosome might decrease instability of the host cell. Another factor to 
consider in bioconversions with oxygenases is the hydrophobicity of the substrates, which tend 
to diffuse easily through the cell membrane, and can result in cell wall degradation and cell 
death. Some of the toxic substrates require counter mechanisms to be implemented in the host 
cell, the control of substrate concentration (e.g. by substrate addition strategies, using small 
concentrations), or use of solvent tolerant strains [245].  
3.1.2.1  Oxygen influence in cell behavior 
Cellular function, especially in tissues, is dependent not only on the oxygen partial 
pressure but also on the balance between available oxygen and oxygen consumption in the cell 
microenvironment [192].  For human cells, for example, normoxia (normal level of oxygen) is 
usually between 2 and 9% and up to 13% in the lungs, which is significantly lower than the level 
in ambient air (21%). Consumption of oxygen by a static cell culture media is enough to generate 
hypoxic environments, and the rate of consumption is dependent on cell density and metabolic 
rates [192]. Oxygen is used as electron acceptor or oxidizing agent in aerobic metabolic activities, 
but high concentrations of oxygen can be harmful due to the generation of oxygen radicals [258]. 
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Escherichia coli (E. coli) is a facultative anaerobe and can switch between aerobic and anaerobic 
metabolism depending on the nutrients and oxygen concentrations available in the 
environment. According to Polinkovsky et al. (2009) oxygen consumption by E. coli increases 
linearly with the division rate of the cells, being between 20 mmol/h per gram of dry mass at 1 
division/h and 6 mmol/h/g at 0.2 divisions/h [259].  
Strains that express oxygenases require oxygen not only for the bioconversion but also for 
endogenous respiration, and so during the biotransformation the oxygen pressure needs to be 
maintained in order to allow the oxidation reaction to compete with respiration. Maximum 
whole cell oxygenase activities over 10h to 15h are usually lower than 50 U/gcdw, which can be 
improved, by focusing on optimizing some of the aspects mentioned  in section 1.2 above [252].  
Microfluidic systems can enable a good control of diffusion and gradient generation, as 
mentioned in the previous chapters, thus providing the perfect environment for studying the 
influence of oxygen levels on cells. 
3.1.3 Screening of biocatalysts 
Biocatalyst screening, especially for new processes or products or when involving non-
natural substrates, is a complex task, involving different levels of screening. A general strategy, 
presented by Ogawa and Shimizu (1999) [260] can be divided in:  
(1) A process step, during which the final industrial (potential) process is designed, and 
the desired type of enzymatic activity defined; 
(2) A microorganism step, where a selection of microorganisms to be screened for the 
enzymatic activity and/or process conditions is performed; 
(3) A screening step, where the choice or development of a sensitive assay for screening of 
the desired biocatalyst’s characteristics is achieved. 
Step (1) is extremely dependent on the target reaction or product, on the type of product 
(whether it is an intermediate compound, a precursor or the final compound), on the industry 
(inorganic chemistry, agrochemical, pharmaceutical, food), on the required degree of purity or 
enantioselectivity desired, and type of application (for profit or for bioremediation, for example).  
Step (2) can be further divided into three factors [261]:  
(a) If a similar reaction to the target reaction has been reported with a similar substrate, 
the same catalyst or one with the same function should be tested;  
(b) If a new reaction is the target, screening of existing libraries is advised, as well as 
testing of biocatalysts with a broader substrate range; 
(c) If library screening has not yielded a good match for the target reaction, wide 
biocatalyst screening should be performed. 
Although, step (2) can be divided in the latter considerations, it usually involves classical 
techniques such as enrichment-culture (for natural strains), where selection is based on the 
ability to assimilate the target substrate, and isolation strategy [260]. Homology search and 
sequence alignment has enabled the identification of novel biocatalysts and the reconstruction 
of ancestral biocatalysts with a wider substrate range, as well as the establishment of libraries 
of biocatalysts with enhanced characteristics by identifying common amino acids, or their 
substitutions, that yield a certain desired characteristic [247]. This has been especially relevant 
for identifying enzymes from non-culturable microorganisms, by extracting DNA of samples 
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collected from the environment and comparing with DNA-cosmid libraries. However, the use of 
gene-libraries disassociates the enzyme from its microbial function [260], which is important to 
fully understand the potential of the enzyme and the challenges in terms of its applicability. 
Rapid and high-throughput genome sequencing, as well as high-throughput analysis of mRNA 
(e.g. hybridizations on microarrays, providing an overview of gene expression and active genes), 
proteins (e.g. 2D-PAGE) and metabolites (e.g. chromatographic methods coupled with mass 
spectrometry or nuclear magnetic resonance to provide an overview of active metabolic networks 
and response to environmental stress) can provide a lot of information regarding enzymes and 
their possible function in the metabolism of the microorganism [245], [247]. High-throughput 
genome sequencing provides an overview of the genetic background of both culturable and non-
cultivable organisms using platforms such as 454 from Roche, Solexa from Illumina or SoLiD 
from ABI [239]. 
Step (3) is often the most difficult of the three steps. The development and 
characterization of new biocatalysts is frequently hampered by the available screening 
technologies, often limited to the screening of a single substrate or function for the multiple 
variants generated.  
3.1.3.1  Screening strategies 
Methods for biocatalyst screening and variant selection require proper design in order to 
maintain the association between the phenotype observed and the genotype measured [262]. To 
perform screening of biocatalysts from wide enzyme or whole cell catalyst collections, not only 
high-throughput growth systems need to be developed (such as the one developed by Doig et al. 
(2002) using a robotic liquid handling system [154]) but also online quantification and/or 
monitoring of the reaction is necessary.  
The majority of traditional approaches used for screening are performed in vitro, thus 
requiring extraction of the sample from the reaction mixture, or to stop the reaction to perform 
the quantification of the reaction components. However, in vivo screening (when the 
biotransformation/bioconversion is monitored in the microorganisms) broadens the number of 
parameters that can be screened and accelerates biocatalyst development and selection. In vivo 
screening strategies present some limitations associated with the host’s transformation 
efficiency and growth rate, but also the expression of the target enzyme, limitations in substrate 
uptake and intracellular background [263]. Furthermore, the choice of catalyst can be made 
following a selection or a screening approach. A biocatalyst selection approach excludes the 
clones without the characteristics of interest (negative clones), while in a screening approach 
all clones are analyzed and then selected, thus increasing the amount of variants to analyze but 
also the precision of the activity measurements and screened parameters [263]. Screening of 105 
to 108 variants, where the complement of a key step in the metabolic network is required, has 
been achieved with selection methods [264]. In selection approaches, the enzyme activity is 
usually linked to cell survival and growth in a way that only enzymes with the target activity 
are able to survive and/or grow under the chosen selective pressure (e.g. enzymes that 
complement auxotrophy or neutralize lethal conditions). However, this leads to a higher number 
of false positives than with screening approaches. A selection approach also does not always 
enable quantification and hence comparison of, for example, conversion rates [263].  
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Most assays tend to be specific to adequately screen for the intended characteristic, 
involving standard analytical equipment such as mass spectrometry (MS), gas chromatography 
(GC), high-performance liquid chromatography (HPLC) or nuclear magnetic resonance (NMR), 
thus being also quite time-consuming if hundreds or more samples need to be analyzed. 
Enantioselectivity (measured by enantiomeric excess, ee), for example, has been screened using 
electrospray ionization mass spectrometry (ESI-MS), using isotopical labels, capable of 
measuring both kinetic resolution of racemates and asymmetric transformation of substrates in 
up to 1000 samples per day [265]. Derivatization with mass-tagged chiral agents that differ in 
a substituent remote to the chiral center has also been used for screening enantioselectivity by 
ESI-MS. This approach does not require chromatographic separation and is tolerant to reactive 
achiral impurities [266]. MS, GC and HPLC based techniques require however extra steps in 
sample preparation such as extraction of the compounds, removal of organic phase and 
separation in a chromatographic separation, which increases the overall analysis time per 
sample [267]. 
Faster screening methods often involve the formation or consumption of a colorimetric, 
luminescent or fluorescent compound and its intensity is related with the substrate’s affinity or 
turnover rate. For example, NADH and NADPH can be measured spectrophotometrically at 340 
nm or 260 nm. Consumption of hydrogen peroxide can be followed by measuring samples at 240 
nm (usually to measure catalase activity). Horseradish peroxidase catalyzes several reactions 
(using as substrates, e.g. 2,2’-Azino-bis(3-Ethylbenzthiazoline-6-Sulfonic Acid), 4-
aminoantipyrine) that produce colorimetric compounds and can thus be followed 
spectrophotometrically. The last method involving formation of a colorimetric compound by 
horseradish peroxidase has also been applied for screening 960 variants from cultures grown on 
a nylon membrane on top of agar plates. The more intense the color the colony produced, the 
higher the amount of target product, thus enabling the selection of the higher producing 
variants for further characterization [268].  
Screening in agar plates usually occurs by formation or disappearance of color on the agar 
surrounding the incubated colonies or by color appearance on the colonies themselves due to 
bioconversion, providing a straightforward identification of positive colonies. Differences 
between activity or catalytic rates are, however, not easily achieved with this type of screening 
and usually only up to 105 variants can be analyzed [263]. Coupling of this method with 
analytical equipment such as HPLC, GC or MS can also be performed. For example, Yan et al. 
(2017) coupled ambient MS with desorption electrospray ionization (DESI) to achieve a label-
free platform for real-time screening of biotransformations in bacterial cultures. The DESI 
system enables sampling from the reaction mixture (ionizing the substrates and products 
directly from the agar plate) at room temperature in real-time. This is followed by an ion 
mobility (IM) component that performs the separation of the different ions generated to decrease 
background noise, and finally by an imaging MS capable of relating the detected chemical 
compounds on the surface of the agar plate with their spatial distribution. The measurement of 
the extracellular product can be performed simultaneously for several substrate libraries, 
followed by analysis of the DNA of the biocatalysts for genotype/phenotype association [267]. 
Metagenomic screening allows the selection of genes with the desired function, by direct 
phenotypical detection, heterologous complementation and induced gene expression, usually 
through isolation in agar plates supplemented with different substrates (e.g. target substrate, 
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certain antibiotics, co-substrates). In this technique, target activity can be further associated 
with the expression of a reporter gene (e.g. green fluorescent protein or β-galactosidase) for 
easier screening [239]. 
Microtiter plates are the most frequently used screening devices, due to high-throughput 
(depending on the number of wells per plate) and compatibility with a wide range of analytical 
techniques, from colorimetric approaches to GC, NMR or MS. Microtiter plates are, however, 
usually limited to libraries of up to 104 variants [263]. UV-Vis and fluorescent microplate 
readers and fluorescent digital imaging (in which mutants are passed on to a nitrocellulose 
membrane from the agar plate where they were cultured) [269] can be used to increase 
throughput during biocatalyst selection. Schwaneberg et al. (1999) developed a high-throughput 
assay using a robotic workstation and spectral analyzer compatible with 96-well microtiter 
plates for the analysis of substrate specificity and the activity of mutants of a fatty acid 
hydroxylating enzyme. This assay was based on detecting the conversion by the mutants of p-
Nitrophenoxyhexanoic acid (pNCA)-containing substrates, and showed results for both pure 
enzymes and cell extracts [270]. This method was then further developed to allow 
measurements directly from the whole cell biocatalysts, eliminating the cell lysis, resuspensions 
and centrifugation preparation steps, by permeabilizing the outer cell membrane of E. coli. This 
method used also a replicator tool (developed by Duetz et al. (2000) [271]) to transfer cells from 
agar plates to the 96-wells plate. Despite the increase in number of samples analyzed in parallel 
(~3000 clones per day) as well as directly from the cell bioconversion, issues of reproducibility 
between screens and differences in activity relative to the one measured in shake flasks (due to 
evaporation, a well-known problem in open microtiter plates) were observed [272]. Samorski et 
al. (2005) developed a system for evaluating induction time and growth differences of whole cell 
catalysts cultured in 96-well microtiter plates. The system used light scattering, NADH 
fluorescence and yellow fluorescent protein to monitor the cell culture in all 96 wells through a 
x-y-stage with an integrated optical fibre bundle. Measurements of optical density (with light 
scattering and NADH measurements) and amount of expression of an induced fluorescent 
protein were performed, allowing the optimization of the initial cell density and the time of 
induction, and the online monitoring of product formation in a microtiter plate  [156].  Codexis, 
a company specialized in enzyme engineering, and other enzyme developing companies (e.g. 
Ingenza, Nzomics, InnoSyn, Almac), provide systems for enzyme screening based on 96-well 
microtiter plates for ketoreductases, acylases, ene-reductases, transaminases, lyases, 
dehydrogenases and halohydrin dehalogenases [261].  
Fluorescent microscopy can help locate proteins and measure their activity, as well as 
protein-protein interactions and protein diffusion coefficients [273]. Infrared multiphoton laser 
scanning microscopy (NIR-LSM) allows the detection of biomolecules within the cells [273]. 
Bioluminescence assays can be used to determine coenzymes and to perform detection of 
reporter genes. However, these methods are not compatible with the long-term measurements 
required for metabolic activity assays due to photobleaching of fluorescent compounds or 
decomposition [273]. Mid-infrared spectroscopy can be used to identify and quantify species 
present in a bioprocess [273]. Scanning electrochemical microscopy (SECM) can provide 
information on cell respiratory activity and other redox processes [273]. 
Spectrophotometric tests are quite desirable due to the possibility of parallelization using 
microtiter plates, and due to the fact that they are usually quite fast and relatively sensitive 
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(signal amplification methods can also be applied). However, most target compounds are neither 
colorimetric nor fluorescent and developing an indirect colorimetric detection method can be 
difficult and time-consuming. The development of surrogate substrates, which are compounds 
that are added to the culture and generate an optical signal proportional to the target activity, 
is a good example of the complexity involved in the development of new detection methods [262]. 
Moreover, these methods, especially colorimetric methods, usually have a high incidence of false 
positive or negative results which lead to lower precision in the quantification of the target 
compound [267]. 
Fluorescence-activated cell sorting (FACS) and Micro Fluorescence-activated cell sorting 
(µFACS) devices have been used to screen for growth in a new substrate, and to select variants 
based on enantioselectivity, by linking cell survival with capacity for catalysis of only one 
enantiomer (selection approach) [274], [264], [247]. Cell survival can also be linked to antibiotic 
resistance [262]. Flow cytometry also allows assessing whole cell biocatalysts viability and 
electron transport, besides enzyme activity, achieving a very high throughput (108 screened 
variants per day [262]). FACS on a chip provides a better control on number of cells per droplet 
(down to single cell), as well as on number of fluorescent reporters per droplet thus presenting 
highly quantitative results [262].  
Recently, some microfluidic approaches to screening of biocatalysts have emerged. 
Microfluidics can enable a faster measurement and/or monitoring of a higher number of 
parameters, due to the ease of flow manipulation but also sensor integration. Furthermore, they 
provide continuous production at lower cost, reagent quantities, higher safety and less waste, 
while also allowing a better spatial and temporal control of the reactions, and operation at 
unusual process conditions and catalyst configurations, thus expanding the operation conditions 
and types of reactions possible  [47]. Abate et al. (2010) used droplet microfluidics to screen 
mutants of horseradish peroxidase generated by directed evolution, at rates of thousands per 
second, being 1000-fold faster than microtiter plate based robotic screening. A stream of yeast 
cells with mutated enzymes on the surface is co-flown with a fluorogenic substrate and aqueous 
pL droplets containing a single yeast cell are formed by dispersion in an oil solution.  The 
reaction is initiated by the mix of the two aqueous solutions in each droplet and continues in 
the incubation section of the first microfluidic device. In the second device, the droplets are 
dielectrophoretically sorted based on fluorescent intensity using a laser connected to a 
photomultiplier tube. The microfluidic device was designed in order to allow reinjection of 
droplets in the systems in order to allow incubation of low activity mutants for later analysis. 
The detection limit in this case was of ~3500 molecules in 6 pL or <1 turnover per enzyme [117]. 
Kintses et al. (2012) has applied a similar strategy, but performing fluorescent detection of 
enzyme reactions in lysates of single cells of E. coli. Directed evolution of arylsulfatase from P. 
aeruginosa expressed in E. coli was performed to explore this enzyme’s substrate promiscuity 
in order to extend its activity towards phosphonate. In the developed microfluidic setup, cell 
lysis and reaction are performed simultaneously by fast mixing of substrate and cell lysis agents 
with the cell solution upon droplet formation. The best variants were selected with laser-induced 
fluorescence in a second device with a dielectrophoretic sorter, and broken in order to isolate 
their plasmid content and use it for the next evolution cycle.  Droplets generated this way, where 
the target compound can be optically read, can also be screened using FACS, requiring that the 
water-in-oil droplets are previously enveloped in water. The second emulsification step however, 
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if performed in bulk, can cause a variation in droplet diameter and hence a lower measurement 
precision. The whole cycle of variants’ screening developed by Kintses et al. (2012) was 
performed in two days with the analysis of 107 droplets every 3 hours [61]. Besides water-in-oil 
droplets, shell-like compartments made with polyelectrolytes can be used to encapsulate cells, 
which are more stable with detergents used for lysis [262]. This technique also enables the 
detection of very small improvements of enzymatic activity [263].  
In another approach, the cells themselves can be used as femtoliter screening vessels, by 
only performing the target reactions inside the cells and detecting the resulting fluorescent 
product also inside the cells by, for example, FACS. In this way, libraries of up to 109 variants 
can be screened [263]. The enzymes can, on the other hand, be displayed on the surface of the 
cells during the assay by fusion with anchor motifs, being thus more accessible to the substrate 
(cell surface display technique). In this approach, the product is also displayed on the cell surface 
and again up to 109 variants can be screened. The required fusion however limits the 
applicability of this approach to libraries of enzyme variants, and needs to be resistant to 
proteases, have a stable structure and be compatible with the target enzyme. This technique 
can also be associated with FACS, but the displayed enzymes may lose activity and fluorescent 
substrate or products need to remain bound to the cell surface during measurement [263].  
Droplet-based directed evolution of whole cell catalysts is a very powerful tool to increase 
screening throughput of engineered biocatalysts, but the use of different sensor technologies 
(such as NIR [275] or Stroboscopic Epifluorescence Imaging [133], for example) is required to 
expand its application. Further coupling of such a system with standard analytical equipment 
such as HPLC, GC or MS would increase its usefulness for biotechnologists and also the range 
of detected compounds. Packer and Liu (2015) provide a good overview of available screening 
methods for protein selection, as well as a short guide on how to select which screening method 
to apply [262]. 
Another approach to screening allows for an indirect measure of the characteristic 
targeted, not by the product or substrate of the bioconversion, but by the genetic reporter that 
encodes that phenotype. This approach is regarded as reaction independent, and the reporter 
may be colorimetric, fluorescent, bioluminescent or result in conditional survival, cell motility, 
acidification or cell display. The activity of the reporter measured is connected to the activity of 
the target enzyme by interference at either the transcription (e.g. activation of a natural or 
synthetic transcriptional regulator by binding of the product or substrate), translation (e.g. by 
binding of the product to a ribozyme or reporter inactivation by the enzyme) or post-
translational modification level (e.g. direct modification of the reporter by the enzyme), or even 
enzyme degradation or solubility (e.g. by fusing GFP to the enzyme variant, and thus only 
soluble GFP variants are positively selected). Reporter-based screening using natural 
transcriptional regulators are usually extremely selective for the target product, having no false 
positives. This may increase the applicability as a screening strategy to more types of enzyme 
and reactions, but still each case requires the proper choice of reporter and approach [263]. 
Genetic circuit design, which involves the capacity to design DNA in order to modulate the 
expression of certain genes or metabolic networks to occur at defined environmental conditions, 
has also been used to measure the activity of enzyme variants from the expression levels of 
reporter genes [276], [277]. 
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A change in pH due to product formation or substrate consumption has also been used as 
an enzymatic screening test (e.g. pantoic acid production by lactonases [260]). 
A summary of the commonly used screening approaches is presented in Figure 39. 
 
Figure 39 – Summary of some of the advantages and disadvantages of the commonly used screening approaches for 
whole cell biocatalysts. 
3.1.3.2  Screening of oxygenases 
Screening of oxygenase variants or mutants is specially complicated since the generated 
products do not cause a change in pH, color or fluorescence, and distinction between 
regioisomers is often the main objective of the screening program. Screening of these enzymes 
is thus usually achieved with more time-consuming and sensitive analytical methods, some of 
them mentioned above, such as GC or liquid-chromatography (LS) often coupled with MS, or 
even nuclear magnetic resonance (NMR) [252]. These analytical methods can provide a high 
degree of throughput. However, this throughput is achieved with a lengthy time period between 
variant development, reaction performance and analysis of product concentration and range of 
compounds. High-throughput screening with robotic microtiter-based devices, as mentioned 
before, enables the analysis of 100 to 1000 samples of cells per day, but tends to provide hits 
with low activities and regiospecificity, especially in Gram-positive cells and fungi. Screening 
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can also be performed through enrichment cultures, where the organisms grown on the starting 
material, might be able to degrade the desired substrate. However, oxidation of the substrate 
might not occur on the target position [252]. 
Measurement of the initial oxygen consumption rate in the presence of substrate excess 
has been used for characterization of dioxygenases [278], [279], [280]. A study performed by 
Parales et al. (1999) used oxygen measurements with Clark-type oxygen electrodes to confirm 
the importance of an aspartate residue for the catalytic activity in NDO enzymes, namely in the 
electron transfer route. When this residue was modified, no oxygen consumption was observed. 
Furthermore in this study a stoichiometric consumption of naphthalene and oxygen for wild-
type enzymes was observed [281]. Rachinskiy et al. (2014) have used monitoring of oxygen levels 
to detect enzyme deactivation as a parameter in a long-term stability enzyme characterization 
model. The model integrates the mathematical description of temperature-dependent enzyme 
(de)activation (considering the enzyme kinetic characteristics) to predict the process properties 
of an enzyme in order to aid enzyme screening for industrial applications [282]. Despite the 
availability of oxygen sensor spots, as well as other formats of oxygen sensors, for integration 
in microtiter plates and shake flasks, the oxygen measurement seems to be used mainly as a 
monitoring or initial characterization parameter, and not as a screening parameter. As hinted 
by the use of purified enzyme solutions in the studies where oxygen assays were performed, this 
could be due to the interference of cell respiration in whole cell solutions (where most of the 
current screening approaches for this type of enzymes are performed). Moreover, the limited 
application of oxygen measurement as a screening parameter so far might be related to the 
lower sensitivity of the traditionally used sensors (Clark-type) or the need of working in closed 
vessels, when working with highly volatile compounds (and so sensors such as syringe or Clark-
type cannot be applied). However, the more recently developed, highly sensitive and fast 
sensors, with which measurement is performed with optical fibers can contribute to the increase 
in their usage in this field.  
In this work, a microfluidic system with such type of sensors is proposed, where the rate 
of consumption of oxygen could be used to distinguish variants with high activity from variants 
with the same activity as the wild-type or even no activity in a fast and parallel way.  
3.1.3.3  Biocatalyst tailoring 
Biocatalyst selection occurs not only by searching or screening available catalysts that fit 
or can operate at the desired process conditions, but also through optimization and tailoring of 
these biocatalysts to perform better at the conditions of the target process [240]. Characteristics 
that allow the catalyst to better fit the process are, for example, higher pH or temperature range, 
higher substrate affinity or turnover rate, higher robustness and stability, altered  
enantioselectivity, conversion of new and/or unnatural substrates, among other characteristics 
[240]. Biocatalyst development can also prevent the synthesis of unwanted compounds or even 
toxic compounds through parallel reactions or other metabolic pathways present [283].  
Enzyme tailoring or development of new enzymes can be achieved by natural evolution 
(enrichment cultures of microorganisms with the target activity, of which metagenomic libraries 
are made and then from which biocatalysts can be selected), by laboratory evolution (generation 
of libraries of randomly mutated organisms from which biocatalysts with the target activity can 
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be selected) or by computational design of new catalysts (using computational models or based 
on existing libraries followed by experimental testing) [263]. 
This tailoring can be achieved through several techniques, from random or site-directed 
mutagenesis and directed evolution which act on zones close to the native target sequence, to 
DNA shuffling and domain swapping which act on areas amid the original sequences [240]. 
Directed evolution is a highly relevant technique for biocatalyst development, being especially 
powerful when there is little knowledge regarding the relationship between structure motifs 
and function [253]. Initially, random mutagenesis and/or recombination of the targeted gene 
(through error-prone polymerase chain reaction (PCR), repeated oligonucleotide directed 
mutagenesis, chemical agents, etc.) are performed and mutants selected for the desired property 
[239]. The genes responsible for the improved enzymes are then targeted in a second round, and 
so forth, until a library of enzymes with the final improved characteristics is obtained [284]. 
This approach can result in an increased stability of the enzyme but often a loss of activity is 
observed. A successful directed evolution requires the occurrence of mutagenesis on the target 
gene through a practical evolution strategy, as well as the existence of a suitable microbial host 
for enzyme expression and a suitable screening strategy [246]. Directed evolution can also be 
performed continuously and in vivo using alternating culturing vessels [285]. DNA shuffling 
can be performed using a computational method (SCHEMA) that estimates the disruption in 
the enzyme’s original structure after DNA recombination is performed. Combinatorial active-
site saturation testing (CASTing), which enables the design and screening of the binding to the 
active site of an enzyme and ProSAR, a program that analyzes the sequence-activity 
relationship of proteins to perform reagent selection, have both contributed to the generation of 
enzymes with enhanced catalytic activity and enantioselectivity [277]. Gene synthesis, new 
bioinformatics tools and protein and mathematical modeling further contribute to the 
possibilities of tailoring biocatalysts to achieve new functionalities, from higher stability and 
activity in organic solvents to catalyzing non-natural reactions.  
Gene synthesis enables the optimization of certain codons, and introduction of promotors, 
restriction sites, etc. at more convenient locations in the gene, even having been used to generate 
complete genomes for metabolic pathway engineering. Another approach employed to achieve 
non-natural catalytic activities (e.g. involving a different type of chemical bond) is based on an 
initially promiscuous reaction, meaning an enzyme capable of catalyzing more than one type of 
reaction, usually with common catalytic steps [247]. Different computational approaches have 
also been applied to rational design, such as free energy perturbation, substrate docking 
simulation, molecular, hydrogen bond energy calculation and the Rosetta method [277]. 
Mechanistic models based on free-energy changes connected to protein unfolding and reaction 
mechanism can lead to the development of better strategies towards achieving the improved 
target characteristic [247]. Molecular dynamic techniques are able to predict flexibility of some 
residues and their association to enzyme function, in order to change enzyme activity or stability 
with temperature. The Rosetta method involves quantum mechanics and computational design 
of enzymes based on existing scaffolds. Currently, most tailoring approaches are a combination 
of structure-based rational design with computational tools and directed evolution [277]. 
Cherny et al. (2013) coupled predictions from a computational model with results from a 
screening test of directed evolution variants to improve the catalytic rate of enzymes capable of 
hydrolyzing nerve agents, as detoxifying enzymes. The initial libraries used for mutant 
Micro scale reactor system development with integrated advanced sensor technology  
97 
 
generation were designed using Rosetta, and the obtained data was fed into a transition state 
model with which new mutants were designed and experimented, until iteratively high activity 
variants were obtained [286]. Röthlisberger et al. (2008) present the combination of enzyme 
design, modeling and directed evolution to obtain an enzyme capable of performing a reaction 
that no naturally occurring enzyme catalyzes. Quantum mechanical transition state 
calculations were performed to design an active site which maximized the stabilization of the 
transition state of the enzyme for the target catalytic mechanism [287]. Packer and Liu (2015) 
present a good overview of methods for generation of mutants and screening approaches [262]. 
The quantification of all or a comprehensive number of the molecules involved in a certain 
synthetic pathway or reaction can not only accelerate development of biocatalysts, by increasing 
the available knowledge on that specific reaction, but also provide enough data to develop 
mathematical models to predict behavior and/or outcome of genetic or process manipulation 
[245].  
3.2 Goal 
In Chapter 2, the meander channel with integrated oxygen sensors was used to monitor 
an oxygen dependent reaction and observe differences in oxygen consumption for different 
reaction times, enzyme activity and in situ oxygen production. This chapter covers an alternate 
application of such device, extended beyond enzymes in solution to other biocatalyst formats, 
such as whole cell catalysts. In this case, a system capable of monitoring and measuring oxygen 
levels and consumption may provide extra input in screening mutants involved in oxygen 
dependent reactions. Rate of consumption, oxygen availability in the reaction mixture, oxygen 
and/ or other substrates diffusion limitation, uncoupling effects and cell density effects are some 
of the possible data that can be obtained with the meander channel with integrated oxygen 
sensors. 
The meander microchannel with integrated oxygen sensors was here used to monitor and 
quantify oxygen consumption rate during the bioconversion of styrene to 1-phenylethanediol by 
naphthalene dioxygenase (NDO) variants in E. coli. This reaction was chosen as the reference 
reaction since styrene has a similar molecular structure to both the native substrate of the 
chosen enzymes (naphthalene) and the target substrates of the modified enzymes (different 
alkenes). Hence, styrene was used to compare the different variants in terms of ability to convert 
this family of substrates. The chosen case study involved the screening of two dioxygenase 
variants and their comparison with the wild-type NDO. The variants were developed by Julia 
Halder and Prof. Bernhard Hauer at the Biocatalysis Group, Institut für Technische Biochemie 
(ITB), Universität Stuttgart [238]. The work presented in this chapter was developed in 
collaboration with the latter researchers, as part of an external stay at ITB.  
The main goal for the collaboration with ITB was to test whether such a microfluidic 
system could be used to accelerate the screening of dioxygenase variants, by identifying the 
earliest reaction time point where a difference in reaction rate could be observed. These 
reactions are usually performed for 20 h and the mutants evaluated by quantifying product 
concentration at the end of the reaction. Thus, the identification of an earlier reaction time 
where reaction rates are distinct enough to identify a better variant, is highly valuable and 
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would allow a better understanding of the kinetics of the different variants with a potential 
increase in screening throughput.  
3.3 Materials and Methods 
The methods for plasmid development, cell culture and induction, as well as, the reaction 
conditions were developed and optimized by Julia Halder from the Biocatalysis Group, Institut 
für Technische Biochemie (ITB), Universität Stuttgart. The oxygen measurement setup and 
approaches presented in this chapter were developed based on previous experience with the 
meander microchannel with integrated oxygen sensors (presented in Chapter 2). 
3.3.1 Materials  
All solvents, buffer components and chemicals were obtained from Sigma-Aldrich and 
Fluka (Steinheim, Germany), Carl Roth GmbH (Karlsruhe, Germany) and Alfa Aesar 
(Karlsruhe, Germany).  E. coli JM109 /DE3)_pDTG141 was obtained by Julia Halder and Prof. 
Bernhard Hauer (Biocatalysis Group, Institut für Technische Biochemie (ITB), Universität 
Stuttgart) from Prof. Dr. Rebecca Parales (Department of Microbiology and Molecular Genetics, 
College of Biological Sciences, UC Davis, University of California, California, USA) [288]. 
3.3.2 Heterologous expression of naphthalene dioxygenase (in E.coli) 
The general protocol followed to obtain the variants/ mutants was described in Gally et al. 
(2015) [256] and further optimized towards a better reproducibility [238]. For the production of 
induced biomass E. coli JM109 (DE3), cells previously made competent using rubidium chloride 
were thawed on ice for 5 minutes. Then, 1 µL of plasmid DNA for naphthalene dioxygenase 
(NDO, Pseudomonas sp. NCIB 9816-4, pDTG141) or one of the tested mutants was added to the 
cells and mixed gently by flicking the base of the eppendorf tube and shortly centrifuging. Cell 
transformation was performed by heat shock by placing the cells in a waterbath at 42 ⁰C for 90 
s, followed by 2 minutes on ice. The heat shock treatment was followed by addition of 500 µL of 
LB medium to the cells and incubation for 1h at 37 ⁰C and 600 rpm. The competent cells were 
then plated on selective agar plates containing ampicillin (100 µg/mL) and incubated overnight 
at 37 ⁰C. In order to generate the induced cells, one colony from the agar plates was used to 
inoculate a 2 L shaking flask with 500 mL of TB medium and 500 µL of ampicillin. The flask 
was incubated at 37 ⁰C and 180 rpm until an optical density (OD600nm) of 0.8 -1 was obtained. 
The cells were then induced with 0.1 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) 
dissolved in water and incubated at 25 ⁰C for 16 to 18 h. Indole (Figure 40 (c)) was added to the 
induced cells as a simple screening test in the solid phase in order to check if induction was 
achieved, since cells successfully induced with NDO or variants produce indigo, turning the 
media blue [289], [283], [290]. A representation of the molecular structure of the different 
substrates used and/ or mentioned in the text is presented in Figure 40. Influence of indigo (blue 
color of the cells) was considered negligible since indigo has a wavelength of 420-440 nm while 
the laser for excitation emits at 620 nm and the detected excitation light from the sensor dye is 
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760 nm. After induction, the cells were harvested by centrifuging for 20 min at 6000 g and 4 ⁰C 
in an Avanti J-26XP centrifuge (from Beckman Coulter, California, USA) and resuspended in 
0.1 M potassium phosphate buffer (pH 7.2) containing 20 mM glucose. 
 
Figure 40 – Substrate (left) and corresponding dihydroxylation product (right) for the biotransformation performed 
(a), the natural NDO substrate (b) and the substrate for induction screening, indole (c).  
3.3.3 Preparation of freeze-dried cells 
To obtain freeze-dried cells, the harvested cells were resuspended in 0.9 % sodium chloride 
(NaCl) solution and centrifuged for 15 min at 4000 g and 4 ⁰C. The cells were then spread 
uniformly in a petri dish and placed inside a freezer at -80 ⁰C for up to 2 h. After freezing the 
cells were placed inside a freeze drier and freeze-dried overnight under vacuum conditions. 
3.3.4 Biotransformation 
The cells for the reaction for gas chromatography (GC) validation were prepared by 
dissolving 0.1 gcww/mL and 0.05 gcww/mL (cell wet weight) for the freshly prepared resting cells, 
or 66 mgcdw/mL and 33 mgcdw/mL (cell dry weight) for the freeze-dried resting cells, in 1 mL of 
0.1 M phosphate buffer (pH 7.2) with 20 mM glucose. The cells for the oxygen measurements 
were also dissolved in 1 mL of 0.1 M phosphate buffer (pH 7.2) with 20 mM glucose, but at lower 
concentrations (0.005 gcww/mL to 0.05 gcww/mL). Glucose was added for in situ co-factor 
regeneration. Immediately, before starting the reaction, styrene (from a stock solution of 100 
mM styrene in pure ethanol) was added to the solution in order to have 1, 1.5 or 2 mM styrene 
present for the reaction. The reaction was performed in 4 mL vials with a plastic cap (GC and 
oxygen measurements) or with a plastic cap with a rubber seal (oxygen measurements) in a 
tabletop orbital MRH11 Heating ThermoMixer (from HCL BioTech, Bovenden, Germany) at 30 
⁰C and 400 rpm (with 3 mm shaking diameter). The rotation chosen to perform the bioconversion 
was optimized by previously measuring oxygen concentration with reaction time using an 
oxygen sensor integrated in a syringe tip (Fixed Oxygen Minisensor OXF500PT from Pyro 
Science, Aachen, Germany) connected to an Optical Oxygen Meter - FireStingO2 (from Pyro 
Science, Aachen, Germany). The rotation which allowed the reaction to be performed with a 
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constant supply of oxygen was the selected one. Two reaction vials were used per residence time, 
one for GC validation and one for oxygen measurement. 
3.3.5 GC analytical measurement 
The samples for GC analysis were prepared by centrifuging the cells and extracting the 
supernatant two times with 500 µL of MTBE. The reaction mixture was analyzed at different 
reaction times by measuring substrate (styrene) and product (1-phenylethanediol) (Figure 40 
(a)) concentration in the GC/FID-2010 (from Shimadzu, Kyōto, Japan). A Zebron ZB-1 column 
(30 m x 0.25 mm x 0.25 µm, from Phenomenex, California, USA) was used, with hydrogen as 
carrier gas (constant pressure of 50.2 kPa) and the injector and detector at 250 ⁰C and 330 ⁰C, 
respectively. For the detection, the column oven was set at 70 ⁰C for 2 min, then raised to 120 
⁰C at a rate of 15 ⁰C/min and then raised to 320 ⁰C at a rate of 50 ⁰C/min. The GC-FID was 
operated in split mode, using 1mM of 1-octanol in methyl tert-butyl ether (MTBE) as standard. 
The retention times of all the substances measured are: 4.016 min for styrene, 6.084 min for 1-
octanol and 7.729 min for 1-phenylethanediol.  
3.3.6 Oxygen measurement setup 
The two setups used for measurement of the oxygen consumption rate in the cell samples 
are presented in Figure 41. The oxygen measurement was performed using the oxygen 
platinum(II) meso-tetra(4-fluorophenyl) tetrabenzoporphyrin (PtTPTBPF) sensors integrated 
in the glass/silicon meander microchannel (from iX-factory, Dortmund, Germany now part of 
Micronit Microtechnologies B.V., Enschede, Netherlands), previously described in Chapter 2 
and in Ehgartner et al. (2016) [174]. Both setups include two Cavro® XLP 6000 syringe pumps 
(from Tecan, Männedorf, Switzerland) with 250 µL syringes controlled with LabVIEW (from 
National Instruments, Texas, USA). The two syringes were connected to the meander 
microchannel by polytetrafluoroethylene (PTFE) 1.5875 mm (OD) x 1mm (ID) tubing (S 1810-
12) (from Bohlender, Grünsfeld, Germany), using Flangeless polypropylene (PP) fingertight 
1.5875 mm (ID) fittings (XP-201) and flangeless ferrules (P200X) (from Upchurch Scientific®, 
Washington, USA). 
In the setup of Figure 41 (a), the sample being measured was first introduced in the 
syringe and then pushed inside the channel. It required two steps between the sampling and 
the measurement of the sample, thus also requiring more sample volume than the second 
approach, which is presented in Figure 41 (b). Furthermore, this approach was used in two 
formats: multiple sampling from the same reaction mixture at different residence times and 
single-sampling of the reaction mixture where the reaction for each of the residence times was 
performed in a different vial. The latter was the one used in the second approach, where the 
sample is pulled directly inside the microchannel from the reaction vial, allowing a faster 
measurement of the oxygen consumption in the sample. Cleaning of the microchannel was 
performed in between samples with ethanol 5% (v/v) in deionized water and then deionized 
water. In the first approach, the cleaning solutions were pushed through the channel’s second 
inlet, while in the second approach deionized water was first pulled through the outlet and then 
the same cleaning procedure as for the first approach was followed.  
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Figure 41 – Oxygen measurement setups used for screening variants for styrene biotransformation: (a) sample 
pushed through inlet; (b) sample pulled through outlet. 
3.4 Results and discussion 
The application of the meander channel with integrated oxygen sensors to the 
measurement of reactions involving whole cells encompassed several challenges. One of the 
main concerns was the possible clogging of the microchannels due to formation of cell clusters 
and its effect on fluid flow. E. coli cells have dimensions (< 2 µm in length) smaller than the 
microchannels in the meander chip used, and so no significant obstruction of the channels was 
expected for relatively diluted solutions used in the experimental work. Another concern 
involved the cell endogenous respiration rate, which in case of high respiration rates could 
rapidly consume the oxygen inside the reactor thus preventing measurement of oxygen 
consumed due to the bioconversion.  
In order to address both issues, several dilutions of the wild-type (wt) NDO containing 
resting cells (E. coli JM109 (DE3) cells which were transformed with a pDTG141 plasmid for 
NDO) without substrate present, were introduced at 1.7 µL s-1 (0.085 m s-1, Re 12.7) inside the 
reactor and the oxygen consumption was measured (Table 16). The flowrate was chosen based 
on previous experiments with the empty-vector (empty) cells (cells without the enzyme of 
interest), where the flowrates were varied between 0.21 µL s-1 (0.0105 m s-1, Re 1.56) and 4.17 
µL s-1 (0.2085 m s-1, Re 31.1). At higher flowrates, the cells tended to accumulate faster both at 
the outlet and inside the channel resulting in a rapid oxygen consumption and leakage issues. 
Thus, lower flowrates were more appropriate to perform the reaction. However, at very low 
flowrates, the oxygen inside the microchannel was completely consumed, leading to the selection 
of an average flowrate (1.7 µL s-1) as the optimal flowrate for the experiments. 
As shown in Table 16, a considerable dilution of the initial sample (1:10) was required in 
order to achieve a rate of oxygen consumption appropriate for sample comparison. The initial 
cell concentration was 0.05 gcww/mL, which was half of the cell density usually used for the 
reaction at lab scale. Since variants with a higher affinity for the substrate or higher reaction 
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rates could result in a faster oxygen consumption, the target oxygen consumption rate of the wt 
cells (without substrate) had to allow the distinction between faster and slower rates. The value 
considered as “good” for the purpose of these experiments was 0.02 mM/min, as highlighted in 
the table below.  
 
Table 16 – Average oxygen consumption rates for different wt cell concentrations calculated for a flowrate of 1.7 
µL/s. The cell concentrations used for the experiments are highlighted in red (initially chosen concentration) and 
orange (concentration used in the final experiments). 
Cell concentration 
(gcww/mL) 
Dilution of initial 
sample 
Oxygen consumption rate 
(mM/min) 
0.05 1 -0.061 
0.025 1:2 -0.051 
0.01 1:5 -0.017 
0.005 1:10 -0.019 
During the sample dilution/ oxygen consumption rate tuning experiment, a leakage was 
observed at the outlet after a short period. This occurrence of a leak was more frequent for cell 
samples that were not properly mixed, and therefore containing previously formed clusters 
before introduction in the channels. The leakage was probably due to accumulation of cells at 
the outlet forming a blockage. The following experiments were then performed by placing the 
meander channel in a vertical position (as in Figure 42) and placing the collection vial below the 
outlet. This approach was expected to ease the movement of the cells out of the channel, 
preventing the formation of big clusters of cells that could obstruct the outlet.  
The concentration of styrene used for the reaction also required consideration. Since the 
integrated oxygen sensors are made of polystyrene (polymer chains of styrene monomers), high 
concentrations of styrene could dissolve the polymeric layer and release the trapped dye, thus 
causing bleaching of the sensors and loss of sensing ability. Furthermore, a high styrene 
concentration could also lead to a faster reaction rate and thus faster oxygen consumption, 
impacting the previously determined optimal flowrate to perform the reaction. In order to test 
the effect of styrene, droplets of 100 mM styrene solution (50 to 100 times more concentrated 
than in the experiments), were placed on sensor spots, with no significant changes observed in 
signal detection. However, since the sensor spots were placed in an open environment, a rapid 
evaporation of styrene was observed and so the true effect of styrene might not have been 
measured. The lack of alternative testing devices, besides the meander microchannels used for 
the experiments, impeded further tests of the styrene effect on the oxygen sensors. The 
concentrations of styrene chosen to perform the reactions were thus based on the ones used for 
the lab scale bioconversions, 1 and 2 mM of substrate. 
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Figure 42 – Picture of the pulling sample setup with the meander microchannel in the vertical position. 
Ideally, the meander microchannel with integrated oxygen sensors would function as an 
online monitoring system. Hence, the experimental setup was assembled in order to allow 
sampling from the reaction mixture at given reaction times. For this purpose, the reaction vial 
was closed using a lid with a rubber seal where an orifice allowed access to the reaction volume 
for the sampling tube connected to the syringe pump. Using the empty cells as the reference 
sample for quantifying endogenous respiration, the oxygen consumption of wt cells was 
measured in the presence of styrene. Initially, however, these experiments did not yield the 
expected difference in oxygen consumption rate between the two cell types measured.  
Several factors were considered to identify the reason for the similarity between the two 
reaction rates: 
• The high volatility of the substrate (styrene) could lead to a decrease in concentration 
over time, since in order to sample the reaction mixture, the vial was not completely sealed 
and the tubing used might be permeable to styrene. 
• The reaction could be faster than expected and have finished at the chosen reaction 
times monitored.  
• The oxygen consumed by the reaction could be meager, resulting in such a slow 
consumption rate that distinction from cell respiration would be imperceptible or within 
sensor signal variability. 
To avoid some of the possible identified issues, a different sampling strategy was tested. 
The validation of the oxygen measurements was performed by implementing parallel reactions, 
instead of quantification of product formation in the outlet of the meander channel, due to the 
small volumes in the microchannel and in order to keep the standard procedures for product 
quantification. The reaction was thus performed in two identical vials per residence time placed 
at the same conditions in the tabletop thermomixer. One of the vials (for oxygen measurement) 
had a cell concentration with a dilution of 1:10 relative to the other vial. At the different chosen 
residence times, the vial with the higher cell dilution was opened and then measured in the 
microreactor, while the other vial was simultaneously prepared for quantification in the GC. By 
performing the reaction this way, loss of substrate due to evaporation was minimized since the 
vial was opened immediately before measurement. Furthermore, measurements were 
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performed at shorter residence times (starting at 5 min instead of 30 min) allowing to detect if 
the reaction was faster than expected. Additionally, since the cell preparation procedure is 
considerably longer than the time required for the oxygen measurement, the comparison 
between freshly prepared cells and freeze-dried cells was also performed. The use of freeze-dried 
cells would enable to perform tests on the same cells for more than one day while guaranteeing 
their stability and comparative behavior, as well as analyze older cell samples or samples from 
different sources (e.g. other laboratory facilities) if required.  
Figure 43 presents the results of the experiments described above for freshly prepared and 
freeze-dried cells at 2 mM styrene concentrations and the corresponding values of product 
formation measured in the GC. As can be observed, the oxygen consumption rate for wt and 
empty cells is still very similar for both cell preparations and with quite low rate values. From 
the parallel GC measurements, it is possible to observe that the bioconversion was much faster 
than expected, since after 5 min around 50% of the substrate had already been converted. At 
the end of 30 min 80% of the substrate had been converted, after which the concentration of 
substrate remained roughly unchanged until the end of the experiment (residence time of 90 
min). These concentrations were equivalent to previous lab-scale assays where the reaction had 
run for 20 h with only end-point GC quantification. The reaction was therefore significantly 
faster than expected, and could be monitored with sampling points until 30 min of reaction time 
was reached. This enables a significant increase in the number of variants and reactions that 
can be screened per day with the standard method. It is also a good example of the valuable 
input that microfluidic systems can provide in terms of reaction kinetics in this field. 
In Figure 43 it is also possible to observe that freshly prepared and freeze-dried cells 
present a similar behavior in terms of oxygen consumption and reaction output, and so 
measurements with freeze-dried cells can not only be performed but also compared with the 
ones made on freshly prepared cells. 
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Figure 43 – Summary of oxygen consumption rate and GC measurements of 1-phenylethanediol concentration 
produced during the reaction for empty-vector (empty) cells and wild-type enzyme containing (wt) cells in (a) fresh 
and (b) freeze-dried preparations at 2 mM styrene. 
Since the oxygen values obtained in these experiments were still equivalent for both cell 
types, the reaction was performed again but at the same dilution as the one monitored in the 
meander channel (0.005 gcww/mL), and measured in the GC. No product concentration was 
detected in these samples, which clarified the similarity in signal for both cell types measured 
for the 1:10 dilution. Moreover, the time required for the uptake of the sample from the reaction 
vial to the syringe, followed by introduction of the sample from the syringe into the reactor was 
higher than 1 min, meaning that the start of the reaction and the probable period for the highest 
substrate conversion was lost during the sampling step.  
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To overcome both issues a different approach was implemented. Such approach required 
the uptake/withdrawal of the sample from the outlet of the meander channel, thereby pulling 
the sample through the outlet, instead of pushing the sample through the inlet (see Figure 42). 
Through this process, by having a short tube at the outlet the sampling time was reduced to 
just a few seconds. This new strategy was further coupled with a lower cell dilution (1:5, in 
orange in Table 16). Shorter residence times (1 and 3 min) were also implemented in order to 
check when the start of the reaction occurred. The new sampling strategy associated with a 
lower cell dilution enabled to measure a difference in oxygen consumption rate between empty 
and wt cells, as can be observed in Figure 44. Cells containing the wt NDO presented almost 2-
fold the oxygen consumption rate of the empty-vector cells. This reaction was also performed at 
lower styrene concentration (1mM), which resulted in a higher substrate conversion than 
previously obtained (74 % at 1 min of reaction time). A lower concentration of styrene was used 
to minimize the impact of substrate concentration on cell behavior, since a decrease in oxygen 
respiration values, possibly related to substrate concentration, had been observed with longer 
reaction times. After 15 min of bioconversion the oxygen consumption rate decreased and a 
stabilization of product concentration is observed, which seems to fit the oxygen consumption 
rate profile. 
 
Figure 44 – Oxygen measurements of the reaction of empty and wt cells in the presence of 1 mM styrene 
concentration, and corresponding GC results for the wt cells of 1-phenylethanediol concentration produced during 
the reaction and percentage of substrate conversion obtained at 1 and 30 minutes of residence time. 
The oxygen consumption rate of two NDO-variant containing cells (V260A and H295A) 
was also measured in the meander microchannel. As can be observed in Figure 45 (a), a 
difference between the two variants as well as compared with the wt and the background (empty 
cells) could be observed. One of the variants (V260A) presented a higher oxygen consumption 
rate, especially in the first 3 minutes of the reaction, which could indicate a slower initial 
reaction rate. This would translate in the fact that it should be possible to observe the initial 
substrate conversion rate, contrary to what was observed with the wt cells. It might also mean 
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that this variant has a higher reaction rate, leading to a faster oxygen consumption rate. As can 
be observed in Figure 45 (b), the latter was verified, since a 90% conversion of the substrate was 
measured in the first minute of the reaction. The other variant presented an oxygen 
consumption rate closer to the one of the wt cells, where the rate during the bioconversion is 
very similar to the endogenous respiration of this variant (value of oxygen consumption rate at 
0 min in Figure 45). The observed oxygen consumption rate is also maintained longer above the 
value for empty cells than for the wt cells. As can be seen in the figure below, this is also the 
variant (H295A) that presents the lower initial conversion with a steady increase during the 30 
min of reaction monitored, while the other two cell types maintain approximately the same 
value after 3 min. Although H295A has a smaller reaction rate than the other measured 
enzymes, the increased cell respiration might indicate an interference of the heterologous 
enzyme with the metabolism of the host organism, which might be interesting to investigate 
further. 
From the presented experiments for empty-vector cells, wt, V260A and H295A, it is 
possible to conclude that higher consumption rates indicate higher substrate conversion. 
Moreover, the duration of the oxygen consumption rate above empty-vector cell endogenous 
respiration levels represents a continuation of substrate conversion, while the decrease in 
oxygen levels translates in a conservation of product concentration without significant reaction 
rate. 
 
Figure 45 – Oxygen consumption rate values for all the cell types tested with the pulling sample approach and 
higher cell concentration (a) and GC results for the two variant containing cells (at 2mM styrene) and wt cells (at 
1mM) of 1-phenylethanediol concentration produced during the reaction and percentage of substrate conversion 
obtained at 1 and 30 minutes of residence time (b). 
To understand the applicability of the meander channel as a screening platform, and 
whether it was possible to distinguish oxygen consumption rates due to different substrate 
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concentrations, further experiments were performed. The bioconversion with wt cells was 
performed at two different concentrations of styrene. As demonstrated in Figure 46 (a), a 
slightly higher oxygen consumption rate was observed for the higher styrene concentration, but 
only in the first minute of reaction. The results of substrate conversion obtained from the GC 
indicate that higher substrate concentration results in a lower initial substrate conversion. This 
can imply some effect of the substrate on the reaction rate. On the other hand, since the 
measured product concentrations for the two reactions are quite similar, this might indicate 
that the reaction rate is limited by substrate diffusion through the cell wall at the concentrations 
tested.  
 
Figure 46 – Oxygen (a) and GC (b) measurements of the reaction wt cells in the presence of two styrene 
concentrations (1 and 1.5 mM). 
It is relevant to mention that the bioconversion at the reaction conditions and cell densities 
used has a relatively high conversion rate (50 to 70% depending on initial substrate 
concentration), which greatly contributed to the measurable oxygen consumption difference 
between the biotransformation and cell respiration. Since higher cell densities might lead to 
obstruction issues, there is a limitation on the use of this platform in terms of reaction rate to 
fast reactions only, which generate oxygen consumption rates higher than the host’s respiration 
rate. This limitation can be observed in Figure 45 for the H295A variant. Reactions with slower 
kinetics, which is usually the case for initial dioxygenase variants, might hence be more difficult 
to detect with this microfluidic platform. Faster reaction rates, on the other hand, can be more 
easily screened, by increasing the flowrate used during the detection and/ or by decreasing the 
cell density used for the biotransformation or for the measurement. 
In the extensive literature review, no values of oxygen consumption rate for dioxygenases 
in whole cells were found. Hence, the attained values during the experiments presented here 
were compared with values for pure dioxygenases measured with the polarographic method 
[278]. The comparison between the values is presented below in Table 17. The values from the 
literature (in blue in Table 17) cited in the table were calculated from the values presented in 
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the articles, considering the enzyme concentration used in the respective assays, so as to have 
comparable values. The values presented in the table for the NDO and variants tested in this 
study (in green in Table 17), are an average of the rates obtained in the first three minutes of 
the reaction (when the highest rates are measured) in sensor 1 (where the more defined oxygen 
behavior seems to be observed), calculated without the background value of cell respiration.  
 
Table 17 – Comparison of oxygen consumption rate/ oxygen uptake of the whole cell catalyst (in green) with values 
for pure dioxygenases found in literature (in blue).  
Biocatalyst Substrate 
Measurement 
setup 
Oxygen 
uptake (mM 
min-1) 
NDO from Sphingomonas CHY-1 
[280] 
Naphthalene (0.1 
mM) Clark-type oxygen 
electrode 
14.95 
NDO from Pseudomonas sp. 
Strain NCIB 9816-4 [279] 
Styrene (0.1 mM) 
0.0700 
 
NDO (pDTG141) wild-type in E. 
coli JM109 /DE3) 
Styrene (1 mM) 
Luminescent oxygen 
sensors 
0.3202 
NDO variant V260A in E. coli 
JM109 /DE3) 
Styrene (2 mM) 0.6553 
NDO variant H295A in E. coli 
JM109 /DE3) 
Styrene (2 mM) 0.4560 
 
A direct comparison between the values retrieved from the literature (in blue in Table 17) 
and the ones measured (in green in Table 17) is difficult since different enzymes, substrates, 
substrate concentrations and oxygen measurement techniques were used. There are one or two 
orders of magnitude of difference in oxygen uptake between the different catalysts, but it is 
interesting to notice that the highest uptake rate was obtained for the natural substrate of the 
enzyme (naphthalene). When comparing biocatalyst performance for the same substrate 
(styrene), it should be noted that the measurement with whole cells was performed at a 
substrate concentration that is 10-fold higher relative to the corresponding substrate literature 
value. If a linear relationship between oxygen concentration rate and substrate concentration 
is considered, then the rate values obtained for the NDO from E. coli JM109/DE3 are half or 
lower than the one obtained for NDO from Pseudomonas sp. NCIB 9816-4. The lower oxygen 
consumption rate could be related to the already discussed diffusion limitations due to the cell 
membrane. It should, however, be taken into consideration that the data presented in this 
chapter indicates that the oxygen consumption rates measured for the NDO from E. coli 
JM109/DE3 are diffusion limited and so a linear relationship between oxygen concentration rate 
and substrate concentration does not occur. 
It is also worth mentioning the degree of variability in the data presented in this chapter, 
especially in oxygen consumption rate results which was not possible to quantify appropriately 
throughout the duration of the experiments. This variability can be related to the used sensors, 
as previously discussed in Chapter 2, especially since there was some degradation of the sensor 
signal during this study due to the use of styrene as substrate and ethanol as part of the cleaning 
procedure. However, variations in the cell concentration used or in the uptake flowrate (in the 
pulling through outlet strategy) can also have influenced the obtained results. When pulling 
instead of pushing a liquid solution with pistons pumps there is less control on the actual 
flowrate being applied, since the resistance to flow is increased by the resistance of the 
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microchannel. If the pressure difference is too high, vapor may be pushed to substitute the space 
created by the uptake of fluid and bubbles will be observed. Also, if there is no possibility for 
entrance of air, cavitation may occur, where vapor fills the void left by the uptake of fluid. This 
is due to vapor formation when the local pressure drops below the liquid vapor pressure, 
establishing a bubble which collapses when higher pressures are applied. Cavitation is more 
likely to be observed when low pressures are applied at the outlet or high pump flowrates are 
used [291], [292]. At the flowrates used to perform the experiments no bubble formation was 
observed. Furthermore, no sensor signal change was measured that could indicate a sudden 
change of pressure (e.g. a sudden pressure decrease that could indicate formation of a vapor 
cavity). Thus, no significant differences were observed during the experiments that could 
indicate such an effect. Data variability is most likely related to differences in the preparations 
of the cell solutions due to small variations in the amount of cells weighed, and thus the amount 
of cells present. The variability in oxygen data obtained can also be inherent to the 
measurement itself, as also described by Jouanneau et al. (2006) with the observed 
discrepancies in the enzyme activities obtained when the oxygen assay was applied 
(polarographic assay using Clark-type oxygen sensors)  they applied [280]. 
 
In conclusion, the microfluidic system presented here cannot compete in terms of 
throughput with most of the screening systems discussed in section 1.3.1 of the Introduction. 
However, it can provide a different type of input (oxygen consumption rate and maybe other 
oxidative properties) than the discussed screening platforms. In terms of throughput, the 
system presented here can perform a single measurement every 10 min (including sample 
uptake and channel cleaning). This means that in a continuous operation, it would be capable 
of performing 47 single measurements in an 8h working day and 129 single measurements in a 
22h working day (with 2h for thorough cleaning of the microreactor, tubing and system 
components). Considering the same reactions performed for this work (around 50 min for each 
to complete), per day we could perform 9 entire reactions in an 8 h working day or 26 entire 
reactions in a 22h working day. Since each single measurement takes around 10 min, in order 
to perform measurements every minute of a certain reaction vial, 10 microreactors of this type 
would have to work in parallel, and such a system is easily achieved with microfluidic units.  
Furthermore, by working in solution and not in droplet such a system can enable a direct 
measurement (e.g. side-loop with recirculation) from the reaction vial using a simpler 
microfluidic arrangement, if a more air-tight setup is assembled. This setup could be achieved 
by using steel or a less permeable polymer as the tubing material, as well as more appropriate 
sealed reaction vial caps. The system can also be connected to one of the droplet-based systems 
discussed in the Introduction so as to achieve a more comprehensive characterization of the 
mutants during screening.  
3.5 Conclusions  
The presented results demonstrate the potential of the meander microchannel with 
integrated oxygen sensors to function as a biocatalyst screening platform for oxygen-dependent 
whole cell biocatalysts. It was possible to measure the endogenous respiration rate of the E. coli 
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cells used, and distinguish respiration rate from oxygen consumption due to styrene oxidation 
by wild-type NDO. Additionally, the two tested NDO variants showed different oxygen 
consumption rates from the ones obtained with the wild-type. Variant V260A presented a higher 
oxygen consumption rate in the first 3 minutes of the reaction, corresponding to a faster styrene 
conversion (90% after 1 min). On the other hand, variant H295A showed a similar oxygen 
consumption rate compared to the wild-type NDO, which was equally maintained throughout 
the monitoring time (30 min), unlike the wild-type NDO, whose consumption rate decreased 
close to endogenous respiration levels after 15 min. This variant, generated however a smaller 
conversion rate with a steady increase during the reaction time, indicating a slower reaction 
rate than the other variants tested. Furthermore, this variant (H295A) allowed to highlight a 
potential limitation in terms of reaction rates measurable by the microfluidic platform, 
identifying the reaction rate below which the microfluidic platform is unable to distinguish 
oxygen consumption due to the biotransformation from the endogenous respiration. The oxygen 
consumption rates measured with the meander channel with integrated oxygen sensors appear 
to be concordant with the values found in the literature. 
The presented platform shows a great potential as a screening platform for mutants 
involved in oxidative reactions, especially enzymes with high reaction rates and fast 
bioconversions. The platform can achieve a relatively high throughput (129 single 
measurements or 26 reactions per day) which can be further improved by adding more 
microfluidic systems in parallel and automating sampling. The current throughput of the 
platform is similar to the one obtained with the GC, where 129 reactions could be measured 
within 21.5h, without time required for reaction preparation (which would imply a further 6h). 
In order to obtain a full characterization of this microfluidic system as a screening 
platform, it would be interesting to perform experiments with additional variants in order to 
detect relevant patterns or tendencies observable by using only the oxygen sensors. It would 
also be interesting to check whether phenomena such as product overoxidation, substrate 
inhibition or toxicity, or uncoupling effects can be observed or detected through oxygen 
consumption rate measurements.  
Moreover, two different screening approaches can be achieved with this platform: variant 
comparison or substrate comparison. The first approach, which was the one demonstrated in 
this chapter, compares the oxygen consumption of different variants relative to the same 
substrate. A higher rate indicates either higher variant activity or higher substrate specificity 
for the target substrate. In the second approach, the same cell type can be tested with different 
substrates. Again, different rates would correlate with differences in specificity and activity. 
Furthermore, in this case, endogenous cell respiration of the cell without the target enzyme, or 
of the mutant at different substrate concentrations could further indicate possible toxicity issues 
from the substrates being screened. 
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Chapter 4 
Multi-purpose platform for sensor integration 
The microfluidic platform presented in this chapter was developed in collaboration with Daria Semenova 
from the PROSYS research group at DTU, Lyngby, Denmark, Peter Panjan and Adama M. Sesay from the 
Measurement Technology Unit (MITY) at Oulu University, Kajaani, Finland 
 
The limited availability of metabolite-specific sensors for continuous sampling and 
monitoring is one of the main bottlenecks contributing to failures in bioprocess development. 
Furthermore, only a limited number of approaches exist to connect currently available 
measurement systems with high throughput reactor units. This is especially relevant in the 
biocatalyst screening and characterization stage of process development.  
In this chapter, a strategy for sensor integration in microfluidic platforms is demonstrated, 
to address the need for rapid, cost-effective and high-throughput screening in bioprocesses. The 
developed platform is compatible with different sensor formats by allowing an easy sensor 
replacement and was built in order to be highly flexible and therefore suitable for a wide range 
of applications (e.g. enzyme screening, glucose monitoring in fermentations, monitoring 
biomarkers in biological samples). Moreover, this re-usable platform can be easily connected to 
analytical equipment, such as HPLC, lab scale reactors or other microfluidic chips through the 
use of standardized fittings. Also, the developed platform includes a two-sensor system 
separated with a mixing channel, which allows the detection of samples that might be outside 
the first sensor’s range of detection, by offering the possibility to achieve up to 10 times dilution 
of the sample solution. 
In order to highlight the features of the proposed platform, inline monitoring of glucose 
levels is presented and discussed as illustrative example. Glucose was chosen due to its 
importance in biotechnology as a relevant substrate. The platform demonstrated continuous 
measurement of substrate solutions for up to 12h.  
4.1 Introduction 
In- or online quantification of reaction products or target compounds in a bioprocess is 
essential to achieve a high degree of knowledge, and consequently control, regarding reaction 
(or side-reaction) kinetics, production yield, by-product formation, biomass concentration, 
process efficiency, etc. [50], [51], [52], [47], [60]. 
Microfluidic systems show a considerable potential in screening applications and online 
monitoring. The variety of achievable geometries, high surface to volume ratio and diversity of 
sensing technologies available at small scale, make them a highly attractive tool for bioprocess 
development [293]. Moreover, a better control of operating conditions, especially flow, permits 
a good definition of gradients of substrate or other components involved, which can be further 
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improved with a higher degree of automation. However, due to the challenges involved in sensor 
development and integration, microfluidic systems are still application-specific, as they are 
typically too rigid to address the needs of different bioprocesses [294]. Therefore, a change in 
the target sample (e.g. type of sample), the used sensor technology or flow conditions, or need 
for integration with other systems, requires a re-design and the fabrication of a new platform. 
This greatly reduces the microfluidics range of applications, and therefore also stands in the 
way for the wide-spread use of microfluidic systems.  
One of the main contributors to this microfluidic challenge is sensor integration. 
Biosensors translate  a biological response (from an enzyme or cell) into a quantifiable signal, 
by connecting the biological element to a transducer, that in turn transforms this signal into an 
electronic signal that can be amplified and further processed [295]. The use of a biological 
component allows to greatly increase the specificity of the sensors to a target analyte or a range 
of target compounds. However, the (bio)sensors in a given microfluidic platform need to be stable 
under normal operating conditions [295] and are thus optimized for a given set of temperature, 
sample or flow conditions, consequently being often limited in application. Thus, the applied 
strategy for sensor integration in a microfluidic platform depends on the detected sample, the 
type of sensor and the materials that form the sensor and the platform. Furthermore, the main 
limitation to sensor integration is usually related to the miniaturization of the transducer 
element [295].  
 
Electrochemical (EC) sensors show great promise in integrated analytical systems due to 
their robustness, the ease of miniaturization and inexpensive instrumentation [296], [295], 
[166]. Miniaturization of the instrumentation has been harder to achieve, but relatively portable 
electrical measurement systems (e.g. potentiostats) have already been developed [297], [298]. 
4.1.1 Electrochemical sensing 
Electrochemistry detects the presence of electroactive species, which can be the target 
analyte or a product of a redox reaction involving the analyte. Electrochemical (EC) sensors, 
unlike optical sensors, do not require transparent materials and can therefore be used in a wider 
range of substrates, from silicon to paper fibers. Additionally, they can be applied to turbid 
solutions and do not show sensitivity to auto-fluorescence effects from biological samples like 
optical sensors. On the other hand, EC sensors are affected by differences in pH and ionic 
strength, and in some situations flow conditions. Also, the sensing area and architecture 
influence the obtained sensitivity and signal-to-noise ratio [295]. The electrode or required 
functionalized area to achieve a good sensor performance also limits the miniaturization 
attainable with electrochemical sensors in order to keep a high sensitivity [299]. 
EC sensors always involve the interaction between the electrode surface (that can be 
covered by a layer of the biorecognition element) and the target analyte, yet the electrochemical 
reaction may occur on (contact EC) or before/outside (contactless EC) the sensor. 
Electrochemical sensors used for contact detection of biomolecules require functionalization of 
their surface with molecules (usually enzymes) specific to the target, either by immobilization 
of the molecules directly on the sensor’s surface, immobilization in a membrane placed over the 
sensor surface, or a combination of both methods. For contactless detection, the electrochemical 
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reaction might occur either in solution or upstream of the sensor by immobilization of enzymes 
in monoliths, for example [300].  
EC sensors usually present a reference electrode (most often made from Ag/AgCl, that 
allows maintaining a stable potential during measurement and is placed at a certain distance 
from the redox reaction), a counter electrode (in contact with the electrolytic solution and 
providing the connection through which a current is applied to the working electrode) and a 
working electrode (the sensing or transduction element, made of the same material as the 
counter electrode, e.g. platinum or graphite), as can be seen in Figure 47 [295], [166].  
 
Figure 47 – Highlighted working, reference and counter electrodes in a commercial DS 110 screen-printed carbon 
electrode from DropSens (Llanera, Spain). 
 
The target analyte can reach the electrode surface through diffusion (due to a 
concentration gradient between the bulk solution and the inner layer), migration (due to a 
potential gradient between the bulk solution and the inner layer) or through convection (due to 
forced movement of the solution) [166]. The inner layer is a charged layer formed over the 
electrode surface when this has an excess of charge, having the opposite charge of the surface. 
Above this layer a second layer is also usually formed, called the diffusive layer, that has a 
gradient of oppositely charged ions relative to the inner layer. Hence, an electric potential is 
found between these two layers [166]. 
Detection with EC sensors can be performed through several methods, with conductivity, 
amperometry and potentiometry being the most common. A visual representation of the main 
electrochemical methods is presented in Figure 48.  
 
Figure 48 - Schematics of electrochemical detection methods: a) Amperometry (current measured is proportional to 
the flux of sample to the electrode surface, which depends on the concentration gradient in the bulk solution and thus 
decreases with time until it stabilizes); b) Voltammetry (e.g. cyclic voltammetry where oxidation/reduction peaks of 
the target substance or a mediator are measured. The magnitude of the peak corresponding to the monitored reaction 
(ip) can be qualitatively related to sample concentration); c) Conductometry (measurement of the change in 
conductivity of the electrode due the presence of charged species); d) Potentiometry (measurement of the change in 
potential (electromotive force (Emf)) at the ion selective electrode due to accumulation of selective ions at the electrode 
surface); e) Impedance (measurement of the change in resistance/capacitance of the electrode or the solution in 
contact with the sensor). Figure adapted from [166]. 
In amperometric detection (Figure 48 (a) and (b)) an electrical current generated by the 
oxidation or reduction of the analyte at an applied constant voltammetric potential between the 
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reference and working electrodes is detected. As can be seen in Figure 48 (a), first a high current 
is measured, which corresponds to the analyte concentration being depleted in the double-layer 
formed above the electrode’s surface. As the analyte depletion starts occurring in the bulk 
solution a decrease in current is observed with the decrease of concentration gradient [166]. The 
potential applied to the working electrode relative to the reference electrode is usually defined 
at the (mass) diffusion limited current region of the analyte, which results in a linear response 
with variation of the analyte concentration [102]. Sensitivity of amperometric sensors can be 
hard to maintain if the sensor surface area is decreased [102]. The most common amperometric 
measurements are performed either by voltammetry or chronoamperometry. Voltammetry 
indicates the reversibility of the system by changing the potential in a controlled fashion, but 
the rate at which the potential is changed affects the obtained results [166]. In 
chronoamperometry current versus time plots are obtained, where the current is measured at 
a constant square-wave potential [295]. In chronoamperometry the observed current changes 
depend on the diffusion layer between the electrode surface and the bulk solution, which 
controls the transfer of the target analyte to be measured at the electrode’s surface [295]. 
Chronoamperometry can be described by the Cottrell equation (Equation 23), where I is the 
current, F is the Faraday’s constant, n is the number of electrons transferred per detected 
molecule, A is the electrode surface area, 𝑐0 is the concentration of target analyte, D is the 
analyte diffusion coefficient and t is time [295]. 
Equation 23 
 
In contact amperometry, care must be taken since many biomolecules such as proteins are 
not electroactive, thus requiring a label [177]. In the case of detection through enzymatic 
reactions, a mediator may be required to transport the electrons to the sensor surface. 
Amperometric sensors can be fabricated together with microchannels by photolithographic 
processes [75], providing an easy integration with the channel but low target flexibility. Paper 
or ceramic based amperometric sensors allow high target flexibility by permiting a change of 
the sensors being used through the use of disposable sensors.  
Conductometry (Figure 48 (c)) detects the conductivity responses that differently charged 
analytes and different analyte concentrations generate between electrodes at a series of 
frequencies [295], [75]. Hence, they can be applied only to charged species or species that can be 
charged, lacking however specificity. The low specificity of the technique in turn allows its 
application to more types of samples with a higher variety of strategies, resulting in an easy 
miniaturization for application in cell studies (e.g. shape, changes in cell membrane) [102]. In 
contact conductivity, the electrodes are placed inside the microchannel in direct contact with 
the sample, while in contactless mode the electrodes are isolated from the sample (for example, 
by covering them with a photoresist layer), which avoids electrode fouling and bubble formation 
[75]. Conductometry devices are usually associated with enzymes, used to study enzymatic 
reactions that create variations in the concentration of charged species [295]. These electrodes 
can be patterned in silicon wafers or glass through semiconductor technology or on printed 
circuit boards (PCBs) which are then covered and integrated with a channel. Conductometry 
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methods are conventional contacted conductivity detection and capacitively coupled contactless 
conductivity detection (C4D) methods such as potential gradient detection [75], [301].   
In potentiometry (Figure 48 (d)), the measurement is performed through the detection of 
a generated potential between a reference and an ion-selective working electrode when no 
current is flown between the two electrodes. This potential is generated due to a built-up of 
charge separation when ions pass through the selective membrane of the working electrode and 
a local equilibrium is established at the sensing interface [295]. Potentiometry measures the 
concentration of ions in a redox reaction up to 10-11 M and is mathematically based on the Nernst 
equation (Equation 24), where 𝐸𝑐𝑒𝑙𝑙 and 𝐸𝑐𝑒𝑙𝑙
0  are the observed potential at zero current and the 
constant potential contribution to the electrochemical cell, respectively, R is the universal gas 
constant, T is the absolute temperature in Kelvin, and Q is the ratio of ion concentration 
between the anode and the cathode [295]. The fabrication strategies of potentiometric sensors 
are similar to the ones presented for conductivity and amperometric detection [75], but 
miniaturization issues are usually involved with the strategy for miniaturization of the 
reference electrode [102].  
Equation 24 
 
Impedance sensors (Figure 48 (e)) measure the change in electrical impedance at a fixed 
or variable frequency between an electrode and the solution when adsorption of the target 
molecule to the electrode occurs. Impedance allows studying intrinsic material properties (e.g. 
polymer degradation, electrolyte degradation, status of car engine oil, cell adherence on sensor 
structures) that result in a resistivity or capacitivity change [299], [295]. It has also been applied 
to monitor biorecognition events (e.g. in immunoassays) occurring at the surface of the electrode 
[295], and presents sensitivity to nonspecific adsorption [166].  
Another type of electrochemical sensors is the field effect transistor (FET). FET measures 
a current resulting from a potentiometric effect at the gate (an electrode where potential is 
varied relative to two other electrodes, the source and the drain) [295]. An EnFET (enzyme FET) 
consists of a transistor where the metal gate is replaced with surface functionalization, while 
an ISFET is an ion-sensitive FET. Target molecule adsorption results therefore in a change in 
potential at the gate causing a measurable signal between source and drain [295]. These sensors 
present however some cross-sensitivity and issues with pH change, as well as difficulties in 
incorporating an appropriate and low-cost reference electrode. The encapsulation of FET greatly 
influences their stability and reproducibility [299]. Nanowires (e.g. carbon nanotubes (CNTs), 
conducting polymer nanowires (CPNWs), nanorods, nanosprings) can be used to connect the 
gates in FET resulting in an increased sensitivity, except for solutions with high ion 
concentrations [177]. Carbon nanotubes, and other nano-objects (e.g. gold nanowires and 
nanoparticles) can also be integrated in membranes of amperometric and other types of sensors 
in order to increase sensitivity and lower the limit of detection [295], [302]. 
The presented electrochemical methods are often coupled with electrophoresis operations 
(such as capillary electrophoresis separation) or in electrophoresis systems.  
  
Miniaturization of the electrode area to the micrometer scale, required for integration in 
microfluidic systems, allows (i) decreasing the measurable currents (down to nanoamperes), (ii) 
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decreasing required sample volume, (iii) increasing the response time to alterations in the 
applied potential, (iv) increasing the efficiency of diffusional transport of the target analyte to 
the electrode’s surface, and (v) decreasing the contact resistance [166].  
Combination of electrochemical and optical detection can also be performed on the same 
chip [102], [303]. EC sensors can be combined with other label-free detection methods (e.g. 
surface plasmon resonance (SPR) [304], quartz crystal microbalance (QCM) [305], optical 
waveguide lightmode spectroscopy (OWLS) [183]) with the integration of a conductive electrode 
on the chip [295]. The electrochemical sensors’ sensitivity, specificity, precision and operation 
stability are highly dependent on (i) the used fabrication techniques, (ii) how the 
miniaturization is performed, (iii) which material deposition methods are used, and (iv) which 
coatings and immobilization methods of biomaterials and biomolecules are used [306], but also 
on (v) electrode size, (vi) geometry, (vii) position in the measuring chamber, and (viii) surface 
structure [166]. So, in other words, the development of EC sensors is a significant and time-
consuming optimization problem. 
4.1.1.1 Glucose electrochemical sensors 
The most successful commercially available and used biosensor is the electrochemical 
glucose sensor [307], with a worldwide market that is estimated to be close to 10 billion dollars 
[166]. Its development revolutionized the management of diabetes mellitus in patients, allowing 
a more accurate and frequent measurement of glucose levels in blood in hospitals, but especially 
in the patient’s home [308]. But the history of glucose and electrochemistry started long before, 
in 1909 with the electrooxidation of glucose to gluconic acid by Walther Loeb in a sulfuric acid 
solution using a lead anode [308].  
The electrooxidation (non-enzymatic detection) of glucose, performed with different metals 
(e.g. Pt, Au, Cu, Ni, TiO2) at alkaline pH shows a high electrocatalytic ability, sensitivity and 
selectivity towards glucose. Polycrystalline or nanoporous metals or metal nanoparticles 
supported in carbon nanotubes developed so far show high stability, but with some degradation 
of the surface due to the alkaline environment which affects the electrode’s lifetime [307]. Also, 
selectivity of electrooxidation of glucose is generally lower than the one obtained with enzymes 
[307]. Au-nanoparticles prepared by citrate reduction can be an exception, functioning as 
artificial enzymes capable of oxidizing glucose without requiring electricity [307]. Furthermore, 
for most of the materials used in glucose electrooxidation, the irreversible adsorption of partial 
oxidation products or of active species in solution causes the poisoning of the electrocatalysts 
used for glucose oxidation [307]. This in turn lead to the wide application of enzymes to perform 
the substrate oxidation [308].  
The most used enzymes are glucose oxidases (GOx) and glucose dehydrogenases (GDH). 
GOx, as mentioned in Chapter 1, has a high selectivity for glucose and oxidation involves the 
reduction of FAD, followed by its re-oxidation in the presence of molecular oxygen. GOx presents 
an apparent formal redox potential of -0.048 V vs. SHE (standard hydrogen electrode) at pH 7.2 
[308]. GDH has a broader substrate spectrum (e.g. glucose, galactose, xylose), and can have 
several co-factors depending on the dehydrogenase (NAD, β-nicotinamide adenine dinucleotide, 
and PQQ, pyrroloquinoline quinone). NAD-GDH require a source of the co-factor (NAD+) and a 
redox mediator to lower the voltage required to oxidize NADH [309]. PQQ, unlike FAD, is not 
Micro scale reactor system development with integrated advanced sensor technology  
119 
 
oxidized during the reaction, however presents a lower stability than FAD or NADH-dependent 
GDH [308], [309]. Glucose oxidation by GDH occurs at a lower potential, 10.5±4 mV at pH 7 and 
in the presence of an excess of calcium ions [308]. Another relevant enzyme in glucose 
monitoring is the isoenzyme 2 of hexokinase, that presents a very high specificity. However, its 
higher price over GOx, dependency on ATP and lower stability prevents its wider application in 
glucose sensors [307].  
Enzyme immobilization on the electrode’s surface can be achieved by physical adsorption, 
however in this case enzyme stability is easily affected by the experimental conditions, such as 
pH, ionic strength, temperature, charges, etc. Addition of bovine serum albumin (BSA) can 
improve stability in physically adsorbed enzymes. Covalent attachment is the most effective 
method for enzyme immobilization, and can be performed with hydroxyl groups of chitosan and 
1,4-carbonyldiimidazole, thiolated gold nanoparticles or using the enzyme’s amino acid residues. 
Other immobilization approaches are the physical entrapment or encapsulation of enzyme 
inside a solid matrix that can be formed of polymers, redox gels, sol-gel or carbon pastes [307]. 
The first enzymatic glucose sensor was fabricated by Clark and Lyons in 1962, and 
involved a thin layer of GOx embedded in a semipermeable dialysis membrane placed over a Pt 
electrode for measuring oxygen depletion (the Clark oxygen sensor mentioned in Chapters 2 and 
3) [309]. Oxygen-based glucose measurement can also be achieved with an indium tin oxide 
(ITO) electrode covered with an oxygen and proton permeable membrane [308]. The first 
amperometric-based glucose sensor was described in 1973 by Guilbault and Lubrano and was 
based on monitoring the produced hydrogen peroxide [309].  
Glucose sensors that rely on the detection of hydrogen peroxide by GOx oxidation with 
molecular oxygen (the physiological mediator), are called first generation glucose biosensors 
(Figure 49) [309].  
 
Figure 49 – Schematics of the sequence of redox steps involved in glucose detection with the different generations 
of glucose biosensors. 
 
In these sensors, amperometric detection of hydrogen peroxide can be performed with (i) 
anodic oxidation (enables regeneration of oxygen for use in the enzymatic reaction) at +0.3-0.8 
V vs. SCE (standard calomel electrode) using Pt on graphite, carbon pastes, carbon nanotubes 
and conducting polymers; with (ii) cathodic reduction at 0.6 V vs. SCE, using palladium, Pt 
nanowires and Au nanoparticles in a porous silicate; or by (iii) cathodic detection by co-
immobilization of a peroxidase (e.g. horseradish peroxidase), which is oxidized in the process, 
followed by its mediated or direct electroreduction [308], [307].  Selectivity of first generation 
biosensors can be increased through tuning of the operating potential to a region where only the 
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target analyte is oxidized or reduced. The use of metal-hexacyanoferrate-based mediators, such 
as Prussian blue (ferric-ferrocyanide) or Rhodium and Ruthenium on carbon, allows reducing 
the overvoltage involved in hydrogen peroxide redox reaction to around -0.1 V vs. Ag/AgCl [309]. 
In this case, the hydrogen peroxide reduces the metal oxide film on the surface of the electrode 
to the metal, which can be electrochemically re-oxidized, thus generating the detected anodic 
current signal [309]. Prussian blue (PB), one of the most used mediators in glucose sensors, acts 
as a peroxidase [307], and can be co-deposited together with the enzyme or be applied together 
with carbon ink in screen-printed glucose sensors [309]. More on the specific application of PB 
in glucose sensors can be found in Karyakin et al. (1999) [310], Karyakin et al. (2001) [311] and 
Ricci et al. (2003) [312]. Several nanomaterials, such as carbon-nanotube modified electrodes or 
metallized carbons, have also resulted in a lower anodic potential with a high selectivity in 
hydrogen peroxide measurement [309], [307]. First generation glucose biosensors are extremely 
dependent on the oxygen tension and the need for oxygen concentration to be at least one order 
of magnitude lower than the glucose oxygen concentration (stoichiometric limitation of oxygen), 
which leads to a reduced upper limit of linearity [309]. Possible solutions to this limitation 
involve the use of polymer films that enable increasing the oxygen/glucose concentration ratio 
by tailoring the flux of the substrates to the electrode, or oxygen-rich carbon paste. Using GDH 
instead of GOx also eliminates the dependence on oxygen [309]. Covering the electrode or 
enzyme-covered electrode surface with a permselective membrane, also reduces the amount of 
electroactive species present in the electrode surface that can interfere with the measurement 
at the used potential in amperometric sensors [309]. This increases significantly the selectivity 
and sensitivity of a sensor. The membrane can be fabricated with a single polymer, or with 
mixed layers of different polymers in order to tune its properties in terms of charge, pore size 
and polarity [309]. Examples of commonly used coatings are cellulose acetate films, negatively 
charged (sulfonated) Nafion and other ionomers, and electropolymerized films such as 
polyphenol and polypyrrole [309]. Glucose monitoring in first generation electrochemical 
sensors depends, not only on glucose and oxygen concentration and pH, as expected, but also on 
the concentration of redox mediator, the enzyme loading and the current applied to the 
electrodes [308]. 
Glucose has also been monitored, although less frequently, through measuring the pH 
change associated with the production of gluconic acid from glucono-δ-lactone hydrolysis. This 
is performed by potentiometry using FET, and is more sensitive to other parameters that might 
affect pH, requiring a well-defined glucose influx and proton out-flux for accurate quantification 
of glucose [308]. 
 
Second generation glucose biosensors (Figure 49) perform the detection through the use of 
a mediator (Medox) capable of transporting electrons directly from the FAD redox center of Gox 
to the electrode’s surface [309]. The reduced form of the mediator, obtained during the re-
oxidation of the enzyme, is re-oxidized in the electrode, generating a current signal proportional 
to the concentration of glucose [309]. The need for redox mediators in glucose oxidase based 
sensors arose from the extremely slow rate at which electron transfer from the reduced FAD 
(FADH2) to the electrode occurred. This low rate of direct electron tunneling derives from the 
depth at which FAD is placed inside the GOx conformation, about 13 to 15 Å below the enzyme 
surface in contact with the electrode [308]. Second generation glucose biosensors can use 
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diffusional electron mediators (soluble mediating species) such as ferrocene derivatives, 
conducting salts, quinone compounds (e.g. Methylene blue), transition-metal complexes, and 
phenothiazine and phenoxazine compounds [309]. These compounds free the reaction from 
oxygen dependency and lower the potentials used in the measurement thus minimizing 
interfering reactions on the electrode [309]. Mediators in second generation glucose biosensors 
must have a low solubility in water, be non-toxic and chemically stable, but most importantly, 
present a higher rate of electron transfer than the rate of the reaction of the enzyme with oxygen 
[309]. Another alternative is to use the enzyme embedded in conducting polymers. The polymer 
provides the connection between the enzyme and the electrode through flexible polymeric chains 
(e.g. poly(vinylpyridine with tethered complexes of Os2+/3+ [308]) and folding around GOx [309]. 
The use of these polymers results in a fast response with high current density and added 
stabilization of the enzyme, allowing the fabrication of ultra-small electrodes [309]. The 
connection of electron relays (e.g. nanocarbon tubes or gold nanoparticles) directly to the enzyme 
or the FAD center can enable a simpler electrical wiring of the enzyme to the electrode and 
result in a significantly higher electron transfer rate which can be controlled by e.g. the length 
of the carbon nanotube used [309]. 
 
Since mediated systems tend to lose stability over time under continuous operation, third 
generation glucose sensors (Figure 49) are currently under development, whereby the enzyme 
is in direct contact with an electrode capable of operating a low potential (close to the one of the 
enzyme -0.5 V vs. Ag/AgCl) [309], [307]. To achieve this, the distance between the FAD redox 
center and the electrode needs to be reduced [309]. A possible solution is the use of conducting 
organic electrodes based on charge-transfer complexes (e.g. tetrathiafulvalene-
tetracyanoquinodimethane (TTF-TCNQ)) [309]. Other approaches involve complex strategies 
for the reconstitution of the apo-enzyme on co-factor-modified electrodes and the reconstitution 
on co-factor functionalized nanoparticles that enable the alignment of the enzyme on the 
electrodes. However, the biggest hope relies on novel nanomaterials such as graphene, 
polyaniline nanotubes, and ionic liquid functionalized carbon nanotubes with gold nanoparticles 
[307]. 
4.1.2 Sensor integration 
The degree of complexity of a microfluidic device tends to increase with the number of unit 
operations and/or mechanical parts that are integrated. However, as stated in Sassa et al. (2008) 
[102], the structure and function of individual components should be simplified to allow the 
operation of sophisticated microsystems.  
When considering a unit of detection, as mentioned previously, the sensor performance 
depends, among other factors, on its position in the microdevice and of the flow rate applied to 
the solution measured. Hence, the manner of integration is highly relevant. Furthermore, the 
integration in microchannels of EC sensors can improve sensitivity due to the closer proximity 
of the electroactive species to the electrode. It can also improve throughput by integrating 
different sensors or sensors for different analytes in parallel channels, all the while decreasing 
analysis time, due to faster diffusion to the electrode’s surface and/or by modifying the flowrate 
used for detection [166]. 
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The simplest strategy for integration of electrochemical sensors involves the fabrication of 
patterns of electrodes directly on the microchannel substrates and/or using thin- and thick-film 
methods [299], [102]. The first approach is generally applied on hard and flat substrates (e.g. 
glass or silicon) [313], [314], [177], [166], where the sensors are deposited onto the channel 
surface using technologies similar or compatible with the ones used for the microstructures 
fabrication (semiconductor industry), such that the fabrication of both structures can be 
performed simultaneously or sequentially [315]. These techniques can also be used in polymeric 
substrates, however differences between the thermal expansion coefficients of the metals and 
the polymer where deposition occurs may lead to metal layer stress and sensor cracking. In the 
thick-film method, a paste containing metal particles or conducting ink (e.g. carbon or graphite 
ink) is spread on a screen with the geometrical pattern of the contact (electrode). This technique 
can be used to print sensors onto paper strips, forming screen-printed electrodes (SPEs). The 
conducting ink or carbon paste can be mixed with biomolecules for direct biosensor printing [86], 
[80]. Using techniques from the semiconductor industry enables batch fabrication of sensors 
and/or integrated structures which in turn greatly decreases its cost, however thick-film based 
sensors allow for overall cheaper fabrication and easier disposability of the sensors [299], [102]. 
Both individual sensors and sensor arrays (for different target analytes) can easily be obtained 
with these fabrication methods [299]. The working electrodes are usually made of Pt, Au, C or 
Ir, while the reference electrode is usually Ag/AgCl [102]. Sensors can be directly integrated in 
the fluidic channel by patterning on the bottom wall, and exist in a three-electrode configuration 
or as arrays of working electrodes, each functionalized for a given analyte and with the same 
working and counter electrodes [102]. The reference and counter electrodes may also be 
fabricated separately and introduced through the channel inlets. Reference electrodes can also 
be accomplished using a salt bridge [166]. Sensors fabricated with other technologies (spray-
coating [174], coating coupled with embossing [183]) can also be irreversibly encapsulated into 
a microfluidic channel. Irreversible encapsulation guarantees a leakage and contamination-free 
operation of the device (after sterilization or when assembled in a clean-room environment), and 
it is the most frequently used approach.  
Another strategy, presented by Frey et al. (2010), involves a permanent integration of a 
thin-film electrode in a flow channel, but the functionalization of the surface can be performed 
after electrode integration and channel bonding through a capillary-driven deposition channel 
connected with each electrode [293]. This extends the life-time of the sensing layer since it was 
not subjected to harsh conditions during channel bonding (e.g. high temperature and/or 
pressure). A further interesting approach to the integration of electrochemical biosensors in 
microchannels requires the immobilization of the biorecognition element of the sensor, 
separately from the electrode, in an area upstream of the electrode position or in the top of the 
channel directly opposite to the electrode position [316]. This has been shown to increase the 
sensing performance in some situations [316], by freeing the electrode’s surface area for more 
efficient electron transfer [166]. Embedding of sensors during the 3D printing process is also a 
possibility, as has already been demonstrated for optical fibers, glass slides and membranes by 
Yuen (2016) [317]. The advantage of embedding structures during printing is the reduction of 
post-processing steps, while integration of glass in 3D printing structures increases visual 
access to the fabricated channels without requiring extra steps of sand blasting and polishing 
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[317]. Electrodes can also be fabricated separately through conventional techniques and 
integrated by gluing or bonding in a glass and polymeric channel [318].  
Traditional sensor integration thus occurs through fabrication of the sensors with the 
microstructures and/or irreversible integration/bonding in the channels. However, diverse 
integration strategies based on either channel or sensor re-usability have recently been 
developed. A platform design that enables the substitution of the sensors in use and the 
integration of different types of sensors widens the sensor and platform applicability. 
Furthermore, devices that require a (re)alignment of the electrodes in the fluidic structure may 
result in increased variability between experiments, depending on the alignment precision 
[319], so the use of ports for sensor introduction decreases such variability by allowing a 
straightforward positioning of the sensors in the platform. This can be achieved using platforms 
where the channel is not irreversibly bonded and can then be easily and frequently opened [320], 
[321], [322]. Electrodes, especially disposable or reusable ones, can thus be integrated in the 
channel through receiving ports [323], [324], [166]. This enables, in the case of re-usable sensors 
to clean or polish the electrode surface from biofouling [166], but it may also allow the 
application of a different functionalization for application towards another target analyte. It 
also permits a re-use of the microfluidic system for different target molecules by allowing the 
introduction of different sensors. 
Erkal et al. (2014) developed 3D printed microfluidic structures for integration of 
electrochemical sensors, where the electrodes were epoxy-embedded on commercial flangeless 
fitting nuts and integrated through threaded ports [319]. In this case, the ports for electrode 
integration in the channel had standard dimensions (same outer diameter), allowing electrode 
interchange, while the inner diameter of the of the tips of the fitting nuts with embedded 
electrodes depended on the electrode used [319]. The design files of the 3D printed structures 
can be easily shared between research laboratories for increased standardization and reliability 
of tests performed [319]. Screen- or inkjet-printed sensors in paper or polymeric substrates can 
be used for detection in paper microfluidics or be integrated through ports in microchannels. 
Reversible encasing of the sensors can be performed through the use of a chip holder (e.g. with 
mechanical clamping [325], [322]) which applies enough pressure for leakage-free flows. A 
reversible encapsulation can facilitate sensor or channel surface functionalization and cleaning 
due to easy access to these surfaces. If the sensor is not irreversibly bonded or encased in the 
device, it can be further re-used in other microfluidic platforms. The cost of such devices can be 
consequently reduced, since the sensors can be the most expensive component of a microfluidic 
platform. 
 Nevertheless, in all approaches, one of the significant challenges is the integration 
between the sensor and the channel, which must be performed in order to avoid leakage at the 
interface [86].  
For increased sensitivity along with a longer sensor life-time (especially in cell 
applications where biofouling can be a significant issue), sensors are usually either covered with 
a polymeric layer or a membrane is placed between the sensor surface and the biological 
elements [299]. 
 
As mentioned in Chapter 1, chip standardization can also facilitate sensor integration and 
use by simplifying the connectivity between microsystems. Detection can then be achieved in 
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different applications with the strategies described above by connecting the microdevice with 
the sensor to the system where the reaction or fermentation is occurring. 
4.1.3 Mixing 
Mixing at microscale occurs mainly through diffusion (which depends on the concentration 
gradient of the species considered) due to the channel and structure dimensions and the 
consequent laminar characteristic of the flows achieved [11]. However, diffusion is a slow 
process and so designs capable of rapidly achieving efficient mixing and/or in a short channel, 
are essential for the development of high-throughput microfluidic systems [160]. Mixing can be 
increased by raising the chaotic advection effect in order to increase the contact area (and time 
of contact) between the flows being mixed, occurring mainly in the direction of flow.  There are 
two main types of strategies to achieve mixing in microchannels: active mixing and passive 
mixing [160]. 
Active mixing involves the application of an external force on the flown fluid. Fluid 
perturbation can be caused by acoustic waves (mixing through generation of microstreams with 
e.g. piezoelectric disks or radio-frequency), dielectrophoresis (mixing induced through particle 
polarization which drives them towards or away from the electrode), magnetohydrodynamic 
flow (mixing occurs by generation of Lorentz forces or actuating magnetic particles), 
electrokinetic pulse (mixing achieved through periodic perturbations of an applied electrokinetic 
force), perturbation of pressure (mixing achieved by flow velocity pulses or alternate 
introduction of sample flows) [11], [105].  
Passive mixing relies on the modification of the channel shape to induce splitting, folding, 
stretching or breaking of the flow, usually using only a pressure head to induce a controlled flow 
[160]. It can be achieved either through lamination-based or advection-based designs. 
Lamination-based mixing involves splitting and recombination of the flow in order to generate 
a higher number of interfacial contacts between the flows. This can be performed with T-
junctions, split T-junctions, hydrodynamic focusing, channel multi-split followed by 
recombination, among others [11], [160]. Advection-based mixing, on the other hand, uses 
structures capable of generating Dean vortices. This can also include intersecting channels (as 
for lamination-based approaches) or convergent-divergent channels, but with geometries that 
increase collision and not just recombination of the flows. Furthermore, mixing can be obtained 
with three-dimensional serpentine channels, where different flows rotate in bends defined in 
the three dimensions, but can also be split and recombined in the vertical direction. Channels 
that possess out-of-channel protrusions in diverse angles are also an alternative design. Tesla 
structures are another advection-based geometry, which involves a combination of thinner 
channels connected to wider sharp curves, with an increased vulnerability to clogging in a mixed 
matrix. Advection-based mixing can also occur through introduction of obstacles, called static 
mixing elements (e.g. staggered herringbone grooves, side-wall protrusions) in one (or more) of 
the surfaces of the channels. This, together with a serpentine structure (introduction of bends 
that induce rotation of the flow) is the simplest strategy to increase mixing efficiency. [11], [160]. 
Mixing in droplets or with slug-flow, is another strategy, resulting in a better control of the 
residence time (no formation of parabolic velocity profile) with the possibility of generation of 
Micro scale reactor system development with integrated advanced sensor technology  
125 
 
inner flows by using serpentine channels or other strategies that have already been mentioned. 
Furthermore, the droplets can also be split and coalesced to improved mixing [11]. 
4.2 Goal 
The developed work summarized in this chapter focuses on addressing the current need 
for adaptable screening platforms with integrated sensors. A flexible multi-function platform is 
proposed, with disposable and changeable sensors, easily integrated with other microfluidic 
platforms through a “plug-and-play” approach by using standardized finger tight fittings. The 
platform can be easily connected to external equipment (e.g. syringe pumps, HPLC), while 
offering the advantage of in-line use, thus not interfering with the reaction vessel. The choice of 
material, the thermopolymeric Poly (methyl methacrylate) (or PMMA), and fabrication 
technology (laser ablation) considered both design flexibility and costs. PMMA and laser 
ablation allow a fast optimization cycle from design, to fabrication and testing with fluids. 
Furthermore, since PMMA is a widely available biocompatible and cheap material, it enables a 
low-cost device fabrication with good reproducibility. Two encapsulation strategies were also 
tested: chemical bonding and lamination with pressure sensitive adhesive tape. 
The classical example of the catalyzed oxidation reaction of glucose by glucose oxidase was 
chosen as the model reaction to highlight the monitoring capabilities of the developed 
microfluidic platform. In order to track the changes in inline analyte concentration, first 
generation amperometric glucose biosensors were chosen for further integration into the 
developed microfluidic device. Amperometric electrodes were employed due to their wide 
applicability [326], [327], [328], [329,330], compactness, stability and low price. The selection of 
first generation EC sensors was guided by its ready availability and knowledge about their 
fabrication and working principle. 
4.3 Materials & Methods 
4.3.1 Reagents and materials 
Glucose oxidase (EC 1.1.3.4, type VII, from Aspergillus niger, ≥100,000 U/g solid) and 
bovine serum albumin (BSA) were obtained from Sigma (St. Louis, MO, USA). Nafion®117 
solution (~5% (v/v) in a mixture of lower aliphatic alcohols and water) and iron (III) chloride 
(anhydrous, 99.99%) were obtained from Aldrich (Steinheim, Germany). Potassium 
hexacyanoferrate (III) (ACS reagent, ≥99.0%) and glutaraldehyde solution (25% (v/v)) were 
obtained from Sigma – Aldrich (St. Louis, MO, USA). D- Glucose (anhydrous) was provided by 
Fluka (Loughborough, UK). Mono – and di-potassium hydrogen phosphate (anhydrous) were 
obtained from Merck (Darmstadt, Germany). Isopropanol (2-propanol, anhydrous, 99.5%) used 
for cleaning was obtained from Sigma (St. Louis, MO, USA). 
All the solutions for sensor preparation were prepared with 0.1 M phosphate buffer + 0.1 
M KCl, pH 6. Standard solutions were prepared daily in the same buffer. All other solutions 
were prepared in 0.1 M phosphate. 
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Customized SPEs on polymeric substrate (DRP-PW-110DGPHOX) were produced by 
DropSens (Llanera, Spain), while the SPEs on polyester substrate (ItalSens IS-C) were acquired 
from PalmSens (Utrecht, The Netherlands). The DRP-PW-110DGPHOX SPEs are made of a 
thicker polymer than the IS-C SPEs. Each sensor is composed of three screen-printed electrodes: 
(i) the carbon working electrode (with graphene oxide layer in the case of the DRP-PW-
110DGPHOX electrodes); (ii) the carbon counter electrode; and, (iii) the silver reference 
electrode. The diameter of the working electrode in the DRP-PW-110DGPHOX SPE is 0.4 cm, 
which results in an apparent geometric area of 0.126 cm2, while in the IS-C SPE the diameter 
is 0.3 cm with an apparent geometric area of 0.07 cm2. 
The extrusion PMMA sheets with a thickness of 2 mm were acquired from Nordisk Plast 
(Assentoft, Denmark). The PMMA plates were patterned using laser ablation with a CMA-4030 
Laser Engraving machine from GD Han’s Yueming Laser Technology co., Ltd (Guangdong, 
China). Chemical bonding of the PMMA plates was achieved using an anhydrous chloroform 
solution, ≥99%, 288306 from Sigma-Aldrich (St. Louis, MO, USA). Adhesive assembly and 
integration of the sensors on the platform were performed with a 142 µm thick mcs-foil 008 from 
microfluidic ChipShop (Jena, Germany). The PDMS thin sheets used as gaskets were fabricated 
using the elastomer and curing agent kit of Sylgard® 184 from Dow Corning (Auburn, 
Michigan). The two 10-mm thick acryl plates that form the custom-made holder were from Rias 
A/S (Roskilde, Denmark). The holder was completed with two outer 5 mm thick SS304 stainless 
steel plates from Sanistål (Aalborg, Denmark). Flangeless polypropylene (PP) fingertight 1.5875 
mm (ID) fittings (XP-201) and flangeless ferrules (P200X) from Upchurch Scientific® 
(Washington, USA) were used to connect polytetrafluoroethylene (PTFE) 1.5875 mm (OD) x 
1mm (ID) tubing (S 1810-12) from Bohlender (Grünsfeld, Germany). 
4.3.2 High-Performance Liquid Chromatography (HPLC) method  
All the reaction samples were analysed in HPLC for quantification of consumed glucose 
and produced gluconic acid. The measurement was performed with reversed-phase 
chromatography on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA) equipped with a 
Phenomenex column with 5-µm sized amine particles (Luna 5u NH2 100A), operated at 40 ⁰C 
and 140 bar. The mobile phase consisted of a 20 mM phosphoric acid (H3PO4) solution, flowing 
at 1 mL/min. The eluted gluconic acid was quantified in the ultraviolet (UV) multiple 
wavelength detector at 205 nm, while the glucose concentration was determined in the Refract 
Max 520 refractive index (RI) detector. The amount of each component was obtained by 
integration of the areas under the corresponding peaks using the HPLC commercial analytical 
software (Chromeleon 6.8), based on a calibration curve performed for each component. Samples 
were measured mixed with 0.5 M sodium hydroxide (NaOH) solution in a proportion 1:2 of 
solution relative to the sample. 
4.3.3 Microfluidic Platform Fabrication and Sensor Integration 
A microfluidic system containing two inlets, two sensing/ measurement chambers, for 
sensor integration, and one mixing unit was developed and is presented in Figure 50. Figure 
50(a) shows a schematic of the microfluidic platform. As illustrated, one of the inlets of the 
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system is connected to the first chamber, where the reference sensor is located. The second inlet 
is connected to the mixing chamber, which serves here as a dilution unit but can also be used 
as a reactor or target labelling unit. The second chamber is positioned after the mixing unit. 
The sensor integrated in this chamber is the one used for sample quantification and is thus 
designated detection sensor. Figure 50 (b) and (c) display one more feature of this system. It 
involves the use of generic rectangular pockets at the bottom plate of the device with direct 
access to the sensing chambers. The sensor can thus be directly placed in the chamber and 
covered with a thin polymeric gasket. The system is then closed by placing PMMA inserts in the 
pockets and sealing the whole platform with help of an outside mechanical holder system. An 
expanded view of the assembled platform is presented in Figure 51. 
 
 
Figure 50 - Schematics of the developed platform, highlighting the different elements and the sensor positions (a) 
and SolidWorks 3D representation of the assembled microfluidic platform with one integrated IS-C SPE (b), and (c) 
DRP-PW-110DGPHOX SPE. 
 
Figure 51 – Schematics of the assembly of the different plates for the three-dimensional mixing geometry and the 
sensor pockets for the graphene oxide-based sensors. 
 
The design of the device was performed in SolidWorks 2015 (Dassault Systèmes 
SolidWorks Corporation, Waltham, Massachusetts, USA). This microfluidic platform consists of 
four PMMA plates ablated by laser ablation, as can be observed in Figure 51. 
After ablation, the plates were thoroughly washed with deionized water, dried and then 
placed in an oven at 80 ⁰C for 1 hour to release thermal stress before proceeding with the 
assembling. Two different approaches were used to assemble the PMMA plates: (i) lamination 
with double sided pressure sensitive adhesive tape (DAT); and, (ii) chloroform bonding. In the 
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first approach, the cooled plates were glued together and then pressurized with clamps and 
placed in an oven at 80 ⁰C for at least 1 hour to remove possible air bubbles disturbing the 
adhesion. In the chloroform bonding, a procedure adapted from Ogilvie et al. (2010) was followed 
[331]. The dried plates were thoroughly washed with a 99.5% isopropanol solution, dried and 
then the surfaces to be bound were exposed to chloroform vapours for 2 min before being glued 
together. The plates were placed at a height of approximately 2 mm from a layer of liquid 
chloroform inside a closed glass Petri dish. In both approaches, after bonding was completed, 
the sensors were put in place using thin PDMS gasket sheets, sealing the sensor around the 
sensing chamber. The PDMS gaskets were fabricated by mixing in a SpeedMixerTM DAC 150.1 
FVZ-K from Synergy Devices Limited (High Wycombe, UK). A 1:10 proportion mixture of the 
curing agent and the Sylgard® elastomer, was poured into a 1 mm PMMA mold with the shape 
of the sensor pockets followed by curing it in the oven for 1h at 70 ⁰C.  
 
Once the chip was assembled, the sensors were placed on the sensor pockets, the PDMS 
gaskets were placed on top and followed by a piece of PMMA. The microfluidic platform with 
integrated sensors was then positioned in an ‘in-house’ fabricated casing, which provided the 
necessary pressure to achieve leakage-free flow. The holder was built by two acrylic plates of 
100x100 mm2 that were micromilled in order to have a cavity with the chip’s size and two outer 
SS304 stainless steel plates with a thickness of 5 mm, to avoid bending of the acryl plates when 
screwing the assembled holder together. This holder provides enough uniform pressure to avoid 
leakage of the microfluidic platform.  
4.3.4 Mixing unit CFD optimization and characterization 
Several passive mixing geometries were designed in SolidWorks 2015 (Dassault Systèmes 
SolidWorks Corporation, Waltham, Massachusetts, USA). The drawings of these geometries are 
presented in Figure 52. Each geometry’s mixing characteristics were studied with the help of a 
computational fluid dynamic (CFD) simulation software, ANSYS-CFX Version 16.2 
(Canonsburg, Pennsylvania, USA). To this purpose, the three-dimensional designs were 
imported into a meshing software, ANSYS ICEM CFD® 16.0 (Canonsburg, Pennsylvania, USA), 
where discretization of the geometries was performed. Discretization divides the geometry in 
smaller elements, in which the required momentum, energy and mass balance equations were 
solved by ANSYS-CFX. The number of elements of the 5 simulated structures varied between 
845 and 1185 elements/µL, except for design (e) which had 9925 elements/µL. A structured mesh 
provides a more reliable and accurate output with respect to the results and reduces for many 
types of problems the simulation time. However, it is more complicated to define and requires 
longer preparation time. So, as a first approach, all geometries were simulated with 
unstructured mesh elements using tetrahedral features for the mesh. The best designs (designs 
(a) and (e)) were then simulated with a structured hexahedron mesh.  
At microscale, the flow is laminar and therefore predictable, simply requiring the solution 
of the Navier-Stokes equation without the use of turbulent models. All geometries were 
simulated at the target flow conditions (steady state with laminar flow, outlet as an opening 
and no slip wall conditions) in the integrated microfluidic platform considering a fluid with the 
same properties as water (at 25 ⁰C) where a liquid tracer with diffusivity of 1x10-10 m2 s-1 was 
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introduced. The average inlet velocity, at the reference sensor, was 1x10-3 m s-1, while the 
velocity of the other inlet was varied depending on the simulated degree of dilution. The 
geometries were evaluated by monitoring the average tracer amount at the outlet, as well as 
the gradient of its concentration. The best performing geometries were then built using the same 
procedure as described above for the microfluidic platform. Subsequently they were 
qualitatively tested using food colouring dies at the simulated flowrates. The geometry that 
achieved the desired 1:9 dilution with no gradient of tracer at the outlet (design (e)) was then 
used in the final microfluidic platform design. More details regarding the CFD simulations are 
presented in Appendix IV. 
 
 
Figure 52 - Mixing chamber designs based on passive mixing structures: slanted grooves (a), squared baffles (b), 
staggered herringbone (c) combination of herringbone and obstacles (d) and three-dimensional serpentine (e). 
4.3.5 Sensor 
The sensors presented in this chapter were fabricated at the PROSYS research group 
together with PhD student Daria Semenova. The presented procedure was based on the 
methods used at the Measurement Technology Unit (MITY) at Oulu University, which were 
acquired during a 3-month external stay, of both PhD students at Oulu University. No work 
related to sensor optimization is presented here, since it is an extensive procedure which has 
been refined by Daria Semenova. 
4.3.5.1 Sensor Preparation  
The used biosensors consist of a SPE with immobilized layers of the hydrogen peroxide 
sensitive catalyst, Prussian Blue (PB) and the biological recognition element, the enzyme 
glucose oxidase (GOx). The PB modification of SPEs and deposition procedures were adopted 
from the procedures developed by Ricci et al (2003) [312] and Mahosenaho et al. (2010) [332]. 
Freshly prepared precursor solutions of 0.1 M potassium ferricyanide (K3Fe(CN)6) in 10 mM 
HCl and 0.1 M ferric chloride in 10 mM HCl were mixed in different proportions. A 1:1 
proportion was used in the DRP-PW-110DGPHOX SPEs, while in the IS-C SPEs a 2:1 
proportion was used for the detection sensor and a 1:2 proportion for the reference sensor. A 
drop of PB (10 µl of total volume) was accurately placed onto the working electrode area, to avoid 
Micro scale reactor system development with integrated advanced sensor technology  
130 
 
contact with the counter and reference electrodes. The electrodes were left for 10 min at room 
temperature and then rinsed with a 10 mM HCl solution and deionized water. The modified 
electrodes were then left to dry for 1 h in the oven at 100°C for stabilization of the PB layer, and 
afterwards stored in the dark at room temperature. 
Glucose oxidase (GOx) immobilization was performed in a Nafion matrix via a cross-
linking method previously described by Ricci et al (2003) [312] and Mahosenaho et al. (2010) 
[332]. A drop of 2.5 µl of glutaraldehyde (1 % (v/v) diluted in water) was placed on top of the 
working electrode area of the PB-modified electrodes and left to dry for 30 min at room 
temperature. A drop of 3 µl of the enzymatic-Nafion membrane was then applied on the modified 
working electrode and placed to dry overnight in a climate chamber at 8°C with 40 % of 
humidity. The enzymatic mixture had the following composition per sensor: GOx (0.074 U in 
phosphate buffer), BSA (5 vol. % diluted in water) and Nafion (5 vol. % diluted in water). All the 
components of the enzymatic layer were mixed in a 1:1:1 proportion.  The complete glucose 
biosensors were stored dry at 4°C until use. 
4.3.5.2 Sensor Characterization 
Cyclic voltammetry (CV) and amperometric measurements (AM) were carried out using a 
MultiEmStat with a DRP-CAST1X8 interface (DropSens, Llanera, Spain) for 8 independent 
electrodes under MultiTrace Software 3.4 control (PalmSens, Utrecht, The Netherlands). Fluid 
flow was maintained by Cavro® XL 3000 syringe pumps from Tecan (Männedorf, Switzerland). 
The behaviour of the PB layer was studied by cycling in a potential range between - 0.5 and + 
1.2 V with a scan rate of 50 mV/s as presented in Figure 53. CV measurements were performed 
in droplets using phosphate buffer solution (0.1 M phosphate + 0.1 M KCl, pH 6).  
 
Figure 53 – Cyclic voltammograms of the sensors used for the microfluidic platforms test: (a) for the graphite-based 
sensors and (b) for the graphene oxide-based sensors. The sensor used in the first chamber is presented in blue, while 
the sensor used in the second chamber corresponds to the red curve. 
The chronoamperometric measurements were performed in a droplet (static condition) at 
an applied potential of -0.16 V (graphene oxide-based sensors) or -0.04 V (graphite-based 
sensors) versus a screen printed internal silver reference electrode, as observed for the CVs 
presented in Figure 53. Static measurements were performed by placing a droplet of 50 µl of 
different glucose solutions (0.1mM – 8mM) on the electrodes. In-flow (dynamic) measurements 
were carried out at the flowrates used for the mixing/dilution chamber characterization. The 
flowrates during characterization varied between 0.25 and 10 µL/s. When a stable baseline 
current was reached (30 s and 60 s, for graphene oxide and graphite sensors, respectively) with 
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phosphate buffer solution (0.1 M phosphate + 0.1 M KCl, pH 6), different substrate 
concentrations were tested and the measurements were recorded. In the static characterization 
of the glucose biosensors, the drop of 50 µl of known glucose concentration (0.1mM – 8mM) was 
placed on top of all the electrodes and the current was recorded until it reached a stable value. 
When the sensors were characterized in flow, a volume corresponding to 3 times the internal 
volume of the microfluidic platform was first pumped to guarantee that only the target 
concentration was inside the system. Data was retrieved after stabilization of the signal.   
4.3.6 Continuous monitoring of diluted glucose solutions 
To perform the dilution inside the microfluidic platform, a 3 mM glucose solution was 
introduced through the inlet connected to the first sensing chamber (working in this case as a 
reference sensor – see Figure 50 (a)). A buffer solution (the same as the one used during 
measurements of the zero point during sensor characterization) was introduced in the second 
inlet (connected to the mixing/dilution chamber). The flowrate for substrate introduction was 
kept the same (1 µL/s) while the flowrate of the buffer solution was increased in order to achieve 
the correct dilution as presented in Table 18. The diluted solution was collected at the outlet of 
the microfluidic platform and measured in an HPLC for validation of the mixing unit and 
compared with the data retrieved from the integrated sensors. 
Table 18 – Flowrates used to test the mixing/ dilution chamber inside the developed microfluidic platform. 
Dilution 
Flowrate second 
inlet (µL/s) 
Flowrate in second 
sensing chamber (µL/s) 
Flowrate used for data 
interpretation (µL/s) 
1:1 1 2 2 
1:2 2 3 4 
1:5 5 6 6 
1:9 9 10 10 
4.4 Results and Discussion 
The microfluidic platform presented in this chapter was built to be suitable in a wide range 
of applications. To this end, the final design required flexibility in terms of the used sensors and 
its easy replacement through the use of sensor ports. In this case, the ports were designed as 
rectangular pockets that allow access of the sensors to a chamber where the sensor can be 
placed. This approach allows for a wide variety of sensor shapes and widths to be integrated 
without requiring the modification of the whole platform. Furthermore, it is important to note 
that the sensor and platform fabrication are independent from each other. In this way, any 
sensor technology compatible with the platform material can be used, which considerably 
broadens the future opportunities for the platform’s use. 
As proof-of-concept, screen-printed electrochemical sensors were chosen due to the cheap 
fabrication and wide use in microfluidic and health related applications. The possibility of 
applying these sensors as single-use detection elements is also an appealing concept due to the 
impending challenges of biofouling that bio-applications can generate during long-term 
measurements.  
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Two different types of electrodes were selected for integration in the microfluidic platform, 
each presenting the same detection principle and target analyte but made of different materials 
and having different thicknesses. The choice of electrochemical sensors influenced the design of 
the platform, presented in Figure 50 (b) and (c), due to the required sensing chamber shape. 
With access to a bigger variety of sensor formats, a more generally applied chamber geometry 
could be efficiently developed, improving the applicability of the platform. For now, sensors with 
functional areas within the area of the fabricated chambers can easily be integrated and used. 
The distance between the measurement chambers (37.2 mm center to center) was defined based 
on the gap between the inlets of the interface connecting the sensors to the potentiostat used 
for measurement. In principle, due to the fast fabrication and assembly cycle of the platform (< 
2 h), adaptation of the platform to most types of sensors (by adjusting the sensing chamber) can 
easily be performed. Moreover, sensors that can fit within the fabricated sensing chambers 
would not require a chamber design, since the PDMS o-rings would provide sufficient coverage 
to avoid leakages during operation.  
The two integrated sensors were subjected to different flowrates during measurement, 
since one was positioned before the mixing/dilution chamber (first sensing chamber), while the 
other was positioned after the mixing/dilution unit (second sensing chamber). So, the first 
sensing chamber was only affected by the flow of one of the inlets (sample inlet). The second 
sensing chamber, on the other hand, experienced a higher flowrate which was the sum of the 
flowrate from the two inlets (sample plus buffer for dilution). The overall internal volume of 
both designs was approximately 500 µl. 
4.4.1 Strategy for PMMA assembly 
Both bonding strategies allowed for a fast assembly of the different plates that form the 
platform (less than 15 minutes required), while also achieving a leakage-free flow and enabling 
the re-use of the platform.  
The chemical bonding procedure, however, was not as reproducible as the lamination one, 
mainly due to the manual control of the exposure time to chloroform vapours. Added variability, 
which sometimes resulted in deformations of the channel structures, was the manual control of 
distance between the PMMA plates and the layer of liquid chloroform, as well as the amount of 
chloroform added to the bonding procedure. Thus, the preferred material for the platform 
assembly was DAT due to easier and more reproducible alignment of the stack of plates and the 
avoided use of toxic chemicals. 
4.4.2 Mixing and dilution unit 
An issue with existing electrochemical sensors is their linear range of measurement, which 
is often shifted or more reduced than desired [293]. The most used approach to solving this issue 
involves optimizing the polymeric/diffusing membrane covering the sensor, thus better 
controlling the analyte diffusion to the electrode’s surface. However, tailoring the sample 
concentration in flow to meet the sensors detection range is also an interesting approach to 
overcoming this limitation [293]. The presented platform enables the application of the latter 
method, as a strategy to widen the applicability of the integrated sensors, by integrating a 
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dilution unit on-chip. The use of the platform can this way be less limited by the available 
sensors and/or their corresponding detection limit. This is especially relevant in biological and 
biotechnological applications, where variable substrate (or other components) concentration can 
occur, often within a wide range (glucose concentrations above 1 mM are usually obtained e.g. 
in glucose monitoring of diabetes patients [308]).  By diluting the fluid matrix that reaches the 
detection chamber, to the linear range of the sensor, the range of detectable concentrations of 
the integrated sensor is thus broadened.  
 
The developed dilution platform was based on passive mixing in order to allow dependency 
on a single piece of external equipment (syringe pump), thus simplifying the equipment required 
for operation [333]. Several mixing designs (presented in Figure 52) were first simulated using 
a CFD software (ANSYS-CFX 16.2), before the best design was integrated in the platform and 
validated. The first designs were based on chaotic mixing generated by obstacles in the channel, 
since this approach provides fast mixing due to an increased interfacial contact between the 
mixing phases [333], [105]. The design of obstacles [11] within a chamber was preferred to a 
zigzag configuration (as presented by Jeon and Shin (2009)  [333]) to avoid a high pressure drop 
[334] due to sharp corners and extended length of the channel. This is relevant when developing 
a system for use in a series of chips, such as in the case of modular platforms. Also, to reach a 
design less prone to clogging,  more complex mixing structures, such as Tesla structures, were 
avoided [335].  
It is also important to consider when operating a passive mixer, that the mixing capability 
is highly dependent on the flow velocity. Therefore, the design must be optimized to achieve 
appropriate mixing at high flowrates. In Figure 54, all designs that include obstacles ((a) to (d)) 
are presented. It can be observed that the slanted grooves design (Figure 54 (a)) has the best 
performance, especially at higher flowrates. However, even the structure showing the best 
performance was not capable of achieving the desired 1:9 dilution. Finally, a 3D serpentine 
channel was designed and simulated for the same flow conditions as shown in Figure 54 (e), 
resulting in the best mixing design to achieve a 1:9 dilution at high flowrates.  
 
It is highly relevant to mention that by performing the study of the mixing efficiency of 
the different geometries presented through CFD, an optimized geometry for the intended 
purpose was quickly obtained (less than 3 days). This allowed to significantly reduce the 
development time of the quantification platform. Furthermore, the comparison of different 
geometries without fabrication and fluidic tests, made it possible that the overall platform 
development cost was significantly decreased.  
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Figure 54 - Comparison of mixing capability between different mixing chamber geometries using CFD simulation 
for 1:1 dilution at 10-3 m/s, and of a 10 times difference between inlet velocities for two geometries (straight diagonal 
barriers channel and the 3D serpentine channel). In the figure, the different geometries tested for mixing are 
presented: (a) slanted groves, (b) squared baffles, (c) staggered herringbone, (d) combination of herringbone and 
obstacles and (e) three-dimensional serpentine channel. For the three-dimensional serpentine channel (e), a view of 
the entire fluid with volume rendering is presented on the top, while the bottom images present two planes defined 
at the top and bottom of the three-dimensional channel. 
4.4.3 Sensor characterization 
The pairs of EC biosensors integrated in the developed microfluidic platform were 
characterized both in a static (droplet characterization) and in a dynamic environment (in-flow 
characterization). Both types of measurements were performed with chronoamperometry for 
the same substrate concentrations. The magnitude of the measured current, obtained by 
applying a constant potential between the working and the reference electrodes, is usually 
proportional to the bulk concentration of the present electroactive species, hence enabling a 
quantitative output. The static calibration allowed checking performance and sensitivity of each 
sensor before integration in the developed microfluidic platform. The dynamic measurements 
were performed at flowrates 0.25 to 10 µL/s. These flowrates were identical to the ones applied 
during the mixing/dilution experiment, thus enabling to study the influence of flow velocity on 
the sensor output.  
Figure 55 (a) and (b) present the measured calibration curves from the static 
chronoamperometry measurements. It can be observed that the graphite-based sensors (Figure 
55 (a)) show a decreased linear range (only until 1.7 mM of glucose) with a slightly higher 
apparent sensitivity than the graphene oxide-based sensors (Figure 55 (b)). The latter sensors 
display a wider range of detection (up to 5 mM of glucose) with a sensitivity lower than 0.2 
µA/mM. This difference in the sensor output can potentially be explained by the presence of the 
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graphene oxide layer, which tends to present high chemical stability and improved 
electrochemical properties. Furthermore, graphene oxide is known to increase the effective 
surface area of a sensor, thus improving its signal-to-noise ratio, as well as facilitating the 
functionalization of the surface [336], [337]. Even though more reliable data was thus expected 
from the graphene oxide-based sensors, both sensor types were tested inside the platform and 
their dynamic response compared with the static approach.  
In Figure 55 (c) and (d) the measured calibration curves for the dynamic method using the 
microfluidic platform are presented for the different flowrates tested. This characterization was 
performed by inducing the same flowrate at the two inlets, and as a result the first sensing 
chamber was subjected to half the flowrate as the second sensing chamber. As illustrated in the 
figure below, the graphite-based sensors (Figure 55 (c)) present a reduced linear behaviour than 
previously obtained in the droplet chronoamperometry, while the graphene oxide-based sensors 
(Figure 55 (d)) show a decrease in the linear range (up to ~4 mM of glucose). Moreover, both 
sensor types display a variation of the calibration curve with flow. A decrease in the sensitivity 
(slope), as well as of the detection range, is observed when the applied flowrate increases. The 
higher difference in static vs. dynamic behaviour observed for the graphite-based sensors can 
be related to the difference in electrode substrate (graphite is less chemically stable than 
graphene oxide). Furthermore, the higher surface area of the graphene oxide sensors permits 
the immobilization of higher amounts of both mediator and glucose oxidase, which along with 
its intrinsic improved electrochemical properties possibly contributes to the different output 
observed. 
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Figure 55 – Droplet amperometric characterization of the biosensors before integration in the microfluidic platform, 
(a) graphite-based sensors and (b) graphene oxide-based sensors, and in-flow amperometric characterization of the 
sensors used to test the microfluidic platform, (c) graphite-based sensors and (d) graphene-based sensors.  
4.4.4 Influence of flow  
The distribution of the measured current relative to the flowrates applied for the 
integrated graphite and graphene oxide-based sensors was also assessed. A similar trend can 
be observed for both sensors (Figure 56), being however more pronounced in the graphene oxide-
based sensors (Figure 56 (b)). At low substrate concentrations, a slight decrease of the measured 
current (more negative) is observed with increasing flowrates. For concentrations higher than 
1 mM, the opposite trend is observed, where the measured current becomes less negative with 
increasing flowrates. Both trends are however less prominent for flowrates higher than 5 µL/s.  
As mentioned by Sassa et al. (2008) [102], the current generated in amperometric sensors 
depends on the applied flow velocity since the analyte used for detection (that permeates the 
membrane layer above the sensor) is a small fraction of the bulk concentration. The thickness 
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of the diffusion barrier formed above the membrane due to flow, together with the concentration 
gradient formed between the bulk and the diffusion barrier, determine the amount of analyte 
that reaches the sensor membrane. The amount of analyte that permeates is then defined by 
the characteristics of the membrane and by the concentration gradient between the diffusion 
barrier and the electrode’s surface (gradient inside the membrane). 
 
Figure 56 - Influence of flow on the current measured for the range of glucose concentrations tested for both types 
of sensors used: (a) graphite-based sensors and (b) graphene oxide-based sensors. 
In a direct measurement of the analyte, at low flowrates, the analyte measurement process 
is limited by its mass-diffusion through the stagnant layer of liquid above the membrane, whose 
thickness decreases with increasing flow rate. Thus, at increased flow velocities, a higher 
amount of analyte is capable of diffusing and a higher current is obtained. This current increase 
will reach a plateau when the stagnant layer reaches its minimum thickness and the process is 
only limited by the analyte diffusion rate through the membrane [318]. However, as it is also 
verified in this work, the opposite trend is observed with indirect measurement of the analyte, 
meaning a decrease in current is observed with the increase of the flowrate. In this work, since 
a higher substrate concentration corresponds to a more negative current, this decrease is 
translated in a more positive current.  
Several papers have reported a decrease of current with the increase of flow velocity in 
amperometric measurements of sensors where the compound resulting in electric signal is not 
the analyte (indirect measurement) [316], [318]. Lamberti et al. (2012) associated this decrease 
with a leakage of the generated hydrogen peroxide and consequent wash out from the membrane 
layer due to the increasing flowrate. This was also confirmed by mathematical and fluidic 
simulations [318]. This is one of the possible causes for the observed current decrease (in 
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absolute values) with increasing flowrate. On the other hand, in Figure 56, a slight increase in 
current was observed with the flowrate in all the used sensors, for a glucose concentration below 
1.2 mM, which was not observed by Lamberti et al. (2012) where the minimum glucose 
concentration used in the experimental studies was 1 mM [318]. This effect is however much 
smaller than the current decrease of flow and might not be significant.  
Lamberti et al. (2012) also observed that the response time of the electrochemical sensors 
decreased with increasing flowrate [318]. This was not possible to determine for the 
electrochemical sensors used, since measurements were performed when the solution was 
considered at steady state, and thus diffusion of analyte through the membrane had already 
occurred. 
Hashimoto et al. (2006) observed that the influence of flow rate on sensor performance 
decreased with increasing channel heights, which is expected since for the same flowrates, 
higher velocities are achieved for smaller cross sections [316]. This indicates that the use of 
deeper channels or, as performed here, wider chambers for sensor integration might aid in 
decreasing the influence of flow.  
 
Since the applied flowrate and the substrate concentration affect the measured current, a 
study on the influence of flow on the sensor performance is required and data can only be 
analyzed by using the calibration curves for each of the applied flowrates.  
Lamberti et al. (2012) solved the issue of signal dependency on flowrate by decoupling the 
sampling unit from the quantification unit in two different modules [318]. The same strategy 
could be applied here, by decoupling the dilution unit (with the first sensor) from the 
quantification unit (second sensor) through the introduction of a metering channel and a valve. 
However, if sufficiently sensitive sensors are integrated, no significant decrease in 
quantification accuracy should be observed. Furthermore, by coupling the sensors with a 
software capable of estimating the decrease in current with flowrate from a one- or two-point 
calibration at a given flowrate, the obtained data can be correctly analyzed. 
4.4.5 Continuous monitoring of diluted glucose solutions 
The successful integration of these sensors and the continuous monitoring of glucose 
samples in a microfluidic platform were achieved. Figure 57 presents the results of the 
mixing/dilution chamber test where the integrated sensors were used for continuous monitoring 
of diluted glucose solutions. The data is plotted relative to an expected glucose concentration, 
calculated by applying the used dilution to the inlet glucose concentration (3mM). Substrate 
quantification results of the outlet solutions from the HPLC measurements are also presented 
in Figure 57. The current measured at the sensors was converted into glucose concentration 
through the in-flow calibration curve (Figure 55 (c) and (d)) corresponding to the flowrate 
applied to the sensor (Table 18). As presented, the graphite and graphene oxide-based sensors 
have a different sensitivity to the substrate, visible by their different response. However, both 
display a deviation from the HPLC data. The graphite-based sensor under-estimates the glucose 
concentration and the graphene oxide-based sensor over-estimates it, which can be caused by 
the influence of the flowrates on the thickness of the diffusion layer above the sensor and thus 
on the glucose diffusion to the electrode’s surface. Additionally, the previously mentioned 
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leakage of produced hydrogen peroxide might explain the lower substrate concentration 
measured by the graphite-based sensor. Considering that it presents a lower chemical stability 
than graphene oxide, a higher amount of hydrogen peroxide could leak without reacting with 
PB and thus the current measured be lower than expected. The difference between the HPLC 
and electrochemically measured glucose concentration in the case of the graphene oxide sensor 
could be due to variability from the HPLC measurement, since only the point at 1.5 mM expected 
glucose seems to deviate from the overall trend. However, tests at more dilutions and with 
different initial glucose concentrations should be performed in order to ascertain the cause for 
the deviations found.  
 
 
Figure 57 – Comparison of diluted glucose concentration values measured online with the sensors and at the outlet 
using HPLC, for both types of SPEs used: (a) graphite-based sensors and (b) graphene oxide-based sensors. 
In terms of extending the range of application of the electrochemical sensors, other 
approaches have been more successfully applied. Frey et al. (2010) used controlled diffusion of 
the sample with a buffer solution (flown between the sample (top of channel) and the electrodes 
(bottom of channel)) to define the thickness of the diffusion layer above the sensor (defined by 
the thickness of the buffer stream) [293]. With this approach Frey et al. (2010) [293] achieved 
online control of the diffusion layer thickness by controlling the flow rate of the buffer solution. 
However, since the integration strategy presented in this work is intended for application of 
different types of sensors (e.g. optical), the focus was on sample dilution to meet the integrated 
sensors linear range. 
Furthermore, it is relevant to highlight that all experiments presented for each set of 
sensors, were performed continuously for around 12 h. The platform’s ability for continuous 
fluidic operation in a wide range of flowrates and for different sensor substrates and geometries 
has thus been demonstrated. 
4.5 Conclusions  
In this work, a microfluidic platform for continuous monitoring of glucose samples for 
biotechnological applications was developed. This platform involved the successful integration 
of two electrochemical sensors with different electrode materials and sensor areas, and their 
validation in continuous monitoring. The comparison between sensor output during static and 
dynamic measurements allowed the observation of a decrease of detection range for both 
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sensors, during in-flow measurements relative to the droplet characterization. This change in 
the sensors’ sensitivity derives from the fluid dynamic influence on the diffusion of target 
analyte to the electrode surface, along with possible leakage of produced hydrogen peroxide. 
Furthermore, a significant difference in current output was also obtained at low (less than 5 
µL/s) and high (above 5 µL/s) flowrates, indicating that effect of flow velocity is relevant at this 
scale for the used chamber geometries. Finally, the platform displays the capability of 
performing sample dilutions of up to 10 times, even at high flowrates, through the use of an 
integrated mixing unit. This unit allowed tuning the sample concentration according to the 
sensor’s detection limit.  
The presented mixing unit can be improved by increasing the number of bends in the 
meandering channel or by introducing some obstacles within the channel, which is large enough 
to implement such structures. Thus, higher dilutions of the initial sample could be achieved. 
Furthermore, since the used sensors present a stabilization in current output at high flowrates, 
the increase of dilution ratio with increasing flowrates should not affect the performed 
measurements. 
Even though fluidic and analytical simulations of glucose sensors at steady state have 
been performed [316], [318], the study of the presented platform through fluid dynamic 
simulation tools (CFD), would significantly increase the understanding on the influence of the 
observed diffusion effects. Moreover, an optimized chamber geometry, a flowrate range or 
operation and/or a mathematical relation between static and in-flow calibration curves could be 
obtained with such a model and thus provide solutions on how to circumvent diffusion effects 
during data acquisition.  
This platform may be further applied to different sensing technologies (e.g. optical, 
magnetic), due to the presented flexibility in terms of sensor format, as well as ease of assembly 
and possibility for re-use of both platform and the integrated sensors. Furthermore, a 
combination of electrochemical and other sensor technologies (especially optical sensing) could 
be achieved on this platform, by using the predefined pockets for sensor integration. Likewise, 
the integrated mixing chamber can display a high variety of functions besides the demonstrated 
dilution ability. It may be further used as a reaction chamber for the screening of biocatalysts, 
as an inactivation or reaction quenching unit, or even as a labeling unit, by mixing the sample 
stream with a fluorescent or magnetic marker, depending on the chosen sensing approach.  
The described sensor integration method could be further improved if the sensors could be 
slid into the sensor pockets instead of mounted by disassembling the outer casing. This approach 
could be achieved by placing a piece of PDMS or other compressible material only in the area 
directly below the sensing chamber, while having a slit in between the plate with the PDMS 
and the chamber plate. By introducing the electrode through the slit, the compressible material 
would apply pressure on the sensor so it closed the sensing chamber to allow leakage free flow. 
An alternative to this compressible material would be to use a spring or even a threaded nut 
that could be screwed, depending on the sensor, to push the sensor towards the chamber and 
thus enable closing the fluidic path. 
 
The developed platform exhibits a multi-function capability using a simple design, 
standard connectors and low-cost materials. Such platform can contribute to increasing the 
number of bioprocess parameters measured online during monitoring, by allowing the 
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integration of different sensor approaches, as well as their replacement, without the need of 
changing the platform itself. The overall cost of such platform makes it accessible both to 
research laboratories and industries. Additionally, the simple design allows for mass 
production, by changing the fabrication method to e.g. injection moulding, and being 
consequently feasible for parallelization at a bigger scale.   
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Chapter 5 
Thermal Inactivation Platform 
The need for fast and comprehensive characterization of biocatalysts has pushed the 
development of new screening platforms, based on microfluidics, which are capable of 
monitoring several parameters simultaneously with new configurations of liquid handling, 
sample treatment and sensing. Modular microfluidics allows integrating these newly developed 
approaches in a more flexible way towards increased applicability of the microfluidic chips to 
different types of biocatalysts and reactions. A highly relevant operation in such a system is the 
inactivation of biocatalysts. Such an inactivation module enables the precise control of reaction 
time at the time of measurement when sensing is performed in another module. This is achieved 
by avoiding the continuation of the reaction in the following sensing module or connecting tubes. 
Such control is important when different modules of reactors and/ or sensing units are used and 
frequently changed. It can furthermore help to regulate the state of the biocatalyst, since 
dependent on the temperature used and exposure time, reversible or irreversible denaturation 
can be achieved. In this work, the development, characterization and application of such a 
module is described for the fast inactivation of two well-known and widely used enzymes, 
glucose oxidase and catalase. The developed thermal inactivation platform is compared with a 
standard benchtop orbital shaker with temperature control (ThermoMixer) in terms of 
inactivation efficiency. Both enzymes were inactivated under flow conditions with 120 s 
residence time at 338 K (65 ⁰C) and 20 s residence time at 353 K (80 ⁰C) in the thermal 
inactivation module. The performance of the flow system was compared with the ThermoMixer 
system at 60 s residence time at 353 K (80 ⁰C). Moreover, partial deactivation of the enzymes 
was observed for the continuous thermal inactivation module when activity measurements were 
performed respectively after one and two days after the thermal inactivation. All the inactivated 
glucose oxidase samples in the microfluidic system presented a significantly decreased activity. 
Some of the inactivated catalase samples recovered the initial activity, but for the longer 
exposure time and higher temperatures reduced or no activity was measured and aggregate 
formation was observed. Final enzyme activity obtained for the samples after inactivation 
conditions with flow in the developed platform was lower than in the ThermoMixer but protein 
aggregation was observed in both cases. The higher observed loss of activity for the enzymes 
inactivated under flow conditions may indicate an effective heat transfer to the fluid under 
dynamic conditions. The presented thermal inactivation unit can easily be integrated in 
modular microfluidic platforms and be a useful addition for enzyme characterization and 
screening. 
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5.1 Introduction 
The effect of temperature on biological systems, from enzyme behaviour to cell growth rate 
and food quality, is an extensively studied effect. Temperature has thus been established as a 
relevant process parameter and the study of its effect is part of the standard optimization 
procedure in current processes.  
The influence of temperature, like other operation parameters, is studied in order to obtain 
the threshold value at which a certain enzyme or organism operates at the maximum rate. This 
value depends on the type of enzyme and its stability, but can be further constrained when other 
operation variables (e.g. pH, ionic strength, solvent used) are considered. An enzyme 
temperature range (thermophilic, mesophilic or psychrophilic) is usually a good indication of its 
structural robustness and how well it will perform under industrial process conditions. Enzyme 
temperature persistence or resistance to denaturation, for example, has provided good insight 
into the structural factors leading to increased enzymatic stability. Stable enzymes display a 
reduced surface area to volume ratio, less cavities, a reduced number of labile amino acids, a 
more rigid secondary structure, an increased hydrophobic interaction and changes in the 
solvent-exposed surfaces [338]. Genetic and evolutionary engineering of organisms and enzymes 
has led to high temperature resistant strains and proteins able to operate at high rates in a 
wider range of conditions or at previously unfavourable conditions.  
Temperature has also extensively been used to inactivate or deactivate enzymes and 
organisms, either to stop a certain reaction (e.g. avoid enzymatic degradation in cells or tissue 
samples [339]), perform protein conformational studies, inactivate pathogens in infectious 
samples (through protein denaturation [339]), or to ensure absence of microbial growth [340] or 
degradation of food [341]. 
5.1.1 Mechanisms for enzymatic inactivation 
The study of enzyme inactivation is the analysis of enzyme stability at different operation 
or reaction conditions. Enzyme stability depends, among other factors, on enzyme mobility and 
folding mechanisms which can vary widely, from natively unfolded proteins that fold upon 
binding of a ligand, to the existence of several stable and active native conformations for the 
same enzyme depending on the environment [342]. Enzymes tend to fold in conformations which 
are the most thermodynamically stable at the environmental conditions. The folding process 
and the lowest-energy conformation depend on the amino-acid sequence, which in turn encodes 
for an energy “landscape” where few interactions between residues allow the low energy 
structure, so folding can be performed rapidly [343]. However, for most enzymes, the native 
active state is only -5 to -10 kcal/mol more stable than the denatured state, due to the latter 
higher conformational entropy (conformational freedom) [344]. The denaturing process can 
occur through the formation of transient intermediate conformations, between the native and 
the denatured state [344]. In this work, the term enzymatic inactivation is used to refer to the 
reversible or irreversible loss of functional activity of proteins. The term enzymatic denaturation 
will be applied when there is inactivation of an enzyme due to an alteration of its conformation, 
as stated in Mozhaev and Martinek (1982) [345]. When there is irreversible loss of enzymatic 
functional activity (meaning irreversible enzyme inactivation), the term enzymatic deactivation 
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will be used. Enzymatic denaturation, or its tendency to reversibly unfold is related to its 
thermodynamic stability, while deactivation depends on the enzyme’s kinetic or long-term 
stability [346]. 
Enzyme inactivation can occur through several mechanisms (e.g. protein aggregation, 
formation/rupture of disulfide bonds, deamidation of asparagine and glutamine residues, 
disruption of the polypeptide chain, dissociation of a prosthetic group from the active site or 
subunit dissociation [344], [345]) that result in loss of conformational structure (denaturation) 
and functional activity (inactivation) [345]. Inactivation due to aggregate formation tends to 
occur in two steps, where first conformational changes occur that lead to protein denaturation, 
and then the denatured proteins aggregate through non-covalent interactions, such as hydrogen 
bonds and hydrophobic interactions. Aggregation decreases with the decrease of available 
denatured enzyme. Aggregation of enzymes in the native state may also occur, without loss of 
activity upon dissolution [345]. Aggregation or misfolding upon renaturation (process of 
regaining enzyme activity following denaturation), generate a high degree of deactivated 
enzymes and is a common process of denaturation since these conformations are kinetically 
favoured. Enzymes can also lose activity when intermolecular disulfide bonds are formed (from 
exposed thiol groups) or destroyed (due to β-elimination of cysteine residues), phenomena which 
increase with increasing enzyme concentrations and also result in aggregate formation. Loss of 
activity through disulfide bond formation or rupture usually occurs in three steps, where thiol-
disulfide exchange (formation of intra-molecular bonds) occurs after non-covalent aggregates 
are formed. Exchange of disulfide bonds is more likely to occur at higher pH, and can also occur, 
especially the destruction of disulfide bonds, without aggregate formation. Among other 
covalent processes that contribute to irreversible denaturation are the chemical modification of 
functional groups (e.g. oxidation of cysteine or methionine residues), deamidation of asparagine 
and glutamine residues (loss of activity due to extra negative charges in the inner zone of the 
enzyme) or disruption of the polypeptide chain (which tends to occur on the denatured enzyme 
only at very harsh conditions or in the presence of proteolytic enzymes) [344], [345].  
The denaturing processes described above can be caused or initiated through a variety of 
process conditions or solvents. Thermal inactivation occurs due to the increase of entropy with 
temperature (which favours the denatured state) more than the increase of enthalpy (which 
favours the native state) according to the Gibbs free energy equation [344]. The rate of enzyme 
inactivation and denaturation is usually higher at higher temperatures, since collision between 
molecules, as well as surface exposure to interactions, is increased [345]. Guanidinium chloride 
and urea cause denaturation by increasing the solubility of the hydrophobic lateral chains, 
increasing the exposition of the hydrophobic groups to the solvent used [344]. These compounds 
are used in the quantification of the thermodynamic parameters of the denaturing process, since 
their effect is reversible. Denaturation with pH occurs by titration of the ionizable amino-acids, 
which might break stabilizing or create destabilizing electrostatic interactions, and so the pH 
value at which an enzyme denatures is greatly dependent on the enzymatic polypeptide chain. 
Studies on enzymatic denaturation by pH are usual performed at low pH values (where e.g. 
carboxylic groups lose their negative charge), since denaturation at higher pH can lead to 
deactivation (due to the exchange of thiol-sulfide groups described above) [344]. Other 
denaturing agents, less commonly used in the laboratory, are pressure, surface tension, 
ultrasound and water removal [344]. 
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Denaturing conditions and/or agents, such as temperature, extreme pH, guanidine 
hydrochloride (GdnHCl) or urea, can also be used to renature an enzyme by acting on the 
structure of the non-native conformation. Reactivation of enzymes from aggregates can 
sometimes be achieved by exposing the enzymes to denaturing agents, since these can break the 
non-covalent bonds formed during aggregation [345]. Renaturation after exposure to denaturing 
agents such as guanidine hydrochloride (GdnHCl) or urea can be achieved, even in the presence 
of high concentrations of these compounds, also due to the persistence of interactions of long-
range order in denatured conformations [347], [348]. In case of subunit dissociation, reactivation 
can also be achieved but is less straightforward [345].  
Denaturation is considered irreversible (deactivation) when the protein cannot regain its 
original functional activity when a sufficiently long period of time has passed since the 
denaturing effect was removed [345]. In the case of thermal inactivation, deactivation occurs if 
upon cooling the enzyme does not recover its functional activity [344].  
5.1.1.1 Study of enzymatic inactivation 
The evaluation and study of enzymatic stability, performed through the analysis of 
enzymatic denaturing mechanisms, can be achieved with a variety of methods. The most 
commonly used are UV spectroscopy, fluorescent emission and circular dichroism. 
In UV spectroscopy, the absorption of aromatic amino acids such as tyrosine and 
tryptophan (which are usually placed in an inner zone of the native enzyme) allows following 
enzyme denaturation. As the aromatic amino acids are more exposed to the water in solution 
due to denaturation, their polarity changes, causing a decrease in the absorption wavelength 
[349]. The difference in the absorption spectra of the native and the denatured enzyme presents 
peaks at 285-288 nm (tyrosine) and/or at 291-294 nm (tryptophan). The low sensitivity of this 
method can be improved by performing the denaturation above pH 9, where the exposed tyrosine 
residues are ionized thus causing an increase in absorption at 250 nm that allows the  
calculation of the degree of residue exposition [344]. UV-VIS spectroscopy can also be used for 
accurate determination of protein concentration in solution (Mach et al., Chapter 4, pp. 91 to 
114 [350]). 
Fluorescence spectroscopy presents a high sensitivity for the study of conformational 
changes of the three-dimensional structure of the enzyme, by following the photo-induced 
fluorescence emission of aromatic residues such as tryptophan (350 nm) at an excitation 
wavelength above 295 nm. Again, the denaturation process is followed by a shift in the emission 
wavelengths to longer wavelengths as the tryptophan residues become exposed to water and 
change their polarity [344]. This technique can also be applied to the study of enzyme dynamics 
and function [351], by employing labelled compounds and/ or techniques such as Förster 
resonance energy transfer (FRET) and single-molecule electron transfer [342]. 
Circular dichroism (CD) is a highly relevant and widely applied technique in the study of 
enzyme stability [349], [352], [353], [354]. This technique is based on the differential absorption 
of left and right circularly polarized radiation in a plane, by optically active chromophores (e.g. 
disulfide bonds and tryptophan) with chiral center, linked to a chiral center or in an asymmetric 
environment. CD allows to follow the denaturation of the tertiary enzymatic structure in the 
near UV (320-260 nm), as well as the enzyme’s secondary structure (e.g. α helices and β sheets) 
Micro scale reactor system development with integrated advanced sensor technology  
147 
 
in the far UV (240 -180 nm), where its intensity is proportional to the content in the secondary 
structure [344], [355]. CD can also provide information regarding co-factors (e.g. FAD) or metal-
centers (e.g. heme moiety), ligand binding and folding intermediate structure, being also used 
for screening of genetically altered enzymes [355]. CD can also be coupled with stopped-flow 
[349]  to enable studies of the kinetic processes during folding, or with an external magnetic 
field [354] to achieve more sensitive measurements. 
Other techniques used to study enzymatic inactivation are nuclear magnetic resonance 
(NMR), light scattering, hydrodynamic methods and calorimetric methods. Among the latter, 
especially differential scanning calorimetry (DSC) measures the apparent molar heat capacity 
of protein as function of temperature, thus detecting the heat exchange developed during the 
denaturing process [344], ([350]). It allows the direct calculation of the enthalpy variation 
occurring during denaturation, as well as the thermodynamic parameters involved in the 
temperature-dependent conformation change. Such analysis can only be performed to reversible 
denaturation or molecular transitions [344], ([350]). Estimations of transfer free energy 
contribution of different bonds (e.g. hydrogen and peptide bonds) can also be obtained from 
solubility measurements [356]. Infrared spectroscopy (IR) enables conformation analysis of 
enzymes in water solutions and is based on the characteristic hydrogen bond patterns of 
carbonyl and amide bonds in the polypeptide chain. It is able of distinguishing α-helixes from β-
sheets and other conformations [349], and chemical entities with covalent bonds can in principle 
be analysed through the corresponding vibrational absorption bands with IR spectroscopy 
(Middaugh et al., Chapter 6, pp. 137 to 156 [350]). Classical methods of protein folding and 
structure characterization are extensively described in Shirley et al. (1995) [350]. 
In order to study enzyme deactivation or quantify the amount of irreversibly denatured 
enzyme, a good approach is to measure its activity, since it is inversely proportional to the 
number of irreversibly denatured enzymes [344]. Enzyme activity can be measured 
spectroscopically [353] or with other analytical techniques such as MS or HPLC, by following 
consumption or production of a compound involved in the reaction, or through a secondary 
reaction involving a reaction product where a colorimetric or fluorescent compound is generated 
or consumed [218]. 
5.1.1.2 Thermal inactivation and deactivation 
Traditionally, thermal deactivation is represented as a two-state model, where 
deactivation occurs when an enzyme denatures irreversibly upon heating. In this classical 
model an enzyme’s temperature-dependent behaviour is determined based on the activation 
energy of the reaction and the thermal stability of the enzyme [357]. Thus, initially a 
temperature increase is translated into an increase in enzyme activity until above a certain 
temperature (enzyme melting temperature), after which further temperature increase results 
in enzyme denaturation and possible deactivation. However, several researchers have suggested 
the existence of an inactive intermediate state in rapid equilibrium with the native state, which 
can simultaneously deactivate through irreversible denaturation at a slower rate than the 
equilibrium [358], [347], [359], [360], [346].  
Mozhaev and Martinek (1982) [345] describe the mechanism for irreversible denaturation 
of enzymes at high temperatures as occurring by enzyme acquisition of non-native non-covalent 
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bonds that lead to a new conformation. The new state, although thermodynamically unstable, 
is kept when the temperature is reduced (e.g. to room temperature) due to conformation kinetics 
and a decreased molecular mobility of the polypeptide chains, thus preventing native state 
recovery by the enzyme. Deactivation is often represented as a first-order exponential decay but 
due to the diversity of mechanisms that can lead to deactivation [361], its mathematical 
representation can be more complex [359], [346]. Ahern and Klibanov (1988) [362] have 
described denaturation as the loss of secondary and tertiary structural order towards increased 
entropy due to random and fast cooperative intramolecular movements that occur above a 
certain temperature (which depends on the environmental conditions). Denaturation is usually 
mathematically represented as a reversible equilibrium reaction, since if no chemical 
modifications of the chain occur after unfolding, renaturation and regain of enzyme activity 
should occur once the temperature is lowered. 
Daniel et al. (2010) [357] proposed a model (Equilibrium model) describing this new 
mechanism, which was developed based on enzyme activity measurements. In this model, it 
appears that differences in the active site generate the differences between active and inactive 
states, and that the thermodynamic equilibrium model parameters do not depend on enzyme 
stability. The shift between active and reversible inactive state, seemed to involve little 
unfolding of the enzyme conformation. This is compatible to previous observations that loss of 
activity preceded loss of native conformation in thermal and chemical inactivation [347]. The 
unfolding in the active site, at higher temperatures than the equilibrium and depending on 
enzyme stability, could eventually lead to the unfolding of the overall enzyme structure and 
thus to enzymatic denaturation or even deactivation at a much slower rate. Furthermore, it 
seems that the thermodynamic parameters (equilibrium temperature and enthalpy change) 
considered in the model vary with the substrate and co-factor used for the same enzyme. [363]. 
Chen et al. (2011) have shortly afterwards suggested a transient model, where the enzyme under 
thermal inactivation can exist in three states: an active state in rapid equilibrium with a 
reversible inactive state and another reversible inactive state reached through the other 
inactive state and with a lower enthalpy [364]. 
5.1.2 Thermal inactivation strategies 
Thermal inactivation with the intent of denaturing or even deactivating proteins is widely 
used. Even though the food industry is the main user of temperature as sample stabilizer and 
inactivating technique, other fields, where the use of chemicals leads to changes in the sample 
further complicating its processing, are starting to apply it as well [365], [339]. Elevated 
temperature results in a fast and unspecific inactivation of different types of samples, and can 
be useful in view of safe handling of bio-samples, food and beverages quality control, proper 
sample analysis, treatment of waste, etc.  
Several technologies, besides conventional heating (e.g. water bath, convection oven), can 
be applied depending on type (e.g. food or waste), state (e.g. liquid or solid) or thickness of 
sample, but also operational conditions (continuous or batch).  
Conductive heating (CH) includes heating strategies, such as temperature applied 
through heat plates or the use of thermocyclers. CH is the standard method applied in 
laboratories for the study of enzyme conformation and kinetics, but it can also be accurately 
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applied to excised tissue samples with up to 7 mm thickness [366], [339]. Other strategies 
usually involve heat transfer through absorption of irradiated electromagnetic wavelengths, 
which is in general more energy efficient and faster than conventional heating. These strategies 
usually require less than 1 minute of irradiation at the same temperature used in conventional 
heating to reach an equal or higher inactivation.  
Microwave (MW) irradiation or dieletric heating enables non-contact heating of a sample 
through conversion of microwave energy (1 mm-1 wavelengths at frequencies between 300 MHz 
and 3000 GHz) absorbed by water and/or polarizable organic molecules (whose dipoles 
continuously (re)align with the applied electromagnetic field) [365]. It presents a rapid 
volumetric heating and better on/off control than conventional heating, with a characteristic 
increased temperature in the bulk relative to the sample surface. MW also presents non-thermal 
effects due to molecule polarization which might result in added breakage of hydrogen bonds 
and/or changes in the secondary and tertiary structures of proteins [365]. MW irradiation has 
been applied for inactivation of tissue samples in situ (e.g. in brain tissue) [339], sludge 
treatment [365], and sterilization (e.g. virus [367], spores [368]). Coupling of MW with other 
processing techniques has also increased its application in the food industry, thus overcoming 
some of its issues like non-uniform temperature and moisture distribution [369].  
Radio frequency-heating (RF) or capacitative dielectric heating generates heat by 
increasing molecular friction and space charge displacement when an alternating electric field 
of frequency between 1 and 300 MHz is applied [340]. RF has been investigated as a substitute 
of conventional heating strategies for solid or powdered foods for blanching and sterilization. 
The sterilization ability of RF-heating depends on several factors, such as moisture and salt 
content of the samples, as well as material density and dielectric properties [340], [370]. RF 
permits a faster heating than conductive approaches and MW of the samples with a more 
uniform temperature distribution and a higher temperature in the bulk [340]. It may also 
present similar non-thermal effects as MW heating [370]. RF is also applied in the polymer 
industry [371]. Since both MW and RF frequencies are within the communication frequency 
range, only certain frequencies for both techniques are allowed to be used [370].  
In Infrared-heating (IR), temperature is increased by changing the vibrational state of 
specific molecules or functional groups by absorption of 0.78 to 1000 µm wavelengths (range 
between visible and microwave radiation). The required radiation time to achieve inactivation 
can span from a few seconds up to 10 min. IR inactivation efficiency depends on the radiation 
spectrum that can be divided in near-infrared (NIR), mid-infrared (MIR) and far-infrared (FIR). 
The used radiation spectrum depends on the type and thickness of the target sample so 
sterilization can be achieved without alteration of sample quality. FIR is more used as a surface 
heating method, while NIR can achieve a better sample penetration [372]. Hybrid IR 
inactivation techniques have also been applied [373].  
Ohmic-heating (OH) converts alternating electrical current to internal heat through the 
resistivity of the samples, and is applied mostly in the food industry, especially to high viscosity 
samples and solid-liquid mixtures [374], [341]. OH has a high penetration depth limit (up to 25 
mm), heating the samples uniformly, unlike the previously explained strategies, but requires 
contact of the samples with the heating electrodes [341], [371]. The generated heat is thus 
dependent on the thermal conductivity of the samples and on the applied current [375]. It is 
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cheap and also compatible with a wide variety of processing formats [374], and possesses a 
better energy efficiency than other methods [371].  
Induction heating (IH) produces heat through generation of eddy currents inside a 
conductor metal, where resistance to so called Foucault currents creates joule heating (heating 
due to the passage of electric current that depends on resistance of the material). IH allows 
targeted heating in a defined area directly opposite to the coil where the current is induced 
[370]. However when the material is placed inside an electricity conducting container damage 
due to surface burning may occur [371].  
5.1.2.1 Temperature control at the microscale and available strategies 
for enzyme inactivation  
Most research laboratories use conventional convective heating, such as water bath, oil 
bath or hot plates, for applying heat or as inactivating strategies. However, these methods have 
several issues, for instance with non-uniform temperature distribution between the heating 
surface and the bulk of the sample and the time required to reach the target inactivation 
temperature. Microfluidics can solve these issues simply by decreasing the distance between 
the bulk of the sample and the heating surface. Thus, at microscale, conductive or contact 
heating is an attractive method to perform fast inactivation.  
Conductive heating at microscale can be achieved with a variety of strategies either by 
integrating heating elements directly in the platform or using external heating elements. 
Integrated heating has been achieved through the use of exothermic reactions in parallel 
microchannels in contact with the main channel [376], but also by on-channel microfabrication 
of resistors and thin-film  resistors [377], [378], [379], [380] or metal wires [376]. External 
heating elements can be hot plates, readily available in most laboratories, but lately 
thermoelectric modules (TEM) or Peltier elements have gained relevance since they enable a 
good control of the applied temperatures and are easily integrated with already existing 
electronic components. In computers and some electronic equipments, Peltier elements are 
customarily used as cooling elements to avoid overheating of the electronic parts as alternative 
or complements to fans. Peltier elements are now relatively ubiquitous in benchtop analytical 
equipment for temperature control [353] (both heating and cooling functions), but are also 
increasingly used in microfluidic applications [376], [381]. TEM systems are employed in 
applications that require a high degree of temperature control with fast switching between 
temperatures, such as on-chip polymerase chain reaction (PCR) [382], [381]. Fast switching 
between defined temperatures or creation of temperature gradients can be achieved through 
pre-heating or cooling of the fluids used in the microfluidic system [383], by placing the 
microchannel between two different Peltier elements, or using two Peltier elements at different 
temperatures separated by a defined gap [376].  
Other (non-contact) heating strategies have also been applied at the microscale, some of 
them already mentioned for industrial application. MW dielectric heating allowed higher 
thermocycling rates in PCR applications [376] as well as accelerated reactions [384] compared 
to integrated heating. This occurs due to the MW’s ability to heat the liquid bulk directly [385], 
[376], but also of heating only specific regions of the microchannel or even single droplets [386]. 
IR heating is another example of an industrially-used heating strategy that has also been 
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applied at microscale [387], [376], with greater emphasis on PCR systems [388]. RF heating for 
example, which is commonly used at industrial scale in the food industry, has been used at 
microscale to perform magnetic fluid hyperthermia (MFH) on cells [389]. MFH is a technique 
that enables cell inactivation (e.g. tumour cells) by targeted delivery of heat to cells. The cells 
are labelled with magnetic nanoparticles, which increase in temperature when subjected to an 
alternating current magnetic field (e.g. generated in copper coils  integrated in a microchip 
[389]), thus causing temperature denaturation of the target cells. The generated temperature 
increase occurs due to thermal losses while the particles align to the alternating magnetic field 
[390]. MFH has also been applied for inactivation of bacteria [391]. Heat inactivation of enzymes 
coupled to nanoparticles can also be achieved through the use of gold nanoparticles. These 
particles can create heat when hit by a laser with a wavelength similar to the particles surface 
Plasmon resonance frequency. The generated heat is localized and can be used to inactivate a 
specific enzyme in a mixture of different biomolecules, using gold nanoparticles with different 
shapes and thus different Plasmon frequency [392]. A summary of the main thermal 
characteristics of these systems are presented in Table 19. 
 
Table 19 – Summary of main thermal properties and applications of several heating strategies at the microscale. 
Heating strategy 
Heating/ 
Cooling rate 
(⁰C/s) 
Temperature 
range (⁰C) 
Response 
time 
Application 
(Thin-film) resistors 5 - 20 25 - 110 
1 s - 3 min 
PCR [393], [378], [379], lab-on-a-
disc [380], protein synthesis [377] 
Thermoelectric 
modules (TEM) 
20 - 100 -3 - 120 
PCR [393], [382], [381], thermal 
management [394] 
Microwave (MW) 
heating 
5 - 30000 25 - 95 ms - s 
PCR [376], Hydrogel 
polymerization [386], Flow 
chemistry/drug discovery [384] 
Infrared (IR) heating 10 - 65 25 - 95 ms - s 
PCR [387], [393], [388], Enzyme 
inactivation [392] 
Radio-frequency (RF) 
heating 
- 25 - 100 - 
MHF [389], inactivation of 
bacteria [391] 
5.1.3 Goal 
The microfluidic system presented in this work was developed as an intermediary step in 
a modular microfluidic platform. This type of platforms, based on the “plug-and-play” approach, 
enable the connection of independently developed microfluidic units, which can be combined or 
arranged differently depending on the application, type of sample or reaction [40], [41], [42], 
[43], [44], [45]. 
To obtain a reliable result from enzymatic reactions, it is necessary for the samples to be 
quantified immediately or at a well-defined reaction time point (residence time). The 
quantification of reaction components under flow conditions (as part of a continuous operation 
platform) requires a comprehensive characterization of the microreactor so that samples can be 
compared at different reaction times. However, in a modular platform, where the reactor and 
operation units can be changed, it is essential that the samples reach the quantitative system 
or sensor in the same conditions. Enzymatic reactions can be stopped through addition of 
reagents that inactivate the enzyme or through compounds that block the active site, but this 
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may interfere with the operation of the sensor used for the quantification (e.g. addition of NaOH, 
as in Chapter 2, or HCl for pH change and enzyme denaturation can destroy the biosensing 
layer of electrochemical-based sensors, such as the ones presented in Chapter 4). 
The presented microfluidic platform intends to address the latter issue by providing an 
alternate inactivation strategy: temperature-based inactivation of enzymes. The control of the 
temperature, as stated above, allows an unspecific inactivation of both enzymes and cells, thus 
simplifying the inactivation procedure while allowing flexibility in terms of application, as 
required in modular microfluidic platforms. It also enables achieving reversible or irreversible 
inactivation of the involved proteins depending on the chosen operation conditions, offering a 
further degree of control on the enzyme state during operation. The use of temperature further 
avoids the application of solvents or other inactivating agents, simplifying the procedure. 
Temperature is also used in different research fields, and so its integration in a modular 
platform increases the platform’s applicability in different technical applications. The developed 
platform’s inactivation ability was compared with the standard laboratory method in order to 
prove its usefulness as part of an enzymatic screening platform. 
This platform was specifically developed to allow enzyme inactivation (hence stopping the 
reaction) in the reaction mixture coming from the silicon meander channel (presented in 
Chapter 2), so glucose quantification could be performed in the chip for electrochemical sensor 
integration (presented in Chapter 4). Due to time constrains, however, the final integration of 
all the platforms presented was not possible. 
5.2 Materials & Methods 
In this work, a new microfluidic platform for thermal inactivation of enzymes was 
fabricated and its inactivation ability compared with the standard laboratory procedure, a table 
top orbital heating device. The required time to achieve the desired inactivation temperature 
was also simulated using computational fluid dynamics as a complement in the study of the 
inactivation ability of the two used strategies. In this section, a description of the different 
performed studies and materials used during this work is presented. 
5.2.1 Reagents and Materials 
Glucose oxidase (EC 1.1.3.4, type VII, from Aspergillus niger, ≥100,000 U/g solid), catalase 
(EC 232-577-1, from bovine liver, lyophilized powder, 2000-5000 units/mg protein) and 
horseradish peroxidase (EC 1.11.1.7, lyophilized, 150 U/mg) were obtained from Sigma (St. 
Louis, MO, USA). D- Glucose (anhydrous) was provided by Fluka (Loughborough, UK). Mono – 
and di-potassium hydrogen phosphate (anhydrous) were obtained from Merck (Darmstadt, 
Germany). Hydrogen peroxide (PerdrogenTM, 30% (w/w)), Sodium 3,5-dichloro-2-hydroxy-
benzenesulfonate (DCHBS) and 4 Aminoantipyrine (4-AAP, reagent grade) were obtained from 
Sigma (St. Louis, MO, USA). All the solutions for sensor preparation were prepared with 50 mM 
phosphate buffer pH 7.5. All solutions were prepared in buffer. 
The 10-mm marlon polycarbonate plate that forms the channel was from Brett Martin 
(Newtownabbey, UK). The 2-mm thick SS304 stainless steel bottom plate of the channel, as well 
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as the structural components of the platform were from Sanistål (Aalborg, Denmark). The 
polycarbonate and steel parts were milled using an ecoMill 50 from DMG mori (Bielefeld, 
Germany). The adhesive assembly of the platform was performed with a 142 µm thick double-
sided adhesive tape mcs-foil 008 from microfluidic ChipShop (Jena, Germany), previously 
patterned using laser ablation with a CMA-4030 Laser Engraving machine from GD Han’s 
Yueming Laser Technology co., Ltd (Guangdong, China). Flangeless polypropylene (PP) 
fingertight 1.5875 mm (ID) fittings (XP-201) and flangeless ferrules (P200X) from Upchurch 
Scientific® (Washington, USA) were used to connect polytetrafluoroethylene (PTFE) 1.5875 mm 
(OD) x 1mm (ID) tubing (S 1810-12) from Bohlender (Grünsfeld, Germany). 
5.2.2 Enzyme activity measurements 
Activity measurements of Glucose oxidase (GOx) and Catalase (Cat) were performed in a 
UV-1800 UV-Vis spectrophotometer with a CPS 240A cell positioner from Shimadzu (Kyoto, 
Japan). GOx activity was measured using a protocol adapted from Heuts et al. (2007) [218], 
where the hydrogen peroxide formed in the presence of glucose, is used by horseradish 
peroxidase (HRP,  4 U/mL) to oxidize 4-AAP (0.1 mM) and DCHBS (1 mM), forming a 
colorimetric (pink) compound. The formation of this compound can be followed at 515 nm (ε515= 
26 mM-1 cm -1) and its absorbance can be directly related to the amount of glucose consumed. To 
measure GOx activity 10 µL of 1:30 diluted GOx solution (~30 U/mL) were added to 990 µL of 
the reaction mixture. For the inactivation study, the initial rates of glucose consumption/ 
colorimetric compound formation were compared for a glucose concentration (400 mM) equal to 
around 10 times the measured KM (~30 mM). The influence of temperature on HRP was also 
attained by performing the previous assay with addition of 20 µL of HRP to 980 µL of a constant 
concentration of hydrogen peroxide (2 mM), 4-AAP (0.1 mM) and DCHBS (1 mM) at different 
temperatures (298 K (25 ⁰C), 310 K (37 ⁰C), 318 K (45 ⁰C), 328 K (55 ⁰C) and 333K (60⁰C)). An 
increase in activity of around 8-fold was observed, between the lowest and the highest 
temperature. Concentration of hydrogen peroxide was chosen based on data presented in 
BRENDA [395] for HRP from Armoracia rusticana. The activity of Cat (~400 U/mL) was 
measured based on the protocols by Beers and Sizer (1952) [219] and Lück (1965) [220], by 
following the decrease of hydrogen peroxide concentration at 240 nm (ε240= 43.6 M-1 cm -1). To 
measure Cat activity 30 µL of 1:10 diluted catalase solution was added to 2970 µL of 10 mM 
hydrogen peroxide. Each spectrophotometric measurement was performed in triplicate for 2 
min. 
5.2.3 High-Performance Liquid Chromatography (HPLC) method  
All the reaction samples were analysed in an HPLC for quantification of glucose consumed 
and gluconic acid produced. The measurement was performed with a reversed-phase 
chromatography on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA) equipped with a 
Phenomenex column with 5-µm sized amine particles (Luna 5u NH2 100A), operated at 40 ⁰C 
and 140 bar. The mobile phase consisted of a 20 mM H3PO4 solution, flowing at 1 mL/min. The 
eluted gluconic acid was quantified in a ultraviolet (UV) multiple wavelength detector at 205 
nm, while the glucose concentration was determined in the Refract Max 520 refractive index 
(RI) detector. The amount of each component was obtained by integration of the areas under the 
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corresponding peaks using the HPLC commercial analytical software (Chromeleon 6.8), based 
on a calibration curve performed for each component.  
5.2.4 Thermal inactivation platform 
 The microfluidic thermal inactivation platform has several components, as shown in 
Figure 58. The microfluidic channel was micromillled in a polycarbonate plate with a meander 
shape with 150 µm deep and 790 µm wide, as well as a pocket for a temperature sensor (Figure 
59 (a)). The microchannel has two main inlets and two side inlets, which provide a wider range 
of residence times. The channel formed by the main inlets will be referred as main channel (with 
a length of 325 mm), while the channel formed by the side inlets will be referred to as secondary 
channel (with a length of 87 mm). The polycarbonate plate was glued onto a thin stainless-steel 
plate with a patterned 142 µm thick double sided adhesive type, giving the channel an overall 
height of 292 µm. A PT 1000 temperature sensor (Platinum Thin Film PTFM102A1A0 from 
Measurement Specialties (Europe) Ltd., Dortmund, Germany) was placed in contact with the 
steel plate and connected to a controller (Laird PR-59 Advanced Temperature Controller from 
Supercool AB, Stromstad, Sweden) which was operated from a personal computer (PC). The 
controller had a EOS LFWLP350-1005 power supply (from EOS, Andheri, Mumbai, India). The 
steel plate was fabricated with a bended shape on the sides and a metal separation in the middle 
in order to allow a good positioning of the thermoelectric modules (Peltier elements from 
Multicomp by Newark element14, Chicago, Illinois, USA), as can be seen in Figure 58. The 
Peltier elements have a dimension of 40 mm x 40 mm x 3.45 mm and a maximum of temperature 
differential of 70 K/ ⁰C during cooling, and can be controlled with the software (SC_Interface) 
provided with the controller. Before assembly the Peltier elements were covered with a thin 
layer of a heat transfer paste (HTS Silicone Heat Transfer compound from Electrolube, 
Leicestershire, UK). To facilitate the cooling of the cool side of the Peltier elements during 
operation, a heat-sink and a fan were connected to the microchannel assembly. The assembled 
Peltier elements were placed on the heat sink structure, which was milled in order to have the 
shape of the Peltier elements and enable a good fit of the microchannel assembly onto the heat-
sink (60mmx40mmx10mm, 153AB from ABL Aluminum Components, Birmingham, UK). The 
fan (614 NGL DC axial fan from Ebm-papst Inc., Farmington, Connecticut, USA) was assembled 
underneath the heat-sink and connected to the controller. Four metal pillars attached to the 
heat-sink provided stability to the assembled platform, while enabling some space between the 
fan and the support of the platform. The connection of the different electronic components was 
performed in-house, and installed inside a 30 cmx 30 cm x 10 mm plastic box. 
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Figure 58 – Schematics and photograph of the assembled microfluidic platform for thermal inactivation of enzymes, 
with the different components highlighted. In the photograph emphasized with blue dots the inlet and outlet of the 
main channel, while in green the inlet and outlet of the secondary channel are indicated. 
 
 
Figure 59 – Schematics of the polycarbonate plate with engraved microfluidic channel (a) where the primary (in 
blue) and secondary (in green) inlets are highlighted, and schematics of the microfluidic channel used in the CFD 
simulations (b), where flow direction, position of the microchannel and heating are highlighted. 
5.2.4.1 Characterization of thermal performance of the inactivation 
platform 
To understand how the thermal inactivation platform behaved at the different 
temperatures, the performance of the controller and the temperature sensor were tested.  
Different controller parameters were tested in order to minimize temperature overshoot 
when the heating function was started (with platform at 298 K (25 ⁰C) to reach the different 
inactivation temperatures), as well as temperature variability during operation. The best 
performance was obtained with a proportional-integral (PI) type of control, set with the 
parameters shown in Table 20. A temperature overshoot of 6 to 16 K/⁰C was obtained when 
heating was initiated. The temperature varied between +/- 0.05 K/⁰C and +/- 2.5 K/⁰C around 
the set point temperature during operation. The highest variability was observed for 
temperatures between 318 K (45 ⁰C) and 338 K (65 ⁰C), while the lowest variability and 
overshoot was observed for 298 K (25 ⁰C), 310 K (37 ⁰C) and 353 K (80 ⁰C). The action of the fan 
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did not seem to yield a significant effect during operation, so the presented experiments were 
performed with the fan turned off. 
Table 20 – Optimized controller parameters used during the experiments. 
Controller parameters Value 
Max power out 30% 
Dead-band 3% 
Heating Gain 1 
Cooling gain 0 
Decay when stopped 0.1 
KP (proportional constant value) 5 
KI (integral constant value) 0.5 
Integral value limit 100% 
KTr (lowpass filter to limit speed of change of a set point) 2 
KTe (lowpass filter of the difference between the temperature 
sensor and the set point) 
3 
5.2.5 Thermal inactivation measurements 
 The study of the enzymatic inactivation ability of the assembled microfluidic platform was 
performed for each enzyme separately, by pumping the enzyme solution inside the channel at 
different flowrates to achieve the desired residence times and temperatures, as presented in 
Figure 60. The used residence times and temperatures are shown in Table 21. Before 
introduction of the enzyme solution, the channel was heated to the desired inactivation 
temperature, and flushed with enzyme solution (Reynolds number of 2.05) for a minimum of 6 
times the channel volume before sampling was performed. The enzyme solution was then 
retrieved at the outlet, appropriately diluted (1:30 in the case of GOx and 1:10 in the case of 
Cat) and measured in the spectrophotometer with the previously described protocol (section 
2.2). GOx solutions were also added to a vial with 200 mM glucose solution in a 1:1 proportion, 
and glucose concentration was measured after 1 day and 2 days respectively in a high-
performance liquid chromatograph (HPLC) Dionex UltiMate 3000 UHPLC system with diode 
array and refractive index detector (from Thermo Fisher Scientific, Waltham, Massachusetts, 
USA). HPLC data was used to check whether inactivation or denaturation occurred in the 
platform. In the case of Cat, the same solutions at the outlet of the microchannel were measured 
after 1 day in the UV/VIS spectrophotometer and hydrogen peroxide consumption compared to 
the one of freshly inactivated enzyme. The samples of both enzymes were kept at room 
temperature following inactivation. 
 
Figure 60 – Schematics of sampling in the microfluidic thermal inactivation platform. 
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Table 21 – Residence times and temperatures used for the characterization of the microfluidic thermal inactivation 
platform and comparison with the ThermoMixer. 
Channel Residence time 
(s) 
Flow rate 
(µL s-1) 
Flow velocity 
(m s-1) 
Temperature 
(K/⁰C) 
Secondary channel 
(~87 mm) 
10 2 0.0087 298/25 
20 1 0.0043 310/37 
30 0.66 0.0029 318/45 
Main channel 
(~325 mm) 
60 1.25 0.0054 328/55 
120 0.625 0.0027 338/65 
180 0.417 0.0018 353/80 
The same study of the enzymatic inactivation was performed in a table top orbital MRH11 
Heating ThermoMixer (from HCL BioTech, Bovenden, Germany), using similar enzyme 
solutions and the same temperatures and residence times as for the experiments in the 
microfluidic system. In this case, 500 µL of the enzyme solution were added to a 4-mL vial 
already at the target inactivation temperature. The consumption of glucose by the enzyme 
solutions inactivated in the ThermoMixer was also measured in the HPLC after 2 days. In both 
sets of experiments GOx solutions were freshly prepared, while Cat solutions were diluted from 
a stock solution (~1000 U/mL) every day. The activity of Cat in the stock solution was measured 
daily. The enzymes were kept in ice (around 277 K (4 ⁰C)) during the experiments and added to 
the ThermoMixer and to the channel only when these were already heated at the inactivation 
temperature being tested.  
5.2.6 Characterization of thermal inactivation platforms with CFD 
Microchannel and 4-mL vial geometries were designed in SolidWorks 2015 (Dassault 
Systèmes SolidWorks Corporation, Waltham, Massachusetts, USA). The time required to 
achieve the final inactivation temperature (353 K (80 ⁰C)) from room temperature (298 K (25 
⁰C)) was simulated using a computational fluid dynamic simulation software, ANSYS-CFX 
Version 16.2 (Canonsburg, Pennsylvania, USA). The three-dimensional designs of the 
microchannel (Figure 59 (a)) and 4-mL vial (Figure 61 (a)) were imported into a meshing 
software, ANSYS ICEM CFD® 16.0 (Canonsburg, Pennsylvania, USA), and discretization of the 
geometry into smaller elements (where the equations for momentum, energy and mass balance 
[396], [397] are solved by ANSYS-CFX software) was performed. The geometry of the 4-mL vial 
was simplified to a slice of 1.24% of the entire volume, defined based on an axial geometry where 
the slice corresponds to the volume of 5⁰ of the cylinder vial perimeter (Figure 61 (b)). The slice 
defined contained 11284 elements (107.5 elements/ µL). The microchannel geometry was 
simplified to a straight rectangular 30 cm long channel with 1/4 of channel width with steel 
underneath and a 5-mm polycarbonate plate on top (Figure 59 (b)) containing 72144 elements 
(2312.3 elements/ µL). Both designs were simulated with a structured hexahedron mesh, 
assuming that the structures and the environment were at 298 K (25 ⁰C). In order to simulate 
the whole structure, symmetry was assumed on both sides of both the slice (axial symmetry) 
and microchannel design. When symmetry is used, the conditions on the areas beyond the 
simulated volume are a reflection of the simulated conditions. The use of symmetry reduces the 
computational time required for the simulation [397]. The fluids were simulated according to 
the Navier-Stokes equation for Newtonian fluids [398] under laminar flow conditions, which 
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was solved coupled with the energy balance [399] using the Thermal Energy model integrated 
in ANSYS-CFX.  
 
Figure 61 – Schematics of 4-mL vial designed in SolidWorks with the slice used for CFD simulations shown (a) and 
simulated slice of 4-mL vial with different parts and heating highlighted (b). 
 
The vial was considered to be made of glass flint, with a height of 9 mm corresponding to 
the liquid (defined as water) and the rest was filled with air. The three phases, solid (glass), 
liquid (fluid) and gas (air), were defined as separate parts in the geometry with a conservative 
interface flux condition, where only temperature is conducted into between the solid and the 
liquid phase. In both the liquid and the air phase, two fluids were defined: water with a density 
of 997 Kg m-3 and air with a density of 1225 Kg m-3. In the air phase, air had an initial volume 
fraction of 1 and water of 0, while in the liquid phase, the opposite was set. Both fluids were 
defined as buoyant with 9.81 m s-2 as the gravitational acceleration towards the bottom of the 
vial. The heat was defined as coming only from the glass outer walls (bottom and side of the 
vial) as presented in Figure 61 (b). The portion of liquid on the bottom was at 277 K (4 ⁰C) at 
the start of the simulation, while the air above it was at room temperature (298 K (25 ⁰C)). A 
homogeneous Thermal energy model was used to perform the glass vial simulations, in which 
the volume fractions of the fluids were defined as coupled. 
The microchannel (Figure 59 (b)) was filled with liquid under laminar flow with a velocity 
of 0.025 m s-1 (Re 5.60), 0.0025 m s-1 (Re 0.56) or 0.0018 m s-1 (Re 0.40), and the heat was defined 
as coming from the bottom of the channel as in Figure 59 (b). All the materials were simulated 
considering the materials’ properties provided by ANSYS-CFX at 298 K (25 ⁰C), and the liquid 
was defined as water. The polycarbonate plate was simulated as polystyrene with a specific heat 
capacity of 1426 J Kg-1 K-1. The walls (top and bottom of channel) were defined as having no-slip 
wall boundary conditions, and the outlet was defined as an opening. The simulations were 
performed transient in order to obtain the time required for both the liquid and the entire 
system to reach the target inactivation temperatures.  
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5.3 Results and Discussion 
The thermal inactivation platform was characterized using two well-known and relatively 
robust commercially available enzymes, Glucose oxidase (GOx) and catalase (Cat), which have 
been extensively studied and improved. A brief look in BRENDA [400] shows the immense 
diversity of these enzymes, especially GOx, in terms of origin (from bacteria and fungi to human 
and other mammals), substrate and catalytic properties. Both enzymes are relatively stable and 
present enzymatic activity in a wide range of temperatures (293 K (20 ⁰C) to 333 K (60 ⁰C) for 
GOx and 303 K (30 ⁰C) to 333 K (60 ⁰C) for Cat), thus providing a good case study to test the 
efficiency and applicability of the developed inactivation platform.  
The platform’s performance was compared with the standard laboratory procedure used 
to achieve thermal enzyme denaturation, a benchtop ThermoMixer. The temperatures and 
residence times presented in Table 21 were used in both platforms. 
5.3.1 Characterization of heating performance with CFD 
A simplified geometry of both systems used to achieve enzymatic thermal denaturation of 
GOx and Cat was characterized in terms of time required to reach the target temperature using 
computational fluid dynamics. Three of the target inactivation temperatures, 298 K (25 ⁰C), 318 
K (45 ⁰C) and 353 K (80 ⁰C), were chosen for comparison of heating performance in the two 
simulated inactivation systems. 
 
Figure 62 shows the results for the simulated slice of the 4-mL vial, when the glass is pre-
heated at 353 K (80 ⁰C) (Figure 62 (a)) or at room temperature (Figure 62 (b)) at the start of the 
simulation. As can be observed, the liquid inside the vial reaches 353 K (80 ⁰C) at a similar time 
in the simulation at around 160 s for both cases. The liquid reaches the desired temperature at 
similar times since the temperature gradient driving the heat transfer is the same. After 300 s 
both the liquid and the air are heated at the desired inactivation temperature, except near the 
top of the vial where there is heat loss to the environment.  
 
Figure 62 – Results from the CFD simulation of part of the 4-mL vial considering the glass was pre-heated at 353 K 
(80 ⁰C) (a) or at 298 K (25 ⁰C) (b). 
For both simulations, uniform heating of the liquid to 353 K (80 ⁰C) is achieved around 
160 s, which is shorter than the longest residence time used for enzyme inactivation in this 
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study, but longer than most of the inactivation times tested. This indicates that the enzyme 
solutions inactivated in the ThermoMixer were not uniformly exposed to the same temperature 
for the shorter inactivation times and so a higher variability might be expected from these 
samples, since no mixing was used. This is also demonstrated in Figure 63 where the 
temperature contour plots of the liquid, air and glass at the same residence times used in the 
experiments is shown. Only part of the liquid is first heated at the target temperature after 120 
s of exposure to 353 K (80 ⁰C) in Figure 63 (a). 
 
Figure 63 - Results from the CFD simulation of part of the 4-mL vial considering the glass was pre-heated at 353 K 
(80 ⁰C) (a), at 318 K (45 ⁰C) (b) and at 298 K (25 ⁰C) (c) for the different residence times used. 
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According to Figure 63 (b) and (c), for 318 K (45 ⁰C) and 298 K (25 ⁰C) respectively, the 
liquid achieves the target temperature earlier than for 353 K (80 ⁰C). The target temperatures 
are achieved between 60 s and 120 s after sample heating is initiated and thus variability for 
the corresponding samples at residence times above 120 s should be very small. Comparing 
heating times for Figure 63 (a), (b) and (c), the lower the target temperature, the shorter the 
time required to reach the desired temperature.  
Figure 64 and Figure 65 present the temperature distribution for the different inactivation 
times across an axial and a vertical line, respectively, drawn in the simulated vial geometry. In 
the figures, the target temperature is reached for all the inactivation temperatures at 180 s. 
This seems to contradict the previous conclusions that a lower target temperature results in a 
lower heating time. However, the presented graphs show a one-dimensional representation of 
the temperature gradient at a defined position in the vial and thus cannot represent the amount 
of fluid volume at the target temperature, which is better observed in Figure 63.  
 
Figure 64 - Results from the temperature distribution along an axial line for the CFD simulation of part of the 4-
mL vial considering the glass was pre-heated at 353 K (80 ⁰C) (a), at 318 K (45 ⁰C) (b) and at 298 K (25 ⁰C) (c) for the 
different residence times used. 
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In Figure 65 it is also possible to observe that the air close to the fluid reaches the target 
temperature slower than the air above it, due to the lower temperature of the liquid. 
Furthermore, the air on the top of the vial, in contact with the environment, presents a constant 
temperature gradient, resultant from heat loss to the environment, which increases with the 
inactivation temperature. 
 
Figure 65 - Results from the temperature distribution along a vertical line for the CFD simulation of part of the 4-
mL vial considering the glass was pre-heated at 353 K (80 ⁰C) (a), at 318 K (45 ⁰C) (b) and at 298 K (25 ⁰C) (c) for the 
different residence times used. 
Finally, in all the presented figures, the wider the temperature difference between initial 
conditions (sample at 277 K (4 ⁰C) and air at 298 K (25 ⁰C)) and inactivation temperature (298 
K (25 ⁰C), 318 K (45 ⁰C) and 353 K (80 ⁰C)), the faster the heating rate.  This is evident in Figure 
63 (a), Figure 64 (a) and Figure 65 (a) where a temperature of 318 K (45 ⁰C) is obtained between 
30 s and 60 s, which is consistent with the higher temperature gradient and therewith a higher 
driving force for the heat transfer to occur in this case (353 K (80 ⁰C)).  
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The results from the CFD simulation for the simplified geometry of the microchannel are 
presented in Figure 66. In this geometry, we considered that the bottom of the microchannel 
(which corresponds to the steel plate) is at an initial temperature of 353 K (80 ⁰C), 318 K (45 
⁰C) or 298 K (25 ⁰C), respectively, when the enzyme solution at 277 K (4 ⁰C) is introduced in the 
microchannel with a linear velocity of 0.0018 m s-1 resulting in a Re number of 0.40.  
As can be observed for the inactivation temperature of 353 K (80 ⁰C) (Figure 66 (a)), the 
liquid flowing inside the channel reaches the desired temperature after 0.6 s. This significantly 
faster heating of the enzyme solution relative to the 4-mL vial (Figure 63) is expected, 
considering the microchannel’ s small height (292 µm) and reduced volume, which enables a fast 
heat transfer from the heat steel plate to all transported fluid.  
 
Figure 66 - Results from CFD simulation of the simplified geometry of the microchannel considering the bottom of 
the channel is heated at 353 K (80 ⁰C) (a), 318 K (45 ⁰C) (b) or 298 K (25 ⁰C) (c), and the average linear flow velocity 
is 0.0018 m s-1. 
The required time for the fluid to reach the chosen inactivation temperature decreases for 
lower temperatures, as can be observed in Figure 66 (b) and Figure 66 (c). However, as observed 
above for the 4-mL vial, the same temperatures (318 K (45 ⁰C) and 298 K (25 ⁰C)) are reached 
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earlier in the 353 K (80 ⁰C) case (at 0.3 s the fluid is already between 338 K (65 ⁰C) and 353 K 
(80 ⁰C)) than for the lower temperatures since the temperature gradient (and thus heat transfer 
rate) is higher.  
It is also relevant to highlight that the inactivation temperature is reached close to the 
start of the channel, as can be observed in the focused regions in Figure 66. This means that the 
enzyme solution is exposed to the desired inactivation temperature through the entire length of 
the microchannel, and thus that the residence times considered during the experiment are close 
to the real ones. The distance from the inlet at which the entire volume of transported solution 
reaches the inactivation temperature also decreases with decreasing inactivation temperatures, 
from 700 µm for the simulation at 353 K (80 ⁰C) to around 550 µm at 318 K (45 ⁰C) and 0 µm at 
298 K (25 ⁰C). In all the simulations, at 0.3 s the temperature around the channel (in the 
polycarbonate plate) is lower than room temperature (298 K (25 ⁰C)) due to the fluid introduced 
being at 277 K (4 ⁰C), but quickly stabilizes to the target temperature. This is more evident in 
the simulation at 298 K (25 ⁰C), since the inactivation temperature is equal to room 
temperature. 
 
To enable the comparison with laboratory enzyme inactivation experiments performed in 
the microchannel, CFD simulations at 353 K (80 ⁰C) were performed at different average linear 
flow velocities varying between 0.0018 m s-1 and 0.025 m s-1, to include the range of velocities 
used in the laboratorial experiments (see Table 21). The temperature of 353 K (80 ⁰C) resulted 
previously in the longest distance from the inlet at which the fluid reached the target 
temperature for the three temperatures simulated. This allows a more comprehensive 
understanding of the influence of average linear flow velocity on such distance, and thus its 
influence on residence time. No significant difference was observed in the overall temperature 
distribution or the times at which the set point temperature was reached between the different 
velocities. However, the distance from the inlet at which the whole liquid reaches 353 K (80 ⁰C) 
increases with an increase in flow velocity, since there is less time due to the fluid’s higher 
velocity for the heat to diffuse across the height of the channel to the solution, as well as some 
transport of the thermal energy in the direction of the flow (Figure 67). At the lowest simulated 
velocity this distance is 700 µm, while at the highest simulated velocity the distance is close to 
8 mm. For the maximum experimental velocity (0.0087 m s-1) this distance is below 3 mm, which 
is around 1/30 of the length of channel used (87 mm), and thus its influence in the final used 
residence time was not considered for the performed experiments. 
The presented simulations provide sufficient confidence that the enzyme solution will be 
uniformly exposed to the inactivation temperature along the entire length of the channel (and 
close to the assumed residence time).  
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Figure 67 - Results from CFD simulation of the simplified geometry of the microchannel considering the bottom of 
the channel is heated at 353 K (80 ⁰C) for different flow velocities. 
In all the simulations, after 10 min the distribution of temperature in the microchannel is 
approximately the same as the one observed after 1 h, with the temperature at the top of the 
polycarbonate plate at 298 K (25 ⁰C). During the experiments however, after approximately 10 
to 15 min the top of the polycarbonate plate was hot to the touch, indicating a temperature 
above at least 313 K (40 ⁰C). This discrepancy could come from the polycarbonate properties 
(namely the specific heat capacity of 1426 J Kg-1 K-1) assumed during the simulation, which 
could differ from the ones of the polycarbonate used for the microfluidic plate. The temperature 
during the experiments may also be higher than the simulated ones. However, since the heat 
provided by the Peltier elements is regulated based on the temperature measured by the PT 
1000 sensor, and this sensor is placed close to the channel, this is not expected to be the case. 
In the simulations, the area surrounding the channel forming most of the platform, as well as 
the possible influence of the double adhesive tape between the steel and the polycarbonate plate 
were not considered. These factors might also affect how heat dissipates from the platform, thus 
influencing the temperature reached on the outside of the platform.  
Nonetheless, since the focus of the CFD simulation was to understand the heat transfer 
to the enzymatic solution flowing inside the channel, which was possible to visualize in the 
performed simulations, the simulation was considered to have yielded enough understanding of 
the heating properties of both inactivation strategies to be able to trust in the design of the 
microfluidic system developed. 
5.3.2 Characterization of inactivation performance  
The results from the spectrophotometric measurements performed after the enzyme 
solutions where pumped through the microfluidic channel at various residence times and 
inactivation temperatures are presented in Figure 68, both for glucose oxidase and catalase. 
The presented values have a standard deviation between 3.87x10-9 M min-1 and 8.66x10-7 M 
min-1 for GOx and 2.90x10-6 M min-1 and 1.29x10-4 M min-1 for Cat. 
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Both enzymes display a similar inactivation trend. At 338 K (65 ⁰C) or higher 
temperatures, a significant decrease in product formation/ hydrogen peroxide consumption is 
observed in both systems, especially for residence times higher than 60 s. In the ThermoMixer 
complete inactivation of the enzymes is observed at 353 K (80 ⁰C) for residence times of 120 and 
180 s. This is in agreement with the simulation results reported in Figure 63, where only for 
these residence times the temperature inside the vial is closer to the desired temperature. In 
the microchannel, enzyme inactivation occurs at lower temperatures than 353 K (80 ⁰C). In this 
system, at 338 K (65 ⁰C) and residence times of 120 s and 180 s almost no activity is observed. 
This is a good indication that the whole volume of the enzyme solution has been subjected to 
the same temperature for the defined residence time in the microchannel, as supported by the 
simulations.  
Both enzymes seem to behave similarly in terms of inactivation at the used temperatures, 
although a faster inactivation of catalase was to be expected since it is known for being the less 
stable of the two enzymes [401]. GOx inactivation is known to occur through loss of its co-factor 
(FAD), which happens around 332 K (59 ⁰C), followed by loss of conformation above 335 K (62 
⁰C) (mid-point for loss of secondary and tertiary structure, according to Gouda et al. (2003)) 
[402]. This mid-point of conformation loss may even occur at a lower temperature (328 K (55 
⁰C)) [403]. The obtained values during the experiments concur with the previous temperatures, 
since the amount of product at 338 K (65 ⁰C) is around half of the values obtained at 328 K (55 
⁰C), and a rapid decrease in activity is observed at 338 K (65 ⁰C). Catalase, such as GOx, is 
prone to denaturation for temperatures above 328 K (55 ⁰C) [404], due to a process of protein 
denaturation [405], [406] by dissociation of its subunits [401]. 
 
Figure 68- Amount of colorimetric product formation by GOx and hydrogen peroxide consumed by Cat, measured in 
the spectrophotometer immediately after inactivation in the ThermoMixer ((a) for GOx and (c) for Cat) and 
microfluidic platform ((b) for GOx and (d) for Cat). 
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The developed platform is intended for use as an intermediary step between reaction and 
quantification, and so it should guarantee that the reaction has stopped at the desired residence 
time before the measurement is performed. Since the measurements executed immediately after 
inactivation (as it would happen in the modular platform) at 353 K (80 ⁰C) show no activity for 
both enzymes, this goal has been achieved. 
5.3.3 Characterization of deactivation ability  
The developed platform could also be applied as a final step in an enzyme screening 
platform, where the inactivated enzyme or reaction mixture could be stored for later use or 
analysis. To check the stability of the inactivation, whether reversible inactivation or 
deactivation of the enzymes was achieved in the platform, the activity of the inactivated enzyme 
solutions was measured after one (Cat) and two days (GOx). The inactivated GOx solutions were 
added to a 200 mM glucose solution in a 1:1 proportion and the amount of consumed glucose 
was measured in an HPLC. The measured glucose concentrations in the HPLC for the different 
samples obtained at the selected temperatures and residence times are presented in Figure 69 
(a). Between the measurements at different times in the HPLC, the samples were kept at room 
temperature (~298 K (25 ⁰C)) stored inside the device’s sampler unit. As can be observed in 
Figure 69 (a), the samples pumped through inside the microfluidic system consumed less than 
10 mM of glucose after 1 and 2 days, while the samples inactivated in the ThermoMixer, 
consumed almost all the present glucose. This may indicate that a partial irreversible 
denaturation of GOx occurs in the microfluidic platform, while in the ThermoMixer the enzyme 
is able to return to the active state after exposure to the inactivation temperatures and used 
residence times. It is also possible to notice that the samples inactivated in the ThermoMixer at 
298 K (25 ⁰C) and 310 K (37 ⁰C), especially at the shorter residence times, present a higher 
overall variability between them. This might be related to the non-uniform distribution of 
observed temperature in the simulations performed for the 4-mL vial at the shorter residence 
times.  
In the results presented in Figure 69 (a), significant deactivation of GOx is observed for 
all the inactivation and residence times tested, even for temperatures below the temperature 
where FAD dissociation occurs (332 K (59 ⁰C), according to Gouda et al. (2003)) [402]). So, the 
observed GOx deactivation (at temperatures lower than 332 K (59 ⁰C)) may indicate that other 
phenomena, besides temperature, are involved in the loss of conformation (e.g. hydrophobic 
interactions with channel walls). On the other hand, Zoldák et al. (2004) observed that 
irreversible denaturation of GOx occurred if the enzyme solution was immediately cooled to 293 
K (20 ⁰C) upon inactivation at 328 K (55 ⁰C). Zoldák et al. (2004) also observed that dissociation 
of the co-factor and of the protein dimer occurred after the inactivation rate limiting step [403]. 
This may explain in part the observed deactivation for the temperatures below 328 K (55 ⁰C), 
but other phenomena might be involved in the extent of detected denaturation, since no 
significant difference is observed between the different inactivation temperatures tested in 
terms of glucose consumption. 
The inactivated catalase solutions were kept at room temperature overnight and 
consumption of hydrogen peroxide was measured in the spectrophotometer the following day 
(Figure 69 (b)). As shown in Figure 69 (b), the samples presented a regain of activity for samples 
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inactivated at temperatures up to 318 K (45 ⁰C), and loss or even no activity for samples 
inactivated at higher temperatures for 180 s.  
 
Figure 69 – Substrate consumed by the static and in flow inactivated enzymes (GOx (a) and Cat (b) after 1 and 2 
days. The black line represents the maximum value of glucose (a) consumed by the enzyme solutions inactivated in 
the microfluidic system. Samples of 20 s inactivation times were only measured for the higher temperatures (328 K 
(55 ⁰C), 338 K (65 ⁰C) and 353 K (80 ⁰C)) used in the microfluidic thermal inactivation platform. 
Activity of catalase pumped through the microfluidic system is lower for 338 K (65 ⁰C) and 
353 K (80 ⁰C) than the one inactivated in the ThermoMixer, since some substrate consumption 
was measured for the latter samples. The occurrence of deactivation in both systems might be 
related to the already mentioned lower stability of catalase relative to glucose oxidase, thus 
translating into a smaller difference in deactivation between the two inactivation strategies. 
Furthermore, the samples from catalase solutions from both inactivation systems formed 
agglomerates overnight, especially for the higher residence time (180 s) and inactivation 
temperatures (338 K (65 ⁰C) and 353 K (80 ⁰C)), as presented in Figure 70. Agglomeration of 
protein indicates loss of conformation due to denaturation of enzymes, and thus enzymatic 
deactivation, which is consistent with the very low substrate consumption measured for these 
conditions. Catalase deactivation associated with protein aggregation is a known phenomenon 
[407]. 
Nevertheless, for both enzymes, a decrease in enzyme activity is observed with increasing 
temperature and a significant difference in substrate consumption between the samples 
Micro scale reactor system development with integrated advanced sensor technology  
169 
 
inactivated in the ThermoMixer and in the microfluidic platform was obtained. The observed 
deactivation phenomenon seems to depend on the type of enzyme, since GOx deactivation 
occurred mainly in the microchannel at all the used temperatures (possibly due to hydrophobic 
interactions with the channel), while catalase deactivation occurs mainly due to the effect of 
temperature. However, for both enzymes, a high degree of deactivation for the duration of the 
assay was observed. 
 
Figure 70 – Photographs showing the formation of agglomerates in inactivated catalase samples after 1 day at room 
temperature for different inactivation temperatures at the longest residence time (a) and at different residence times 
at the highest inactivation temperature (b). 
The observed (partial) deactivation for both enzymes in the microfluidic system could be 
influenced by other factors such as the closer proximity of the microfluidic transported enzyme 
to the heat source (steel plate forming the bottom of the channel) and considerably faster heat 
transfer to the solution (0.6 s instead of 161 s according to the simulations). The microfluidic 
system also provides an environment with a more uniform distribution of temperature and time 
controlled exposure to the desired inactivation temperature, which might contribute to less 
variability in the measured data and a higher denaturation (resulting in a high degree of 
aggregation in the case of catalase).  Also, the presence of air/vapor bubbles in the fluid, 
especially at the higher temperatures (338 K (65 ⁰C) and 353 K (80 ⁰C)) can contribute to higher 
denaturation of the enzymes in the microfluidic channel. Proteins are sensitive to the 
interaction with air/liquid interfaces, which are known as a major cause of enzyme 
denaturation, due to exposure of hydrophobic regions and increasing protein-protein 
interactions, as well as adsorption of the proteins to the interface, which in turn may lead to 
enzyme aggregation [408], [409]. Furthermore, the platform has a layer of double sided adhesive 
tape between the steel bottom plate and the channel polycarbonate plate, thus forming part of 
the walls of the channel. During fluid flow the enzyme may have been exposed to residues of 
adhesive from this tape, which could further contribute to denaturation. However, since the two 
enzymes performed differently when pumped inside the system (aggregation in the case of 
catalase but not glucose oxidase, for example), this is probably not a significant factor. 
Deactivation at high temperatures occurs through a mix of conformational changes and 
covalent process [410]. If no covalent bonds are formed or are formed to a small extent, only 
denaturation occurs and full functional activity could be regained using one of the strategies 
previously mentioned in the introduction. In this work, no special enzyme treatment was 
applied to induce reactivation, except placing the enzyme at room temperature after the 
inactivation, since the goal was to achieve enzyme inactivation. However, the capability to 
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control both inactivation and reactivation, especially in a continuous format is very interesting 
in terms of potential applications, and could be tested using the presented platform. 
The described system may not allow heating and cooling rates as fast as some other 
technologies presented in the introduction (e.g. MW heating), but offers a simpler setup and 
easier integration with other modules. The used Peltier elements can be easily substituted if a 
wider range of temperatures is required, and together with the integrated PT 1000 sensor, 
provide a good control of the applied temperature. Integration is facilitated by using standard 
inlet finger tight connectors, but also by designing the meander channel with dimensions 
compatible with most commercial microfluidic systems. Furthermore, the inclusion of two 
channels with different lengths increases the flowrate range and thus the number of different 
inactivation times possible for the platform, further increasing its flexibility towards different 
reactor or sensing modules.  
5.3.4 Other considerations 
The specific application for which the thermal inactivation platform presented here was 
developed, was to achieve inactivation of the reaction mixture coming from the silicon meander 
channel so as to perform online quantification of glucose with the glucose electrochemical 
sensors integrated in the platform presented in Chapter 4. Due to time constraints, however, 
the final integration of all these platforms was not possible. Nonetheless, it should be 
highlighted that inactivation of both enzymes (GOx and catalase) could be achieved within the 
flowrates used in the silicon meander channel (between 0.125 and 2 µL s-1). Furthermore, the 
solutions should cool rapidly to a temperature close to room temperature, especially if dilution 
of the inlet solution would be applied, thus not significantly affecting the integrated sensors. 
However, tests with the integrated platforms would need to be performed in order to validate 
this hypothesis. In the case when cooling had not proceed at sufficient speed, due to the reaction 
being already stopped, a longer outlet tubing, connecting the thermal inactivation and the 
quantification platforms, could be used to guarantee the reaction mixtures are always at similar 
temperatures during quantification. 
5.4 Conclusion 
The presented thermal inactivation platform is capable of achieving fast inactivation of 
mesophilic enzymes, such as glucose oxidase and catalase. Inactivation is achieved in this 
system at temperatures around the mid-point of inactivation at relatively long exposure time 
(120 s at 338 K (65 ⁰C)) or at a higher temperature in a duration compatible with continuous 
inactivation of enzymes coming from a reactor module (20 s at 353 K (80 ⁰C)). Furthermore, the 
system causes partial deactivation of both enzymes towards a possibility for storage of the 
enzymes without the reaction proceeding significantly. The developed continuous thermal 
inactivation platform has an improved performance relative to the standard inactivation 
method at laboratory scale, a benchtop ThermoMixer, since inactivation is achieved faster for 
both enzymes and with a lower residual activity. The characterization of temperature 
distribution and heating efficiency of both inactivation methods by using computational fluid 
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dynamics, also showed a faster heating rate and uniform temperature distribution for the 
developed microfluidic system. The simulations also demonstrate that the introduced fluid is 
heated to the inactivation temperature within 3 mm of the channel length for all the 
experimental flow velocities. The assumed inactivation times can thus be considered as close to 
the real inactivation exposure times that the enzymes experienced.  
Control of the reactivation process could be a further advantage with this system. If a 
solution with denaturant agents is added to the enzyme upon collection at the outlet or by 
coupling with another microchannel, formation of covalent bonds and thus irreversible enzyme 
denaturation, can be avoided. The continuous enzymatic thermal inactivation system could also 
be used to perform reactions at well-controlled temperatures, allowing introduction or removal 
of reaction components through the secondary channel. The platform could be further applied 
for the characterization of enzyme activity at different temperatures, by coupling the system 
with an online sensor for a reaction product, or even a camera if a colorimetric assay is used, 
since the system is transparent. By inverting the position of the Peltier elements, in order to 
achieve temperatures below ambient temperature or even temperatures below 273 K (0 ⁰C), 
characterization of psychrophilic enzymes could be performed. On the other hand, by changing 
the Peltier elements to other thermoelectric modules with a wider temperature difference 
between the cool and the hot side, characterization of thermophilic enzymes could also be 
attained, thereby greatly extending the applicability of this module.  
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Chapter 6 
Project outcome and future perspectives 
As described in this thesis, there is an increasing need for fast, comprehensive and high-
throughput platforms for the screening and characterization of biocatalysts. Despite the 
constantly developed creative and multiplexed microfluidic approaches, the achieved high-
throughput capabilities still fall short of the required. Microfluidics can still not compete with 
the high-throughput requirements provided by microtiter plates and standard analytical 
equipment, such as HPLC and GC. Nevertheless, microfluidic systems can significantly 
accelerate the screening phase of process development by simplifying intermediary screening 
and characterization steps. 
 
This simplification can be achieved through the fabrication of generic microfluidic 
modules, which can integrate different sensing methods or accommodate a wide range of 
concentrations of the target analyte. Another approach is the use of a general sensor, e.g. oxygen 
or pH, to quickly compare different catalysts before proceeding to a more detailed 
characterization or to be used as a complement to the characterization achieved with benchtop 
analytical equipment. Furthermore, the automation and parallelization of such systems would 
allow an operator-free performance of these simplified approaches. Both strategies were 
investigated in more detail in Chapter 4 and Chapter 3, respectively. 
Acceleration of screening could be further increased through the combination of such 
simple automated quantification and monitoring chips with sorting modules, such as the ones 
described in Chapter 1. A higher amount of data could thus be gathered from the parallelized 
online monitoring, but also a collection of optimal biocatalysts would simultaneously be 
obtained. Interconnectivity between the different systems could even result in an iterative 
selection of the optimal biocatalyst or operational conditions, by (re)submitting the sorted 
optimal catalysts to a narrower set of process parameters. An example of such strategy has been 
applied in droplet-based directed evolution, as mentioned in the introduction of Chapter 3. 
Computational fluid dynamic models, similar to the one presented in Chapter 2, as well as 
mechanistic models could be linked with sensor data, thus providing in-depth understanding of 
reaction kinetics and the biocatalysts’ window of operation. 
However, such endeavor can only be achieved if standardized microfluidic designs and 
connections are offered and applied. An effort to share designs of microfluidic structures should 
be made, similar to current attempts at sharing and/or facilitating access to developed 
mathematical and mechanistic models. For the latter, this has resulted in effortless 
incorporation and application of different models, even when developed in different 
computational languages. However, unlike mathematical models, the outcome and combination 
of microfluidic designs can vary greatly with the fabrication technique, especially its resolution, 
and/or materials available. Hence, careful selection of the fabrication technology and assembly 
method has to be made in order to ease device validation and modular application. 
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In this thesis, a small contribution to such vision is presented in the form of three 
microfluidic systems with different functions: online reaction monitoring with oxygen sensors 
in a microreactor, sensor integration with in situ sample dilution in a quantification module, 
and thermal enzyme inactivation. 
 
The microreactor module was applied to two different types of biocatalysts, an enzyme in 
solution and a whole cell catalyst, demonstrating the flexibility of this microdevice in terms of 
sample material. The chosen case-studies also allowed demonstrating this microreactor’s 
applicability to different types of study performed during a bioprocess screening phase: 
characterization of reaction kinetics and operation window (Chapter 2) and comparison of a 
desired property, such as oxygen consumption rate (Chapter 3).  
The former study (Chapter 2) was performed with the help of a computational fluid 
dynamic model, demonstrating the usefulness and capabilities provided by the association of 
data acquisition with a reaction model, in terms of attaining increased knowledge on the 
reaction. The performance of this model would be significantly improved by combination with a 
mechanistic model, where different reaction mechanisms, kinetic constants, side or competitive 
reactions, deactivation models and/or thermodynamic parameters could be defined, enabling an 
iterative and automated optimization of the reaction parameters. Such a model could thus 
contribute with added insight into an unknown reaction mechanism besides the empirical 
knowledge gained from the experimental data. The use of mathematical and fluidic models can 
considerably improve the accuracy of a mechanistic model as well as enable the prediction of 
properties of a certain biocatalyst or of its behavior in the presence of a given substrate, based 
on previous empirical knowledge obtained at a different set of operational conditions and/or 
with similar biocatalysts.  
In the second case-study (Chapter 3), different biocatalysts were screened in terms of 
oxidation rate (the target property) for the same reference substrate. It would be also possible 
to apply such strategy in the microreactor system, but to the characterization of a biocatalyst 
with different and more industrially relevant substrates. This would require the use of a multi-
entry valve system (to introduce a metered volume of the different tested substrates) coupled 
with a mixing system in case the reaction dynamics are slower than the ones measured in the 
case presented in Chapter 3. Solvent resistant materials would have to be used in the valve 
system, tubing and mixer used, but the presented designs for the commercial polymeric valve 
(Chapter 2) and for the mixing/dilution unit (Chapter 4) could still be applied. 
 
The platform for sensor integration with in situ sample dilution (Chapter 4) has been 
successfully used for a long period of time (up to 12 h) with two different screen-printed 
electrochemical glucose sensors, capable of quantifying diluted glucose solutions. The chosen 
materials (PMMA and double sided adhesive tape) and fabrication method (laser ablation), 
enabled a fast prototyping cycle from design to use. New chamber sizes and geometries can thus 
be easily implemented in the microchip design, if differently sized or shaped sensors are 
required. However, the improvement of the sensing chamber design towards a slip-in/slip-off 
type of sensor port would result in a more practical device.  
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Validation of the mixing/dilution unit was performed by comparing data from the 
integrated sensors and HPLC measurements at the output. The influence of flow velocity 
inherent to this type of sensors, due to the laminar flow conditions and membrane over the 
sensing element, was taken into account considering the previously performed in-flow 
calibration curves. Quantification by these sensors can be refined by tailoring the chambers’ 
dimensions or even separating the dilution and the quantification units. The platform’s 
performance may be further improved if electrochemical sensors with direct analyte detection 
are used. In this case, by operating at higher sample dilutions (and thus high flowrates), a 
minimum diffusion layer, as well as minimal influence of flow velocity, may be achieved. The 
same can be accomplished by decreasing the height of the chambers resulting in a higher 
velocity on the sensor surface for the same applied flowrates. 
The platform presented in Chapter 4 may also serve as a microreactor module with a two-
point monitoring. The two integrated sensors could, in such case, be used to quantify the 
substrate at the inlet and at the outlet of the microreactor, providing direct product 
quantification as long as reaction stoichiometry and compound interactions are known. 
Alternatively, the first sensor could present exact substrate quantification at the inlet, while 
the second sensor would quantify the product or a side-product at the outlet. The latter strategy 
would be extremely useful for cascade systems requiring spatial separation of the reactions 
involved, and in situations where the substrate of the reaction occurring in the module is the 
product of a previous reaction. Moreover, depending on the integrated sensor and on its 
functionalization, more than one reaction compound could thus be monitored. 
Another possible application for the developed quantification/dilution platform is as an in-
flow labeling unit, by enabling a good contact between the two introduced streams, as well as 
by tailoring the provided amount of each stream. Further tests, possibly aided by the already 
developed CFD model for this mixing/dilution unit, should be performed to assess the efficiency 
of the platform as a labeling unit. 
 
The thermal inactivation platform (Chapter 5) allowed to take full advantage of the fast 
heat transfer occurring at microscale, resulting in the inactivation of two different enzymes in 
flow within 20 s at a relatively high temperature (80 ⁰C). Denaturation of part of the enzymes 
in solution was also achieved within this very short interval, suggesting that control of the type 
of inactivation, may also be possible with this system by better studying the relationship 
between exposure time and inactivation temperature, and denaturation, as well as the 
percentage of irreversibly inactivated enzymes in the process. Furthermore, if upon collection 
at the outlet or by coupling with another microchannel, a solution with denaturing agents is 
added to the enzyme, formation of the covalent bonds resulting in enzyme denaturation may be 
avoided, and a better control of inactivation reversibility be attained.  
This system may also be used to perform reactions at well-controlled temperatures, 
allowing introduction or removal of reaction components through the secondary channel. The 
platform could then be further applied to the characterization of enzyme activity at different 
temperatures, by coupling the system with an online sensor for a reaction product, such as the 
quantification platform described in Chapter 4. 
Activity studies of extremophiles at different temperatures may also be possible in the 
developed platform simply by changing the integrated Peltier elements. The electronic circuit 
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established can hence be changed in order to allow a fast switch between different 
thermoelectric modules to increase the applicability of the platform. 
  
Both platforms presented in Chapters 4 and 5 are simple to fabricate, using low cost and 
accessible materials, have a design and concept compatible with mass production and are re-
usable, which further lowers their overall cost. Their characteristics, together with the 
biocompatibility of the materials selected, wide application channel design and standardized 
connections make both platforms good additions to any modular microfluidic-based screening 
platform. 
 
Finally, even though it was not possible to accomplish it during these past three years, it 
would be exciting to connect the different modules discussed above and monitor the glucose 
oxidation with the GOx and catalase cascade reaction system, as initially intended. The 
application of the developed platforms to such a well-studied reaction system, would allow to 
validate their modular capabilities and ease of operation, as well as to identify possible 
operational issues. The validation of the different developed modules operating together would 
then enable its application to relevant case studies towards eventually establishing it as 
standard biocatalyst screening tool for laboratory facilities. 
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Summary of all the simulations performed in Chapter 2 
Table 1 – Summary of simulation performed assuming an enzyme diffusion coefficient of 6.7x10-10 m2s-1. 
Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen 
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
5xGOx+9
4 U/mL 
50 
250 0.002586 0.00000028 0.002199 0.000530 
0.002417212 
0.00515362 0.224474 
0.6895 
0.31147 0.294541 24.7623 
24.252 
24.67530 
250 0.002586 0.0000028 0.002199 0.000530 0.0262652 0.224474 0.726703 0.636911 24.7623 24.2601 
250 0.002586 2.8E-05 0.002199 0.000530 0.0444744 0.224474 1.09712 0.947414 24.7623 23.8897 
5xGOx+8
30 U/mL 
250 0.002586 0.00000028 0.00232907 0.000654703 
0.002182663 
0.00515363 0.225212 
0.777 
0.311647 0.294368 24.7616 
26.6155 
24.67510 
250 0.002586 0.0000028 0.00232907 0.000654703 0.0262653 0.225212 0.726765 0.636838 24.7616 24.26 
250 0.002586 2.8E-05 0.00232907 0.000654703 0.0445108 0.225212 1.09876 0.948593 24.7616 23.888 
500 0.002586 0.00000028 8.15E-05 6.86E-05   0.22527    24.7615   
                
10xGOx 
5 
1000 0 0.00000028 1.70E-05 1.69E-05 
0.000242486 
0.00195692 0.225236 
0.241 
0.321407 0.299731 2.27336 
4.245 
2.17719 
250 0 0.00000028 0.0147181 0.00190571 0.00419216 0.225747 0.317202 0.295881 2.27285 2.1814 
1000 0 0.0000028 1.70E-05 1.69E-05 0.0158762 0.225236 0.87839 0.750939 2.27336 1.62021 
250 0 0.0000028 0.0147181 0.00190571 0.0318055 0.225747 0.659268 0.584901 2.27285 1.83933 
5xGOx 
1000 0 0.00000028 3.68E-05 3.40E-05 
0.000307 
0.00293761 0.225467 
0.623 
0.319074 0.298218 2.2731 
4.202 
2.17949 
250 0 0.00000028 0.102187 0.0755216 0.00620117 0.153634 0.311331 0.290175 2.34505 2.18735 
1000 0 0.0000028 3.68E-05 3.40E-05 0.0218548 0.225467 0.776762 0.67478 2.2731 1.7218 
250 0 0.0000028 0.102187 0.0755216 0.0484365 0.153634 0.514591 0.469225 2.34505 1.98409 
1xGOx 
1000 0 0.00000028 0.125009 0.102487 
0.144863 
0.00719884 0.125878 
0.236 
0.305889 0.285745 2.37283 
6.111 
2.19282 
250 0 0.00000028 0.198304 0.19209 0.115585 0.0330976 0.136845 0.127197 2.46560 2.36185 
1000 0 0.0000028 0.125009 0.102487 0.0571119 0.125878 0.455071 0.419137 2.37283 2.04364 
250 0 0.0000028 0.198304 0.19209 0.149533 0.0330976 0.13842 0.12854 2.46560 2.36028 
                
5xGOx+9
4 
U/mL+0.2
5 mM 
H2O2 
50 
250 0.002586 0.00000028 0.017552 0.00712544 
0.044547623 
 0.206827 
1.1885 
  16.3729 
16.83 
 
250 0.02586 0.00000028 0.0177466 0.0073167  0.207395   16.3723  
250 0.2586 0.00000028 0.0196618 0.00920078  0.213091   16.3665  
250 2.586 0.00000028 0.0359201 0.02513  0.257232   16.3225  
250 2.586 0.00000028 0.0539291 0.0411364 0.00616504 0.235065 0.386954 0.2792 16.34470 16.19280 
250 2.586 0.0000028 0.0539291 0.0411364 0.0325052 0.235065 0.72934 0.572979 16.34470 15.8504 
250 2.586 2.8E-05 0.0539291 0.0411364 0.0539711 0.235065 0.964063 0.774477 16.34470 15.6157 
250 25.86 0.00000028 0.0816688 0.0630347  0.352193   16.2276  
250 25.86 0.00000028 0.109029 0.091745  0.297937   16.28180  
250 0.002586 0.00000028 0.0305797 0.01624 0.00616265 0.198319 0.298135 0.364499 16.38140 16.28160 
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen  
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
5xGOx+83
0 
U/mL+0.25 
mM H2O2 
50 
250 0.002586 0.00000028 0.0177466 0.00731667 
0.097672507 
 0.207426 
1.259 
  16.3723 
16.896 
 
250 0.02586 0.00000028 0.0196619 0.00920035  0.213151   16.3665  
250 0.2586 0.00000028 0.03592 0.0251271  0.257197   16.3225  
250 2.586 0.00000028 0.0816687 0.0630346  0.352193   16.2276  
250 2.586 0.00000028 0.0720164 0.05344 0.00616887 0.370598 0.542897 0.123515 16.20920 16.03690 
250 2.586 0.0000028 0.0720164 0.05344 0.0325512  0.870866 0.430325 16.20920 15.7089 
250 2.586 2.8E-05 0.0720164 0.05344 0.0540937  1.10544 0.630947 16.20920 15.4744 
250 25.86 0.00000028 0.0913324 0.0678447  0.376219   16.2036  
250 25.86 0.00000028 0.120446 0.0992354  0.313119   16.26670  
250 0.002586 0.00000028 0.0143212 0.0052831 0.00616263 0.209289 0.298431 0.363611 16.37050 16.2814 
5xGOx+94 
U/mL+830 
U/mL 
250 0.002586 0.00000028 0.0176895 0.00726546 
0.029340463 
 0.207075 
0.6445 
  16.3726 
16.1065 
 
250 0.02586 0.00000028 0.019103 0.00869773  0.209803   16.3699  
250 0.2586 0.00000028 0.0314163 0.0210636 0.0052114 0.231868 0.3414 0.243474 16.3478 16.23830 
250 0.2586 0.0000028 0.0314163 0.0210636 0.0273886 0.231868 0.741156 0.574505 16.3478 15.8385 
250 0.2586 2.8E-05 0.0314163 0.0210636 0.0467426 0.231868 1.06195 0.845477 16.3478 15.5177 
5xGOx+83
0 
U/mL+830 
U/mL 
250 0.002586 0.00000028 0.0178313 0.00740237  0.207542   16.3722  
250 0.02586 0.00000028 0.020451 0.00999427  0.21443   16.3652  
250 0.2586 0.00000028 0.0391728 0.0279015 0.00521236 0.260736 0.386154 0.19948 16.3189 16.19350 
250 0.2586 0.0000028 0.0391728 0.0279015 0.0273981 0.260736 0.77908 0.535414 16.3189 15.8006 
250 0.2586 2.8E-05 0.0391728 0.0279015 0.0468004 0.260736 1.09988 0.806264 16.3189 15.4798 
5xGOx+94 
U/mL+H2
O 
  0.00000028 0.0302236 0.0191952 
0.00203 
 0.248468 
0.5575 
  16.3313 
14.9535 
 
250 0.002586 0.00000028 0.0175462 0.00711969 0.0061626 0.20683 0.297559 0.28131 16.3729 16.28220 
250 0.002586 0.0000028 0.0175462 0.00711969 0.0324827 0.20683 0.651915 0.577096 16.3729 15.9278 
250 0.002586 2.8E-05 0.0175462 0.00711969 0.0539384 0.20683 0.894593 0.784894 16.3729 15.6851 
5xGOx+83
0 
U/mL+H2
O 
  0.00000028 0.0544072 0.0394311 
0.01114 
 0.32448 
0.779 
  16.25530 
16.586 
 
250 0.002586 0.00000028 0.0307588 0.0164246 0.00616267 0.19868 0.29883 0.2805 16.38110 16.2810 
250 0.002586 0.0000028 0.0307588 0.0164246 0.032483 0.19868 0.652285 0.575679 16.38110 15.9275 
250 0.002586 2.8E-05 0.0307588 0.0164246 0.0539963 0.19868 0.89525 0.783658 16.38110 15.6845 
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase  
(s-1) 
Doxygen  
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Sensor 
5 (sim) 
Outlet 
(sim) 
Sensor 
5 (exp) 
Outlet 
(tube) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
1xGOx+83
0U/mL 
50 
250 0.002586 0.00000028 0.123499 0.103842 
0.018839168 
 0.124091 
0.8075 
  24.8628 
23.9285 
 
500 0.002586 0.00000028 0.0550014 0.0343572  0.194235   24.7926  
1000 0.002586 0.00000028 0.0068 0.00226466 0.0058587 0.22412 0.311031 0.292265 24.7627 24.67580 
1000 0.002586 0.0000028 0.0068 0.00226466 0.0299016  0.691043 0.607828 24.7627 24.2958 
1000 0.002586 2.8E-05 0.0068 0.00226466 0.0497915  0.993768 0.863798 24.7627 23.9931 
0.5xGOx+8
30U/mL 
250 0.002586 0.00000028 0.170349 0.158484 
0.034514333 
 0.0678416 
0.594 
  24.9191 
21.2758918
9 
 
500 0.002586 0.00000028 0.123513 0.10386  0.124076   24.8628  
1000 0.002586 0.00000028 0.0550182 0.0343718 0.00914674 0.194226 0.304638 0.28605 24.7927 24.68230 
1000 0.002586 0.0000028 0.0550182 0.0343718 0.0455332  0.567002 0.509069 24.7927 24.4199 
1000 0.002586 2.8E-05 0.0550182 0.0343718 0.0700276  0.708898 0.632692 24.7927 24.278 
2000 0.002586 0.00000028 0.00680491 0.00226666  0.22413   24.7627  
                
1xGOx+83
0U/mL 
(3.083 s) 
10 
1000 0.002586 0.00000028 0.166405 0.154306 0.151596039 0.00441158 0.0741354 0.542094017 0.319164 0.915701 4.80295 3.99182906 4.55792 
1xGOx+83
0U/mL 
(4.625 s) 
250 0.002586 0.00000028 0.202167 0.197252 
0.123739242 
 0.0283068 
0.5055 
  4.9189 
4.125 
 
500 0.002586 0.00000028 0.180808 0.171247  0.0557999   4.89139  
1000 0.002586 0.00000028 0.139851 0.122078 0.00673907 0.107655 0.276018 0.25612 4.8395 4.67114 
1000 0.002586 0.0000028   0.0423075  0.393374 0.354443 4.8395 4.55378 
1000 0.002586 2.8E-05   0.0712063  0.430639 0.387505 4.8395 4.51652 
1000 0.258 mM 0.00000028 0.139851 0.122078 0.116221 0.107655 0.461336 0.415415 4.8395 4.485820 
1xGOx+83
0U/mL 
(6.17 s) 
1000 0.002586 0.00000028 0.113286 0.0902762 0.065687257 0.00439839 0.139854 0.554196581 0.320226 0.291006 4.840310 
3.42401709
4 
4.65994 
1xGOx+83
0U/mL 
(9.25 s) 
250 0.002586 0.00000028 0.17969 0.169183 
0.110886788 
 0.0568452 
0.689 
  4.94054 
4.626 
 
500 0.002586 0.00000028 0.137673 0.118163  0.109608   4.88779  
1000 0.002586 0.00000028 0.0644809 0.036992 0.00640897 0.192573 0.312374 0.291037 4.80481 4.68501 
1000 0.002586 0.0000028   0.0409734 0.192573 0.583367 0.523228 4.80481 4.41402 
1000 0.002586 2.8E-05 0.0644809 0.036992 0.0676724 0.192573 0.687105 0.617952 4.80481 4.31028 
1000 0.02586 0.00000028 0.0644809 0.036992 0.00640844 0.192573 0.313999 0.289341 4.80481 4.68338 
1000 0.2586 0.00000028 0.0644809 0.036992 0.00641387 0.192573 0.331242 0.27178 4.80481 4.66614 
1000 2.586 0.00000028 0.0644809 0.036992 0.00643514 0.192573 0.431203 0.16611 4.80481 4.56618 
1000 25.86 0.00000028 0.0644809 0.036992  0.192573   4.80481  
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase  
(s-1) 
Doxygen  
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Sensor 
5 (sim) 
Outlet 
(sim) 
Sensor 
5 (exp) 
Outlet 
(tube) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
1xGOx+83
0U/mL 
(18.5 s) 
10 
250 0.002586 0.00000028 0.135475 0.114933 
0.026724109 
 0.111688 
0.7965 
  4.88893 
4.50659459
5 
 
500 0.002586 0.00000028 0.060737 0.032526  0.195268   4.80539  
1000 0.002586 0.00000028 0.00195548 0.000322005 0.00769506 0.225648 0.3742 0.351152 4.77438 4.62583 
1000 0.002586 0.0000028 0.00195548 0.000322005 0.0440309 0.225648 0.876404 0.80383 4.77438 4.12362 
1000 0.002586 2.8E-05 0.00195548 0.000322005 0.0698596 0.225648 1.07163 0.989242 4.77438 3.9284 
200 1000 0.002586 0.0000028 0.000191937 0.000170382 0.001880697 0.0300138 0.225979 1.055 1.09354 0.9802 99.7747 97.42 98.9071 
1xGOx+83
0U/mL (37 
s) 
10 
250 0.002586 0.00000028 0.0594424 0.0307167 
0.000508363 
 0.196589 
0.759 
  4.80357 
3.86110810
8 
 
500 0.002586 0.00000028 0.00173098 0.000435421  0.227052   4.77289  
1000 0.002586 0.00000028 0.000168555 0.000167702 0.00935793 0.227888 0.49605 0.466228 4.77202 4.503860 
1000 0.002586 0.0000028 0.000168555 0.000167702 0.0484676 0.227888 1.40098 1.32291 4.77202 3.59893 
1000 0.002586 2.8E-05 0.000168555 0.000167702 0.0740795 0.227888 1.73353 1.65069 4.77202 3.26638 
1000 0.002586 0.258mM 0.000168555 0.000167702 0.124152 0.227888 2.001460 1.920720 4.77202 2.998440 
0.5xGOx+8
30U/mL 
(3.083 s) 
1000 0.002586 0.00000028 0.194691 0.188432 0.188467169 0.00924474 0.037854 0.542094017 0.302663 0.276023 4.8391500 
3.31761538
5 
4.57434 
0.5xGOx+8
30U/mL 
(4.625 s) 
250 0.002586 0.00000028 0.213033 0.21054 
0.098479688 
 0.0142486 
0.39027027 
  4.93297 
4.34791891
9 
 
500 0.002586 0.00000028 0.202167 0.197252  0.0283068   4.9189  
1000 0.002586 0.00000028 0.180814 0.171255 0.0500766 0.0557913 0.217697 0.199536 4.8914 4.72949 
1000 0.002586 0.0000028 0.180814 0.171255 0.0995402  0.236248 0.215034 4.8914 4.71094 
1000 0.002586 2.8E-05 0.180814 0.171255 0.121197  0.241652 0.219645 4.8914 4.70554 
1000 0.002586 0.258mM 0.180814 0.171255 0.171844  0.251127 0.227841 4.8914 4.696060 
2000 0.002586 0.00000028 0.139864 0.122093  0.107639   4.83952  
0.5xGOx+8
30U/mL 
(6.17 s) 
1000 0.002586 0.00000028 0.166433 0.153406 0.142687313 0.00785836 0.0740057 0.619752137 0.305976 0.279842 4.906260 
3.26214529
9 
4.67429 
0.5xGOx+8
30U/mL 
(9.25 s) 
250 0.002586 0.00000028 0.201595 0.196195 
0.122764202 
 0.0288472 
0.501702703 
  4.96854 
4.26318918
9 
 
500 0.002586 0.00000028 0.17969 0.169183  0.0568493   4.94054  
1000 0.002586 0.00000028 0.137687 0.118182 0.0115505 0.109613 0.294546 0.275839 4.88778 4.70285 
1000 0.002586 0.0000028 0.137687 0.118182 0.0692117  0.407869 0.37578 4.88778 4.58952 
1000 0.002586 2.8E-05 0.137687 0.118182 0.0986961  0.431654 0.397702 4.88778 4.56574 
2000 0.002586 0.00000028 0.0645017 0.0370114   0.19255    4.80483   
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase  
(s-1) 
Doxygen  
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Sensor 
5 (sim) 
Outlet 
(sim) 
Sensor 
5 (exp) 
Outlet 
(tube) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
0.5xGOx+8
30U/mL 
(18.5 s) 
10 
250 0.002586 0.00000028 0.178541 0.167447 
0.04522381 
 0.0579554 
0.642918919 
  4.94248 
4.50659459
5 
 
500 0.002586 0.00000028 0.135475 0.114932  0.111689   4.88892  
1000 0.002586 0.00000028 0.0607579 0.0325461 0.0118503 0.195248 0.361745 0.340965 4.80541 4.638910 
1000 0.002586 0.0000028 0.0607579 0.0325461 0.0674234  0.663199 0.620755 4.80541 4.33746 
1000 0.002586 2.8E-05 0.0607579 0.0325461 0.0966097  0.734479 0.690435 4.80541 4.26618 
200 1000 0.002586 0.0000028 0.00302871 0.00106401 0.003765649 0.0440333 0.225085 0.849351351 0.905624 0.824982 99.7757 
90.5478378
4 
99.0952 
10 
2000 0.002586 0.00000028 0.00195815 0.000322326 0.04522381  0.225656 0.642918919   4.7744 
4.50659459
5 
 
0.5xGOx+8
30U/mL 
(37 s) 
250 0.002586 0.00000028 0.134761 0.113687 
0.001961409 
 0.112622 
0.73227027 
  4.88752 
3.86110810
8 
 
500 0.002586 0.00000028 0.0594427 0.0307087  0.19677   4.80332  
1000 0.002586 0.00000028 0.00173208 0.000434823 0.0138348 0.227053 0.476935 0.452155 4.77291 4.523030 
1000 0.002586 0.0000028 0.00173208 0.000434823 0.0716926  1.05793 1.01258 4.77291 3.94203 
1000 0.002586 2.8E-05 0.00173208 0.000434823 0.100296  1.19305 1.14744 4.77291 3.80691 
1000 0.002586 0.258 mM 0.00173208 0.000434823 0.164194  1.321810 1.275770 4.77291 3.678150 
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Table 2 – Summary of simulation performed assuming an enzyme diffusion coefficient 4.95x10-11 m2s-1. 
Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen 
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
5xGOx+94 
U/mL 
50 
250 0.002586 0.0000028 0.004500 0.001562 0.00241721
2 
 0.224321 0.6895 
 
  24.7626 
24.252 
 
300 0.002586 0.0000028 0.002182 0.000647 0.0236714 0.224793 0.756334 0.658998 24.7621 24.2306 
5xGOx+83
0 U/mL 
250 0.002586 0.0000028 0.00463227 0.00168894 
0.00218266
3 
 0.225131 
0.777 
 
  24.7618 
26.6155 
 
300 0.002586 0.0000028 0.00228897 
0.00075068
2 
0.0236463 0.225667 0.757894 0.658319 24.7612 24.229 
                
10xGOx 
5 
1000 
0 
0.0000028 1.71E-05 1.69E-05 
0.00024248
6 
0.0158757 0.2256 
0.241 
0.878573 0.75078 2.27303 
2.37098 
1.62006 
800 0.0000028 2.28E-05 2.12E-05 0.0174969 0.225696 0.847286 0.727346 2.27294 1.65135 
300 0.0000028 7.87E-03 1.46E-03 0.0286608 0.226627 0.692374 0.609567 2.27204 1.80629 
250 0.0000028 0.0213497 0.00578261  0.223767   2.27491  
5xGOx 
1000 0.0000028 1.93E-04 4.18E-05 
0.000307 
0.0218578 0.226147 
0.623 
0.777396 0.674732 2.2725 
2.62881 
1.72125 
800 0.0000028 0.0010407 0.00013662 0.0244739 0.22657 0.740472 0.646673 2.27208 1.75818 
300 0.0000028 0.0845417 0.0561467 0.043213 0.175127 0.55879 0.503513 2.32356 1.9399 
250 0.0000028 0.105514 0.0797485 0.0484454 0.150798 0.514389 0.467745 2.34790 1.984310 
1xGOx 
1000 0.0000028 0.127604 0.105779 
0.144863 
0.0572454 0.123737 
0.236 
0.448572 0.417418 2.37497 
2.77336 
2.04427 
800 0.0000028 0.145954 0.127883 0.0720098 0.100671 0.389239 0.359482 2.39804 2.10947 
300 0.0000028 0.193949 0.186726 0.141238 0.0390863 0.164075 0.151945 2.45963 2.33464 
250 0.0000028 0.198897 0.192846  0.0326726   2.46604  
                
5xGOx+94 
U/mL+0.25 
mM H2O2 
50 
 
300 0.002586 0.0000028 0.0281441 0.0134121 
0.044547623 
0.0291318 0.200284 
1.1885 
0.682862 0.683173 16.3795 
16.83 
15.8969 
300 0.02586 0.0000028 0.0283588 0.0136368  0.20075   16.379  
300 0.2586 0.0000028 0.0304678 0.0158485  0.205267   16.3745  
250 2.586 0.0000028 0.0612789 0.046877 0.0324984 0.22267 0.709173 0.593863 16.35710 15.87060 
300 2.586 0.0000028 0.0481456 0.0345107 0.0291464 0.238977 0.747022 0.615632 16.34080 15.8328 
300 25.86 0.0000028 0.100148 0.0823456 0,0291743 0.309729 0,867044 0,484823 16.27000 15,7127 
5xGOx+83
0 /mL+0.25 
mM H2O2 
300 0.002586 0.0000028 0.0127715 0.00389953 
 
 
0.097672507 
 
 
0.0292902 0.209951 
1.259 
0.682934 0.674688 15.7812 
16.896 
15.3082 
300 0.02586 0.0000028 0.014215 0.0052563  0.216055   16.3637  
300 0.2586 0.0000028 0.0265273 0.0167552  0.263577   16.3162  
250 2.586 0.0000028 0.0806781 0.0619495  0.347709   16.23210  
300 2.586 0.0000028 0.0652629 0.0467368 0.0292062 0.376541 0.902097 0.458561 16.20320 15.6776 
300 25.86 0.0000028 0.0751761 0.0501244 0,0292135 0.408895 0,939785 0,418665 16.1709 15,64 
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen 
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
5xGOx+94 
U/mL+830 
U/mL 
50 
300 0.002586 0.0000028 0.0161246 0.00564555 
0.02934046 
 0.208044 
0.6445 
  16.3717 
16.1065 
 
300 0.02586 0.0000028 0.0178383 0.0072091  0.21153   16.2686  
250 0.2586 0.0000028 0.0403365 0.026896 0.0273881 0.226056 0.739576 0.574807 16.3537 15.84020 
300 0.2586 0.0000028 0.0319829 0.019979 0.0246496 0.234847 0.772379 0.596387 16.3449 15.8074 
300 2.586 0.0000028 0.0667084 0.0467522  0.297733   16.282  
300 25.86 0.0000028 0.0603778 0.0401005  0.343885   16.2359  
5xGOx+83
0 
U/mL+830 
U/mL 
300 0.002586 0.0000028 0.0162418 0.00575519 
- 
 0.208534 
- 
  16.3712 
- 
 
300 0.02586 0.0000028 0.0189374 0.0082311  0.215791   16.364  
250 0.2586 0.0000028 0.04722324 0.0332728  0.250999   16.3287  
300 0.2586 0.0000028 0.0374267 0.0248136 0.0246591 0.263936 0.812538 0.555565 16.3158 15.7672 
300 2.586 0.0000028 0.0560496 0.0377804  0.337725   16.242  
300 25.86 0.0000028 0.0553405 0.036642  0.353575   16.2262  
5xGOx+83
00 
U/mL+830 
U/mL 
300 0.002586 0.0000028 0,0174009 0,00685505 
- 
0,0273845 0,213343 
- 
0,708459 0,60744 16,3664 
- 
15,8713 
300 0.2586 0.0000028 0,0502698 0,0347214 0,0274211 0,332305 0,861518 0,449565 16,2474 15,7182 
5xGOx+83
000 
U/mL+830 
U/mL 
300 0.002586 0.0000028 0,026681 0,0155768 0,0273949 0,250115 0,757055 0,55729 16,3296 15,8227 
300 0.2586 0.0000028 0,0545465 0,0363486 0,0274379 0,352947 0,890457 0,417805 16,2268 15,6893 
5xGOx+94 
U/mL+H2
O 
250 0.002586 0.0000028 0.023049 0.00983621 
0.00203 
 
0.032484 0.203674 
0.5575 
0.651221 0.576887 16.3761 
14.9535 
15.92860 
300 0.002586 0.0000028 0.0159439 0.00548206 0.0291317 0.207743 0.682962 0.601424 16.3720 15.8968 
5xGOx+83
0 
U/mL+H2
O 
250 0.002586 0.0000028 0.0389812 0.0220088 
0.01114 
 0.192456 
0.779 
  16.38730 
16.586 
 
300 0.002586 0.0000028 0.0282959 0.0135665 0.0291561 0.200668 0.684142 0.600831 16.37910 15.8956 
                
1xGOx+83
0U/mL 
50 
250 0.002586 0.0000028 0.122971 0.104066 
0.018839168 
 0.124927 
0.8075 
  24.8621 
23.9285 
 
500 0.002586 0.0000028 0.0566694 0.0372226  0.192625   24.7944  
800 0.002586 0.0000028 0.0199434 0.00978666 0.0341833 0.218571 0.654692 0.578412 24.7684 24.3323 
1000 0.002586 0.0000028 0.010126 0.00427456 0.0299261 0.223228 0.692713 0.608249 24.7637 24.2942 
0.5xGOx+8
30U/mL 
250 0.002586 0.0000028 0.16973 0.158153 
0.034514333 
 0.0688226 
0.594 
  24.9181 
21.27589 
 
500 0.002586 0.0000028 0.122985 0.104082  0.124911   24.8621  
800 0.002586 0.0000028 0.0786935 0.0575224 0.0524642 0.172425 0.52298 0.471712 24.8146 24.464 
1000 0.002586 0.0000028 0.0566852 0.0372363 0.0455968 0.192612 0.568232 0.508978 24.7944 24.4188 
                
1xGOx+83
0U/mL 
(4.625 s) 
10 
1000 0.002586 0.0000028 0.135628 0.120323 
0.123739242 
0.0422708 0.112382 
0.5055 
0.397151 0.355216 4.83477 
4.125 
4.55 
800 0.002586 0.0000028 0.152378 0.139633 0.0539954 0.0915403 0.358973 0.322868 4.85561 4.58818 
1000 0.002586 2.8E-05   0.0710629  0.434502 0.0710629  4.51265 
1000 0.002586 0.258mM   0.116018  0.465327 0.416466  4.48183 
1000 0.002586 0.00000028   0.00668666  0.279051 0.256318  4.6681 
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen 
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
1xGOx+83
0U/mL 
(9.25 s) 10 
1000 0.002586 0.0000028 0.0678637 0.0416443 
0.110886788 
0.0410414 0.189395 
0.689 
0.58434 0.522747 4.80802 
4.626 
4.41307 
800 0.002586 0.0000028 0.0939903 0.0683461 0.0474617 0.162318 0.533174 0.481557 4.8351 4.46424 
1000 0.002586 0.00000028   0.00641165  0.313749 0.291094  4.68367 
1000 0.02586 0.00000028   0.00640998  0.314317 0.290503  4.6831 
1000 0.2586 0.00000028   0.00641526  0.31983 0.284815  4.67759 
1000 2.586 0.00000028   0.00642076  0.369469 0.232372  4.62795 
1000 25.86 0.00000028   0.00642071  0.430271 0.170503  4.56714 
1xGOx+83
0U/mL 
(18.5 s) 
1000 0.002586 0.0000028 0.00413121 0.00067439 
0.026724109 
0.0440915 0.225515 
0.7965 
0.877353 0.804566 4.77467 
4.506595 
4.12283 
800 0.002586 0.0000028 0.0145544 0.00328086 0.0503952 0.223363 0.810222 0.748203 4.77696 4.19010 
200 
1000 0.002586 0.0000028 0.000310214 0.000184037 
0.001880697 
0.030027 0.226084 
1.055 
1.09504 0.981439 99.7747 
97.42 
98.9057 
800 0.002586 0.0000028 0.000713418 0.000292282 0.0339027 0.225949 1.03598 0.932958 99.7749 98.9649 
3000 0.002586 0.0000028 5.62E-05 5.61E-05 0.0166885 0.226353 1.34743 1.18718 99.7744 98.6533 
1xGOx+83
0U/mL (37 
s) 
10 
1000 0.002586 0.00000028   
0.000508363 
0.00935974  
0.759 
0.49601 0.467076  
3.861108 
4.504000 
1000 0.002586 0.0000028 0.000169498 0.000167699 0.048538 0.228017 1.4044 1.32623 4.77199 3.59561 
800 0.002586 0.0000028 0.00022917 0.000210349 0.0547717 0.227811 1.29133 1.22478 4.7722 3.70868 
1000 0.002586 2.8E-05   0.0740795  1.73362 1.65079  3.26639 
1000 0.002586 0.258mM   0.124149  2.001350 1.921910  2.998660 
0.5xGOx+8
30U/mL 
(4.625 s) 
10 
1000 0.002586 0.0000028 0.178463 0.170113 
0.098479688 
0.099315 0.0585338 
0.39027027 
0.238789 0.21597 4.88864 
4.347919 
4.70838 
800 0.002586 0.0000028 0.187378 0.180608  0.0471474   4.90003  
1200 0.002586 0.0000028 0.169658 0.15978 0.0830889 0.0697316 0.278539 0.251676 4.87743 4.66862 
1000 0.002586 0.00000028   0.049558  0.219959 0.200271  4.72721 
1000 0.002586 2.8E-05   0.120905  0.244201 0.220587  4.77030 
1000 0.002586 0.258mM   0.17155  0.2537 0.228839  4.69347 
0.5xGOx+8
30U/mL 
(9.25 s) 
1000 0.002586 0.0000028 0.139065 0.120117 
0.122764202 
0.0696285 0.108703 
0.501702703 
0.408266 0.375346 4.88872 
4.263189 
4.58916 
800 0.002586 0.0000028 0.155236 0.139528  0.0884519   4.90897  
1200 0.002586 0.0000028 0.123413 0.101648 0.0588398 0.127917 0.458765 0.419329 4.86951 4.53866 
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Name 
[glucose 
in] (mM) 
kcat 
(s-1) 
kcatalase (s-1) 
Doxygen 
(cm2 s-1) 
[Oxygen] (mM) [Gluconic acid] (mM) 
[H2O2] 
(mM) 
[Glucose] (mM) 
Sensor 5 
(sim) 
Outlet 
(sim) 
Sensor 5 
(exp) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
Outlet 
(tube) 
Outlet 
(sim) 
Outlet 
(exp) 
Outlet 
(tube) 
0.5xGOx+8
30U/mL 
(18.5 s) 
10 
1000 0.002586 0.0000028 0.0651115 0.0365112 
0.04522381 
0.0675538 0.191463 
0.642918919 
0.662413 0.619873 4.80895 
4.506595 
4.338 
800 0.002586 0.0000028 0.0917885 0.06388  0.163925   4.83649  
1200 0.002586 0.0000028 0.0428222 0.0179671 0.0602235 0.20969 0.721808 0.672119 4.79072 4.2786 
200 
1000 0.002586 0.0000028 0.00469412 0.00166786 
0.003765649 
0.0440701 0.224644 
0.849351351 
0.90679 0.825898 99.7763 
90.54784 
99.0942 
800 0.002586 0.0000028 0.0101777 0.00415662  0.222311   99.7787  
1200 0.002586 0.0000028 0.00231592 0.000782312 0.0397884 0.225471 0.957224 0.867905 99.7754 99.0436 
3000 0.002586 0.0000028 0.000121258 0.000112717 0.0241981 0.226217 1.19621 1.0641 99.7746 98.8046 
0.5xGOx+8
30U/mL 
(37 s) 
10 
1000 0.002586 0.00000028   
0.001961409 
0.013842  
0.73227027 
0.476844 0.453028  
3.861108 
4.523190 
1000 0.002586 0.0000028 0.00251765 0.000513647 0.0718141 0.227061 1.0587 1.0138 4.77297 3.94134 
800 0.002586 0.0000028 0.0112583 0.00210561  0.225353   4.77474  
1200 0.002586 0.0000028 0.000697572 0.000300875 0.0645182 0.227454 1.1481 1.09523 4.77256 3.85192 
1000 0.002586 2.8E-05   0.100296  1.19309 1.147752  3.80694 
1000 0.002586 0.258 mM   0.164191  1.321700 1.277060  3.678330 
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Test of assembled silicon meander channel and polymeric valve chip 
The assembly of the silicon meander channel and the polymeric valve chip was also 
evaluated by continuously introducing glucose, while alternatively introducing pulses of 
Gluzyme (0.2 g L-1) or water. All the solutions were introduced at 0.05 µL s-1 (images 1. 2 and 3), 
0.2 µL s-1 (images 4 and 5) and 0.4 µL s-1 (images 7. 8 and 9). Tests with food coloring dye 
performed only with the valve chip allowed to precisely time when the pulse of Gluzyme solution 
was introduced in the silicon meander, and are used in the figures below to illustrate the 
different points in the experiment. The images are numerated according to the order in which 
the corresponding moment in the graph presented occurs. The same schematics as presented in 
Chapter 2, section 2.3.2.1 were used.  
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CFD physics reports (Chapter 2) 
Table 3 – Domain Physics for meander channel for the simulation 1xGOx+830 U/mL at 9.95 s. 
Domain - Meander 
Type Fluid 
Location 
INLET_ASSEMBLY INLET_BLOCKS, PIPE_ASSEMBLY PIPE_BLOCKS, 
PIPE_ASSEMBLY PIPE_BLOCKS 2, PIPE_ASSEMBLY PIPE_BLOCKS 3, 
PIPE_ASSEMBLY PIPE_BLOCKS 4, PIPE_ASSEMBLY PIPE_BLOCKS 5, 
PIPE_ASSEMBLY PIPE_BLOCKS 6 
Materials 
Water 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Settings 
Buoyancy Model Non Buoyant 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Additional Variable Catalase 
Kinematic Diffusivity 4.9500e-11 [m^2 s^-1] 
Option Transport Equation 
Additional Variable GOx 
Kinematic Diffusivity 4.9500e-11 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Gluconolactone 
Kinematic Diffusivity 6.7000e-10 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Glucose 
Kinematic Diffusivity 6.7000e-10 [m^2 s^-1] 
Option Transport Equation 
Additional Variable H2O2 
Kinematic Diffusivity 2.1000e-09 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Oxygen 
Kinematic Diffusivity 2.1000e-09 [m^2 s^-1] 
Option Transport Equation 
Turbulence Model Laminar 
Domain Interface - Domain Interface 1 
Boundary List1 Domain Interface 1 Side 1 
Boundary List2 Domain Interface 1 Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection Automatic 
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Domain Interface - Domain Interface 2 
Boundary List1 Domain Interface 2 Side 1 
Boundary List2 Domain Interface 2 Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection Automatic 
Domain Interface - Domain Interface 3 
Boundary List1 Domain Interface 3 Side 1 
Boundary List2 Domain Interface 3 Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection Automatic 
Domain Interface - Domain Interface 4 
Boundary List1 Domain Interface 4 Side 1 
Boundary List2 Domain Interface 4 Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection Automatic 
Domain Interface - Domain Interface 5 
Boundary List1 Domain Interface 5 Side 1 
Boundary List2 Domain Interface 5 Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection Automatic 
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Table 4 – Boundary physics for meander channel for the simulation 1xGOx+830 U/mL at 9.95 s. 
Domain Boundaries 
Meander 
Boundary - Inlet GOx 
Type INLET 
Location INLET_ASSEMBLY INLET1 
Settings 
Additional Variable Catalase 
Additional Variable Value 2.8530e-03 [m^-3 mol] 
Option Value 
Additional Variable GOx 
Additional Variable Value 6.0470e-04 [m^-3 mol] 
Option Value 
Additional Variable Gluconolactone 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Glucose 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable H2O2 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Oxygen 
Additional Variable Value 1.9000e-01 [m^-3 mol] 
Option Value 
Flow Regime Subsonic 
Mass And Momentum Normal Speed 
Normal Speed 2.5000e-02 [m s^-1] 
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Boundary - Inlet Glucose 
Type INLET 
Location INLET_ASSEMBLY INLET2 
Settings 
Additional Variable Catalase 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable GOx 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Gluconolactone 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Glucose 
Additional Variable Value 1.0000e+01 [m^-3 mol] 
Option Value 
Additional Variable H2O2 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Oxygen 
Additional Variable Value 2.5800e-01 [m^-3 mol] 
Option Value 
Flow Regime Subsonic 
Mass And Momentum Normal Speed 
Normal Speed 2.5000e-02 [m s^-1] 
Boundary - Domain Interface 1 Side 1 
Type INTERFACE 
Location INLET_PIPE_CONNECTOR 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
 
  
Micro scale reactor system development with integrated advanced sensor technology  
202 
 
 
Boundary - Domain Interface 1 Side 2 
Type INTERFACE 
Location PIPE_ASSEMBLY PIPE_OUTLET 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Domain Interface 2 Side 1 
Type INTERFACE 
Location INLET_PIPE_CONNECTOR 2 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
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Boundary - Domain Interface 2 Side 2 
Type INTERFACE 
Location PIPE_ASSEMBLY PIPE_OUTLET 2 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Domain Interface 3 Side 1 
Type INTERFACE 
Location INLET_PIPE_CONNECTOR 4 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
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Boundary - Domain Interface 3 Side 2 
Type INTERFACE 
Location PIPE_ASSEMBLY PIPE_OUTLET 3 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Domain Interface 4 Side 1 
Type INTERFACE 
Location INLET_PIPE_CONNECTOR 3 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
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Boundary - Domain Interface 4 Side 2 
Type INTERFACE 
Location PIPE_ASSEMBLY PIPE_OUTLET 5 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Domain Interface 5 Side 1 
Type INTERFACE 
Location INLET_PIPE_CONNECTOR 5 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
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Boundary - Domain Interface 5 Side 2 
Type INTERFACE 
Location PIPE_ASSEMBLY PIPE_OUTLET 4 
Settings 
Additional Variable Catalase 
Option Conservative Interface Flux 
Additional Variable GOx 
Option Conservative Interface Flux 
Additional Variable Gluconolactone 
Option Conservative Interface Flux 
Additional Variable Glucose 
Option Conservative Interface Flux 
Additional Variable H2O2 
Option Conservative Interface Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Outlet 
Type OPENING 
Location PIPE_ASSEMBLY PIPE_OUTLET 6 
Settings 
Additional Variable Catalase 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable GOx 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Gluconolactone 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Glucose 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable H2O2 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Oxygen 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Flow Direction Normal to Boundary Condition 
Flow Regime Subsonic 
Mass And Momentum Opening Pressure and Direction 
Relative Pressure 0.0000e+00 [bar] 
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Boundary - Meander Default 
Type WALL 
Location 
INLET_ASSEMBLY WALL, PIPE_ASSEMBLY MEANDERWALL, 
PIPE_ASSEMBLY MEANDERWALL 2, PIPE_ASSEMBLY 
MEANDERWALL 3, PIPE_ASSEMBLY MEANDERWALL 4, 
PIPE_ASSEMBLY MEANDERWALL 5, PIPE_ASSEMBLY 
MEANDERWALL 6, PIPE_ASSEMBLY SENSOR, PIPE_ASSEMBLY 
SENSOR 2, PIPE_ASSEMBLY SENSOR 3, PIPE_ASSEMBLY 
SENSOR 4, PIPE_ASSEMBLY SENSOR 5, PIPE_ASSEMBLY 
SENSOR 6, PIPE_ASSEMBLY SIDEINLET, PIPE_ASSEMBLY 
SIDEINLET 2, PIPE_ASSEMBLY SIDEINLET 3, PIPE_ASSEMBLY 
SIDEINLET 4, PIPE_ASSEMBLY SIDEINLET 5, PIPE_ASSEMBLY 
SIDEINLET 6 
Settings 
Additional Variable Catalase 
Option Zero Flux 
Additional Variable GOx 
Option Zero Flux 
Additional Variable Gluconolactone 
Option Zero Flux 
Additional Variable Glucose 
Option Zero Flux 
Additional Variable H2O2 
Option Zero Flux 
Additional Variable Oxygen 
Option Zero Flux 
Mass And Momentum No Slip Wall 
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Table 5 – Domain physics for the tube for the simulation 1xGOx+830 U/mL at 9.95 s. 
Domain - Fluid 
Type Fluid 
Location LIQUID 
Materials 
Air at 25 C 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Settings 
Buoyancy Model Non Buoyant 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Additional Variable Catalase 
Kinematic Diffusivity 4.9500e-11 [m^2 s^-1] 
Option Diffusive Transport Equation 
Additional Variable GOx 
Kinematic Diffusivity 4.9500e-11 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Gluconolactone 
Kinematic Diffusivity 6.7000e-10 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Glucose 
Kinematic Diffusivity 6.7000e-10 [m^2 s^-1] 
Option Transport Equation 
Additional Variable H2O2 
Kinematic Diffusivity 2.1000e-09 [m^2 s^-1] 
Option Transport Equation 
Additional Variable Oxygen 
Kinematic Diffusivity 2.1000e-09 [m^2 s^-1] 
Option Transport Equation 
Heat Transfer Model Isothermal 
Fluid Temperature 2.5000e+01 [C] 
Turbulence Model Laminar 
Domain - Tube 
Type Solid 
Location SOLID 
Settings 
Domain Motion Stationary 
Domain Interface - Domain Interface 1 
Boundary List1 Default Fluid Solid Interface Side 2 
Boundary List2 Default Fluid Solid Interface Side 1 
Interface Type Fluid Solid 
Settings 
Interface Models General Connection 
Mesh Connection GGI 
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Table 6 – Boundary physics for the tube for the simulation 1xGOx+830 U/mL at 9.95 s. 
Domain Boundaries 
Fluid 
Boundary - Inlet 
Type INLET 
Location INLET 2 
Settings 
Additional Variable Catalase 
Additional Variable Value 2.8530e-03 [m^-3 mol] 
Option Value 
Additional Variable GOx 
Additional Variable Value 6.0500e-04 [m^-3 mol] 
Option Value 
Additional Variable Gluconolactone 
Additional Variable Value 1.8940e-01 [m^-3 mol] 
Option Value 
Additional Variable Glucose 
Additional Variable Value 4.8080e+00 [m^-3 mol] 
Option Value 
Additional Variable H2O2 
Additional Variable Value 1.8178e-01 [m^-3 mol] 
Option Value 
Additional Variable Oxygen 
Additional Variable Value 4.1644e-02 [m^-3 mol] 
Option Value 
Flow Regime Subsonic 
Mass And Momentum Normal Speed 
Normal Speed 5.0000e-03 [m s^-1] 
Boundary - Default Fluid Solid Interface Side 1 
Type INTERFACE 
Location INNERTUBE_2 
Settings 
Additional Variable Catalase 
Option Zero Flux 
Additional Variable GOx 
Option Zero Flux 
Additional Variable Gluconolactone 
Option Zero Flux 
Additional Variable Glucose 
Option Zero Flux 
Additional Variable H2O2 
Option Zero Flux 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Mass And Momentum No Slip Wall 
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Boundary - Outlet 
Type OPENING 
Location OUTLET 2 
Settings 
Additional Variable Catalase 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable GOx 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Gluconolactone 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Glucose 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable H2O2 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Additional Variable Oxygen 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Flow Direction Normal to Boundary Condition 
Flow Regime Subsonic 
Mass And Momentum Opening Pressure and Direction 
Relative Pressure 0.0000e+00 [Pa] 
Tube 
Boundary - Default Fluid Solid Interface Side 2 
Type INTERFACE 
Location INNERTUBE_1 
Settings 
Additional Variable Oxygen 
Option Conservative Interface Flux 
Boundary - Toptube 
Type WALL 
Location TOPTUBE 
Settings 
Additional Variable Oxygen 
Additional Variable Value 8.6000e+00 [m^-3 mol] 
Option Value 
 
  
Micro scale reactor system development with integrated advanced sensor technology  
211 
 
 
Boundary - bottom 
Type WALL 
Location BOTTOMTUBE 
Settings 
Additional Variable Oxygen 
Additional Variable Value 0.0000e+00 [m^-3 mol] 
Option Value 
Boundary - wall out 
Type WALL 
Location OUTWALL 2 
Settings 
Additional Variable Oxygen 
Additional Variable Value 8.6000e+00 [m^-3 mol] 
Option Value 
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CFD physics reports (Chapter 4) 
Table 7 – Domain Physics for meander channel for the slanted grooves geometry (1:1 dilution). 
Domain - Fluid 
Type Fluid 
Location SOLID 
Materials 
Water 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Settings 
Buoyancy Model Non Buoyant 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Additional Variable tracer 
Kinematic Diffusivity 1.0000e-10 [m^2 s^-1] 
Option Transport Equation 
Turbulence Model Laminar 
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Table 8 – Boundary Physics for meander channel for the slanted grooves geometry (1:1 dilution). 
Domain Boundaries 
Fluid 
Boundary - inlet1 
Type INLET 
Location INLET1 
Settings 
Additional Variable tracer 
Additional Variable Value 1.0000e+00 [kg m^-3] 
Option Value 
Flow Regime Subsonic 
Mass And Momentum Normal Speed 
Normal Speed 1.0000e-03 [m s^-1] 
Boundary - inlet2 
Type INLET 
Location INLET2 
Settings 
Additional Variable tracer 
Additional Variable Value 0.0000e+00 [kg m^-3] 
Option Value 
Flow Regime Subsonic 
Mass And Momentum Normal Speed 
Normal Speed 1.0000e-03 [m s^-1] 
Boundary - outlet 
Type OPENING 
Location OUTLET 
Settings 
Additional Variable tracer 
Additional Variable Value 0.0000e+00 [kg m^-3] 
Option Value 
Flow Direction Normal to Boundary Condition 
Flow Regime Subsonic 
Mass And Momentum Opening Pressure and Direction 
Relative Pressure 0.0000e+00 [Pa] 
Boundary - wall 
Type WALL 
Location WALLS 
Settings 
Additional Variable tracer 
Option Zero Flux 
Mass And Momentum No Slip Wall 
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CFD physics reports (Chapter 5) 
Table 9 – Domain Physics for glass vial geometry at 353 K. 
Domain - air 
Type Fluid 
Location AIR 
Materials 
Air Ideal Gas 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Water 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Settings 
Buoyancy Model Buoyant 
Buoyancy Reference Density 1.2250e+03 [kg m^-3] 
Gravity X Component 0.0000e+00 [m s^-2] 
Gravity Y Component -9.8100e+00 [m s^-2] 
Gravity Z Component 0.0000e+00 [m s^-2] 
Buoyancy Reference Location Automatic 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Heat Transfer Model Thermal Energy 
Homogeneous Model On 
Turbulence Model Laminar 
Domain - fluid 
Type Fluid 
Location WATER 
Materials 
Air Ideal Gas 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Water 
Fluid Definition Material Library 
Morphology Continuous Fluid 
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Settings 
Buoyancy Model Buoyant 
Buoyancy Reference Density 1.2250e+03 [kg m^-3] 
Gravity X Component 0.0000e+00 [m s^-2] 
Gravity Y Component -9.8100e+00 [m s^-2] 
Gravity Z Component 0.0000e+00 [m s^-2] 
Buoyancy Reference Location Automatic 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Heat Transfer Model Thermal Energy 
Homogeneous Model On 
Turbulence Model Laminar 
Domain - glass 
Type Solid 
Location GLASS 
Settings 
Domain Motion Stationary 
Domain Interface - Default Fluid Fluid Interface 
Boundary List1 Default Fluid Fluid Interface Side 1 
Boundary List2 Default Fluid Fluid Interface Side 2 
Interface Type Fluid Fluid 
Settings 
Interface Models General Connection 
Mass And Momentum Conservative Interface Flux 
Mesh Connection GGI 
Domain Interface - Default Fluid Solid Interface 
Boundary List1 Default Fluid Solid Interface in air Side 1,Default Fluid Solid Interface in fluid Side 1 
Boundary List2 Default Fluid Solid Interface in glass Side 2 
Interface Type Fluid Solid 
Settings 
Interface Models General Connection 
Heat Transfer Conservative Interface Flux 
Mesh Connection GGI 
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Table 10 – Boundary Physics for glass vial geometry at 353 K. 
Domain Boundaries 
air 
Boundary - Default Fluid Fluid Interface Side 1 
Type INTERFACE 
Location WATER_2 
Settings 
Heat Transfer Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
Boundary - Default Fluid Solid Interface in air Side 1 
Type INTERFACE 
Location Primitive 2D C 
Settings 
Heat Transfer Conservative Interface Flux 
Mass And Momentum No Slip Wall 
Boundary - top 
Type OPENING 
Location TOP 
Settings 
Flow Direction Normal to Boundary Condition 
Flow Regime Subsonic 
Heat Transfer Opening Temperature 
Opening Temperature 2.5000e+01 [C] 
Mass And Momentum Opening Pressure and Direction 
Relative Pressure 0.0000e+00 [Pa] 
Fluid gas 
Volume Fraction Value 
Volume Fraction 1.0000e+00 
Fluid water 
Volume Fraction Value 
Volume Fraction 0.0000e+00 
Boundary - sym1_air 
Type SYMMETRY 
Location SYM1 
Settings 
Boundary - sym2_air 
Type SYMMETRY 
Location SYM2 
fluid 
Settings 
Boundary - Default Fluid Fluid Interface Side 2 
Type INTERFACE 
Location WATER_1 
Settings 
Heat Transfer Conservative Interface Flux 
Mass And Momentum Conservative Interface Flux 
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Boundary - Default Fluid Solid Interface in fluid Side 1 
Type INTERFACE 
Location Primitive 2D A 
Settings 
Heat Transfer Conservative Interface Flux 
Mass And Momentum No Slip Wall 
Boundary - sym1_water 
Type SYMMETRY 
Location SYM1_WATER 
Settings 
Boundary - sym2_water 
Type SYMMETRY 
Location SYM2_WATER 
Settings 
glass 
Boundary - Default Fluid Solid Interface in glass Side 2 
Type INTERFACE 
Location Primitive 2D, Primitive 2D B 
Settings 
Heat Transfer Conservative Interface Flux 
Boundary - sym1_glass 
Type SYMMETRY 
Location SYM1_GLASS 
Settings 
Boundary - sym2_glass 
Type SYMMETRY 
Location SYM2_GLASS 
Settings 
Boundary - top_wall_glass 
Type WALL 
Location TOP_WALL 
Settings 
Heat Transfer Fixed Temperature 
Fixed Temperature 2.5000e+01 [C] 
Boundary - wall 
Type WALL 
Location WALL 
Settings 
Heat Transfer Fixed Temperature 
Fixed Temperature 8.0000e+01 [C] 
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Table 11 – Domain Physics for meander channel for the thermal inactivation platform at 0.0087 m s-1 inlet flow. 
Domain - fluid 
Type Fluid 
Location FLUID 
Materials 
Water 
Fluid Definition Material Library 
Morphology Continuous Fluid 
Settings 
Buoyancy Model Non Buoyant 
Domain Motion Stationary 
Reference Pressure 1.0000e+00 [atm] 
Heat Transfer Model Thermal Energy 
Turbulence Model Laminar 
Domain - pmma 
Type Solid 
Location PMMA 
Settings 
Domain Motion Stationary 
Domain Interface - Default Fluid Solid Interface 
Boundary List1 Default Fluid Solid Interface Side 1 
Boundary List2 Default Fluid Solid Interface Side 2 
Interface Type Fluid Solid 
Settings 
Interface Models General Connection 
Heat Transfer Conservative Interface Flux 
Mesh Connection GGI 
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Table 12 – Boundary Physics for meander channel for the thermal inactivation platform at 0.0087 m s-1 inlet flow. 
Domain Boundaries 
fluid 
Boundary - inlet 
Type INLET 
Location INLET 
Settings 
Flow Regime Subsonic 
Heat Transfer Static Temperature 
Static Temperature 2.5000e+01 [C] 
Mass And Momentum Normal Speed 
Normal Speed 8.7000e-03 [m s^-1] 
Boundary - Default Fluid Solid Interface Side 1 
Type INTERFACE 
Location TOP_CHANNEL_1 
Settings 
Heat Transfer Conservative Interface Flux 
Mass And Momentum No Slip Wall 
Boundary - outlet 
Type OPENING 
Location OUTLET 
Settings 
Flow Direction Normal to Boundary Condition 
Flow Regime Subsonic 
Heat Transfer Opening Temperature 
Opening Temperature 2.5000e+01 [C] 
Mass And Momentum Opening Pressure and Direction 
Relative Pressure 0.0000e+00 [Pa] 
Boundary - sym1_fluid 
Type SYMMETRY 
Location SYM1 
Settings 
Boundary - sym2_fluid 
Type SYMMETRY 
Location SYM2 
Settings 
Boundary - heating 
Type WALL 
Location METAL 
Settings 
Heat Transfer Fixed Temperature 
Fixed Temperature 8.0000e+01 [C] 
Mass And Momentum No Slip Wall 
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pmma 
 
Boundary - Default Fluid Solid Interface Side 2 
Type INTERFACE 
Location TOP_CHANNEL_2 
Settings 
Heat Transfer Conservative Interface Flux 
Boundary - sym1_pmma 
Type SYMMETRY 
Location SYM1_PMMA 
Settings 
Boundary - sym2_pmma 
Type SYMMETRY 
Location SYM2_PMMA 
Settings 
Boundary - endings 
Type WALL 
Location END 
Settings 
Heat Transfer Adiabatic 
Boundary - envrionment 
Type WALL 
Location ENVIRONMENT 
Settings 
Heat Transfer Fixed Temperature 
Fixed Temperature 2.5000e+01 [C] 
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